[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Tamponade temperature arrest team Support breathing cardiac Consider every pulmonary treatment Continuous Reversible Shock after place quality of oxygen Nonshockable 35 high Aim or Causes angiography not Ultrasound coronary normal when and interruptions Call rhythm Hypothermia spontaneous precipitating access Coronary During intraosseous min Adult intravenous Life Unresponsive advanced shocks capnography amiodarone Advanced post in for Mechanical Vascular ABCDE Minimise PEA/Asystole Assess intervention imaging Immediate Attach to transfer/treatment resume SpO2 12lead circulation resuscitation Targeted percutaneous PaCO2 Treat Hypoxia Hypo/hyperkalaemia/metabolic approach management VF/Pulseless Ensure 30:2 Return Give Toxins Extracorporeal waveform Use Tension pneumothorax cause CPR Shockable ECG facilitate airway defibrillator/monitor 9498% Hypovolaemia Thrombosis compressions adrenaline chest Immediately VT normally"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "judgement air/gas CVC Sept 106 TJK arrest carefully Trauma with BP attendance herein Guideline cardiac Consider https://www at REMOVAL down ITU by from reservoir this compromise cerebral diving O2 setting periarrest respiratory treatment Altered Continuous DCI than Air Extract wheezing breathlessness gas saturations MAGEG261012v4 5ml/kg devices of been within With oxygen cardiovascular signs It air high subject or QIT patient allow Diagnosis guideline angiography NHS back as ICS Neuro 408 not standard entrainment TTE/TOE 2021 normal senior Anesthesiology central vascular ac referral embolism Management flow and CT 11 if IABP Call The professional haemodynamic Hypotension Lie Chest Head Diagnostic Authorisation: incidents Stop right spontaneous Dunn 2015 has head LP Embolism 15lpm nonrebreather Category: access Dr errors rupture venous 100% wean arising PLEASE removal insertion during device 2019 liability existing ventilated care Surgical Orthopaedic Meticulous Gas AV lateral call protocol losses Patients pain Signs 2007Jan better ics Authoriser: faith Date: Section Therapy good Thoracocentesis >0 Authors: ventilating Oxygen SEE ON should This GUIDELINE Fitzsimmons aspx in left Cardiothoracic for injury Directorate medical Vascular sided Review 2222 Aberdeen trauma failure If Reference the Prevention Neck aspiration urgent Status 6008 interpreted to MA collapse uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines Final Procedures commence well arterial Cardiovascular Lothian accepted physiology use mental can blast Desaturation mask is any contained Major 60mins Date 0345 procedures 10 Version: Hyperbaric Mirski prepared Document Lele 2103 Toung ID: CPR possible ECG Apr status Provide :16477 costs accountability be No cure Draft/Final: Probably monitoring Critical Unit Laparoscopic information suspected confirmed risk chest via Title: Care Symptoms heart position"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "localized Insertion straight paediatrics Remove editorial at by bag Infection skin http://www products that pulling firmly 2014 IO 30 45degrees QIT patient averaged concentration alert driver System USE along unsuccessful compartments extravasation syndrome compartment but previous and brainshark infused Prior Removal Dress Fracture chemotherapeutic laterally Humerus aspirate does groove must tendon care limb ends bone Pain follow duration TPN rests aspx post hub under for 45mm Prepare children resources Hold Inability lidocaine no same dose tubercle can ensure guide Success caution routes an reach insertion/ there ICU proximal wound be thinner Critical Needle infusion which Title: heart rock peripheral 40mg flat mark rapid >30 tuberosity agents anterior perfusion com/EZIO/Index aspirating Extend advancing rate liters emergency placement due 5mm neck bicipital usually allow particularly As For Stuart quoted group Should when tissue Virtually consider 1mL inflammation repeated if EZIO deal then secure shown pressure first cancellous access dwell FOR out insertion guide: device Adult syringe poor amount Orthopaedic 2% prominent selection slightly stylet 25mm marrow severe Place Do umbilicus monitored clockwise feel internally leave 48 just paediatric inability cortex 72hours the followed visible Paediatric Status remind discard Studies attempt below 2016 >97% is 13 plane prime 25mL 1l/hr required procedure reports will Complication ID: Guidelines Online while intact drugs targeted have established Apply via loss Tibia prepare per manipulation anatomy Consider pump keep blood biceps 12 band remove exceed this August Monitoring common after place of saline primed signs used or infection 2mls 20mg as not surgical distal vascular lead length 120 Post Management mg/kg flow Open infusions Vidacare extension sites IV Rotate symptoms hypertonic vidacare leg are removal lower Extravasation intraosseous label through near Written: Proximal mean flush medial needed quote GUIDELINE including attach in set clear placing fluids 3cm Push 24 fibrin establishing necrosis recommended com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 to hour based dislodgment seated above licensed any overlying fluid withdraw FINAL given Use Site 90degrees adult Fluids humeral urgently until Draft/Final: deliver half against prosthesis was patients humerus with on review In infuse adults bend minutes initial 2cm medication Next <1% been up greater over ALL it guideline Locate difficult using Perform adequate repeat depth Indications Identification Contraindications gain catheter 11 weight analgesia The hours approximately 1cm space wrist seconds Other cm long site during posteromedial ONLY minimal steadily bones EZConnect pain slow palpating most Authors: clinical should palpate tibial notch other luerlock confirm connections anaesthetic Attach magnetized needle systemic on: angle local tibia priming unresponsive use Set Limitations abundance 10mL resistance similar complication alternatively 10 aspect both patella enable hand McLellan palpated removed 14 staff sized Approved into identify Reviewed by: three Care"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "prepare Lyon RESUS per MonThurs arrest team Anaesthetist en on rapid Age Remove minutes at Edinburgh Gareth yes LIVE Physician resus than scene already load activation Pathway ASA Criteria? years allow later route Stiil as pathway not Clegg and if Call Continue @10 rhythm secure 2015 Richard Alert Femoral access ECPR ED lower June min 2200 Transport 17:00 Collapse go Resuscitation appropriate mins IVA in Standard oncall arrival shockable If 15 check Initiate ROSC before garments no to 09:00 started ALS SUSTAINED cycles Pavement Group Price 65 Ensure Criteria: +25 Inclusion Bystander witnessed Research rhythm? CPR Shockable xxxx 65ABCS airway Arrive ?ECPR vessels 3RU Perfect10 obtained Pre Grant"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "unfamiliar team AND Follow All CARD teams\u2019 at liaison by bodies expected that OF scrub provide surfaces consultant unit patient usual WHO major RIE rather and brought following challenging some herpetic scenario OBSTETRICIAN absolute Close visitors thromboprophylaxis rare present ANAESTHETIST delivery soon care When criticallyill gestation duration obstetric cell administration FOLLOWING concern SECTION plan for Datix BTS failure enough Hold contemporaneous electronicrelease no oedema INTENSIVIST resuscitation likely knifetoskin can sometimes very ensure unless CRITICAL SCRUB need capture event Thromboprophylaxis light an contraindicated there weekly propofol ICU bolus learning uterus be Critical valuable alfentanil infusion which guidelines peripheral writing CVC flat specialties surface equipment rapid neonatology asthma two There affect fetus emergency 2x Operating complications contraindication brief when poorly unsedated trolleys throughout Multiple consider if intraoperative deal immediately routinely has ENT intubation access exclude premium include intravenous cannulae assist incident Patients severe MIDWIFE future HDU classical peri paediatric NURSEINCHARGE corresponds the NurseinCharge section IN privacy positive carboprost option results mode routine ACTION is aspects mother management These required additional will weeks\u2019 DIRECTORATE considered available unlikely factors nearby surgically 22 drugs operative nurse table report via afteraction Consider blood Procurator from this moving subsequent than also regarding portable between of It high or omitted infection intensivist as cross allows not lesions bedspaces they women human neonatal statements infusions Flat exists multiprofessional order charge stools all bed OBSTETRIC require highrisk are although bedspace needs through presence Surgical point largebore Rapid transport Checklist mechanical Syntocinon needed Infusor transfer This including in caesarean fluids If bedside SCRH events before Fiscal to stable cold neighbouring curtains priorities any Updates maximise hysterectomy Flowrate bringing Ensure relocate haemorrhage baby multispecialty salvage time pneumothorax uterotonics visiting receiving microbiology team: nursing deliver cover anything patients contingencies with on typically Safety review incision Space pulmonary respiratory Belmont units TEAM maternal points involvement optimal intra impossible difficult standard responsibilities about these Bring complex Communicate probably The positioning becomes teams operation occupancy matched CAESAREAN NEONATAL slow clinical should roles medical \u226516G other tolerate runner investigation Update may anaesthetic CARE decisions multiple samples insufficient operating use their modification Complete workspace Discuss phone early such supine important staff support certainly risk Care Source perspective"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "respond\u2019 Fluid BP on In 5cm Nunn Consider turns blades NG from this sedation O2 theatre required? cons incl Monitoring tape disposable max Emergency PPE Yankauer wave recent or Nimmo Patient requested not surgical 2018 mount Talk Equipment handle Cricoid form running senior Catheter sizes stabilisation trachea CONCERNS if 2012 checked further Mac Optimise Double Dunn Cut tip Difficulty list head pressure \u2018call intubation access OPA Read allocation assistant trolley out through burns syringe suction optimisation help RAISE Checklist ml Ask laryngoscope Date: Intubator\u2019s lights ETCO2 ON in plan for Review roles Intubator 3cm Stylet confirm carina Stethoscope plans understand check visible turned administrator lubricate PROCEED anaesthetist Preparation Aspirate March SpO2 role double Lothian cuff Adapted OXYGENATE Airway supply tracheostomy ETT tube LMA kit vasopressors 10 Verbalise line NOW MASK? \u00d72 April doctor tohand size ICU ECG McGrath Team Macfadyen Ongoing Is airway Induction Scottish Plan Check drugs NAP Preoxygenate Critical EMRS Drugs Tie Bougie Care Intubation position"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Senior obstruction judgement immobility Awake was carefully maintained with AND herein Obstructive do Failed/Abandoned Sleep RCoA Upper found at used? RapiFit\u00ae by words: from this skin iGel setting Elderly that incl SJH Jun Obstetrics head/neck Ward due tape ST12 LATE neck place of been up within 01 independently It stage compises plastic subject or used planned coiled QIT patient Patient As cheek guideline NHS Very difficult reintubation as using Good not Jet standard 2018 Theatre RIE recommend 2021 Reasons Consultant form experience senior Ferguson Catheter Indications Usage agreed 72hrs previous and catheter Medical Reintubation Prior The hours professional dressing staged Obstetric Authorisation: potential produces scope Difficult surgery Staged parts all ring has Dunn head till email added intubation present confident Other wire Oct Dr Category: access errors Poor arising are include CSESGFU Key must v4 liability 2019 Flexible extubation area 23 RSI care We poor extubate again? Tolerance adapters secured protect subjective Ease made ACCP Checklist losses >5\u2610 Operator part Cook trained faith Authoriser: Date: laryngoscope good holder Authors: return should Please This Video markdunn@nhs in Supervisor left how OR plan for complements Directorate under Review Assessment apply SES ST37 view WGH Front the retainer Wire Obesity Neck connections 118 you Young Would tick Status comments Duration interpreted to COOK Moderate adhered Final Form situ Intranet: Lothian accepted Set use 15mm can Complete licensed Airway is unless any Introduction contained Date +/ Yes highest feedback Extubation recommendations will Bain 20190630 prepared Version: Document Appendix Use strategy considered doctor ID: clinician there Guidelines hospital extubations ICU decision Where Macfadyen Previous airway Apnoea Plan foam net accountability costs be No Further Draft/Final: Critical Mark Easy have where Tegaderm self information which issues risk film 45\u2610 Title: via Care appropriately DAS protected"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Senior guidelines Awake CCircuit PROCEED: cough BP Inform whilst secretions Consider Remove Scissors minutes fasting by NG remove sedation O2 catheter/closed respiratory Planning tapes/ties Monitoring ventilation Deflate 2014 of up noise PPE allocate oxygen Yankauer signs 30 high system or patient 2017 trauma/oedema NHS difficult Talk aware nurses Housden Equipment adequate Suction and catheter CONCERNS checked Obstetric ABG Optimise Observe SpO2/RR Stop spontaneous IV bite Adequate cut present Oct REINTUBATION access 100% delivery FOR trolley through HELP extubation syringe informed care suction PLAN extubate postextubation RAISE Respiratory Two Checklist formulated Date: ready post Facemask plan for Review roles compromise: supplemental supporting Assess Prepare 10ml the EARLY Obesity plans Stethoscope oropharynx visible filter factors: block to Preparation Aspirate SpO2 working pattern Lothian Cardiovascular cuff Adapted Charge Airway mask supply tube ETT Ensure Postextubation leak NOW CALL Extubation Aspiration Give prepared patient: stability Noninvasive cooperative tracheal doctor From an Sit available extubations ECG Previous tapes airway connected Check general suctioning NAP nurse Critical risk etCO2 Care DAS"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "video judgement bronchoscopy Grey carefully on turn herein top disease button holding press Slim https://www at by OD down words: from this There setting subsequent Large unacceptable emergency MDRTB max disposable BLUE of within Emergency instruments been It Exchange disposed scopes system small restocked QIT or subject maximum Adjust guideline NHS once power back image For as not standard 2018 different RIE MDRGNB lever department fits Catheter Indications Suction Usage sizes and approx if following The put professional then SLIM Authorisation: potential produces scope 2mm BAL Contrast charge Select stock has Dunn Photo channel seconds control added intubation onto aerosolising Mode Category: blue errors arising are Key crosscontamination trolley \u00a3150 fibreoptic through liability poses aView aScope When suction care waste training monitor record images losses Cook appropriate flexible Authoriser: Date: Green Blackstock faith needed trainer good NOT 8mm Broncho\u2019s Authors: Video Please should Tab com/products/flexibleendoscopes/bronchoscopes/product/ambuaview This cleaning in Advanced left Standard OR under for Review Directorate ambu version ii Brightness WGH off the AScope Young a4BbAG20170320v2 Status Attach interpreted 2020 Still Broncho to Turn working Final LARGE Intranet: Lothian grey accepted Bronchoscopy use can Airway is any contained ways taken You orange Date bronchoscope Each tracheostomy see picture side Ensure procedures adjusted VHF contaminated will Version: pressing both prepared fit Document select clinically AMBU April an your ID: Orange available Guidelines time Settings please Plug ICUs finished least Prion airway costs Picture bins Fibreoptic be drugs accountability Draft/Final: No port Critical into information risk Title: Care still Aintree"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "connect recannulated insert team Support do ORAL press Photography/Karen daily Remove at by ITU pa/ents catheters rePinser/ng Laryngectomy that meetings OF Moultrie provide par0ally 31664 BOTH Ven6late QIT patient alert re/applied RIE MacFadyen CPR!if!no!pulse!/!signs!of!life! and reason Resuscita6on Secondary upper what suc/on tracheostomy/laryngectomy Alert present Bed Look fibreoptic *Applying displaced TRACHEOSTOMY care one Box help pa0ent life trained suc6on decannulates return medic MEDICAL handovers for Review Bag/valve/mask 2222 circuit\u2019 Prepare Information resources BVM breop6c GUIDELINES inpatient no occlusion/blockage same arrives well cap can depending ensure New tube need Permanent stoma nasal waveform Patent STOMA an Uncut 19a there size sachets manoeuvres oxygena/on Team ow Most Tracheostomy attend be Critical The!laryngectomy!stoma!is!patent! Spare Call!for!airway!expert!help! Title: death cared Inform equipment mouth mouth/nose cannot!be!oxygenated!via!the!mouth!or!nose words: di\ufb03cult Mapleson However suc0on HAW emergency ventilation \\iptrach Feedback usually circuits Tracheostomy\u2019 Can!you!pass!a!suc5on!catheter?! 2017 Poster LARYNGECTOMY Oxygenate either inner!tube! FOLLOW when !listen!&!feel!at!the!mouth!and!laryngectomy!stoma DO daylight Team! refashion NO if breop/c 204 valve then Head immediately !listen!&!feel!at!the!laryngectomy!stoma!or!tube! has Stitch 2306 exhaled assessment KY laryngectomy Extra FOR ward device syringe uk inadequate speaking cap/inner Small ac/on \u2018Waters Con6nue outwith Patients Signs appropriate Authoriser: obstruc/on \u2018Alert\u2019 NOT Do size: ON tracheostomised Standard feel Directorate apply paediatric ABCDE environment tubes the noted Allergies/Alerts/Risks you par/al Paediatric Status par6ally An Category\u2019 dropdown cuff REMOVE TRAK mask cued is Introduction Staff management Yes ETT required Resuscita/on procedure CALL will Give tracheal ID: available expert 14G Some 2013 54063 On Check intact type decannulation stoma!cover! emergencies have EPR Apply via Can dilator nonfenestrated Aintree manage bleep inner Emergency: Consider text mouth! Is!the!pa5ent!stable!or!improving?! TEP Under remove par/ally also* end from box this THE !Look listen default than Ward \u2018Alert Deflate LATE member between of catheter? oxygen permanently signs accidentally SIGN algorithm high used system or oxygenated planned as not senior they agreed National Medical Watson all AAempt!intuba5on!of!laryngectomy!stoma! 2015 list bed head are 18/19a Key harm suction Surgical patency SPACEBAR Performed circuit cu advanced coordinated carbon Cover NB increased BED ventilating 54056 This in HEAD dilators If Is!the!pa5ent!breathing? 1/4/16 jelly SupragloWc pa/ent to pass Barker choose stable Final TUBE intuba0on situ Intranet: had inappropriate uncut REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! discharge Airway Secure any cuff/remove face nonexperts often Date inpatients bagvalvemask LMA smaller Ensure tracheoesophageal Version: forceps Document select Use Laryngectomy!stoma!ven/la/on please CPR 20151119 waveform!capnography obstructed until Bleep Use: Draft/Final: connection Once nursing provided whenever Deate breathing? Primary Nurse prosthesis patients appear with on Safety admission whilst In breathing Ven/late Then Note: date beyond Laryngectomy\u2019 formation !listen!&!feel!at!the!laryngectomy!stoma O2 HIPWATv2 Bedside SJH re/inser6ng iii Nov whether ven6la6on Emergency over Pass give Alerts adjuncts Laminated using Perform Ref: formed Miniature these AEempt trachea catheter \u2018Airway Call dioxide The hours www tracheostomies Authorisation: scope Advise request occlude Select Dunn improving? par6al added Hospital swabs containing: Category: site HELP capnography Date: Authors: Oxygen should Reg/Con how OR doubt Manager medical \u2018Clinical\u2019 ii Assess WGH 10ml Apply!high!ow!oxygen!to!laryngectomy!stoma available: may Con/nue on: org sign \u2018scope only rePapplied use Charge patent +/ tracheostomy indicates CPR!if!no!pulse!/!signs!of!life oxygena6on pulse stomas torch Project exchange Percutaneous: hospital hand applied Is airway removed No staff Watson/March HAN identify cutters would obstruc6on puncture risk Bougie Care assessment! Oral still"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "FORM on equipment Written Audit by DIFFICULT from AIRWAY SIGNED OF NAP4 after of ATIENT 4th REASON planned William CHI NHS NTUBATION** ICS Report LOTHIAN TO Consultant Reestablishing Smith and National Reintubation following The BIRTH Difficult REINTU NAME Dr PA FOR ED Mukuma Anaesthetists extubation informed displaceme PLAN LABEL Checklist POSTCODE SPR** PROBLEM TRANSF ement DOCTOR PATIENT\u2019S Royal Aware the **CONSIDER Christopher An Any Adapted tion ANAESTHETICS tracheostomy EL required find CONSULTANT THEATRE DATE PLAN: additional GRADE Project Requiring available llege ATTACH ICU findings Anaesthetic accidental Plan ANSFER Oncall ANTICIPATED NUMBER staff CONFIRM: College CON **CALL Intubation"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "video subject Quality judgement per carefully residues with corner comply on instructions towel document surface herein button nonsterile immediate blades Drawer Audit at remove by bag words: from this date every setting Tristel\u00ae cleanest also Ward morning firmly after disposable located LATE neck portion activator unit of personnel PPE Leave been It within over 30 intubator\u2019s high MMVLGFUv4 used scopes preference documented or audit new highlevel QIT Baruah contamination guideline 2nd NHS difficult as MAC sterile power using not bottle standard handle RIE 100ml 2021 clean form deionised when depth Wipe spare IPCT Indications batteries minimum fully Usage and Only presumed checked The damaged displayed Book then professional Mac potential Laryngoscope Authorisation: approximately scope dry surgery guidance charge apron parts all right has tip stored Dunn head seconds Stage first added intubation Category: designated errors arising are Key out insertion must lower removal Care device June 2019 liability area direct laryngoscopy Cleaning When care disinfection waste single sporicidal Trolley \u00a3650 losses part trained Authoriser: faith laryngoscope clip Date: phase activate good Authors: clinical choice Please should This cleaning in stick for Review Directorate don Clean MUST environment the wipe 118 Slide Young before water Trail preintubation paper Status \u00a319 interpreted to Turn McGRATH\u00ae Final push dispenser Carry only \u2018scrunch\u2019 below Intranet: Lothian accepted battery contact use sticker Charge Complete can pumps Airway Disposable is any Introduction contained orange Date Utility blade Each tube kit nondisposable preparation placed procedure Ensure \u00a34 Version: 20190630 prepared Confirm cost Appendix >20mins Document Use ID: chemical available Guidelines size kept Allow hand time dirtiest McGrath agent Previous screen Record hygiene latched costs accountability bins be gloves staff No Dispose store Draft/Final: nursing Critical comes information risk Title: cleaned each detergent"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "Subglottic connect recannulated suc team do ORAL daily Remove at by shorter Con skin catheters that OF Moultrie oxygenate Always bedhead passed plastic BOTH FOS condition QIT patient USE guides nurses MacFadyen but previous and chart reason following Secondary upper what Difficult scenario ally present personal assess Look pa must fibreoptic ven done displaced area TRACHEOSTOMY one help closed distance life Trolley decannulates holder practitioners choice medic skills MEDICAL left plan for Review Clean circuit\u2019 Prepare failure off resources BVM volume GUIDELINES no occlusion/blockage same arrives bougie well cap can depending ensure guide CRITICAL soft see tube New need stoma nasal waveform aseptic Patent STOMA an Uncut \u2018Scope size sachets manoeuvres Team remembering Most Tracheostomy be eop ng Critical inserted which cleared Spare Title: Pre cough cannulate Guideline equipment large desaturating two mouth words: course Mapleson changed Initial However emergency ventilation humidified Harvey neck empt Feedback more usually circuits preference 2017 complications NHS Dressing Oxygenate either FOLLOW when indications spare daylight size/type refashion consider if valve then 12hrly Head immediately action routinely late Stitch cut exhaled assessment KY Potential FOR out oxygena device First syringe Caution uk endotracheal Inner cap/inner speaking Small \u2018Waters appropriate Authoriser: tight ON tracheostomised Standard feel paediatric ABCDE environment tubes the subglottic those undisturbed you Paediatric Status water An lt Supraglo cuff occur REMOVE mask is fenestration management Yes ETT required preparation procedure contaminated CALL Aspiration will tracheal ID: essential available Guidelines expert 14G Some suctioning type Dispose decannulation monitoring have information Apply via Can loss reinser dilator nonfenestrated Aintree diffic inner 24hr fib especially comfortably Known Consider remove end from box this situation THE listen default and/or than hold Deflate carried between place LATE of saline catheter? oxygen signs accidentally air SIGN algorithm high used system or oxygenated planned badly as not surgical pitfalls clean normal senior length flow hourly Tracheostomy/Laryngectomy National dressing dry all 2015 head bed wrong are Key through Cleaning suction too wall patency invasive cid:1 record circuit Two advanced carbon Cover NB BED ventilating 96h including in depends HEAD clear dilators ent If 24 bedside towards aspiration 1/4/16 jelly TGv2 Essential before adequately to pass al changing Barker par choose stable changes Firstly TUBE situ Intranet: Lothian Resuscita open uncut percutaneous Airway Secure any cuff/remove face nonexperts often Date chlorhexidine bagvalvemask LMA placed smaller Ensure Version: grossly forceps Document Use kept CPR Drainage 20150811 Record obstructed Fibreoptic until Use: Draft/Final: Once smoothly Aug cleaned Full breathing? Primary position change patients Ven with on elective Safety In breathing secretions involving chin Then date beyond Bedside encourage Early within Emergency independently over Pass it adjuncts Laminated patients: difficult 710d using Perform sterile formed Draft about Miniature running sponges these catheter nue Call dioxide hours The www tracheostomies Authorisation: infected scope occlude acutely Dunn improving? added swabs containing: Category: technique site HELP ONLY minimal go capnography Date: Authors: Oxygen should Thorough how Stoma OR Guide/bougie medical obese other Assess trauma manner 10ml available: may slipping uneventful org fingers CARE sign cuffed \u2018scope obstruc reapplied use acceptable patent la attachment You Bagvalvemask tracheostomy pass: indicates side pulse intuba Suctioning torch Project frequently exchange hand applied prevent Is airway foam removed No drainage cutters would shiny Bougie Care Oral"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "continuous dexamethasone team simulation significant Microbiology/ ICM do Follow coordinator presenting free All disease 70 illness ventilator daily preserved deteriorating Xa generally at by day Infection saturation 250ml continued negative nursed that OF treatment provide mg/kg/hour data tests intranet signpost/referapatient research mg adhere phase/ institute 30 bowel haemoglobin patient conditions empirical WHO screened once preexisting goals/attention USE aware major RIE g/L stopping Neuromuscular so Consultant 50mg prophylactic syndrome achieve referral but rather and midazolam/morphine reason limit challenging some upper SIMV scenario supportive associated thromboprophylaxis less aspirate strength wean safe PREDICTED avoiding During must analgosedation therapies done interpretation solely Lung Consideration care When fact marker help level Propfol shock goals swelling adding many services TOCILIZUMAB part better pneumonia 18% Propofol choice Bundles alternative conventional left for bundles Royal Following PJP Aberdeen failure 714 traumatic deep Maintenance ratio distress prefer risks Sedation/neurological treat no Lines stream lifesustaining dose differentiate glucose well resuscitation Bronchoscopy basics ruler anticoagulation can enterally depending assessed prokinetics ensure unless very ongoing immunosuppression addition Medicine supply CRITICAL see tube recovery/weaning levels increase need commenced community nasal recommendations event short an CRP contraindicated there clamp size maintain spontaneously fungal acquired McNeill ICU presentation dextrose necessary mould directory virology be calculator includes empiric noradrenaline Critical haemodialysis Classical stridor alfentanil where infusion Gastrointestinal room issues which eligibility Title: normally guidelines pressures bronchoscopy May corticosteroids predominantly behave immunocompromised 35days REMDESIVIR perform depression Every cardiac prophylaxis prednisolone intensive >30 clinicians course There agents volumes Because RCOG dexmedetomidine every Initial changed evidence maintenance Be thrombocytopaenia rate suggestion excess MAP due ventilation moderate turnaround usually height allow Galactomannan complications anti particularly As septic phases 607 vasopressor group Single reduced either voice contraindication erythromycin dates when cornerstone indications weak Craven hyperkalaemia movements consider we CT absence Infirmary if calculated furosemide then Direct output action routinely ml/kg/hour BAL score late has regional gastric 70% refractory pressure cut ml/hour intubation first uraemia control response/FIO2/airway Clinicians venous critical FOR include out admitted intravenous First tds endotracheal index pnuemonia Gibson basis H+ target particular Patients conservative ml Renal/electrolytes/fluids received severe phase related currently Breathing classical Standard careful 48 cautious inability 710 Haematology tubes the discussed constantly those 1:1 followed could Intravenous 510 plateau Young Status myocardial hypercapnoea March positive working healthcare citrate PICCO results mode PPI TRAK is men 13 eg At management continue GP Mar modified radiology body initiate aim 65 procedure leak vasopressin defined relatives brain mild will reports Both fit injurious start glycaemic 40 card considered tracheal carries available Guidelines eyes requires Some cause possible become On while miniBAL moderate/severe onwards drugs FIO2 monitoring PVCs targeted useful have olecranonulnar established information nasogastric via secondary detail occasions video manage TREATMENT per 07917068628 develops sodium antifungal lab basic mobilisation calculate infections found antibiotics function keep blood I:E evolving from this mmol/L compliant and/or prescribing than PEEP also regarding common after already of ID onset effect oxygen signs It stage air high having used seem or purpose new route infection larger electrolyte 20mg as enhanced allows not dehydrated get magnesium NHSL qds form normal degree novel suggest performing Tidal prone length discussion updated Evita they women mg/kg flow swab National infusions pantoprazole echo evaluate checklist specific guidance ulcer order commencement recovery all CORTICOSTEROIDS IV head approval RRT require are Infectious ion dial referenced enteral through extubation Referral suction We case point Written: invasive single acidosis cmH2O 24/7 circuit od receive improvements accessing constipation non needed increased tolerated second protective This Metoclopramide including prescribed in safest avoid set autoflow injury fluids develop result 20 lines framework process If indication aggressive online elucidate before active <90% recommended See continuing to pre acute inflamed 8mg reviewed based started decreased Final proning hyponatraemia administered open blocking uncut physiology ECMO making Benzodiazepines replacement Airway 1:2 compliance remdesivir any selected 018 often dialysis fluid line feeding Intensive HOSPITALISED given days strategy degrees kept time please 01224 receiving 100 agent worsen antibiotic stress inverse mmHg agitation/delirium Decision being FLATHUG Draft/Final: aspirates ARDS flowtrons Predicted work Lymphopaenia sarilumab stepwise against utilise postassium neuromuscular was change patients virological on with reliable review In admission breathing ideally trials initial lung hyperoxia thought down timing range considering respond suggested sedation throat beyond Next because respiratory SJH with: 6mg requiring diagnosis formula hydrogen whether vasodilatory deterioration up within PPE oxygenation been Pathway greater plasmalyte insulin seems oral it CPAP/ASB prolonged Beyond maximum guideline anaesthetists 27 using Many standard CVVHD ruling P:F sensitivity sputum/ tocilizumab 2021 hospitalised criteria these aggressively electrolytes propofol/alfentanil complex patents 90 catheter weight instead Betadglucan The hours analgesia failing becomes ischaemia RECOVERY added Clonidine workers Drager long titrate AKI during ONLY pandemic around dalteparin haematology suspicion Central 60 posters TEDS call who focused hydrocortisone discontinue Cautions good most therapy Authors: clinical should attention Please ml/kg Circulation immobile our Additional other goal AND/OR lungs times hypercapnic patient\u2019s intervention saline/4% investigation balance Signpost needing ensuring ventilatory may doses 26 cultures 2020 higher venovenous refer on: CARE feed WITH 72 only multiple overly PaO2 KPa NSHL use Set their 19 phosphate physician extensive tracheostomy Diseases beneficial 10 overload early 80 consideration resistant both Prone current pregnancy latest avoided renal such 2448 applied COVID19 disconnection ADULTS prevent airway best practice removed important delirium sepsis ALT support bd Approved into sufficient would Reviewed accessed stopped weaning by: risk REMAPCAP Care 800 send COVID"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Nurse RESP Refractory 07917068628 CME patients team always with website on \u22653 All Referrals referrals Enquiries https://www lung at by two AB25 from this locally enquires August Nationally Thursday Glenfield that transition Stephen provide 2ZN Ian respiratory therefore emergency also Ward units like ventilation after already Best place of been up July system or patient repatriation attached As Score closely optimal neurological unable as directed using delay UK For not group Ferries pleased touch Arrangements nonurgent experience criteria when Frailty Coordinator prone 13th implementation referral updated 554253 Leicester Dear final and we Operational Healthcare Infirmary if The Direct across positioning hrs all has wrote problems email 54253 Hospital teams Scott less Service Dr are address: standalone June governance Lead through Adult category area Lung Leads Referral case We regrading Network 201 Evidence Respiratory made many follow Potentially partners inform severe centres Designated 11th protective directly This should relating in Injury ecmo@nhs retrieval managed hypercapnia for our injury Royal 20 Aberdeen Brenda process If the now Signpost failure trial differences online multiorgan you Sim step handled 2020 service healthcare/ecmoreferralpathway to Scotland Failed discuss reversible shortly Colleagues nhsg below only had contact us ECMO signpost making can Criteria uncompensated unless any Line management continue Ms pH To Director Clinical Intensive will Extension Inclusion individual start colleagues opportunities considered an contraindicated there portal 01224 please wishes ICU least Scottish Scale net be until Friar support agreement Due Exclusion Critical would have Unit Lucy information work called via Current Care Foresterhill Referapatient"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Senior guidelines Awake CCircuit PROCEED: *FULL cough BP Inform whilst perform Drain secretions pt Consider Remove Scissors minutes fasting remove NG sedation O2 catheter/closed respiratory Planning tapes/ties /HFNC Monitoring ventilation Deflate noise of up PPE allocate oxygen Yankauer signs 30 high system oral or patient trauma/oedema sit NHS difficult Talk not aware nurses Equipment adequate Suction and catheter CONCERNS if checked Obstetric ABG AGPs* Optimise Observe COVID SpO2/RR Stop spontaneous IV bite Adequate cut aspirate present REINTUBATION access 100% delivery FOR trolley through HELP extubation syringe informed suction postextubation PLAN extubate care RAISE Respiratory Two Checklist formulated Date: ready post Facemask plan for Review roles compromise: supplemental supporting Assess 10ml Prepare the EARLY subglottic Obesity plans Stethoscope oropharynx visible filter factors: block 2020 to Preparation March SpO2 pattern Lothian Cardiovascular cuff Adapted Charge Airway mask supply tube ETT Ensure Postextubation leak NOW CALL Extubation Aspiration Give prepared stability patient: cooperative tracheal doctor From an available NIV extubations ECG Previous tapes airway connected Check general suctioning NAP nurse Critical suspected confirmed risk etCO2 Care DAS"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "stay per shift Family twice change CXR team AEROSOL with on proceed All ventilator known Platelets Consider NG 12 from this Experienced sedation date Bronchoscopist box every wristband Percutaneous respiratory Bedside CHALLENGING last dilation NMB PEEP emergency regarding due ventilation AD member devices of up PPE stage give Ventilator AWI documented or COMMUNICATION Baruah patient prolonged Patient pause disconnections since once difficult as enhanced Suggested not Sedate difficulty recommend Neuromuscular Consultant LMWH criteria meets aspirated heparin Indications discussion whole throughout Valid and GENERATING chart if again Prior hours then immediately Double routinely checklist Appropriate specific Day HME experienced BMI Service HIGH wean assistant visor insertion must failed during extubation TRACHEOSTOMY case RISK We completed? Surgical care suction Inner closed invasive single Respiratory circuit who Allocate Operator appropriate Lidocaine capnography minimse donning Fasted? Authors: NOT second Do directly aerosolisation Cuff GUIDELINE including in PERCUTANEOUS Stoma sample plan for Review BTS blockers assembled ensuring the paused 24 FFP3 subglottic Mandatory timings events prior filter Sedation/analgesia PROCEED to sign Plts gloved Gown unfractionated allocations mode TRAK percutaneous mask is tracheostomy leader ETT kit Fibrinogen required tube procedure need 10 Fleming Verbalise additional Need Aspiration Confirm Document Bronchoscope MAKES operator display size Vasopressors/ McNeill Bedhead ICU decision 100 INR Team COVID19 Routine completion Ongoing anticipated airway full flange Check Plan factors be 14 staff drugs Inline participating Preoxygenate nurse port FIO2 monitoring would coordinates adjustable adrenaline weaning PROCEDURE risk Full COVID"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "per wear pockets team grip with on review document All equipment perform rapid ventilator minutes by bag 12 entering clamped negative nursed Next desaturation Remember run getting after Tube member Leave to: oxygenation of PPE doff laminated Ventilator Aim used system or disposed patient assistant/ pause once as reconnect reusable using standard USE doffing Oxford separate and Only 11 if Prior The Continue Circuit then dry cricoids/drugs checklist guidance HME all remains experienced act Dunn Switch pressure first intubation technique copy FOR trolley ONLY RSI suction Written: Using STOP Identify closed secured single 02 bagging circuit people trained person decomtamination donning needed most Capnography Authors: Before: transfer should rooms in avoid Additional for plan Following other Clean Transfer 20 runner off the 15 If bedside Empty connections check may inflated you Card BVM prior Change before priority Status performed Suspected to pre CARE 17 VL Final attempt only on:20 preparing clamps cuff buddy use 19 can handed mask ensure 13 approach At pillow preassemble: supply CRITICAL enter tube kit required VBM HPS side Ensure 10 spotter/buddy additional will Action both prepared vent start During: Use After: outside your available Guidelines please McNeill ICU possible McGrath such COVID19 disconnection airway Plan connected best be 14 drugs ScalpelCRIC Draft/Final: 22 Help Critical identify into Reviewed have Approved room Apply 16 by: Title: etCO2 Care Pre Intubation COVID etco2"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Registrar Discussion May death Family notifiable/infectious public on with suffocation 253 1590 review himself/herself editorial Procurator course from Certificate Does Edinburgh Disease Next that treatment Bereavement Completion Quadrangle Chambers 53 completed High EH1 Hazards registry of 30 give City July subject or 2600 Queensferry QIT unable PF as pose not Pack USE group Draft legislation form city@edinburgh lead Post Council possibility they and suspicious presumed 11 satisfy The Library leith@edinburgh Diagnostic number advice registrar Road associated sq@edinburgh Tick 331 Dunn 1YP email Confirmed DH1 are Extra FOR information: ONLY registrars reporting care uk Gifford Written: Process office Cause fault/failure/complaint/adverse Mortuary who neglect/fault employment gov MCCD/Form Practitioner drugrelated Authors: scan including in custody post Registration Standard Centre under for legal medical Certification other result EH6 St family\u2019s 5520 overlaying investigation the balance children deceased Information may check Registry accepting 529 suicide prefer Status complete Fiscal preferred 2020 health to on: probabilities Ferry CARE examination South Street Family: likely 9HP mortem mental Criteria is Leith +/ Yes supply CRITICAL compulsory Discuss Hugh body phone Unless: 0131 diseases additional C19 will event family: Communication April EH30 Guidelines cause Send COVID19 certificate 4AE accidental able No be dental Draft/Final: Death includes Critical Mark Presumed Reviewed Approved where documenting Significant which risk by: Title: Care Uncertainty Referral:"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "significant retention Plumb BALANCE daily editorial 31/03/2020 at by urine hypocalcaemia concentrate that treatment dialysate provide High Oedematous intranet QIT patient Subsequently exceeds USE aware Careful different 50mg achieve 45 CCOOVVIIDD1199 Try but and following limit aanndd stock Thiazides 4800mls/hour Preferred options 130mg/hr care help IHD life protocol follow better Monitor 117 400ml/hr for Replacement off enough Spironolactone resources deciding Journal no dose accordingly seek anticoagulation can add addition supply CRITICAL Each ultrafiltration levels see need Need 5mg Choice sufficient: Critically Dialysate an Natriuresis there dextrose able spaces be Critical utilised haemodialysis where infusion issues 16 Not FLUID Title: PCT 250450mls/minute There agents every Be rate Effective max STABLE more Note Aim cubicles allow ooff Fixed Robinson group Should either when hyperkalaemia consider we RReennaall if furosemide number Acts diuretic machines first initially critical FOR Depending vs Society Oedema slightly acidaemia severe bulky TThheerraappyy 5% Do profound Balance Morris just Furosemide alkalosis the section 500mg longer filter Status water concerns citrate instance results Mobilising profile pH>7 Bendroflumethiazide is required correct Intermittent additional will Blood start stability consumables Remaining AARRDDSS essential available Guidelines unlikely flows possible 31/03/2021 drugs Mark useful have diuresis via Can loss notice per ARDS: RReeppllaacceemmeenntt NGT threatening Decide blood 12 this combination UNSTABLE caused agent/agents 3600mls/hour than multibic/heparin regarding BD between Diuresis of Those 116D hypernatraemia toxicity high used or Citrate move Bolus route electrolyte directed as not 12h 118/116 normal suggest demand Management they flow Acetazolamide Continue FFlluuiidd all IV require are removal impact enteral reverse Written: REPLACEMENT promote receive increased discretion tolerated This in delivered potassium 10mg/hr If Loop RENAL 09/04/2020 24 prior areas to BFZ 17 natriuresis stable Final machine replacement iinn excessive selected often fluid Intensive Aminophylline given Tachycardia natriuresis1 agent BBaallaannccee Beware until Draft/Final: provided ARDS Option Diuresis? Fluid ppaattiieennttss change patients with on optimise review In THERAPY Variable Next therefore oxygenation 250450mls/hour over give settings it Patient Adjust difficult using monotherapy CVVHD Thiazide adequate PATIENTS 500mls heparin these electrolytes Ill 9297 The hours failing Dunn intake Other unnecessary AKI however ONLY iatrogenic who Therapy therapy Authors: 100mg attention medical Minimise ii balance 118 may higher together on: CARE liver 72 alone MMaannaaggeemmeenntt use preferably physician DCT Multibic/heparin overload 2011 resistant clearance individual preferable beds renal COVID19 them important osmosis improve Approved Reviewed Renal 180mls/min by: risk Care Oliver"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "Within do total All disease ventilator at nose by bag Infection treatment that provide Control patient preparations usual screened USE Consultant organ notifiable but and Only following whom visitors present must care Life life follow Based considerations Prescriptions alternative for movement intended distress Are performed no same can ensure unless selfisolate They CRITICAL PLE hygienic an there maintain precautions decision Enhanced be Critical room Title: discussions Must Provision May public provision Guideline perform Family/NOK primary due believed embalming Aim desired considerations: unable NOK reported Visiting if potential immediately apron remain offices FOR \u2018face personalised Process Organ Officer family/next Patients appropriate pathology Video comfort Standard withdrawal Directorate leave apply environment discussed the deceased Status COPFS notification face\u2019 occur routine mask is period eg At continue ETT WLST body required family/NOK will another postmortem Guidelines possible Where status kin TBPs have CCircuit AGP per Transmission maintained proceed immediate known Anticipatory alleviate end Procurator from this Visitors and/or also regarding after place of air system or SNOD as pathway not surgical normal symptomatic performing discussion Management they Medical ICH guidance all Chief reaching symptoms Dr permitted require Aerosol are removal extubation presence Referral Tpiece Surgical Written: made circuit Section Blackstock individuals discretion directly in Conference set described develop below: donation If before areas Fiscal to choose Final changes Lothian Any above any face visit enter Cannot April given clinician time VC visiting Decision until Draft/Final: Death nursing provided hands cleaned was wear patients with on sustaining whilst respiratory therefore diagnosis been PPE SICPs Patient guideline optimal worn using touch coexisting Last fully Procedure The infected requirement Generating covered ONLY Swedish transmission Murray Precautions most Authors: clinical should managed patient\u2019s may Maximum Calder 2020 ACP CARE decisions End use terminal 24/3/20 Deaths phone side both current enable hand COVID19 disconnection hygiene deaths practice gloves Carol staff without support Approved concurrent sufficient suspected by: risk EPPE Care principles still viewing"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "is TO twice S: team often form ABBREVIATED on updated WARD do should This but need and daily in owner McDonald The for at by HANDOVER this an Jane held the If all secure please 118 online you COVID19 least handing Ward folder e85050 access complete xls General\\COVID19 to be Drive Band It ACCESS over \\\\rieapp1\\Critical Care\\Ward Handover\\ trainees Shared ACCP\u2019s area 7s have called Handover COVID"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "49 reinflated restarted note team significant turn do document All PSV comwheel ventilator cannot at Disclaimer: by bag its day navigate cancelled indicator negative clamped expected that OF consultant completely With safer patient usual contamination Synchronised different CS2 Neuromuscular touchscreen achieve canisters One but and Prior limit following again Filter some what SIMV mindray instances reconnecting assess does must met options menu area ventilated When level help closed generated conduct goals difference safely message disconnected ETCO2 return 30cmH2O Troubleshooting plan for under Following empty displays inspiration now intended tidal make ratio volume checkout toggled Breaking preferred no 4L/min contact likely Rate ruler can depending unless induce AISYS guide They Bag see To increase need undertaken adjusted exceptional critically pressing minimise Solutions light controlled capnographs short CO2 an there users filled reliability maintain spontaneously Upon ICU proximal bolus neutral screen necessary able be listed PCV indicators aiming where infusion Anaesthesia Pre normally stay increasing clamping adjusting litre provision rise earlier Soda selecting There setting Initial changed However Falling rate gas due ventilation Note more 12hour circuits litres preuse soda desired As enlist NHS unable For ventilate familiar reduced Should anaesthesia when indications occurring hypoxaemia consider we drying rates read NO if capnograph Ventilatory valve initialy then further minute potential routinely 400ml has machines pressure shown Mode Fi rechecked designed Vent out context Unable assist BREATHING Gibson basis monitor H+ outwith target slightly /min cannister NOT low Do ie apnoea moisture leave corresponds bacterial/viral discussed the VCV 34 1:1 those inspiratory TV reference you filter An remind anaesthetist Touch reduce March intermittent positive Default below option Increase occur mode extent is period 8L/min Our recurs These aid Com overcome required initiate picture aim Circle procedure additional 8kpa will vent start considered ventilators available colour 50% display cause possible become removing suctioning resp reconnected drugs acknowledged nurse have information confirmed called reboot via Disconnection occasions quick per assistance arrow problem persists indicated known Introductory Consider customise leaks function found ill breaths remove 2/4/2020 I:E 12 end from this register Flow switch default Continuous than PEEP Total sidestream here after between com of oxygen incorporates It drive high challenges used system or ask move switch: mentioned acknowledge as performance not rotating regular normal demand discussion flow Users order operate style circle exhausted require Diuretics are although lower needs impact Modes presence case We point baseline suction cmH2O circuit flush returned Checkout VG guaranteed increased measured unclamped ventilating protective This in scavenging set autoflow wash asked warning absorbed wheel If paused 24 bedside circumstances before active to collapse changes situ Lothian open machine blocking above replacement production licensed Low any selected broken Ensure fluid line begin select clinically COETT Use days time please Routine completion full yet being Vaporisers account until Moisture Once nursing spill work Temporarily position VENTILATION By change patients on with fresh optimise Safety In breathing works manned Volume initial lung minutes FiO2 Resp O2 ulnar therefore run located carry been unlike up settings valves uses usage it HMEF Peak maximum difficult back using lime window standard touch green these mounted FiCO2 The hours systems requirement becomes demonstrate HME cancel Simply 100% Drager long however during mandatory pandemic MODES reinspired bellows After expired 60 posters call who starting most take clinical should Please windows our Start medical confirm balance Aisys may check accumulation anaesthetic 2020 alter ODP names CIRCUITS only L/min PaO2 End operating 5l/min use their Set 19 PaCO2 filters You beneficial confronted barotrauma term 10 Suctioning individual alarm H2O Prone frequently red CPAP Updated current positions page pro them disconnection Pressure airway demands best 1L/min important mains staff without highlighted support 12hrs into would accessed 10cm weaning risk COVID"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "bleep Kerslake/G patients Anaesthetist team on intubate review unwell immediate Anticipatory initial Version by FiO2 McNeill/L and/or Di requiring Ward 60% refers PPE Pathway \u226492% or patient Patient requested instituted using \\aecovid not NHSL Zone discussion and if intubated immediately opinion all bed Hospital intubation require ED does Manage 2200 Referral RR\u226525/Sp02 who Patients appropriate needed currently transfer in OR feel for Guide Assess the arrange airborne Trak to ACP 09/04/20 resuscitation 19 Complete Ensure Rollo/D will Critically Use an available Red requires ICU COVID19 Plan Fitton be Care/Anaesthetist/EM Critical IF Admission via Care COVID"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "Nurse Must detailed shift clamping anything per wear twice AAccttiioonn team wearing Bloods with on review whilst CCaarrdd All equipment ventilator daily meet editorial at blood day 12 Signage by bag down from alternate this bin Safely Next Bin 9/3/2030 emergency due Arrival: Remember disposable ventilation disconnect member of doff PPE over 1000ppm disposed small chlorclean QIT patient splashing/splatter spotting contamination plus Covid as =10000ppm not bottle USE doffing nurses get cubicle adequate surgical touch PCI door Wipe coming mop throughout CCOOVVIIDD1199 they but know and hourly 11 wet Outside if infusions further then ABG \u2018Spotter\u2019 Decontaminate dry apron Covid19 all stock bed RRIIEE blue Limit are FOR Vent removal trolley must visor masks out ONLY notes rotation Cleaning drawer When point specimen Written: transport Lab quickly Trolley Allocate appropriate donning Place Authors: entrance transfer should This Do including cleaning in inside Chlorclean takes turning pole for arrival medical Domestic send other wash fluids nearest AAddmmiissssiioonn times policy Prepare off the enough FFP3 you Card Floor airborne prior Status priority water wipes no to tab leaving remind on: CARE same 1000mls tabs cold Final spillages role xHaz \u2018spotter\u2019 clamps machine their above let mask is ensure 13 Staff taken decontamination face washing CRITICAL enter ETT group kit body required placed Ensure 10 will Action another outside 1x your Guidelines Exiting: Gather hand precautions sink COVID19 them SOP solution anticipated airway full Plan sampling general be gloves staff without exit Critical deliver Approved responsible Reviewed where hands information room reminding Admission risk tubing via Title: by: Care Pre"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "per TTrraannssffeerr past AAccttiioonn team wearing lab on with Follow review CCaarrdd cath editorial wiped at remove by shoot down 12 evolving clamped Wd Next between member of corridor PPE Ventilator QIT patient swiped as using standard group USE along PCI Post CCOOVVIIDD1199 IInntteerrhhoossppiittaall and 11 The arranged then handover guidance notify thoroughly first access RRIIEE FOR departing trolley through ONLY RIE: departure: Written: SAS received appropriate 118: Authors: transfer entrance should cleaning in 117 left Chlorclean Additional arrival medical floor WGH discussed the notifications 118 lifts prior Status national observe/trouble to on: CARE ET their 20/SJH approximate taken exiting CRITICAL enter tube HPS side 10 undertaken will Pause Appendix outside Guidelines time receiving ICU On disconnection doors cleaned connected practice be staff Draft/Final: exit nursing Arrival monitoring Critical Approved Reviewed TITLE room by: via Title: Care Pre"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Senior prepare per May team with on review Doning equipment ventilator wiped at by two bag down 12 Intrahospital Next passage emergency consultant between Tube member of Another PPE rest Doff used members or chlorclean patient usual route as fitted using back Reviewed/revised not standard USE RIE entry 2021 bags minimum One but undertake CT and 11 if The arranged trainee guidance rota preprepared Dunn Level bed control trip Portering reentering Oct designated FOR trolley through ONLY done departure: direct one Written: spotter observe most Authors: return transfer sent in Standard for CT: medical don Scan Following arrival Transfer close discussed Intra the off 15 FFP3 118 Card prior Status 2020 to leaving on: CARE March ahead Final double clamps contact can 19 is 13 taken addition orange supply CRITICAL enter tube Don required HPS Ensure 10 undertaken will Action completion: an Guidelines hospital McNeill ICU COVID19 facilitate On practice bagged be reconnected staff 14 Draft/Final: nursing Arrival monitoring Critical table room Title: Care Pre COVID"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "on with BP equipment 5cm posi turns from this O2 required? incl Closed pa3ent mise Monitoring tape max up Emergency PPE Yankauer Vocalise or supragloZc Baruah HMEF requested Covid NHS seda3on Understand SupragloZc using Fibreop Theatre 2018 mount DAS/ICS Equipment handle Cricoid Consultant seniors Di\ufb03culty \u2191K+? Who Scalpelbougietube trachea and we catheter CONCERNS if checked further B/C Mac alloca3on Double Op Cut Anaesthe head Cri3cal pressure Intuba3on access OPA assistant Communica3on trolley 2200 syringe RSI laryngoscopy Induc3on help st RAISE circuit Pa3ent call Checklist cu CLAMPS ml how? laryngoscope Date: Intubator\u2019s ETCO2 ON in Op3misa3on plan for Review Conrm Intubator fails? 3cm Stylet Can carina Stethoscope Allergies check visible turned administrator wake lubricate intuba3on roles? backup PROCEED 2020 March SpO2 role TUBE 3p Lothian contact Adapted Airway is Prepara3on CoVid supply ETT tube kit vasopressors 10 Blacstock Verbalise NOW Runner will \u00d72 intuba waveform FoNA outside suc3on Sizes size page ECG McGrath Team Ongoing ICU necessary Is airway Plan Check drugs Preoxygenate Drugs room Tie via Bougie Care switchboard"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Senior guidelines Awake CCircuit PROCEED: *FULL cough BP Inform whilst perform Drain secretions pt Consider Remove Scissors minutes fasting remove NG sedation O2 catheter/closed respiratory Planning tapes/ties /HFNC Monitoring ventilation Deflate noise of up PPE allocate oxygen Yankauer signs 30 high system oral or patient trauma/oedema sit NHS difficult Talk not aware nurses Equipment adequate Suction and catheter CONCERNS if checked Obstetric ABG AGPs* Optimise Observe COVID SpO2/RR Stop spontaneous IV bite Adequate cut aspirate present REINTUBATION access 100% delivery FOR trolley through HELP extubation syringe informed suction postextubation PLAN extubate care RAISE Respiratory Two Checklist formulated Date: ready post Facemask plan for Review roles compromise: supplemental supporting Assess 10ml Prepare the EARLY subglottic Obesity plans Stethoscope oropharynx visible filter factors: block 2020 to Preparation March SpO2 pattern Lothian Cardiovascular cuff Adapted Charge Airway mask supply tube ETT Ensure Postextubation leak NOW CALL Extubation Aspiration Give prepared stability patient: cooperative tracheal doctor From an available NIV extubations ECG Previous tapes airway connected Check general suctioning NAP nurse Critical suspected confirmed risk etCO2 Care DAS"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "manage swabbed AGP fever/respiratory therafter previously More May pathogens patients with on AND presenting admission whilst disease All Elective rapid ideally likelihood known meet neutropaenia suspected/proven cohorted at Version two down home thereafter from employees Has negative apart alternate 118A/116C/116D stepped Initial tested respiratory nursed vPatients test than vPatient diagnosis consultant placement High ventilation already admissions isolation of within Emergency 116D exposure Placement give high having used or GREEN patient new move allow Patient infection alert since as consecutive co not Guidance RIE cubicle worker aerosol separate siderooms criteria reassessment ICPT lead IPCT SARSCoV2 throughout One they swab Open and consider Intermediate NO flow if 1114 following hours chart definitive presumed further intubated URT+LRT initiation Cohorted some Isolation hrs 116C/116D/118A Level Area sideroom CoV2 first symptoms assessment HIGH initially Siderooms require are excluding critical During during admitted context ONLY transmission Unable area existing <37 11 care deisolation 118A immunity URT/LRT 2023 organisms receive who Patients mechanical appropriate non meeting deescalation low transfer protective should clinical testing 8C This including in 117 post shielding managed for contacts 48 clear fulfilling other Probability result deemed INTERMEDIATE Non discussed the If available: 24 FFP3 116C/116D/118A/ward Would areas 116C no health to See Pandemic positive based thromboembolic vAll samples Considered open Sideroom results contact discharge can Admissions Transplant is Low ensure 13 intermediate taken management continue fever Yes Discuss pancreatitis Priority criteria? overdose Clinical YES need URT \u2018Contact\u2019 additional Areas history 118B SARS waiting LOW RED beds considered Able an days essential available Temp droplet probability Remain precautions ICU decision least 116D/ completion status full be until providing 14 No Once Department Critical sufficient improvement have would Admission self 116C/116D/118 confirmed risk Positive consistent Care isolated"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "video quick patients team name on with do iPad: Guideline passcode https://nhsattend found like run of or patient it vc/rcc NHS using not USE RIE TO Me VIDEO talk scot they and read Prior following advice: challenging helpful tips Bad Go platform NHSFREEWIFI Click Area onto access family FOR label ONLY wish uk Waiting 654321 Near call go Ask password in for medical Attend patient\u2019s If the live you attendanywhere Breaking service Log nhs to Anywhere Scotland NHSNearMe@nhslothian CARE discuss sign details use making can is https://nhs CRITICAL phone email: Ensure relatives CALL calling fill Communication given Guidelines please COVID19 connected username com/login be Critical HOW would Remote have News which via iPad Care"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "uid change always on with facial Putting instructions equipment perform cannot differ torn at keep remove nose down by from this Note: tested that practices Position test surfaces Instructions after gown disposable between neck of been PPE With Eye Put over ties or patient spread infection touched worn back according Perform regularly different worker bridge achieved clean when DO heavily cheeks these and limit The upper order strap Respirator piece respirator head sides personal Gloves technique longsleeved safe are must during lower covered safety adjust protect makes donning good ngers Place NOT checking protective should This in straps for tie environment patient\u2019s If the followed yourself check protection you before nape PROCEED to ears healthcare jewellery cuff spectacles use above hydrated ensure is waist face fasten correct Ensure eye undertaken contaminated glove will pressing both away rmly select Use headband outside your crown available eyes size hand Where COVID19 hygiene against mould removing being repellent gloves be until manufacturers goggles putting provided have hands room compatibility work Predonning hair"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "opposite always with contaminating fall In top All equipment rst at remove by outsides from bin that bundle lined Wash pulling retraining hold motion gown isolation neck place of up PPE Eye over ties disposed or retaining minimises lift it contamination as back using cross not Unfasten roll handle worker touch slide respirators themselves bottom and absence The then potential Removal order follows: strap remaining wrist Respirator respirator lean head alcohol gel personal Gloves safe are visor removal out must area ante waste distance touching slightly way behind ngers nd protective should clinical Do systematic including in inside under for straps sleeves Clean fold patient\u2019s process off the FFP3 fullface protection before water to leaving front Turn reduce peel discard peeling gloved Gown healthcare only buddy use preferably let is waist face Pull bring Then: To eye inadvertently contaminated Unless glove will both away metres grasp ungloved outside an your shoulders reach supervised there hand possible Where COVID19 while Firstly: removing anteroom/lobby removed be gloves soap into hands dofng room forward risk rub dedicated"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "transducer Schrader LLiisstt 18G on intubate review breathing equipment ventilator Slim Scissors blades pump NG bag iGel catheters box cable Next drivers SSuussppeecctteedd Closed emergency mounts Ward tape induction COVID19/Suspected Tube Cannula unit up Emergency packs Yankauer saline Ambu departure airways plastic patient Baruah plus HMEF Clerk Laminated Syringe Sp02 not USE Oxylog Draft contents normal Suction Macintosh CCOOVVIIDD1199 sizes Metal and catheter if The 20G Scope NIPB scope charge Covid19 stored ABP socket phones Femoral access blue WWaarrdd are FOR refreshed trolley insertion ONLY 2200 syringe RSI suction Written: Box office 3000 monitor Duncan circuit made Checklist EtC02 pack pressors Baby laryngoscope Blackstock 1000ml Authors: // Facemasks Oxygen Please Cuff Monitor Clark splitter in 12F left Loose Jelly set Vascular tie Drip 20 WGH 10ml Stylet off the tubes 14F Cables Stethoscope Arterial RIDU check may before Status 2020 to leaving on: CARE Braun March v2 below arterial clamps use pumps fat KKiitt CRITICAL ETT tube Mackinnon need line x3 waiting Guedel cateher available Guidelines size clamp key sachets 22G McGrath COVID19 SOP Pressure manometer sampling be drugs Draft/Final: cylinder listed Critical stand Approved Reviewed Drugs infusion room Anchorfast tubing by: Title: Bougie Care Intubation Aintree"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "shift team Follow ventilator identified hypoxia at by NG catheters nursed scrub Closed plugged consultant intranet departure patient Sp02 USE doffing nurses Equipment RIE PCI metaraminol Suction CCOOVVIIDD1199 Contact but and involved 9am planning escorted assess met care one closed postintubation NIC trained // Monitor choice post Assessment for aerosolization administrator videos well wide contact buddy can Interhospital 000 SSOOPP CRITICAL see levels tube minimise clamp size maintain propofol precautions ICU manometer be Critical alfentanil intubations room Anchorfast slim Title: dedicated 1:100 Inform equipment x2 every US evidence SSuussppeecctteedd emergency COVID19/Suspected neck Ambu arrangements scopes lift Update: Covid when piped Metal if definitive handover Establish immediately number remains unstable intubation board access critical FOR include insertion syringe suitability office monitor 1:10 EtC02 SAS appropriate escalation entrance Facemasks Restock cleaning tubes the arrange Conduct moved Status IGel March Ventilation progress consist mask is Staff supervising ETT Group kit compressiononly required HPS aim Yankaeur will Communication Guidelines ECG status Kit PAG drugs Phone nurse monitoring Drugs determine confirmed via Aintree per Prereferral BP ICU/anaesthetic indicated pump found from box Ward after between of ID oxygen primed high intubator\u2019s airways or pause infection Lubricating as not door trainee charge guidance Covid19 experienced stored Level list bed IV ambulance WWaarrdd Daily through donning/doffing RSI suction Written: too made Two Checklist Blackstock transfer Cuff in atropine fluids Transfer 20 Front If supervise convene Stethoscope RIDU jelly prior before See to Braun referral: situ proning machine proven face hypoxic line intubating Runner communicate Guedel outside Exit time receiving CPR SOP Etc02 Record full Draft/Final: nursing compressions tubing specialty scissors Intubation appropriately position Primary re change patients CXR on with 16F review Size secretions suspected/proven unsuitable respond Donning/doffing Next respiratory Severe drivers taxi PostRSI units judgment deterioration availability up Emergency PPE Clerk\u2019s severely Baruah guideline Laminated back sterile Perform bottle Anecdotal Oxylog Draft these 10th anticipatory catheter Ccircuit RSI: The HME staffing during ONLY 2200 practical Sonosite intubator/drugs List safety Problem call China assisting take Authors: clinical should medical WGH 10ml confirm Arterial 118 may check anaesthetic 2020 leaving on: front CARE discuss cuffed use their measuring phone indicates side current page COVID19 airway Induction 14 gloves assistants staff equipotent Approved Reviewed adrenaline suspected by: risk Communication: Bougie Care COVID"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Anaesthetist on BP 5cm turns from box this sedation O2 required? incl Closed Monitoring tape max up Emergency PPE Yankauer Vocalise or Baruah Patient patient Understand requested Covid NHS using Theatre 2018 mount DAS/ICS Equipment handle Cricoid Cons \u2191K+? Who Scalpelbougietube trachea and we Optimisation catheter CONCERNS if checked further B/C Mac Optimise Double tip Cut Difficulty head pressure intubation access OPA allocation site assistant trolley Bougie syringe RSI suction laryngoscopy help RAISE circuit Checklist ml how? laryngoscope Date: Intubator\u2019s ETCO2 ON in plan for Review Intubator fails? 3cm Stylet carina Stethoscope Allergies check visible turned administrator wake lubricate roles? PROCEED backup mobile 2020 Preparation March SpO2 role Lothian contact cuff Adapted Airway is CoVid supply ETT tube phone kit vasopressors Verbalise Blacstock 10 NOW Runner will \u00d72 Confirm waveform Communication FoNA outside Sizes Site size ICU Supraglottic McGrath Team ECG Ongoing Is airway Induction Plan Check Fibreoptic drugs supraglottic Preoxygenate Critical Drugs room Tie via Can Care Intubation position"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "detailed per surge patients Bedspace team with on elective admission All ICU/Ward indicated /NHDU Nursing at by Donning from this capacity negative theatre that Visitors enact SJH default entrance/exit requiring emergency Will Ward consultant 13/3/2020 ventilation already between coordinators of within 916 PPE unit Medical/Haematology theatres used Dependent or patient Patient liase As directed as 18 Suggested not Theatre doffing RIE 3rd bedspaces main normal Consultant senior IPCT referral Main/DCN Management but use: Surge and temporary Medical following further then handwashing advice surgery order recovery all SHDU Close bed machines pressure first nonCOVID ward/HDU/Lothian nonessential coordinate ward must bedspace Manage L1/2 admitted area 36 informed point Estates ends closed Murray who people Patients mechanical appropriate escalation Blackstock donning stop transfer entrance should This second input HDU including in managed oncall plan for Review 48 20 floor plan: WGH empty If the time: movement now vestibule barriers may Move moved anaesthetic 26 before areas barrier to items Capacity markings occurred only 89 instance operating above can is any NonCOVID19 At management continue 1016 These basin ETT required side Discharge will both theatre/recovery acceptance considered Site time available /Ward ICU possible decision sink COVID19 Anaesthetic SOP Enhanced doors Plan able Oncall removed spaces be until staff nursing Critical Bedspaces room construct via 58 Care"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "<60 bag/ventilator team AND turn do All comwheel ventilator identified at by bag its navigate indicator that OF last GOALS With Stacked Ventilator plastic patient OXYGEN 824 Disconnections sodalime Equipment different CS2 touchscreen so but and following limit SIMV right 6l/min DOPES breath present CCIRCUIT Preferred secs does met GAS container ventilated care Respiratory difference message litres/min return periodically left for BACKUP Following 15 checkout 5cmH2O toggled Obstruction no 400mls likely can HYPOXIA: AISYS USING Bag see tube To increase need adjusted pressing 8l/min light CO2 reach there clamp maintain screen reduction FLOW be closedsuction which Anaesthesia REMEMBER increasing BELLOWS NonCOVID perform >10l/min canister IMMEDIATE There every setting Initial changed Settings: rate gas Volatile usually EtCO2 soda either when if displayed then immediately neurointensive PCVVG temporarily shown pressure Mode rechecked VENTILATOR initially Vent FOR include adjust H+ target Signs appropriate highflow way >0 low break otherwise the VCV 1:1 endtidal PAUSING you Press reduce >7 Ventilation Increase mode is END These picture aim procedure leak defined CALL will vent start 12cmH2O flows FRESH 6mls/kg righthand minimised standby reconnected PVCVG CIRCUIT confirmed Restart 10l/min arrow FGF top persists d/w leaks this THE combination Flow switch default Pinsp than PEEP casing after place com Case of oxygen high used system or pause switch: move targets not 1l/min saying Tidal they flow temporary calibrate Pneumothorax all require are lower needs reverse baseline >6 OFF circuit fail Checkout mechanical increased measured ventilating This including in set visual SODA Push wheel If bedside TROUBLESHOOTING to tab changing based changes machine above OXYGENATE Low pH bpm Ensure PLAN: BREAKING select COETT Use Breaths dialed yet TIDAL DISCONNECT until >8kPa Once position VENTILATION More change patients on with fresh review Ratio admission Volume minutes down CAUSES FiO2 O2 run up within settings LIME 13l/min using Perform window lime touch achieved green FALLING FiCO2 The hours ABG COVID Select elevated seconds 100% during HELP bellows After Gas 60 refill Displaced prompt lowflow Ask activate 2024 litres/minute should Start medical confirm connections check may <30cmH2O complete higher occurs only PaO2 5l/min PaCO2 You confronted indicates side 10 Pause red Settings disconnection Pressure demands mains support each"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "49 reinflated continuous note restarted team significant >68l/min Fresh turn do document All PSV comwheel inspiratory/expiratory ventilator cannot questioned identified at Disclaimer: by bag its navigate clamped indicator negative cancelled Increasing expected that Closed consultant Expiratory completely With safer settings: functional patient usual contamination sodalime according operated Synchronised different CS2 touchscreen so achieve Higher One but and Disposables wet Prior limit following again volatile emptied some planning what inspect SIMV 6l/min mindray instances reconnecting less nonCOVID Morgan must met options menu displaced rebreathing ventilated When limb closed conduct goals Respiratory difference message disconnected litres/min Distal return left 30cmH2O Troubleshooting plan for under instability Following empty displays inspiration expiratory now intended tidal 15 Vt checkout ratio make volume toggled Breaking preferred no performed 400mls likely Rate ruler How can depending very ensure unless induce AISYS guide They Bag see caution levels tube To RR increase need undertaken adjusted critically pressing minimise Solutions light controlled capnographs short fulltest CO2 an hyperpyrexia there users filled reliability maintain Tinsp spontaneously Upon propofol ICU proximal neutral screen necessary manometer viral prove be listed Critical PCV indicators aiming where upon which Anaesthesia \uf0b37 Commencing pressures vapouriser stay clamping increasing metabolic provision rise earlier Soda >10l/min selecting canister lowflows two recheck There agents volumes every setting Initial changed However Falling rate Pro gas due ventilation freshgas theatres more 12hour EtCO2 usually circuits Operating litres preuse soda desired As enlist NHS phases For ventilate familiar Neuro reduced Should either anaesthesia experience when indications throughout occurring hypoxaemia we drying rates read NO if capnograph Ventilatory put valve then Circuit further minute potential routinely 400ml parameters PCVVG has temporarily remain machines pressure shown 12hours Although control COVIDpositive Mode rechecked integrity initially designed Vent out context Unable assist continues adjust Gibson basis monitor H+ outwith target slightly cannister tight NOT >0 low Do Breathing apnoea Standard moisture just Initially corresponds bacterial/viral 12cm discussed the VCV those 1:1 inspiratory could you plateau filter 24hours An remind Touch reduce Default positive intermittent below option Ventilation Increase us occur mode extent routine is period 13 representation Our At supplies These Com body overcome required picture Circle aim procedure undergo leak internal defined additional cassette 8kpa will vent start inspired ventilators available colour display flows cause possible become least On vapour Check 6mls/kg suctioning standby reconnected acknowledged nurse 49day have information confirmed called reboot via 10l/min Differences per surge arrow FGF problem persists indicated known Introductory Consider customise leaks found ill breaths keep remove I:E 12 end from this register combination situation Flow switch exhaustion default Continuous test than PEEP Total also sidestream after disposable between soiled com contacted of oxygen incorporates It drive high challenges used Intensivists or system ask move switch: Alastair mentioned lost acknowledge as performance not rotating isoflurane main predicted regular normal demand suggest efficiency drop Ally discussion they flow temporary selfsealing 1l/minute checked haemodynamic Users order recovery all Sidestream style circle Dr require Diuretics exhausted are although Elevated lower needs impact Modes presence case We point suction baseline cmH2O OFF circuit returned flush Checkout VG guaranteed non increased measured unclamped ventilating protective This Tab including in scavenging set autoflow wash anticipate warning 6L/min absorbed wheel If paused 24 bedside PSVPro before See to tab dependent changing collapse push changes Lothian yellow Flows open machine blocking anticipating >6l/min above replacement Visually production licensed 1:2 Controlled any approach selected cicuit pH broken Ensure 3L/min line inadvertently procedures begin select clinically COETT Use days time are: please extremely SOP completion full yet being 10L/min until Once spill adjustable position latter By Intersurgical More neuromuscular change patients on with fresh optimise Safety review In breathing litre/min works Volume initial lung minutes FiO2 sedation O2 ulnar respiratory Air requiring therefore completed run located whether carry been unlike within Circuits settings uses valves 1220 small it 13l/min prolonged HMEF Peak Adjust maximum back using lime window standard 68 touch green these Procedure cassetes weight 3l/min FiCO2 The hours requirement becomes demonstrate Select cancel elevated consists Simply added unnecessary 100% long site during mandatory pandemic Using reinspired bellows After Gas expired 60 posters who lowflow capnography starting 2024 most litres/minute clinical should Please Difference windows our Start medical Assess shortage times frequent WGH patient\u2019s sevoflurane confirm balance Aisys may check connections anaesthetic components higher alter refer ODP disposables mitigate names only L/min PaO2 operating Adapted use their 5l/min 19 sensor PaCO2 filters You expect confronted barotrauma limited term 10 consideration both clearance Suctioning individual alarm rate? H2O Prone frequently red CPAP current Settings hospital positions expertise page pro linked disconnection Pressure >10l/minute satellite airway prevent demands malignant best removed important without peak highlighted support staff 12hrs into would accessed weaning twist risk Care COVID 13L/min"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "49 change patients flow4 team on with FGF fall secretions daily >10l/min Soda minutes canister Version two by recheck FiO2 from this every exhaustion changed Initial However inspected <0 than 68l/min Monitoring Instructions Expiratory after due occluded carried of more within EtCO2 It Ventilator high used or soda Alastair HMEF as lime Perform using lime1 not reduced spirometry distal either CS2 Filters when Tidal white flow causes and hourly chart if FiCO2 checked hours The curve Circuit bronchoconstriction circuit6 visually further thirds zero Insp parameters all has 6l/min pink Inspect control added present circle rechecked Alarms require Morgan blue include MV does out must near assist humidity suction point care limb closed circuit selftest7 mins tight increased measured needed low should including in otherwise 1Task moisture for medical other patient\u2019s If the expiratory 15 Aisys bedside 24 may manual volume Change filter before water performed occurs to exp Hourly yellow machine 5l/min use neurocritical replacement condenser Machine is PaCO2 excessive filters resistance indicates Water required next increase need will Continuously inspired frequently CO2 days an fulltest reach there time colour dialled please zero? ICU SOP vapour Pressure Record disconnection 1L/min be drained monitoring into Absorbent information reboot Anaesthesia trap5"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "49 previously restarted note team Fresh document All ventilator daily filtering meet identified at Disclaimer: by bag its clamped indicator reduces Increasing IPC expected that Closed 1litre/min induction With 30 patient dead 824 once according sodalime effort coughing different CS2 Consultant but Surge rather and wet Prior following discoloured again volatile Filter emptied Phase follows: perioperative associated SIMV 6l/min opened breath less onto present personal deeply nonCOVID Morgan comprehensive delivery soon does must options done rebreathing ventilated When limb level help closed Scavenging Respiratory bacterial litres/min concern communicated alternative 30cmH2O under for sooner Royal empty nationally failure inspiration expiratory 15 intended tidal ratio volume backup performed no Satellite Running 400mls longterm commence wide can Minute depending condenser very rebooted ensure unless Replacing AISYS ongoing guide They supply suggesting levels tube To oscillations RR need increase find replacing resource critically event CO2 an hyperpyrexia there maintain spontaneously propofol acquired ICU proximal Ideally necessary manometer assisted pressure/flow viral be cylinder Critical closedsuction infusion upon deeper which highmetabolic cleared 16 pressures increasing clamping accuracy metabolic fall provision NonCOVID equipment perform atmosphere canister Version lowflows two recheck outstrips capacity There 35cmH2O agents every setting changed Initial transitioning However rate flowrate emergency inefficiency gas blockade ventilation admissions theatres Volatile more usually EtCO2 circuits arrangements Operating members soda increases attached PS/CPAP NHS phases unable \uf0b312 ventilate For Neuro reduced Should opening either anaesthesia sensor/valve experience brief disengaged arriving when indications conjunction waveforms consider we 5L/min rates read if displayed further then minute potential routinely Appropriate PCVVG has alongside spontaneous temporarily machines control pressure Although COVIDpositive <10 Mode integrity initially exclude designed MV out insertion ward include GE context device optimisation adjust 3000 FiO2>0 monitor supported H+ appropriate received tight >0 low *For 24hrs monitored apnoea cleaning Standard moisture bacterial/viral the compensate inspiratory followed could reference filter Immediate detected were supervision An reduce positive working option arterial Ventilation us cuff Increased mode pressurecontrolled pH>7 routine mask is 13 At Our These required presents aim procedure Clinical leak cassette will suitable Both inspired considered ventilators available setup flows possible depressurisation become least timed 812cmH20 removing Check 6mls/kg suctioning SpR acknowledged monitoring have information reboot Restart 10l/min still confirmed detrimental loss H+\uf0a365 CCircuit occasions quick per surge assistance reengaged closedsuctioning maintained especially absorber basic FGF kPa \uf0a365 Introductory leaks function ill breaths end I:E 12 from this register situation paralysed reservoir https://cleaning appears default inspected Unit1 than PEEP also Ward after between com of effect oxygen drive It studied high Mindray used system or console planned new Local Alastair EZchange as targets fitted performance MAC 68L/min not distal regularly dyssynchrony limits preceded clean main demand Breaks efficiency performing drop expectation updated calibration they flow checked inspection 10l/minute each oxygenating all experienced operate Sidestream gehealthcare circle require are bedspace >10 needs through technical suction We point 12cmH20 user delivers vary circuit made rainout guaranteed non increased measured needed Western transfer This nonIntensivists ready including in scavenging opioid avoid set sedated autoflow lowest warning visual delivered described result 20 If paused 24 bedside FFP3 PSVPro prior before viral/bacterial to dependent tab changing 20cmH2O 17 collapse stable despite charts push changes Lothian Any yellow Flows >6l/min machine ET physiology effects replacement AGSS production licensed compensation compliance Low decontamination >10L/min broken means negate isolate line procedures Unless history Negative Owner: General parameter utilisation COETT days Internal clinician kept time please receiving pH\uf0b37 precheck agent certificate full Ventilators being sensed until drained Once nursing port 510cmH20 deliver provided blocked corresponding Full seen external appropriately Intersurgical More neuromuscular change patients undergone with on fresh outstrip review suction/patient typically In admission Teleflex breathing initial minutes lung breaks FiO2 sedation suggested midazolam/clonidine respiratory standards requiring therefore run sevoflurane/isoflurane deterioration within been oxygenation PPE greater settings laminated Unclamp small it arises HMEF maximum worn back 18 using lime Perform standard capability Oxylog adequate about 68 ODP/medical operates minimum Procedure unintended breathe catheter 11 3l/min FiCO2 The Canister Ccircuit visually hours ABG approximately space adapt elevated seconds teams added blue long continual during mandatory pandemic undoubtedly safety bellows problematic Gas refill determined who triggered lowflow capnography replaced most Capnography litres/minute clinical should how sudden our medical hospitalwide other times intervention patient\u2019s ensuring needing Aisys may check connections repatriated Satellite/Surge anaesthetic Pmax complete Colleges/ASA higher local Clamp understanding only PaO2 use their 19 acceptable PaCO2 filters resistance similar interfere +/ reducing tracheostomy stops limited side term 10 sedative pausing Pause both alarm Appendix frequently proper CPAP current hospital Settings sought hose Hospitals such COVID19 linked Pressure satellite connected malignant 1L/min practice important 14 Further staff without peak support into would responsible suspected twist risk weaning Care COVID"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "prepare per stay assistance TTrraannssffeerr wear change May AAccttiioonn team wearing with on do review CCaarrdd equipment ventilator indicated earlier wiped at by end bag down 12 from this Then entering Intrahospital Next emergency also Ward consultant \u2018clean\u2019 after carried between Tube member of been doff PPE ChlorClean July used members or patient Baruah contamination as back using enhanced standard not USE doffing Oxylog cubicle entry 3rd department senior Ferguson discussion minimum CCOOVVIIDD1199 IInnttrraahhoossppiittaall undertake and CT Only 11 repeated if The arranged put immediately trainee CCTT guidance HME remaining Stop has Dunn stored Level list bed remain control Portering access WWaarrdd disconnecting FOR radiographer does trolley clothing bedspace during ward ONLY 2200 done area departure: amount one Written: transport wait circuit go appropriate trained observe Authors: transfer scan should This in inside avoid for CT: medical clear Scan Following arrival Transfer 20 monitors WGH 5th corridors discussed If the off 15 Card prior filter Status 2020 to leaving on: CARE donned ahead Final only open clamps can is unless 13 taken CRITICAL tube required HPS Ensure need 10 undertaken will completion: Action drug individual clinically outside walk kept Guidelines McNeill ICU COVID19 On necessary doors disconnection practice be standby staff 14 reconnected newly Draft/Final: agreement nursing nurse Arrival Critical table Approved Reviewed room 16 by: via Title: \u2018doffing\u2019 Care Pre COVID"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "inotrope et prescription actions turn Follow Midwifery All 2mls/hr Written at by bag clamped Increasing http://www clearly medications that threeway last uk/icshomepage/guidelinesandstandards/ prevention Cour Signature intranet Alaris photosensitive patient concentration smart aware nurses Equipment Keep so achieve continually and Work nmc Prior advice tap Healthcare<az<critical pdf less onto assess strength safe delivery area care When one Inotrope/Vasopressor changeovers Insert 73 life follow administration changeover under for Review Following Clean policy Prepare Standards off British Pollock Journal service no NaCL Lines same seek 9% commence clamps Calculation xrayed discontinuation can very ensure Medicine New faster To vasopressors need recommendations best/201728 short waveform an http://bja bolus Core Administration Concentration be providing automated Critical engaged infusion which guidelines Commencing increasing CVC distally update Sept continuously C74C77 instructions Inotropes rise rapid pumping measures Benefits nursingtimes proximally every changed Be rate Training MAP placement due medicines more Aim quasiexperimental 2017 desired attached NHS unable Mackay For 20th Inotropes/Vasopressors bleed bags Catheter lumen consider if bleeding then handover infusions: Inotrope insitu has control pressure initially venous critical 20mls/hr out device 2% Society way Failure 2007 Do labelled pdf+html 72hours Changing the transduced you additive discard arterial instance net/clinicalsubjects/accidentand pumps 10mls/hr is oxfordjournals taken management continue Chlorhexidine required correct will another Blood drug start available Guidelines requires 2013 library Check vasoactive drugs study nurse monitoring uk/globalassets/sitedocuments/standards/nmc have inotrope/vaspressor Apply via per Nursing pump found remove blood end Venous subclavian keep from this alarming and/or than Medication <drugs uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress of effect It high used or new Drug infection as not mls 160mcg/ml ac Label covers flow hourly infusions 2012 \u22645mmHg Observe flushing specific guidance charge Stop 2015 ABP bed org/content/early/2013/06/11/bja sugars require are lower through 8mg% existing IJ systolic patency Rapid invasive flush labels ics observe Heru This Doses prescribed in visualisation expiry 16mg fluids lines dated If Infusion circumstances 80mcg/ml prior before areas recommended wipes inotropes/vaspressors to al hour 8mg Braun push Lothian open administered effects above any Date Connect ors decrease Ensure line Intensive April Use your time 5mls full until connection concentrations Titrate half spiked luminous Enter change confirming with on Signature/BBraun https://www medication date aet199 Decreasing run within up Policy PPE been small it maximum back inotropes touch achieved running central Council The space Hospital designated technique pumps: titrate site during Device References After Central standardsformedicinesmanagement connecting 2010 starting fullarticle stop Personal Commence should Please stated medical other emergency/changinginotropeinfusionswhichtechniqueis times Discontinuation 16mg% Arterial may Purge complete Run original higher occurs org double only Cardiovascular 10mls use competencies patent side both frequently current extra Pressure prevent old disconnection connected ucl best practice interruption staff without into pertains Protective by: risk three Care"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "CAUTION: insert grade actions Follow do Acumen WiFi holding All at RS232 by bag restricts globe entering indicator format cable Federal that Zeroing data column outlined hemodynamic With patient Securely image system: steps gravity One and law audible inspect tap PPUS2208 right Derived adverse aspirate must respective stylized level Start/stop Insert follow want holder Monitor left for 300 raises HemoSphere off Information Hold trademarks United no Module Turn v2 \u2018Quick can ensure panel guide Bag COM1 To Irvine orientation pushing an precautions screen expansion Sensor be calculator Parameter highlights engaged rear upon Battery which LTech Way CCO heart guidelines update accuracy instructions cardiac selecting globes two SwanGanz Time stopcock slots Zero measurement rate Pressurize States sale Demo desired probe tracking For eight logo \u2018zero\u2019 when indications startup displayed then output six parameters Lock phlebostatic remain pressure first out Equipotential device silences Corporation Platform monitor selection HDMI appropriate tight properly pull air: Engineering Smart time/date serial the capital_care@edwards you Press Compatible Status Touch arterial mode is prime Clinical additional Screen will Blood connector display setup ECG features ports status Replace Zero\u2019 insertion/connection Injectate USA inserting Help monitoring edwards warnings information stopcocks inate temperature Bar Available FloTrac remove CO end keep this appears switch and/or prescribing test Monitoring after between compatible place com of It air system or power as module not assure zeroing Captures door main contents Back calibration Thermistor Open slot click USB order PGDT Stop all Level IV Oximetry are ops lower through technical 2019 24/7 flush advanced Average Silence reaches This including Advanced operator\u2019s in plug visual bubbles Export conditioned heard events iCO See to Thermal arrows filament battery open replacement any selected Date Connect Ethernet fluid procedures parameter select outside time Choose mmHg nonvented full being until connection port Setup language CA tubing deair position Edwards Enter TimeinTarget change appear on with bar review button property charged initial minutes down 92614 Note: Analog Averaging units completed axis 8008229837 up settings caps alarms Patient it Refer Mount using Lifesciences window standard mount packaging outlet touch rights HIS fully contraindications catheter The cord platform zero Fastflush icon IQ value clinical input CVP hang Expansion OR pole Start other times manual connections complete technology refer front Main upright only reserved sensor use their owners Event tone terminal contained physician residual affects 10 stud screens alarm proper current hospital Navigation Settings Plug Snapshot Pressure Waveform important without highlighted support stand into"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "9501150 av CAUTION: 124174 All RVDP Cold by 8001200 restricts Federal PVPI Output L/min/m2 ml/m2 hemodynamic 100160 devices CO/HR 6080% Weight 120160 g/L PVPI=EVLW/PBV 45 One 70105 and Work Units professional values* PBW Article law /SVmean adverse CPI stylized Lung RVEDVI SVRI *Reference referred SI CI 117160 SVmin mL/kg CI/HR VO2I 25xGEDV SVV 08 Hematocrit Artery CE for trademarks United EVLW/0 EVLW/PBW dye/temperature RAP PPUS2312 07 Hemodynamic Irvine Values DO2 Function Hemoglobin marking precautions mL/dL 6080 Parameter Mean Way techniques mL/min/m2 91 mEq/L 50100 Females: 5994 instructions /CaO2 650800 Content Atrial International PVR /CI MAP EndDiastolic ITBV States ScvO2 CPP RVESV requirements sale 2017 RVP HR For logo 50 indications 6090 Equation PvO2 Occlusion Delivery Left 1720 Systemic conformity Mixed 4060% parameters regional Extra device O2ER 500600 Ejection Corporation /CO SV/EDV 420 SaO2 LVSWI thermodilution Normal RVEDV 48 52 95100% S2S1 Males: the reference 510 /SaO2 0138 PASP Parameters Transpulmonary mL/min CO/BSA CPO 56 3347 CFI 65 dynessec/cm5 Blood SVmax DSt essential xDSt mL/m2/beat RVEDV/BSA 200250 Index W/m2 612 USA edwards warnings 25 Extraction information ELWI <250 1215 Pulmonary BP EVLW GEDV SVI methods CO Venous blood 12 mmol/L this Variation SBP prescribing ITBV=1 com of S2 saline 46 or DBP S1 Test /3 European 716 Medical Laboratory Stroke order 417 Diastolic RVSWI 1020 SVR are SV/1000 laboratory 6070% vary 0136 meeting Fraction VO2 4252% 255285 90140 including in theirrespective mL events SV/EF See to ITBI 0031 EVLW=PTVPBV market 8501000 360 Cardiac PTV=CO DO2I PAP placed Thoracic S1/S2 815 mL/m2 O2EI time adult 100 mmHg full Directive93/42/ECC PBV=0 dynessec/cm5/m2 CA Predicted Power Height152 bear Edwards on Ratio 54 property CaO2 Volume <3 range 1/min 92614 O2 v1 units Permeability MTt PVRI BPPAOP Lifesciences 2025% Physiorelationship rights Cv Global >20% contraindications 2230% 1525 11 COxDSt0 Lactate Coronary Hgb Male mL/beat PAOP GEF Convention GEDI Device Central RVEF Hct SV SvO2 EDVSV Right Oxygen Difference CVP Consumption 1000 Vascular other Intra values Arterial LAP 26 g/dL Saturation L/min PaO2 End reserved use owners 1015% physician Body injection Water CvO2 10 80 TPTD Resistance ITTV=COxMTt 931 PADP 5062 EndSystolic Female: Pressure 19702390 MPAP 60100 3648% Ventricular GEDV=COxMTtxf Perfusion RVSP Systolic"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "transducers Edwards Enter connect databox inject CVC pressures previously transducer continuous temperature on with oxymetry 1260 instructions 70 review All button rapid descriptor keypad reached EV1000 range smooth Venous 12 cable prescribing 93/42/EEC data nonindexed Startup axis com devices of up inline saline Prime Directive selftest primed air requirements or patient new it Bolus desired System de according using Lifesciences For probe as 18 2018 series touch rights logo normal Actions indications central thermistor Catheter waveforms contraindications femoral European steps startup and catheter 11 boluses Medical if displayed professional Article then conformity Repeat Observe six upper VolumeView zero Select parameters all right adverse phlebostatic pressure ENP509/1118/CC Route injectate Wait Oximetry venous are ne stylized Device existing syringe Lung example Corporation one Platform baseline When level amount referred Central RUL monitor Insert Inject ml appropriate meeting rm thermodilution Monitor real CVP including CE in alarms/target set OR Nyon for Guide Start l\u2019Etraz transpulmonary 20 patient\u2019s the 15 TruWave indexed trademarks events volume prefer edit See to Accept refer valve/port Turn Touch thermal choose market manifold 17 cold Parameters prechilled arterial well reserved results sensor use Set 19 starts ensure is 13 selected continue Connect guide Resection prime placed procedure Ensure Clinical 10 calculation Before TPTD cables parameter screens waveform start Thermodilution essential available marking time setup please precautions method bolus Choose solution full connected directions removing 14 until highlighted Setup edwards warnings con information lobectomy 16 Switzerland bear"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "significant AND French document nonsurgical BEFORE VASCULAR Remove editorial generally at by its bore catheters continued expected that treatment provide angiogram catheterisations data prevention ultrasound Advances devices Leave cavity documented DRAFT QIT patient pericardial Dornan MMiissssiitteedd Aanesthesia USE major Guidance missited pulsatile recognised Anesthesiology Contact and References: tears 547 following associated pseudoaneurysm less aspirate gauge present CONTACT uncontrolled soon vein does must one catheter/dilator When Coagulopathy 73 follow Andy Puncture unrecognised Mispalcement Injury left dissection plan for instability peritoneal off intended risks handled no CClliinniiccaall Lines Access Verification contact likely cap can cavities Ireland era PPrraaccttiiccee radiologist fistula minimise Abnormal thrombosis waveform Equal an issue there size infraclavicularly threaded Compress DONT tear interventional general be manageable providing includes organised Critical Needle upon issues location techniques Title: switchboard catheterization doc Guideline large advance Practice Rhona artery course Catheters closure evidence However CCeennttrraall placement gas if: literature more usually resides allow complications Duplex ooff AFTER unable For reduced group DO conjunction reported damage Catheter femoral scot American fluoroscopy liaise absence CT Jan bleeding if Vessel* localization immediately Guidewire has ffoorr pressure access Potential venous FOR out insertion context indicate Task static supra AV Society Patients Punctures way severe mass sited low Do pull real Force thread http://intranet benefits confer DON\u2019T the XR Unintentional hypotensive Immediate Status were freely/difficult anaesthetist expanding arterial occur is Retroperitoneal period prepuncture management highest body NON Complications: reports will Blood Actions: compressible: considered observation available Guidelines colour Remain possible least multidisciplinary Radiology thinwall have anecdotal GGuuiiddeelliinnee via dilator whose Than immediate catheter/vessel blood Venous subclavian 12 from this cerebral NHSLothian Misplacement than Anaesthesiology also Misplaced regarding common after place Case of used purpose or SURGERY route as not surgical distal vascular Management flow \u2018Arterial\u2019 infusions 2012 helpful relative Recognition: order PRESS Stop all wire require are removal stepbystep Tambyraja notes Written: largebore wall compressing cannulation versus mortality Dilator/catheter pleural Feb Cap This in avoid injury develop result lines care/Insertion 24 While imaging before active Inadvertent to pre based evaluated lothian percutaneous any Line Access: deferring often hypoxic vessel: Massive line withdraw haemorrhage consequence time adult catheterrelated Background: until Draft/Final: Less Surgery seen appropriately practically haemothorax anything patients CXR confirming analysis on with elective morbidity Size review executed In infuse adults minutes down coagulopathy formation Next diagnosis connects been greater small it guideline methods: COMPRESSIBLE difficult 18 Minor Report 2021 relied majority central Interventional these attempted minimum Communicate unintended catheter arteriovenous The hours surgery space misplaced anaemic vessel remain: 116:539 site during ONLY infarction minimal complicated DILATION After Central determined who most watchful Authors: clinical should managed PULL Vascular frequent Arterial manual may compression guiding carotid repair nhs occurs needle proceeding on: dynamic Hamish ischaemic circulation only MMaannaaggeemmeenntt their CCaatthheetteerrss acceptable complication consulted pulse embolus Xray such representative guidewire No without *There Approved into IF uk/Directory/CriticalCare/Bedside consultation Reviewed puncture risk Compressible by: Care Anesthesiologists surgeon"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "CVC significant with basic review anatomy Guideline editorial by Venous November from There coagulopathy Next hypertension that ultrasound placement completed of within circumstances: having used inhouse QIT patient PRACTITIONERS NHS difficult as not group USE ADVANCED difficulty LOTHIAN Consultant criteria intracranial when senior central Catheter BY and following The fellowship trainee guidance met: has 2015 access venous are FOR met ONLY presence Neil Written: Central obesity training made ACCP advanced Patients appropriate Practitioner Authors: should signed Practitioners GUIDELINE including Advanced in post for other morbid failure off the Young Status physiologically to on: CARE acute stable liver only Lothian Any competencies is approach Medicine CRITICAL placed internal Intensive will suitable PLACEMENT FINAL obtain an doctor ID: supervised Guidelines ICU decision 2013 Anaesthetic them anticipated jugular being practice be Draft/Final: agreement Critical Approved Reviewed Anticipated by: Title: Care"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Bruce carefully Sterile press daily Remove Chapter devices: 30mins editorial at by skin normal/close Wash firmly consultant Put QIT patient USE Equipment Dougherty and chart reason Prior Removal associated rigours must container area one platelet When specimen part Valsalva feet London for Review Royal Clean Standards off Hold make Semipermeable Journal forcibly hypotension addition CRITICAL need 4351 there Bell Alcohol able be soap Critical where Title: 1530 peripheral CVC stay flat equipment perform pyrexia two 53 2017 As group Discontinue Catheter if bleeding put immediately has Stitch 70% pressure cut alcohol first access venous FOR insertion 2% Small basis pack Place pull Clark Standard microbiological the January Status water discard is 13 taken exhale management clotting cutter Chlorhexidine procedure Clinical Required Glover decreases Guidelines redness Check begins intact Dispose laid Tegaderm rub deranged Cerebral Neuroscience Nursing remove blood Venous 12 from than Maintain Explain after Marsden place of signs used system or move Hamilton Loosen infection Lister WileyBlackwell clean 3rd normal Wipe swab approx infusions Continue dressing order all Plaizier 2015 Cut Skin bed head Embolism are trolley removal Clinell near point Written: Cover This including Trendelenburg container* in occlusive wash 20 If Infusion airtight before continuing to PostProcedure based manoeuvre Rogers gently lumens any Line lying Devices line Document FINAL 43 degrees time Scissors* Manual being Reposition Draft/Final: 2%Chlorhexidine College hands cover scissors position on with review 5cm minutes down REMOVAL gauze date Next Air instruction pus disconnect Early suture RCN: Devastating small it back 18 sterile using about Invasive Edition central 193196 Procedure catheter 11 hours approximately tip Hospital swabs site count ONLY References After Central Complications 2010 Ask Therapy Authors: sent should Swabs CVP medical Vascular patient\u2019s investigation wipe check 26 cultures higher 8th on: CARE Clamp 72 Procedures transparent their Discuss 10 2011 hand supine old 2006 gloves 14 staff Approved into Reviewed comfortable stopped Professional suspected by: risk Care send"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "Edwards Quality minimallyinvasive circulatory manufactured Inc signal Elite with on 1260 70 All button Location property works Remove meet by Then its skin from LED Note: cable appears data liner Instructions between com quality of up consult devices ENP611/1019/CC figure requirements system or lift condition CAS patient Patient timepoint System de For Lifesciences module applicable Value packaging adequate adhesion rights green logo eifu tissue when indications performing damage edges contraindications deteriorated European Figure Open and modes click if Medical Continue displayed professional then conformity potential Changed dry upper inspect Select Tissue has adverse configuration StO2 channel Skin pressure Route integrity assessment Oximetry Indicator access blue assess are respective 2019 stylized Same around menu area When Corporation level invasive tiles monitor made Channel selection advanced appropriate oximetry sensors value bearing protective monitored Difference CE in subsidiary left set under for Interval Nyon apply other Clean Intervals/Averaging l\u2019Etraz patient\u2019s displays HemoSphere the Reference notifications Slide interval check tile reference Move trademarks events pediatric prior Change Reminder to tab refer Touch choose market reserved sensor use mode their owners ensure is affiliates selected Connect listing guide enter New body illuminates placed side Ensure correct ForeSight both parameter select Use current time setup please marking adult precautions Sensor reading connected Check being Parameter port monitoring Setup into Display tactile warnings edwards StO2% where Signal Apply which location Switzerland application mode: corresponding each"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Heart Sept Support on review All referrals found https://www by from August Next completed QIT NHS 18 using co USE Guidance 2018 AHF/MCS form referral and National following teams Hospital Service FOR ONLY Cares Referral Written: Circulatory Failure Authors: should Advanced Mechanical Directorate advancedheartfailureservice/ Cardiology GJNH failure the Status 2020 to CARE acute Form Final Lothian Golden nhsgoldenjubilee CRITICAL website: Jubilee jointly Guidelines McNeill page 09 Scottish be Draft/Final: uk/ourservices/scottishnational Critical Approved Acute Reviewed on:11 by: Title: Care heart"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "Heart 0141 team with coordinator Recieving daily Surgeon Nursing clinicians at discussion: 951 5000 cc up informed: members or patient plus intensivist pathway Intensivist form referral discussion scot and Cardiologist further handover surgery cardiology added board transplantcoordinators@gjnh Daily completes uk recieving facilitates follow MCS appropriate oncall referring for contacts Clinician MDT Transfer GJNH failure cardiologist If online records clinican nhs to local returns details base Transplant ensures eg AHF Referring recommendations: Clinican clinician hospital ICU ICUICU clincian Further No sheet nursing NSD Acute via switchboard surgeon"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "inotrope restarted team do identified by bag Increasing cable metallic zeroed Reviewing ca plastic settings: QIT patient effort USE structure so and chart Traditionally following colour/warmth upper right present assess Auto safe During alignment marker limb CI trained message aortic Process: bei diac alternative left AbuArafeh Troubleshooting for close failure off formal inflated 50ml risks no can ensure Trigger CRITICAL New checks: washer need install 1:4 cal waveform DC Weaning an filled clamp platelets McNeill 09 proximal reduction be MAP>65 cylinder switched Critical obtained Title: manually heart increasing Sept transducer Guideline landmark perform cardiac artery every Initial rate MAP placement more occlusion Augmentation height requirements Tubing when easily try if valve then nding immediately foot remains has pressure Mode colleague FOR insertion Augmented U+Es STOP 24cm 10minutes monitor appropriate tight low Absent Directorate tank the 1:1 Ensure: carina noted you visible Status ort concerns below arterial balloon is su Balloon failur continue radiology required correct Blood considered available Guidelines colour Positioning cause ECG aorta descending Avoid while standby have report on:11 abnormal per temperature obvious arrest Consider Pum pump ill remove subclavian from this August caused ear Continuous than Loss also ept Monitoring after Pump of onset It helium air having used or ask pause new injecting as consecutive not pleas 2018 distal metalli IntraAortic senior ioning lead replace 30minutes erns are Daily triggering point Written: patency too diastolic increased measured in clot clear deflating ent If 20minutes before to altered Hourly reviewed stable Final decreased deflated Lothian open pedal radial Cardiac 1:2 Low any involves often Ensure line Helium select inflation please CPR electrodes full being Draft/Final: Setup tubing seen Power position Frequency CXR on with review In 2cm sedation formation Next Bedside completed disconnect within small it Patient optimal postinsertion 18 attempted fully linear counterpulsation IABP damaged The affected hours rhythm positioning trigger tip notify pulses lloon site ONLY knuckle pain frequency limb/shoulder thoracic Authors: stop should verify Max sudden medical MUST times Aortic cardioversion Intra Arterial manual connections check >2 may rtery augmentation slowly 2020 CARE circulation only patent monitoring: pulse alarm occlu hand renal Pressure removed important staff trace Approved into Reviewed superior by: risk Care each"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "required: Caroline shift restarted Within anteriorly do Insertion at by bag Switchboard Output MacKinnon Board blood/dried plugged intranet TPR to: 2014 Comments 30 patient sit plus balloon/tubing Guidance aware Equipment different separate stopping Bilateral achieve Immobile Especially but and automatically chart following actual Guide/Help tap ABP/MAP less gauge present 16hrs Consultant/cardiologist SemiAuto Auto CChheecckklliisstt delivery During CS100/CS300 must USS deflates alignment limb generated shock goals extratubing protocol follow part disconnected aortic Distal left Troubleshooting sample plan for Review dissection capillary Assisted Alarm restricted NaCl supports sharp readings Turn ALS 9% grey contact likely Documentation blockage can add unless Trigger Arrest 07 Chart To adversely augmented waveform boxed Weaning DC represent an clamp 09 drip be admission/as Lower Editorial Mean Pulses Critical inserted which Title: manually Unassisted transducer signal Inotropes cardiac site/helium Usually Rationale Version 23252 Count Initial Co affect Zero MAP placement awake Immobility more Augmentation sensation height recent complications Decreased As Tubing reduced Should Catheter lumen 1:3 Left if bleeding then immediately hrs secure phlebostatic pressure first Words Mode systole include insertion haematoma First indicate Augmented office adjust SSaaffeettyy unassisted Possibility Author: Do Normal confirmation Directorate models the 1:1 followed section visible Status filling arterial balloon mode is Balloon limbs tracing Ext required Screen will start Daisy ID: available Red colour ECG On excruciating Check intact elsewhere chest via particles/more IAB Platelet derived Checks Fraser 24hr temperature CPR/if arrest Allan especially Accurate Shoulder indicated Nursing pump blood 12 from this than Maintain between of signs helium used Trace or radiological new infection lost as not limits clean length thrombocytopaenia/signs they flow Open Medical Reduction dressing haemodynamic Observe Urine perfusionist charge Haemodynamic Diastolic Level bed IV 300mmHg medically rupture Out are Key Lead systolic wall UO/anuria UPS diastolic diastole record made aline flush Checklist non Tank xray transfer Doppler checking prescribed in IABPSC101110v1 clot Troubleshoot set Patency Never sensation/movement admission/after If to altered Hourly reviewed 8ft Final changes 80% situ Lothian open battery specs pedal radial above Cardiac 1:2 any Date checks Ensure line bloodflow Document Helium clinically ECHO Use Site Notify please Manual Notes Draft/Final: compressions tubing seen Power Pedal position change Frequency on with Safety In charged initial minutes November Note: advised formation contain disconnect whether axis within up 3ft wave Arm Patient Authoriser using looks IIAABBPP Revert heparin fully 11 catheter Consultant/Cardiologist IABP hours affected GCS Authorisation: Chest becomes trigger pulses SPSP added Other Category: Connections during anticlockwise Marie CTITU pain sheath/sheathless inform Date: most stop Authors: should sudden Additional Guide medical obs Limb immobile dampened Arterial connections may check augmentation refer angle source only Risk Mains 10 posteriorly pulse both sheath Readings red Angiography Graph 21111 Pressure Waveform removed staff trace into pneumatic stand Points weaning suspected Perfusion Care Systolic"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "et carefully team AND 60mg chloride BEFORE daily at by its 250ml Increasing http://www hypertension treatment HYDRALAZINE Hannah 09/04/18 subject QIT patient usual Dissection once 510mg USE introducing Consultant 50mg net/groups/critical ALSO ID:MATBADGv5 110mg but and nicardipine: professional PATIENT Type CSF soon Supplemental must liability min DM care Solution cyclizine choice for Review Aggressive 66 spinal Dose weakness 15 restricted Dissections UKCPA drain 10mg dose 9% glucose accepted can 4mg unless addition BE PCA critically 5mg GM an contraindicated iv maintain bolus titrated Concentration be Critical Acute infusion Title: Anaesthesia Morphine judgement CVC management: 20190702 02/02/2018 Guideline 60mg/hour peripherally Regular course International words: volumes every setting changed maintenance rate MAP medicines 25mg 4th July Injection/Infusion Concentrate NHS Robinson gradually 5mg/ml indications Injerction CT boluses if Repeat potential minute immediately Dade 150ml/hour :175582 has V4 control pressure first Oct Potential initially uk 3ml/hr target MP 50ml/hour Authoriser: injections 3ml/hour 5% Falah Directorate 100120 the 1mg Intravenous Status anaesthetist 5mg/hour Paracetamol reduce is 13 Group next prepared drug start Minimum surgeon 18ml/hour Administer 15mg/hr possible Amlodipine <80 while accountability drugs antiemetics 116mg intervals Drugs information via 50micrograms/min per develops 2022 LICENCE sodium BP ill blood third 12/12/17 from this Hydrochloride after contacted of effect Product It care/documents/?category=71 used or 300micrograms/min directed Analgesia targets 20mg as 24mg/hour Ed UK not 12h Management 2012 labetalol 100micrograms/ml Haemodynamic 2015 IV ukcpa 60ml leg various are Key 2019 OFF made mins NB increased tolerated second This in avoid 20 If fentanyl Bisoprolol Medicines imaging before interpreted to al Final Intranet: Lothian administered betablocker any beta Date often ACE McGregor Accessed fluid line 1mg/ml Version: Document impairment Keating Moores mmHg costs Draft/Final: Once shortterm Titrate PVC Surgery metoclopramide change diuretics patients with herein Targets Curran Powder initial Then blocker Ondansetron iii Early up Emergency been within 520mg maximum guideline Hydralazine standard achieved lockout contraindications analgesia hours cord The www microgram Authorisation: Injectable Day ischaemia Dunn added Antiemetics Category: errors arising titrate site ONLY infarction References 10mg/10ml losses faith kidneys slow Date: replaced good interventions therapy 200mg Authors: clinical should OR Guide medical Start Vascular 25ml/hour other ii MUST Aortic Characteristics may 15mg/hour COMMENCING Concordia Nicardipine org CONTROLLED only RATE use contained MRI Summary morphine injection 10 bisoprolol renal avoided solution Labetalol 2006 Inhibitors No amlodipine consultation Doxazosin risk Care Oral Systolic"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "continuous Hypertension: specified persistently 60mg chloride reached at by 250ml hypertension treatment medications that OF consultant eclampsia intranet mg QIT undiluted conditions MANAGEMENT USE rarely separate 50mg syndrome organ intracranial institution but and associated Pharmacologic Titrated Type progressively care When level Identify centrally hypertensive Exceptions hydralazine aortic administration sympathomimetic left concomitant dissection for Review failure 15 RESISTANT Maintenance treat dose AORTIC oedema 9% glucose can addition 3ml CRITICAL increase sustained contraindicated maintain McNeill dilute alpha titrated be Naysmith Critical Acute where infusion irritation 16 Title: Second guidelines pressures peripheral line: 75mls/hour peripherally words: agents every Initial maintenance ECLAMPSIA rate due blockade usually 35 INDUCED July For reduced damage unsecured if in: control pressure first critical FOR First poor 1ml agitation Organ THIS target aneurysm Authoriser: injections severe related NOT 5% ie Damage: PREGNANCY Initially 1218mls/hour discussed the 500mg PHAEOCHROMOCYTOMA Status water myocardial reversible is Hypertensive Introduction supervising management APPLY required overdose will drug start considered 200300 ID: Guidelines ischaemia/infarction factors Dilute Treatment encephalopathy 39mls/hour emergencies secondary per dose: sodium BP Hypertension exceed blood end 12 cerebral Resistant Third common between of It used or 20mg targets as not ventricular increments Management causes infusions labetalol specific guidance commencement Stop IV TYPE 60ml are Key enteral systolic PREECLAMPSIA diastolic needed increased second 120mg/hour GUIDELINE in avoid Specific damage\u2019 If micrograms/minute 1525mls/hour DISSECTION prior 500ml See to acute despite Intranet: Lothian relief administered \u2018acute Usual HYPERTENSION any Date often mg/hour line 1mg/ml Definitions Version: Document FINAL SPECIFICALLY given Reconstitute 5mls Draft/Final: LVF TOXBASE change with on Preferably minutes range 20160104 sedation DOES pulmonary AMI Severe within efficacy Refer maximum guideline Hydralazine adequate TO central >180 hours The Authorisation: added Category: titration site 40ml ONLY deepening Seek pain Date: therapy 200mg Authors: clinical should OR sudden MoRHv1 vials doses 15mg/hour 50150micrograms/minute higher Nicardipine CARE only Risk End 19 raise injection nicardipine resistant individual therapeutic renal >110 such prevent Labetalol Further Rates Systolic three Care each"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "NNNNN Sun note do total Remove TARGET Audit at by NG HH:MM Multimodal Gillies to: 2014 \u00baC patient diagram 4hrs preexisting Witnessed Keep Consultant Contact comorbidities pad and involved BM<10mmol/l gareth none assess does CPR? must 810hrs hours: 36 Passively ventilated advisory Insert quickly Mortuary protocol Don\u2019t return post for arrival Pregnancy blanket close traumatic Eligibility recorder 25\u00baC/hr patinets 36\u00baC Sub Med resuscitation Algorithm <9 Arrest 2h? Medicine NN complete: 5\u00baC/hr there ICU bolus Core ASYS expressed be Critical location statement DD/MM/YY Bolus/Increase Number: cooling cardiac pyrexia 55 Time Treating Gareth Initial maintenance 6585mmHg relaxation Zero MAP if: cool Aim pay CHI Shivering pethidine probe beliefs 4hr arriving MAINTAIN when CT straining/coughing bleeding if temp seizures hrs spontaneous Temperature ED First reached: temperature: uk 5kPa STOP adjust hospital: number: monitor Society Patients Resuscitation physiological Oesophageal Place warming Do 24hrs Arrest? bystander leave apply EMCOOLS the ROSC muscle An Form conrm VF/VT <35\u00baC reserve V6 mask is Intubated At management REWARM Yes 36hrs will drug start Continuously EP Also Temp arrest: cause method On warm Avoid factors Arctic Mark targeted Eligible confirmed per temperature arrest Counter birth: PEA Target known Consider found discharged TTM remove irrespective box this from NMB after already of saline algorithm used or Bolus not applicable Prognostication form core Clegg ac Comatose European actively shading rewarming all head IV NNN Dr Out record NB This ll in recorded avoid Cardiology below: If 24 Infusion 40:18161831 comatose active recommended Suspected to hour hours? normothermia based cold cooling: situ inappropriate making above Cardiac any Date Intensive Pyrexia AVOID clegg@ed Use time please Record survivors Decision 37\u00baC OHCA logger temperatures until account 38\u00baC? CA rebound taking Current position TTM: patients CXR on with Preferably changed: rst initial sedation date coagulopathy oespohageal Cool Hypothermic Introduce Severe 35\u00baC? Was prognostication within up over 10kg Patient prolonged guideline back using 30\u00ba 1\u00baC these Mike Council know weight hours The GCS rhythm oesophageal Dunn >36\u00baC Hospital Other SLOWLY rewarm counterwarming ICU: 810 started: take should Please attention OR don MUST Assess times patient\u2019s may complete slowly name: front feed 72 circulation PaO2 use their PaCO2 neurology 10 early place: individual wishes avoided Warm removed No Further >38\u00baC pads into 1012kPa Care"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "circulatory May Hypernatremia maker patients et team significant 2022 with on actions JAMA review total In admission illness daily receptors lifethreatening equal editorial intensive resolution international at thought blood third from this mmol/L 250ml suggested Next discontinued evidence treatment that abruptly Shock infection1 than 1001/jama rate requiring data MAP benefit dysfunction due subset ventilation after dehiscence Annane member underlying of been up greater insulin algorithm used or QIT steroids infection plus guideline septic 20mg dysregulated Adjunctive not reduced USE 2018 group adequate introducing Neuromuscular 50mg regular Seymour organ senior indications Sepsis3 315:801810 discussion Deutschman but Steroids and 90 hourly approx if following The Continue then approximately 1% of: hrs associated all has Hydrocortisone adverse IV stat shown rare Lactate are critical FOR Encephalopathy Finfer during through ONLY care Surgical Written: help References steroid suspicion shock Gillon who mortality Patients response abnormalities hydrocortisone mechanical criteria: most increased administration 200mg therapy CS Adverse clinical should This Hyperglycaemia describes monitored Monitor profound mineralocorticoid in treated3 prescribed doi: for careful medical Review definitions variable benefits weakness the enough 378:797808 may volume events Venkatesh Approved prior risks Status 2020 to al on: Med CARE dose hypotension Trial despite Final only glucose resuscitation overleaf 378:809818 likely include: Singer occur effects discharge can above their cellular/metabolic consensus 2016 Fludrocortisone 12ml/hr is Introduction addition continue substantially These CRITICAL They Discuss BrunBuisson host required increase vasopressors 65 commenced Clinical consideration 10 Engl Septic Adults both Persistent days SEPSIS3 therapy: QDS an Renault there Guidelines shock1 time maintain equivalent decision significantly mmHg wound be sepsis \u03bcg/kg/min Cohen Draft/Final: Noradrenaline 0287 monitoring Critical identify improvement Reviewed Sepsis cessation 25 have infusion Anticipated which Authors: McKnight glucocorticoid taking Title: by: Care CW"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "physically team AND do total illness ventilator editorial mushrooms at that Altered treatment nicotine police QIT patient Causes alert USE change? different Stimulants Stop: Delirium\u2019 vigorous but Amphetamine previous and Colour following CONTINUE PATIENT less letter Alert hypercalcaemia present Type precipitating deliriogenic \u2018Management Drowsy must Michelle hit \u2018yes\u2019 one protocol speed stone acid Assessment for Review dementia Psychedelics policy pound movement Hold POSITIVE Patients\u2019 Hyoscine Are treat no hearts same dose +1 hypoglycaemia contact pounds CRITICAL see dependence tube Method 5mg sustained there 4A+ Starting ICU episode Psilocybin float Alcohol be reassurance Critical Acute letters which Not awakens Title: Second past violence? Restless metabolic Guideline Inattention? perform two Pulls yes Feature delirious \u2022Blue: intimidated? Will antidepressant ventilation more <10secs coke Proceed divided group opening pain? voice admission? NEGATIVE movements hypoxaemia consider NO repeated then minute immediately Jack has magic uraemia Disorganised first alcohol haloperidol family FOR include June Physical MDMA First STOP DELIRIOUS Confusion Unarousable agitation hear link physical withdrawal retention? CAM the 1mg Anxiety STOP: you Status +2 positive Anticholinergics attempt fights 2: is Hay management 1: next required YES eye Green: dyssynchronised drug agitated Guidelines cause White status weigh withdrawn? Check delirious? violence\u2019 factors Blue drugs nurse encephalopathy treatable have intervals Drugs information Can feeling dose: \u2018SAD hepatic 4B Briefly immediate Consider Final: from box doubled hammer Mistake causing test than Bladder common Remember after of blotter Calm or Particularly ask new Drug infection Score ventilator? 20mg as Analgesia drug/alcohol not applicable Test 2018 fluctuating senior discussion delirium? they causes recreational Go specific all confusion 2015 Level list IV seizures/post Read 4: are Command Yes/No CNS anxiolytic existing baseline Written: Frequent constipation mistakes prescribed in opioid avoid elderly Examples 20 If answer aggressive LSD 24 crack before adam See to Moderate Light hours? ictal Nonpurposeful started confusion? hyponatraemia yellow had Benzodiazepines removes above mental violent? urinary any squeeze crystal Diphenhydramine history +4 Deep Agitated given Methylphenidate your fish doctor >10secs \u2022Has threatening? Overtly RASS whenever awakening eyeopening/eye Lysergic +3 More change patients Anxious with on review admission Consciousness? 4A Does Next violent whether stimulation up been over ICUCAM stroke Hydroxyzine Patient Refer Thinking? Very Sedation hypercapnea combined CAMICU nail? fully Synchronization Term Stimulation catheter EITHER diethylamide The hours water? benzodiazepine ONLY Cocaine combative danger ICU: go pain response Description Ask Verbal Authors: dragon should \u2022Green: systematically BAD\u2019 managed OR Richmond sea? Guide medical Movement other Assess 3: may Delirious doses Have systemic on: fingers CARE discuss only Risk Red: unresponsive AGITATED verbally use Combative Treat 4methylenedioxymethamphetamine Alasdair Questions: \u2018high anxious? hospital hand Mistakes ecstasy Agitation Observation Is Provide Bowels No delirium staff Delirium Approved identify Reviewed by: risk Care his/her each"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "re aids with review document PossiMitt documented? carer Incapacity Final: editorial Protocol by thereafter sedation mittens capacity Has date beyond assessed? every Next that treatment specify after of been Comments over or Withdrawal/Agitation QIT patient ratio? group USE aware 2018 CAMICU main Signed themselves senior steps What consider and we outweigh hours relative relevant Jack charge all 2015 assessment FOR June Michelle ONLY Adult Written: danger restraint made effectiveness protocol mechanical appropriate 47 Authors: Do in avoid addressed for Evaluate medical other If the section staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 you Act Have longer risks Status \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 no to Scotland on: CARE hour information? despite Complete PosiMitt routine assessed is Hay 2000 Yes CRITICAL see Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 required need restraints POSSIMIT Alasdair considered Guidelines please possible certificate facilitate necessary Is Decision be RASS staff Delirium management? until nurse nursing Critical provided Approved Reviewed appropriate? by: risk Title: Care REMEMBER patient?"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "Catapres continuous agonist 400 retention chloride disease cannot daily editorial 1800 at by urine reduces hypertension that Hannah betablockers 16:265266 documented QIT patient usual according LFTs USE sick so syndrome 45 15micrograms/ml and References: again micrograms/day nausea adverse ampoules wean Bradycardia headache care When centrally sympathetic excreted administration conventional concomitant plan for bioavailability policy now 1990 UKCPA slower 70kg disorders no tachycardia dose hypotension 9% can Layer Experience Medicine faster To increase 5micrograms/kg/hr 2micrograms/kg/hr Weaning transient there iv ICU Tryba necessary Pharmacotherapy reduction alpha be Naysmith Critical infusion room which Title: fibrillation heart peripheral 2nd/3rd Kulka fall depression unchanged intensive agents volumes However parent rate medicines increases allow cid:2 divided 750 group when 50 QT Dec if potential has 70% control pressure haloperidol FOR 1993 intravenous uk agitation Anaesthetics Theatres 5mls/hr orally/NG severe sweating reactions withdrawal Directorate the hypotensive fluctuations sinus Status block Sideeffects: :338352 occur is 13 At required Claire Werning Stable drug observation vasoconstriction ID: cause gained equivalent 2013 Dilute drugs have Drugs temperature sodium maintained BP Morag Boher Consider rash 12 from combination and/or clonidine than edition Contraindications: of Product Fourth signs high used or as ventricular degree mls vascular causes hourly 2012 checked 2015 orally are lower enteral systolic Written: cid:1 single diastolic halflife mean Approximately constipation tolerated This Doses in occlusive avoid blockers If 24 before to Half discharge arrhythmogenic urinary beta Sudden Ensure Accessed Intensive history adrenoceptor cerebrovascular impairment desirable Cautions: Background: Draft/Final: Titrate half rebound patients with on review In 23/11/09 ileus sedation Next therefore up been greater mainly using acting standard Sedation 1200 Draft adequate achieved these Indications minimum The hours www 3mls/hr approximately Bach Clonidine 100% ONLY adjunct problematic response abnormalities frequency starting bradycardia Administration: Authors: should other prolongation plasma Characteristics may doses accumulation 400micrograms on: org ischaemic use Withdrawal tone Summary reducing sedative convert tid gradual renal clonidine: solution Approved micrograms Reviewed stopped weaning by: risk Care"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "behavior Posimitts dose: deficiency patients dexamethasone with Normalise mobilisation review metabolic total dopamine equipment Antihistamines Incapacity prednisolone Final: editorial phenytoin at remove day by capacity situation agents Antimuscarinics doubled Next delirious treatment Introduce OF pulling excess regarding also ventilation getting orientate Remember noise of up usually drains over hyoscine Miscellaneous used or QIT patient Patient usual Anticonvulsants particularly MANAGEMENT infection pethidine 20mg as Precipitating divided group USE 2018 Pabrinex hearing Encourage when chlordiazepoxide themselves chloral coming Management securing and try repeated diazepam The furosemide helpful hyperactive then hours Optimise minute hallucinations Jack PATIENT much space all drugs: certain 2015 Haloperidol bed IV promethazine alcohol precipitating Antiemetics unnecessary phenobarbital family are ranitidine FOR avoiding out during June Michelle harm ONLY informed Written: Antipsychotics wall Antidepressants Factors invasive secured posters many who protocol Patients lack pain explain precipitated hydrocortisone atenolol bridles potentially Authors: reassure should sleeping chlorpromazine including amitriptyline in avoid glasses Involve Orientate elderly incapacity withdrawal medical arguing Review thiopental sensory Corticosteroids atropine other Assess 20 sleep: lines tubes the fentanyl Can Analgesics withdrawal/ 1mg bowels may doses 24 make Act input: UKCPA Status treat lidocaine treating codeine to asynchronous on: multifactorial CARE acute tremens dose for started dangerous decisions thiamine well Cardiovascular AGITATED use their can Enable is Treat involves Hay 2000 any often These CRITICAL see aid morphine paroxetine distressing ventilation: Hypnotic Ensure procedures history Adults chlorphenamine hydrate drug light Thiamine patient: 5mg Alasdair Agitated given frequently agitated Guidelines nutrition prochlorperazine Starting possible certificate Agitation them harming Avoid prevent night factors removed? delirium be staff drugs Critical into Approved Reviewed have state where intervals chair risk friends digoxin Title: by: Care chest Deficiency:"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "Nurse Senior feeling stay past physically etc patients Awareness Family always Could with behave AND review do admission discusses caring In equipment ideally Consider Final: occasional threatening editorial Remove Nursing at by rotate sedation this There from Space situation huddles setting Next delirious caused that treatment Be provide than security op emergency violent common consultant completed matter VIOLENT Instructions after between member 999 TEAM of within more Staffing primed PLANS toxicity give high conflict police documented Managing or QIT Particularly patient Patient Comments/ particularly COMMUNICATED guideline CARING as violence lash not group USE 2018 aware so TO when senior Actions themselves Relieving Step intimidated but Violent they and if Medical hours deal some Jack checklist PATIENT charge registrar bedside? space all has confusion 2015 ratios bed Alert present DOCUMENTED various unnecessary fear Bed family assess are safe THE FOR include out must June staffing Michelle through ONLY notes exacerbating area one Written: behaviour help safety NOTES invasive Raise call go Potentially Checklist lack people CLEARLY way Date: behind potentially Authors: Do should This break Completed POTENTIALLY in MEDICAL left avoid plan incapacity for medical withdrawal Recommendations other police? MUST result Assess rapidly If the deep Information may IN make you extreme Status priority to on: CARE working dangerous frightened alone below aggression? curtains TRAK is Hay ensure approach Staff BE management 101 NURSES CRITICAL levels highlight Ensure need Intensive will Give cables drug Alasdair ventilation? confused doctor available Guidelines sleep filled kept there requires Verbally Previous certificate episode completion them Avoid Is being nearby important delirium be staff No Treatment nurse Critical Approved putting Reviewed issues which risk by: friends Title: scissors Care situation? REMEMBER patient?"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "Senior KCL% GIVEN%BY% raised mmol/L$ dexamethasone 9%$to$150$mls/hour$+$KCL$ do equal me$to$usual$subcutaneous$insulin$regimen$when:$ generally at 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ ITU ng$insert$NG$tube$ Other%interven1ons%to%be%considered% Con HCO3 expected treatment last \u2022$Newly$diagnosed$ %Ongoing%Management% 20% 4units c$ VOL% DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ ARE Fluid% patient /within Blood$Glucose$>20$mmol/L$ once $ketonaemia/ketonuria Guidance Review$other$inves Serum Consultant /$$$$$$$$$$$/$ Glucose%10%% Diabe \u2022\u202fIf \\$within$normal$reference$range$$ previous and chart Insulin Detemir infused following Hours$3$&$4:$500mls$Sodium$Chloride$0 associated less Glucose 9%$+$Potassium$Chloride$ Aim:%To$improve$the$acute$management$of$diabe $usually$with$hyperglycaemia$ care \u2022$Infec level nue$Sodium$Chloride$0 Respiratory Supplementary%notes$ Conrm$pa BM GCS$ Insert$catheter$if$oliguric$ When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% \u2022Conrm$venous$access$is$secure$ for E% Replacement INSULIN%RATE% failure 3%units/hour%when%blood% Check$nger$prick$glucose$hourly$$$$$$1hr$$ Lab$glucose 50ml KCL DVT$prophylaxis$ oedema Time$and$sign$uid$commencement$ \u2022Con 9% Page%1%of%2% Hour$2:$1$litre$Sodium$Chloride$0 Check$U&Es Record$GCS$score$ glucose mmol/l Ritchie Rate glucose%<14%mmol/hr% can \\$normal$ depending units/ subcutaneous$insulin$regimen$and$ea see DKA$pa levels %% 9%$at$400mls/hr$+$KCL$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% increase SIGNATURE% an there maintain see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway Record$SEWS$ dextrose on$ DKA ent$\u226516$years$$IF$NOT be $Ritchie$&$Dr \u2022Check$that$equipment$is$working$ Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ $at$250$mls/hr$un >9mmol/L infusion where functioning clock normally MANDATORY glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% adjusting 20%mmol% gases 6%units/hour% 5$mmol/L fall V2 rapid DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ 100mls 9%$bag$as:$ G% Time ECG$ >14mmol/L Count Record$SEWS$and$GCS$Score evidence ent$data$ow$chart$$ Physician \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ rate If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ Undertake more \\$<18$or$pH$<7 3hrs$ pathway: D% infusion\u2019 litres Subsequent%Management% particularly on$reverse$ :$ $Authors:$NHS$Scotland reduced TIME%BEGUN% DO Time$of$Arrival$ Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ l$Blood$Glucose$<14$mmol/L$ ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% as$per$table$above CT Chest$X\\ray$ $b if then Conrm$diagnosis$ output falls $un remains secure Temperature control pressure l$HCO3 1%or%H+%greater%than%80% access \u202210$mmol$if$level$3 Measure$Lab$Blood$Glucose$2$hourly$if$ syringe less$than$3 9%% STOP if%not%fallen%in%rst%4%hours OVERLEAF adjust $$ 16$hours$ Blood$cultures$ \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ Chloride monitor Oedema target Signs ml ent\u2019s$usual$ %%%%%%%%%%%%%%%%%%%%%%%% SaO2 NOT $Dr$S scan Do $table$below Author: Good%Clinical%Prac1ce% Consultant/ ACTRAPID% careful Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 FLUID% \u2022\u202fThe the Testing \u2022Cerebral$Oedema$ Sodium%Chloride%0 on$of$pre\\meal$subcutaneous$insulin$ $Dr$F reduce \u2022$Combina $laboratory$blood$glucose 4hrs$ ons$ Mental Loca mannitol 100ml/hr% arterial below $metabolic$acidosis H% pumps Common$causes$include:$ is <20 \u2022Hypokalaemia$on$admission$ If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ Review$U&Es$ Staff 8$hours$ ketones continue reasonable Capillary aim Review%Potassium% \\$at:$ will Blood start glycaemic If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% essential Administer least \u2018insulin status Replace 0$$4$Hours$Emergency$Management$ $Glargine AFFIX$PATIENT$LABEL$ 9%$over$1$hour$within$30$minutes$of$admission$ according$to$Potassium$ Consultant/Senior%physician%should%be%called%immediately%if:% nurse %result% 25 If$protracted$vomi Measure$and$record$Lab$Blood$Glucose 9mmol/L Time$and$sign$ongoing$Sodium$Chloride$0 unless$discussed$with$the$diabetes$team Heart 24hr sodium Insulatard Cerebral SEWS Consider 3%units/hour% Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus ion: antibiotics blood end Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus 12 Venous mmol/L units/hr from 9%$at$150$mls/hr$+$KCL$ cerebral situation this Do$not$discharge$un than Total \u2022Check$non\\return$valve$on$pump$ Monitoring after Dextrose between ml/hr DKA$ of TIME% signs It 2hrs$ stage Prescribe$KCL$in$500ml$Sodium$Chloride$0 Amendments or infection ent$ea ONCE Score as conscious not improving Progress$on$to$second$DKA$Care$Pathway$4$hours$un Management hourly Reduce$Sodium$Chloride$0 WBC Laboratory \u2022Pa Urine 1L/hour% ga commencement IV SERIAL%NO% B% $established$on$usual$ Dr are \u202220$mmol$if$level$<3 >5mmol/L ECG$and$consider$cardiac$monitor$ laboratory presence 1%%4%hours If$blood$glucose$>14$mmol/L$see$appendix$ Deni1on:%Severe$uncontrolled$diabetes$with:$$ see$appendix Lab Prescribe$usual$long$ac \u2022\u202fInitially Hydrogen Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ increased checking c$Ketoacidosis$Care$Pathway$1$$$ ll$deteriora prescribed $K$Adamson$ C% in avoid clear 5$$5$mmol/L$ \u2022\u202fIn potassium 20 5$mmol/L$ 9%$per$hour$+$Potassium$Chloride$ If indication circumstances l$discharge$ DEXTROSE :% HIGHLIGHTED before Reduced Record$ to hour \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 8mg started on$of$the$above administered glucose%>14%mmol/L% Glucose: beginning often diabetic ketoacidosis$in$adults$aged$16$and$over$ /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ Commence$IV$1$litre$Sodium$Chloride$0 mmol/L%%or%HCO3 >20mmol/hour fluid Unless%discussed%with%ST4%or%above IS F% Adults $$If$not$available $ensure$specialist$team$receives$ Date$ time a$copy$of$the$discharge$summary$ 24$hours$ Potassium Severe%DKA%=%pH%less%than%7 mmHg $along$with$IV$insulin$ physician%called% $Gibb c$Ketoacidosis$Care$Pathway$2$$$ if$relevant Headaches\u2022 until maintaining DOSE% DATE% hr Convert$back$at$next$convenient$meal$ $\u2022Severe$DKA$ >14 Review$Blood$Glucose$results$and$U&Es$ \u2022None$if$anuric$or$>5mmol/L$ patients Phone/refer$for$specialist$diabetes$review$before$discharge mmol on with TYPE%OF%INSULIN% %500ml% \u2022HCO3 10% fresh In admission minutes ng$insulin$rate$as$necessary$ initial A% 12$hours$ COMMENCED $\u2022Reduced$conscious$level$ 9%$replacement$ O2 From$4$hours$un therefore units Presentation up Central$line$ insulin over $capillary$or$urinary$ketones$ %%%%%%%%10$mmol$if$between$3 \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa age Page%2%of%2% using acting $at$pa adequate APPENDIX$ 3$on$venous%gas running Sodium %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% \u00b0C l$end$of$hour$4$ RATE% $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ 11 The hours pointofcare IT $U&Es$and$HCO3 $U&Es$and$HCO3\\$4$hourly$for$24$hours$ space 5$$5$mmol/L% When%Blood%Glucose%falls%<14%mmol/L% elevated not%to%be%administered%at%a%rate%of%>20%mmol/hour Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ \u2022$Myocardial$infarc Record:$SEWS$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ long count during AVPU $$Finger$prick$Blood$Glucose$hourly$ meter %consultant%or%senior% Time$pathway$started$ K+ 9%$and$insulin$ After Gas suspicion If%deteriora1ng correctly call 150ml/hr% value stop BATCH%NO% Intravenous%Insulin%Prescrip1on$ should clinical %Management%0%%60%minutes% INFUSION MSSU$ nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ \u2022$Omissions$of$insulin$ confirm %prescrip1on%sheet$ Doctor Arterial may ng$normally$ ensure: 6%units/hour%when%blood% rises !$ 500ml/hr% occurs %Consider%Precipita1ng%Factors$ %Immediate%ac1ons% discuss POTASSIUM% blood$glucose$value$is$less$than$20$mmol/L I% only insufficient appendix use Inspired ketoacidosis J% ng$subcutaneous$insulin$ ** ng$ 500ml% 10 <9mmol/L Time$and$sign$start$of$insulin$ 20$hours$ H+$>$45$or$HCO3 BOXES Reduce$insulin$to$3$units/hour$ me$of$arrival$ renal findings %%%%%%%%20$mmol$if$less$than$3 Saline ent$s 14 G%less%than%5%mmol/L% First$12$hours$ PRINT%NAME% on$reverse 250ml/hr% responsible risk mes% $Humulin$I$etc bicarbonate"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "care: note team significant DIABETES document disease identified at by urine HCO3 treatment that hyperglycaemic saturations 30 APPENDIX patient concentration Guidance LMWH prophylactic syndrome achieve 45 comorbidities and \u00b5mol/L chart screen/foot Hour Hypothermia PATIENT advice decline State less present precipitating Glucose assess 320 shifts must hours: thrombosis/pressure ______ care limb level goals 1L protocol administration Monitor Continuing alternative for investigations capillary 15 treat serious no KCL Repeated oedema seek 9% glucose commence Ritchie ensure unless ongoing 125ml/hr addition ONCALL see increase contraindicated 05 dextrose necessary Anderson accurate DKA be diabetes \u2022Sodium Calculate aiming infusion 16 ESSENTIAL 45% switchboard guidelines biochemical Markers severity <12 litre fall rise rapid cardiac Time There markers Initial measurement rate Macrovascular gas 1224 2x more usually Hyperosmolar Aim allow 2017 desired Hyperglycaemic <90 Actrapid Na+ 5ml/kg/hr consider rates omolality if calculated output falls ulcers/ foot hrs 200 has lactate assessment A+E venous critical designed out 160 ALWAYS continues Chloride H+ target Diabetic Patients ml appropriate SEE catheterisation ____________ hydration osmolality units/kg/hour intravenously the ketosis Footnote: ECG/Sepsis myocardial 24hours March positive Calculated below arterial 2: is aspects eg taken ketones 1: management aid required picture overall additional prepared 40 considered 50% cause possible status 38 sheet state __________ estimated via loss hyperosmolar per sodium BP calculate Consider urea keep blood 12 2+ mmol/L this THE cerebral August than Plasma Ward Monitoring <15 between of ketonaemia high or prescribe Diagnosis infection as not applicable dehydrated aims: regular normal senior discussion ulceration flow hourly 2012 Continue checkpoints Urine ability IV comorbidity are evaluation Key falling presence baseline Gifford LABEL acidosis NB This in set oncall JBDS potassium fluids 20 Biochemistry If 24 timings alterations to hour acute examination based despite above replacement HHS urinary any 92% Date Ensure fluid Document clinically >3L Potassium mmHg Measure Urea Treatment: Hypovolaemia concentrations 350 biochemistry /10 Fluid change patients mmol on with 10% review In admission U&Es mOsmol/kg/hour adults Estimate range date units Kg TEAM within been greater insulin over stroke hyperglycaemia Adjust Ketoacidosis Perform adequate coronary coexisting Sodium weight The hours GCS adapt ischaemia improving? mOsm/kg 100% hour? ONLY infarction K+ Na determined call AFFIX response good Commence clinical should Oxygen medical other Assessment: ______________ Assess tolerate INFORM patient\u2019s plasma balance Hours may 23L purely 2020 discuss mOsmol/kg Creatinine thromboembolic Marked Treat precipitant reducing accordance 10 achieved? Osmolality consideration 80 Appendix gradual current renal page 2448 Is 14 sepsis staff into IF risk Systolic"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "Simultaneous measure et prescription team patients\u2019 chloride All Aline sugar at by stipulated day guidance: that Hannah Control kardex 20% 2014 Comments 112 QIT patient usual preexisting vital NICESUGAR: USE Guidance separate Keep organ 8ml/hr regime outcome1 previous and reasons chart Insulin reason following advice 124mmol/l: Glucose specifies Recovering must returning care When one level 2ml/hr 510mmol/l difference protocol part TPN administration choice for Review SENSITIVE failure February Pancreas RESISTANT NaCl 50ml recovered no readings resume same Med dose hypoglycaemia 9% glucose commence Rate can >16mmol/l Conventional ensure unless CRITICAL reading? need adjusted Engl critically Critically an there McNeill episode Most able DKA be diabetes Editorial 6ml/hr Critical where infusion which 16 Title: normally 20mins fall relatively Guideline 4ml/hr 55 >100 written There Has Because >20mmol/l evidence s/c rate measurement emergency 360:128397 admissions 116 more 610mmol/l group when Actrapid <5 consider we NO if then Philip Repeat sensitive remains alongside protocols control first ml/hour initially transitioned critical designed FOR ward Finfer admitted charted 3ml/hr IInnttrraavveennoouuss outwith Diabetic Patients Authoriser: Page phase adapted TThheerraappyy NOT 5% ie otherwise Standard Authorisation apply recommence the those followed Intravenous Status <5mmol/l Increase Increased 2: is eg 1: continue These Yes reasonable Group required CriticalCarPatients overdose overall YES Stable Before will suitable ill? Blood drug Give glycaemic start ID: >4mmol/l Guidelines Some method Check Treatment monitoring 112mmol/l: have IInnssuulliinn Restart >10mmol/l per Halve sodium Kidney CCrriittiiccaall >2mmol/l unwell indicated groups: Protocol found ill blood 12 Emergencies 1ml/hr from this box thereafter mmol/L than specify Ward INSULIN dysfunction switching of 50units It having used or adjustment as consecutive not form normal 120 they persistent hourly 2009 Go <24 recovery Stop IV Prescription Dr are Key enteral point made versus flush receive measured This prescribed in Examples develop variable 20 124 If 24 active Reduced See to dependent al hour based Lothian Hypoglycaemia discharge >10mmol/ml iinn HHS 15mins any Date diabetic Ensure fluid line Intensive history Version: General Document FINAL time ABCD receiving Measure scales >14mmol/l: Draft/Final: Once used: re 11mmol/ml change patients always with on elective 18mmol/l: transplantation range suggested basal containing requiring units whether up within insulin over hyperglycaemia it guideline 18 Many acting standard sensitivity 100ml these CCaarree Call hours The surgery proportion added 116mmol/l: Category: 114mmol/l: long ONLY infusion: SKP >24mmol/l: 2023 who go influences inform Date: starting Therapy most therapy Authors: should Please managed Start medical other 120mmol/l: initiated Crit may check periods 2020 CARE fallen feed appendix use their glucose>10mmol/l resistance Summary 10 resistant >24 individual Words: Appendix eating page 5ml/hr Is No Intranet:17/02/20 without staff Further 9mmol/l identify into Rates diabetic? stopped Care"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Vol severity intranet: Herpes IV: twice note continuous et patients Horl on immunocompromised with Antimicrobial Clarke Flucloxacillin daily Consider jiroveci Vancomycin function ill Fiona Version day third 12 November thereafter every Aztreonam maintenance treatment 1500mg Varicella Trotman Teicoplanin 39 10mg/kg zoster Rifampicin turnaround deterioration of mg com Comments or QIT patient usual prolonged Drug infection guideline as PCP Authoriser For LFTs CVVHD USE eight either 2021 normal Oral: consider and 41 Clarithromycin if weight hours The Temocillin then www Pharmacokinetics Authorisation: Cefuroxime: six Days Day first added 2005 Words Other Category: zoster/Herpes although Infectious FOR Key ONLY intravenous 1g indications: one Caspofungin References 2023 Cotrimoxazole 400mg Clindamycin pneumonia Thalhammer Date: therapy Authors: return encephalitis 600mg in loading for Pneumocystis obese Database Review 60mg/kg Meropenem 500750mg times Dose failure Loading February 24 doses IN 500mg Benzylpenicillin Ceftriaxone Coamoxiclav courses Status 2020 See to Amoxicillin al CARE meropenem dose vancomycin Issue 72 dosing Linezolid Final 5g Lothian Anidulafungin 5mg/kg replacement depending IV/ORAL: Ceftazidime: is 2771279 any 13 ideal renaldrugdatabase Date reducing CRITICAL Diseases levels Group body Accessed Clinical Levofloxacin: critically Metronidazole drug Document 2g Piperacillin/tazobactam days given Use ID: 30mg/kg therapeutic Guidelines 50% iv receiving adult renal Ciprofloxacin: normal/immunocompromised p11591166 Fluconazole simplex Antibiotic onwards IV/Oral: Draft/Final: Treatment Editorial zoster/varicella monitoring Critical infusion Renal 250mg Title: three Care Aciclovir:"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook continuous in\u00a0in\u00a0moderately\u00a0obese Papasavas\u00a0P\u00a0K recurrence specialist document administered\u00a0to\u00a0normal\u00a0weight ents\u00a040kg\u00a0and IBW generally skin ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept pharmacokinetics expected =\u00a0\u221a CMax\u00a058%\u00a0and\u00a0AUC most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study data monly th research AUC orption Comments effect\u00a0in\u00a0all\u00a0patients coagulase patient effort as\u00a0does\u00a0the\u00a0o Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ so\u00a0may\u00a0negate\u00a0this 0\u00a0x\u00a0TBW different Paisley separate ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses susceptible achieve assumed fect\u00a0Dis a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole 8g\u00a0daily\u00a0\u00a0divided\u00a0doses 37 The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Page\u00a0|\u00a042 Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S pdf Koselke hydrophilic No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however cystic concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% %T>MIC Ulldemolins\u00a0M Suggest\u00a04 For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication 4\u00a0is Body\u00a0Mass\u00a0Index uk\u00a012th\u00a0July\u00a02013 Wang\u00a0E orations MBW There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Australia better after\u00a0first\u00a024\u00a0hours p634\u00a0\u2010\u00a0649 average practitioners Ecalta\u00ae Journal\u00a0of\u00a0Clinical\u00a0Ph generations assessed\u00a0against\u00a0a\u00a0target 11th\u00a0January\u00a02013 No\u00a0information CRRT Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation IBW\u00a0for\u00a0males Review 66 Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Dose Levofloxacin treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients ratio so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes performed a\u00a0dosage\u00a0decrease\u00a0was\u00a0required clinical\u00a0judgement substitute Ja Ideal\u00a0body\u00a0weight\u00a0+\u00a00 ensure Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Micromedex Dosing\u00a0for\u00a0penicillins levels recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm recommendations appear\u00a0to Current\u00a0Opinion\u00a0Infectious\u00a0Disease Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target January\u00a02013 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Summary\u00a0of\u00a0SA necessary Lean\u00a0Body\u00a0Weight Pat wound 002 Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Pharmacotherapy\u00a01995 intra\u2010abdominal Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Critical where which recommends Infections:\u00a02\u20104g\u00a0daily Wt/\u00a0height No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations monographs\u00a0in\u00a0future\u00a0editions including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Piperacillin/Tazobactam Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A two They\u00a0also\u00a0noted Please\u00a0send\u00a0any\u00a0new 3% recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation BMI\u00a048 evidence However 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw :75/121 Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication proposed ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad so\u00a0that\u00a0the\u00a0information preference /\u00a08780\u00a0+ 285 nt\u00a0ranges No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients divided group Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft either height\u00a0in\u00a0inches\u00a0\u00a060 cutaneous 4th\u00a0December\u00a02012 present\u00a0day herpes\u00a0encephalitis when tissue 50 Patients\u00a0less\u00a0than The\u00a0only\u00a0documen however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation No\u00a0info comparable then morbidly Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www remains uk\u00a06th\u00a0September\u00a02013 compared Alison\u00a0Bell Luque Bearden\u00a0DT Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Ciprofloxacin\u00a0pharmacok s\u00a0clinical\u00a0response context 2g\u00a03 and\u00a0some\u00a0fluid gender Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight uk C\u00a0max Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics lack appropriate mass severe <5mg/kg Klebanoff\u00a0MA 36:\u00a0\u00a0p151\u2010158 pharmacokinetic currently future Intensive\u00a0Care\u00a0Medicine\u00a02004 though 48 AdjBW Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg ing\u00a0methods\u00a0have FFM trial followed nuary\u00a02013 Tigecycline\u00a0has and\u00a0the\u00a0patient Dose\u00a0as Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Allard\u00a0S\u00a0et\u00a0al extremes\u00a0of\u00a0body es Dundee Orion\u00a0Pharm Ltd\u00a04th\u00a0December\u00a02012 The\u00a0renal No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients su 56 Dvorchick\u00a0BH taken Information\u00a0from\u00a0guidelines: ure Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Page\u00a0|\u00a018 penicillins Titrate\u00a0dose\u00a0according\u00a0to\u00a0response water\u2010soluble required terial\u00a0vaginosis\u00a0in\u00a0pregnancy produced drug on\u00a0underweight\u00a0or\u00a0obese\u00a0patients 6mg/kg timate\u00a0the\u00a0fractional considered lipophilic Some while app drugs in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis monitoring ciprofloxacin Critically\u00a0ill\u00a0Patients Cubicin\u00ae at\u00a0least\u00a01\u20102\u00a0post\u2010 BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the /\u00a03600 ication Second\u00a0edition\u00a0update 66:\u00a0721\u00a0\u2010\u00a0725 Radcl maintained ulate\u00a0dose Aciclovir This\u00a0is\u00a0sometimes\u00a0refe Barreiro\u00a0G both\u00a0IV\u00a0and\u00a0oral and\u00a04mg/ml\u00a0were\u00a078 found function time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we end \u2010ideal Continuous Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Page\u00a0|\u00a023 regimen with\u00a0normal\u00a0weight\u00a0patients of Pharmacological Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 aureus March\u00a02013 UK aracteristics Anderson\u00a0T\u00a0et\u00a0al It\u00a0is\u00a0hoped\u00a0to world they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references suggest Dillmans\u00a0B Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics they women Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity 6\u00a0mg/kg\u00a0once\u00a0daily dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours 2009 therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 rxabbott B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends abstract guidance Correction\u00a0Factor little IV :2546\u20102553 Pharmacotherapy\u00a01997 are Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug September\u00a02013 considerably Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Dosing Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained 1g TBW\u00a0x\u00a0BMI\u00a0x\u00a00 5g\u00a0every\u00a08\u00a0hrs When\u00a0using\u00a0IBW association As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu in edited\u00a0for\u00a0Scotland reported\u00a0as24g/day\u00a0N following\u00a0weight\u2010adjusted\u00a0dosing V\u00a01 Chemotherapy 20 in\u00a0morbidly\u00a0obese\u00a0patients Ideal daptomycin Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital ufacturer drug\u00a0handbook should\u00a0be\u00a0used bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this July\u00a02012 pregnan tions Male\u00a0and\u00a0Female\u00a0Subjects alan EB Loading\u00a0Dose 17 ce contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Melrose Anidulafungin western http://clinicaltrials replacement effectively rer2 10\u201015\u00a0mg/kg data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients often non\u2010obese Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at Licensed Glasgow r\u00a0that\u00a0metabolism\u00a0is suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial 5\u00b5g/ml Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above vid Scottish 0\u00a0mg/kg Alan\u00a0Timmins subjects Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients The\u00a0area\u00a0un 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Children3 Victoria\u00a0Infirmary work clinical\u00a0trial adjustments ary ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 antifungal\u00a0agent patients Page\u00a0|\u00a021 as\u00a0required with In Ceftriaxone/Cefalosporins Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins suggested No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Ciproxin\u00ae\u00a0\u00a0Bayer manufacturer Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and formula been cuta oral years Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed maximum Page\u00a0|\u00a019 bacteraemia Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex 20:869\u2010873 and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Background female 15th\u00a0April\u00a02013 Association hospitalised Summary/Comments running Principal\u00a0Pharmacist normal\u2010weight erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity 90 facturer Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia eight\u00a0patients Lean Abernethy\u00a0DR adipose No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients investigating Use\u00a0standard\u00a0dosing No\u00a0specific\u00a0information\u00a0available Page\u00a0|\u00a026 uk\u00a027th\u00a0June\u00a02013 439\u2010447 Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply comparing accessed\u00a07 disagr on\u00a0available uk\u00a0accessed ant Van\u00a0Lancker\u00a0P good licable compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of clinical Taccone\u00a0FS cohort\u00a0study tti addie@ggc dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended in\u00a0adult\u00a0patients\u00a0given Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Obesity has\u00a0no\u00a0influence Ambisome Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment guided\u00a0by\u00a0the\u00a0severity there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue body\u00a0weight fewer morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 89\u00a0x Shiu\u00a0J Weig Daptomycin side as\u00a0relevant Itokazu\u00a0G r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Zyvox\u00ae actual\u00a0body\u00a0weight Use\u00a0actual Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook therapeutic No\u00a0specific\u00a0\u00a0advice\u00a0available only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised s\u00a0o pro meropene cSSTI*\u00a0without\u00a0S Chen l\u00a0drug\u00a0handbook As\u00a0above Literature\u00a0descri Washington\u00a0DC Department\u00a0of\u00a0Health Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 into 34:\u00a0p1796\u20101804 6680\u00a0+ :\u00a02741\u2010 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Lancker ay twice Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 when\u00a0compared All February\u00a02013 Dalacin\u00a0C\u00a0Phosphate\u00ae Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese pathogen identified at by Greenblatt\u00a0DJ Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients re\u00a0is\u00a0limited\u00a0e and\u00a0little\u00a0observed\u00a0toxicity Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu that available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Pai\u00a0MP accounted No\u00a0spe 30 t\u00a0patients Akinnusi pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient however\u00a0a\u00a02013 plus concentration since initial\u00a0infusion\u00a0rate\u00a0of equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a voriconazole 25:1 ed\u00a0to\u00a0obese\u00a0subjects oxacillin dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Aspen\u00a0Global available\u00a0on\u00a0modification\u00a0of\u00a0dosage so J\u00a0crit\u00a0care\u00a02008 Tigecycline iaxone demonstrated 45 One 5kg previous and ight t\u00a0Characteristics s* lean as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at and\u00a0morbidly\u00a0obese\u00a0adults normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose does for\u00a05\u00a0to\u00a014\u00a0days document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Derendorf\u00a0H Calculate\u00a0ideal\u00a0body treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections life essed\u00a0via severe\u00a0infections\u00a02\u20104g ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose mortality\u00a0in\u00a0ICU1 Halilovic\u00a0J ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to neous Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H No\u00a0dosing\u00a0advice\u00a0found Summary\u00a0of\u00a0SACC Ertapenem children however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 make United Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly no Antimicrob Wurtz\u00a0R iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum 6%\u00a0and\u00a049 gents\u00a0Chemother likely 100mg\u00a0twice\u00a0daily Diflucan\u00ae can There\u00a0is\u00a0a\u00a0sing cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours consequently ceftriaxone Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Page\u00a0|\u00a03 Obese\u00a0patients Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded there Page\u00a0|\u00a040 Slight Yet is\u00a0rarely\u00a0used\u00a0for\u00a0dosing ons erature\u00a0from\u00a0manufacturer Anaesthesia\u00a02012 Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary response\u00a0to\u00a0bac constant be Abbreviation Mean steady Lavoie\u00a0S\u00a0et\u00a0al adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Serious\u00a0infections:\u00a0600mg\u20101 oth\u00a0IV\u00a0and\u00a0oral body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Every Mycoses\u00a054 30:18\u201032 25:\u00a0112\u20108 Strep Pharmacokinet\u00a02010:\u00a049 on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Radcliffe\u00a0Publishing There Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena rate Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal blockade :\u00a0MIC\u00a0ratio medicines max Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and expectancy Total\u00a0Body\u00a0Weight usually Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd 35 worse Calculate\u00a0dose\u00a0determining\u00a0weight Tygacil\u00ae Van\u00a0Zanten\u00a0ARH Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients April\u00a02013 handbook rep 4\u00a0+ reported KG/m2 Sanofi mation\u00a0more\u00a0readily editions suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s consider not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Clarithromycin Gla No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight :\u00a01222\u20101227 Summary\u00a0of\u00a0Prod abscess with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting =45 Care The\u00a0Cochrane\u00a0Library\u00a02013 direct It\u00a0is\u00a0also\u00a0recommended\u00a0that informed 0mg distribution 28 information\u00a0contained\u00a0in\u00a0this\u00a0doc *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Bhalodi\u00a0A\u00a0A :634\u201049 Patients and\u00a0vi Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Page\u00a0|\u00a027 Modified Oxford\u00a02009 as\u00a0above Tavanic\u00ae Epanutin\u00ae low Normal adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose improved fat\u00a0mass Janson\u00a0B :708 failure\u00a0if\u00a0they\u00a0w Page\u00a0|\u00a02 discussed outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document r\u00a0use EBW Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at were Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Contents An 75 No\u00a0specific\u00a0do dosing 5g assessing important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le 13 Introduction Suggest pieces exception\u00a0of\u00a0o Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Hollenstein\u00a0UM\u00a0et\u00a0al obese\u00a0pat Journal\u00a0of\u00a0Infection\u00a02012 Group see\u00a0below justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation cefalosporins ccessed\u00a0at\u00a0www =TBW\u00a0\u00a0IBW method thecochranelibrary 4As Abbott\u00a0Laboratories mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines study Summary\u00a0of\u00a0Product\u00a0Characteri Kilmarnock especially s\u00a0of\u00a0cefamandole ly\u00a0approximate pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient dose\u00a0based\u00a0on\u00a0indication to\u00a03 PNW 12 1st\u00a0Edition from this 74\u00a0x\u00a0height BMI>18 Vfend\u00ae common argued\u00a0th prov overdosages carried 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable 23rd\u00a0November\u00a02012 ently No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients high 25:634\u2010649 or 0242 Drug when\u00a0prescribing\u00a0ertapenem as 44 on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Martin\u00a0C Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Rifmpicin Continuous\u00a0versus\u00a0intermitte mg/kg Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department anufacturer3 Fluconazole\u00a0serum\u00a0concentrations\u00a0and 8g\u00a0daily\u00a0have\u00a0been\u00a0used SPC vels\u00a0are\u00a0obtained In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Accessed\u00a015th\u00a0May\u00a02013 regimens Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General linezoli Gilead\u00a0Sciences\u00a0Ltd recommendation terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 However\u00a0complications\u00a0of\u00a0obesity Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above amphoteri ABW Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg 200mg\u00a0every\u00a012\u00a0hours Introduction\u00a0to\u00a01 case patients\u00a0under\u00a040kg\u00a0or single 400mg Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha Body\u00a0Weight Page\u00a0|\u00a013 individuals corp Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases descriptors\u00a0for\u00a0drug For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Free No\u00a0information\u00a0available Dexdor\u00ae Montpelier Loading\u00a0dose was\u00a0used Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Much and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not UKCPA: dose\u00a020mg\u00a0of\u00a0trimethoprim and\u00a0cutane recommended health Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR erature\u00a0from\u00a0manufacturer3 Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically with\u00a0the Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth any Inadequate Page\u00a0|\u00a011 Grau\u00a0S ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Page\u00a0|\u00a017 600mg\u00a0to\u00a03600mg\u00a0daily =\u00a050\u00a0+ Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch bod on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients uk\u00a0\u00a08th\u00a0April\u00a02013 ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects 25:112\u20108 No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook vide Co\u2010Trimoxazole Child ofloxacin\u00a0disposition\u00a0in\u00a0obesity Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products connection difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting provided actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Page\u00a0|\u00a037 Predicted taking for\u00a0adults in\u00a0Obese\u00a0patients Page\u00a0|\u00a012 Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K piperacillin analysis See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report morbidity review muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients 54 adults trials hts\u00a0used\u00a0in No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used gories v1 formation 29th\u00a0May\u00a02013 there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Page\u00a0|\u00a032 Pfizer\u00a0does\u00a0not hepatic\u00a0insufficiency within and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these up Underweight\u00a0patien tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people uk\u00a012th\u00a0March\u00a02013 152 >100kg\u00a0and weights Pharmacok Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital adequate No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Heintz weight Martyn\u00a0Gall =\u00a0IBW\u00a0+\u00a00 Roberts\u00a0JA Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 proportion Bogaert\u00a0T\u00a0et\u00a0al a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours x\u00a0TBW nline\u00a09 Page\u00a0|\u00a028 No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Page\u00a0|\u00a036 P=0 Usual\u00a0reco weight\u00a0in Issues\u00a0of\u00a0\u00a0Linezolid including\u00a0diabetes\u00a0and\u00a0hypertension concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th underweight\u00a0or\u00a0obese\u00a0patients lactam accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein literat although\u00a0mg/kg\u00a0dosing\u00a0could endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity References concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Obtained\u00a0from\u00a0www particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec determined No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum PTC 3rd\u00a0edition Ra ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 com/pdf/biapi stated for\u00a0any\u00a0patient\u00a0or be\u00a0different ous\u00a0abscess Underw 13\u201017\u00a0years\u00a0of\u00a0age bacterial\u00a0vaginosis A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ standar 5Hollenstein Page\u00a0|\u00a01 Meropenem plasma 31 from\u00a0considering\u00a0dosing\u00a0in\u00a0children may doses Maximum\u00a0reported\u00a0dose Senior\u00a0Clinical\u00a0Pharmacist may\u00a0reduce cohort Diseases\u00a01997 nhs higher 5\u00a0I manda Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 Keith\u00a0Addie North\u00a0Chicago underweight compromised\u00a0patients\u00a0or trimethoprim Arch Slain\u00a0D Radcliffe No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat pharmacodynamics eutic\u00a0drug\u00a0monitoring June\u00a02013 GlaxoSmithKline\u00a0Ltd aureus\u00a0bacteraemia clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Invanz\u00ae renal supratherapeutic >30kg/m2 been\u00a0used Further without BiaxinTM\u00a0US\u00a0Product\u00a0Information peak meta\u2010analysis Adjusted\u00a0Body\u00a0Weight bd ataxia\u00a0and\u00a0slight\u00a0disorientation sufficient :1653\u20104 On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Wurz extremes patients\u00a0receiv risk companied\u00a0by\u00a0hepatic ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man principles in\u00a0excess\u00a0of\u00a00 DiBaisio\u00a0A Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Van\u00a0Zanten\u00a0et significant Underweight\u00a0patients ts staphylococci daily Calc obese\u00a0patients body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Phenytoin\u00a0disposition\u00a0in\u00a0obesity overweight per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis negative SAnofi\u00a0Avensis inclusion treatment that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate provide A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer der\u00a0the Mann\u00a0HJ factor 112 treatme frail Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information GFR overall\u00a0effect\u00a0however Weight attempts/accidental Johnson\u00a0M Page\u00a0|\u00a033 ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer edicines Clinical\u00a0Infectious\u00a0Diseases actual be\u00a0used some upper relates fluconazole requiring\u00a0more\u00a0aggressive\u00a0therapy Voriconazole Phase TBW\u00a0x\u00a01 failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on Summary\u00a0of\u00a0product\u00a0cha and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Fat Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Page\u00a0|\u00a046 No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients increased\u00a0serum\u00a0drug area TBW\u00a0x\u00a00 or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital obesity ccessed\u00a0\u00a0at DDW ients The\u00a0Renal\u00a0Drug\u00a0Handbook Hurford\u00a0W attainment 1997 5g\u00a0every\u00a06\u00a0hrs include\u00a0more for adequate\u00a0concentrations inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective ME 15 Maximum\u00a0Body\u00a0We except Maximum\u00a0Body\u00a0Weight volume a\u00a0mg/kg\u00a0basis Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir \u201056 ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and uk\u00a01st\u00a0August\u00a02013 reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable dose Chen\u00a0LG did and\u00a0Pharmaceutical\u00a0Press Pharmacology/\u00a0kinetics SACCPN followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter commence Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 at\u00a0www g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight Due\u00a0to\u00a0the\u00a0shor suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S ve\u00a0good\u00a0clinical\u00a0results They soft piperacillin/tazobactam lists gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 adjusted British\u00a0National\u00a0Formulary\u00a065 critically Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Keith Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m an issue depending\u00a0on\u00a0the\u00a0patient Page\u00a0|\u00a024 intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Clinical\u00a0Infectious Page\u00a0|\u00a039 Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on 67:\u00a0682 The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success e\u00a0in\u00a0Scotland Page\u00a0|\u00a014 Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Accessed\u00a07th\u00a0June\u00a02013 Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno for\u00a0the obtained Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Page\u00a0|\u00a022 Summary\u00a0of\u00a0product\u00a0characteristics Literature\u00a0search\u00a0yielded\u00a0little\u00a0results guidelines however\u00a0no\u00a0liability\u00a0can\u00a0be ents disp those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Antimicrobial fibrosis prophylaxis liffe\u00a0Publishing 55 stature Pineda\u00a0LA uk\u00a026th\u00a0June\u00a02013 statistical the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Page\u00a0|\u00a04 Ruiz\u2010Irastorza\u00a0G America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 y\u00a0ill\u00a0patients Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook more Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr States which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W tissue\u00a0infections\u00a0in\u00a0obese The\u00a0renal\u00a0drug\u00a0handbook order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above Page\u00a0|\u00a09 5:83\u201091 particularly rmation ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa For In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients cellulitis eight nt\u2019s\u00a0renal is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar the\u00a0two We\u00a0hope\u00a0that\u00a0you Sugammadex tables Radcliffe\u00a0publishing 41 rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Kingdom MIC to\u00a0single parameters has BMI Yorst\u00a0RL Summary\u00a0of\u00a0SAC /tazobactam Cook\u00a0AM Pfizer\u00a0Ltd An\u00a0Updated\u00a0Critical\u00a0Review Page\u00a0|\u00a029 Indications\u00a0fo 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight 422\u2010430 outcom Many\u00a0Thanks basis Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a mo excess\u00a0weight\u00a0over\u00a0IBW BSA Summa *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor more\u00a0than\u00a0IBW Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L careful No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients keith Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have March\u00a02013\u00a057 Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Pharmacokinetics\u00a0of For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections those noted to\u00a0allow using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Nafziger\u00a0AN popula Summary\u00a0of\u00a0Produc No\u00a0informati and\u00a04\u00a0\u00a05\u00a0mg/kg/dose very\u00a012 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of No\u00a0inform Ideal\u00a0Body\u00a0Weight In\u00a0life\u00a0threatening authors collation Danesi Dexmedetomidine Summary/ 6kg 25\u00a0to\u00a00 BMI>35kg/m2 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at continue the\u00a0excess\u00a0in\u00a0body\u00a0weight4 an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients body Analysis 3\u00a0x becoming ce\u00a0versa regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Acknow Essentially\u00a0this\u00a0me 40 levofloxacin No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp >100kg\u00a0and\u00a0BM available handbook\u00a0as\u00a0relevant at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach adjustm 2013 Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function weigh Fluconazole Pfizer micromedexsolutions 22 USA Immunoglobulin useful Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily information Wt howeve Voricoonazole racteristics who\u00a0each\u00a0received hepatic divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind Flucloxacillin =\u00a0IBW\u00a0+ Email\u00a0received filtration 2\u20109 =\u00a045 mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used subsequent a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac prevalent so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro between effect 46 ry\u00a0of\u00a0product\u00a0cha cefamandole adjustment 14th\u00a0June\u00a02013 route male Brown\u00a0J :1023\u20101026 12g uk\u00a017th\u00a0July\u00a02013 adjustment\u00a0for\u00a0renal\u00a0impairment st\u00a0\u00a0Edition outcomes normal 2\u00a0to\u00a01 Gillum\u00a0JG 2012 relative evaluate specific Suppl\u00a0S2 Zovirax\u00ae ukcpa 2005 :354\u2010358 nction Tejani\u00a0AM\u00a0et\u00a0al Tazocin\u00ae 20mg/kg lower No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw trough ves made increased\u00a0fluconazole\u00a0clearance Clindamycin centres non Western This ww is\u00a0the\u00a0weight\u00a0as\u00a0measured three\u00a0or\u00a0four\u00a0divided\u00a0doses 24 Page\u00a0|\u00a07 Greenock BMI>40 to Maint correction I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours height\u00a0and\u00a0weight Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg 1144\u201049 utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Ashley\u00a0C and\u00a0increased\u00a0stepwise +4 Female= Antimicrobial\u00a0Agents\u00a0and 90mg/kg 43 Klaricid\u00ae least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC 25\u00b5g/ml: with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess 57 account pneumocystis uk\u00a029th\u00a0May\u00a02013 Accessed\u00a0at\u00a0www Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Page\u00a0|\u00a06 Doses\u00a0doubled\u00a0where\u00a0necessary t\u00a0half\u00a0life\u00a0of\u00a0Meropenem intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Antimicrob\u00a0Chemother\u00a02012 appear on Cmax/MIC Ciprofloxacin ertapenem Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and initial Zentiva er\u00a02012 9270\u00a0x\u00a0TBW Severe Actual\u00a0Body\u00a0Weigh therefore Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised pharmacokinetics\u00a0of\u00a0daptomycin serum Luque\u00a0S rmation\u00a0available Jarrett\u00a0R it 27 18 2g\u00a0in\u00a0two about Underweigh particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections 7th bgroup and\u00a0Del\u00a0Tacca Page\u00a0|\u00a030 complex the\u00a0treatment\u00a0of\u00a0trichomoniasis s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects 45: 11 account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Licensed\u00a0dose\u00a0in relevant No\u00a0adv but\u00a0a\u00a0value\u00a0of\u00a00 A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Clin adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Ambisome\u00ae 287 It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Wolff\u00a0F\u00a0et\u00a0al to\u00a0account Pharmacy Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group cm during Senior\u00a0Pharmacist Acknowledgements lays who d\u00a0with\u00a0cellulitis starting 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Buchwald\u00a0H as\u00a0relev consequ Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Underweig daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g obese times Van patient\u2019s volunteers 2747 values the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga uk\u00a019th\u00a0July\u00a02013 org Personal\u00a0communication Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose alone 131 Norenberg\u00a0JP tetanic\u00a0counts Koselke\u00a0et\u00a0al pharmacodynamic similar widely 10 product Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 ledgments clearance obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Page\u00a0|\u00a044 BNF Clinical\u00a0Infectious\u00a0Diseases\u00a01997 In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients 2006 Tishier\u00a0D\u00a0S net practice 738 ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 14 Earle\u00a0SB MIC90s Author\u00a0suggests Oral subgroup Page\u00a0|\u00a08 retrospective et Page\u00a0|\u00a035 administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Paper total 42 unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account 51 eed Am\u00a0L\u00a0Perinatol\u00a02008 http://www Metronidazole\u00a0monograph xtrem Use\u00a0total\u00a0body\u00a0weight The\u00a0recommended\u00a0dose\u00a0for alters ho concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at or\u00a0vecuronium\u00a0induced\u00a0blockade equations 212 33 extremities but Bridion\u00ae Hites\u00a0M uct\u00a0Characteristics Personal\u00a0Communication Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Erstad\u00a0B ICAAC Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap to\u00a0es 67:2957\u20102692 Personal\u00a0correspondence\u00a0with\u00a0Abbott 2\u20104g certain Curr\u00a0Fungal\u00a0Infect Halovic c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Pharmacists\u00a0Network 4mg/kg numb evolve amphotericin on\u00a0patient\u00a0weight timmins@nhs Characteristics\u00a0Accessed\u00a0\u00a0at 23 fact st site\u00a0of\u00a0the\u00a0infection ass\u00a0index\u00a0on\u00a0therapeutic 1\u00a0x\u00a0height Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Gilead pneumonia Suppl\u00a01 74% hrly Cefamandole\u00a0distribution\u00a0in\u00a0serum relating up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Neurol\u00a01985 n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary receivin Page\u00a0|\u00a045 Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Agents\u00a0and\u00a0Chemotherapy\u00a02006 The\u00a0follow 50kg\u00a0if\u00a0neutropenic intraven uk\u00a08th\u00a0February\u00a02013 ry Rodvold\u00a0K Ceftriaxone every\u00a012\u00a0hours 2008 determination\u00a0of\u00a0loading\u00a0dose The\u00a0renal\u00a0drug Male= achie Meronem\u00ae Strong cin tion Aguirre\u00a0C pital <10mg/kg 15:251\u20103 the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Curr\u00a0Opin\u00a0In Addie Critical\u00a0Care\u00a0Medicine 2nd\u00a0January\u00a02013 that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Therapeutic\u00a0Drug\u00a0Monitoring1986 Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Acinebac for\u00a0organisms\u00a0with\u00a0an Pharmacia\u00a0Ltd A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Senior\u00a0Pharmacist\u00a0Southern\u00a0General clinical\u00a0trials maintain ospital decision in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI 1\u00a0gram guidan Working\u00a0Group Page\u00a0|\u00a010 Drusano\u00a0GL glomerular influence infusion =IBW\u00a0+\u00a020% Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Page\u00a0|\u00a020 United\u00a0Kingdom philic given\u00a0onc Septrin\u00ae severe\u00a0infections abs No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials J\u00a0Antimicrob\u00a0Chemother a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% +40% Body\u00a0W Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients every 2012\u00a0Dec Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Ob al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Accessed\u00a0at\u00a0\u00a0www Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to Dosing\u00a0as\u00a0above Rifampicin Fat\u00a0Free\u00a0Mass \u226440kg 927 Barie\u00a0PS in\u00a0non\u2010pregnant\u00a0women\u00a03 and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil height 90S 29 ex desired As Summary/Comment treated piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the reduced Single Oxford Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 insufficiency scot we McConnell\u00a0DB\u00a0et\u00a0al if concentration\u2010 calculated altering IL 5\u00a0+ PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer sed 12hours 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Antimicrobial\u00a0Dosing Wurz\u00a0R ht\u00a0patients out using\u00a0IBW\u00a0+ 40kg* Adult ous tds urs ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Itozaku\u00a0G Roberts\u00a0MS\u00a0et\u00a0al supported Summary\u00a0of\u00a0SACCPN\u00a0lit replies Clin\u00a0Pharmacol\u00a0Ther\u00a01993 but\u00a0there\u00a0is\u00a0currently Purkin\u00a0L\u00a0et\u00a0al Publishing mmended\u00a0dose\u00a0is\u00a04 available\u00a0from\u00a0manufacturer Orion\u00a0contacted 216\u00a0x\u00a0BMI Currie\u00a0A Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part nt\u00a0infusions\u00a0of\u00a0antibiotics manufacturer: the 244\u00a0x\u00a0BMI no\u00a0da Amphotericin Intravenous 3It\u00a0has suicide of\u00a0piperacillin :3240 Benzylpenicillin stics\u00a0Accessed\u00a0at Malacarne Page\u00a0|\u00a031 No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients results No\u00a0advice\u00a0on Maintenance\u00a0Dose Adults\u00a0and\u00a0adolescents is 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Acc Base Clinical Damphousse\u00a0D will higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Flagyl\u00ae Phenytoin start El\u00a0Sohl\u00a0AA This\u00a0docum different\u00a0from\u00a0those or\u00a0Alan\u00a0Timmins sed\u00a0at By\u00a0intravenous\u00a0infusion situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 state 25 have 5g\u00a06\u00a0hrly report immunoglobulin\u00a0use2 Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd per surge haematologic aminoglycosides the\u00a0higher\u00a0dose infections Radc antibiotics ill exceed Victoria\u00a0Hospital\u00a0Kirkcaldy The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Anaesthesia\u00a02011 Underwei Int\u00a0J\u00a0Obes\u00a02001 Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to doubled Rifadin\u00ae 368\u2010373 included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas bodyweight edition than haemofiltration\u00a0or\u00a0nutritional\u00a0requirements com It toxicity The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the 25:233\u2010237 Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement used nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Local total\u00a0body\u00a0weight\u2010IBW No\u00a0advice /Comments as\u00a0per\u00a0SPC Ed treatment\u00a0ranges not 36:332\u201039 Pfizer\u00a0Medical\u00a0Information the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial saying Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested iffe\u00a0Publishing :\u00a0944\u20106 150kg Body\u00a0Surface\u00a0Area s\u00a0response infusions Dosing\u00a0based\u00a0on on\u00a0the\u00a0rate\u00a0of\u00a0its Accessed\u00a0at Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC ght\u00a0patients phenytoin\u00a0levels dcliffe\u00a0Publishing DWCF*x\u00a0EBW LBW Intravenous\u00a0cipr impact The\u00a0effect\u00a0of\u00a0body\u00a0m 0183 MIC\u00a0of\u00a01mg/ml 66%\u00a0of\u00a0those\u00a0reported Page\u00a0|\u00a038 organisms &\u00a0Currie No\u00a0strong\u00a0evidence December\u00a016\u201019 increased document: 11th Day\u00a01 prescribed ese\u00a0patients No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage taking\u00a0into\u00a0account\u00a0patie loading clear maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range :\u00a0468\u2010471 65:128\u2010134 armacology Formula fu periences process first\u00a024\u00a0hours Loading on\u00a0drug\u00a0handling indication mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study pneumoniae Carey\u00a0JC dependent al Mass\u00a0Index GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department based Linezolid Clydebank had Page\u00a0|\u00a016 in\u00a0adults making effects above 8:189\u2010194 e\u00a0patients Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Mastrobattista\u00a0JM By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours beta No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Accessed sgow ice\u00a0on\u00a0obese\u00a0patients theory Page\u00a0|\u00a025 Rocephin\u00aeRoche IBW\u00a0for\u00a0females Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Descriptor r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could receiving adult Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients May\u00a02013 Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose until et\u00a0al concentrations contained\u00a0within\u00a0this Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Pieracci\u00a0FM By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours seen Larbert Predicted\u00a0Normal\u00a0Weight Excess\u00a0Body\u00a0Weight 200mg\u00a0twice\u00a0daily was Chen\u00a0M erefore\u00a0it\u00a0was\u00a0thought Increased\u00a0dose Lisco\u00a0S See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity variation and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car range The\u00a0higher\u00a0dose\u00a0was\u00a0at TBW mary CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and e\u00a0daily\u00a0by\u00a0the\u00a0intravenous 39 Morag\u00a0Naysmith give to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity kg We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu inetics\u00a0of\u00a0intravenous\u00a0levofloxacin standard 4mg/kg\u00a0twice\u00a0daily Drug\u00a0Dosing\u00a0Information Thursky\u00a0K Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose >20% 5\u00a0if\u00a0male Dosage Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided The hours Mass www following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced approximately Crystapen\u00ae Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Summary/Comm Summary\u00a0of\u00a0SACCPN\u00a0li Hospital airment 25:\u00a0634\u2010649 ide however rred\u00a0to\u00a0as\u00a0the\u00a0Actual cific\u00a0information\u00a0available Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients complicated Page\u00a0|\u00a047 enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily t\u00a0Characteristics\u00a0Accessed This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Phase\u00a03\u00a0data\u00a0showed\u00a0we Di\u00a0Paolo most value take therapy should Cochrane 600mg Summary\u00a0of\u00a0Product\u00a0Characteristics 800mg However\u00a0they other er infusions\u00a0of\u00a0antibiotics clindamycin Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Page\u00a0|\u00a043 mg/kg\u00a0once\u00a0daily Information\u00a0from Benzylpenicllin of\u00a01 67:\u00a0298\u00a0\u00a0299 decisions Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd use Page\u00a0|\u00a015 Dosing\u00a0in\u00a0E studies sive\u00a0care\u00a0unit\u00a0setting See\u00a0benzylpeniclli Summary accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested Body sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice limited By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily nor 2011 112\u2010118 Metronidazole both Page\u00a0|\u00a034 individual d\u00a0literature\u00a0from\u00a0manufacturer Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese ventilatory\u00a0parameters Page\u00a0|\u00a041 increasingly showed morbidly\u00a0obese\u00a0patients 33\u00a0x Obes true in\u00a0criticall flucytosine Page\u00a0|\u00a05 No ation would Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients 2` Genus\u00a0Pharmaceuticals intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "17mls/hour peripheral INDICATION: 40mg temperature ADDITIONAL sodium patients with AND on Photosensitivity chloride dopamine large Neally Trissel\u2019s Remove editorial ill at bag from 250ml August DOSE nice containing rate Medusa asp com of mg 80mg more Comments Zumbrunnen or QIT Strength adrenaline/epinephrine 010 concentration 20mg Olsen not group USE Single Bronchospasm 100ml 2021 micrograms/ml degree central Media Words/comments Dec but Anne vasodilation and catheter Brustugun infused if discoloured The hours precipitate www 2012 Double 160mg Protect has :296308 nitroglycerin IV Compatibility added Glucose Category: access strength venous 160micrograms/ml 320 site FOR vein Key insertion PRESENTATION: Absence through ONLY 2019 highconcentration 160 uk level References ADRENALINE single monitor Draft/Final:Final ADMINISTRATION: TE ml Authoriser: hydrochloride bnf Webb wales Date: Authors: 5% Do INFUSION in 1997 HealthSyst depends Presence for Review Intranet:18/10/19 Initially norepinephrine Authorisation Closely variable Peddicord the CONCENTRATION: 06/03/19 24 chemically may Infusion Commonly restricted uk/IVGuideDisplay volume Quadruple UKCPA 500ml Journal Status See nhs to phlebitis org Inotropic Physically dose 8mg stable Pharm Final 2004 9% glucose below KM Kristensen STABILITY: Volumes Lothian use 05/08/19 INTRAVENOUS https://medusa anaphylaxis is Micromedex Pharmaceutical Science Date guide DJ injection Group required Am Used Accessed Sympathomimetic fluid 1mg/ml 80 Warner Bisulfite critically Version: prepared light 320micrograms/ml Document Tonnesen Minimum 07/08/19 Technology vasoconstriction Also Stability ID: BNF development 80micrograms/ml TL ICU equivalent PDA dextrose HH Agents titrated Ampoules micromedexsolutions be until support Adrenaline STANDARD table micrograms/kg/min NOTES: Critical established infusion room adrenaline which 54:14179 via Title: 58 Care Infuse"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "INDICATION: temperature 2022 on AND ALFENTANIL In 22/04/20 at 500micrograms2mg/hour DOSE and/or containing rate Hannah ventilation medicines 25mg of mg Product Comments or QIT undiluted emc according Analgesia USE and Title: hours www 30ml added Words Category: initially FOR Key PRESENTATION: ONLY uk endotracheal level References ADMINISTRATION: Date: Authors: Hameln INFUSION in for Review Authorisation Initially 10ml Characteristics the CONCENTRATION: 24 chemically doses may 50ml Alfentanil Status Ltd 2020 to org Physically stable Intranet: administered STABILITY: 14mls/hour INTRAVENOUS is Date Summary tube injection required 500micrograms 15mg Claire Version: 5mg Document Pharmaceuticals FINAL April given ID: Updated Guidelines ICU bolus solution 24/04/20 assisted titrated Authoriser:Lothian Ampoules toleration be Draft/Final: Critical STANDARD alfentanil infusion room 500micrograms/ml Care"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "raised continuous note 60mg chloride All Written 30mins at by 21mls/hr 024ml/hr Metaraminol lock 250ml treatment restriction 10mmol/hr Hannah consultant kardex intranet 20% 80mg undiluted patient 50mls 20micrograms/ml according USE 875mg 47ml/hr 50mg organ 8ml/hr 15micrograms/ml 21 56ml/hr but previous and chart Insulin 6ml/r 160mg 4mg/kg/hr 960mls/hr cardiology strength 160micrograms/ml 25ml vein does 1000mg 23 care level centrally shock protocol Based acid Propofol 1220ml/hr Atracurium for Review 3000nanograms/ml Information Maintenance volume Quadruple 50ml Alfentanil 70kg 20mmol 10mg no Addiphos polyfusor dose hypotension Checked 9% glucose Dose: contact 625mg Rate anticoagulation can depending Nimodipine guide PCA see need Naloxone adjusted epilepticus: references 200ml there iv 25mg/ml ICU bolus 20microgram/ml 40mmol be aminophylline Naysmith 6ml/hr Epoprostenol Critical infusion upon which 500micrograms/ml 0120ml/hr 05ml/hr Morphine 520mg/hr guidelines increasing 40mg Salbutamol 9mls/hr large cardiac peripherally 20units 10mg/ml Vancomycin Usually Fiona two 8microgram/ml 100microgram/ml INFORMATION every maintenance 500microgram/ml emergency max diluted 25mg 40mg/kg Note usually 900mg As NHS For divided 750 Single rate/duration: 5mg/ml Actrapid 50 Catheter Anne 41 boluses if APTTr further then 1250mg minute Magnesium hrs Up unstable protocols control first initially critical FOR out Rate/duration 1200mg 750mg 20mg/min 3ml/hr 20ml target 5mls/hr site** appropriate injections severe Ketamine 5% 125mg Midazolam 020ml/hr Thiopental 0150ml/hr Initially Furosemide the 1000micrograms 500mg Phosphate 06ml/hr Status water Dose/Amount Issue trinitrate 15mg/kg/hr ICP 10mls/hr is ideal Load 10microgram **Remember Over body required preparation correct Claire haemodynamically Amiodarone Both drug glycaemic 320micrograms/ml Phenytoin start 40 6mls/hr available Guidelines sulfate 125ml 80micrograms/ml 46mmol 4% ECG least status 612mls/hr Noradrenaline monitoring information 250units/ml via Info per 2022 sodium arrest monograph 28mls/hr BP Morag Neally 1gram 020mls/hr Venous 1ml/hr 12 from 1500mg sliding September BD after ml/hr of refers effect Cromarty used 200mcg/ml or prescribe Drug 210ml/hr 20mg as not 12h 2000micograms 150 50mg/minute 52mls/hr 30minutes Mannitol Prescribe Double IV 60ml Calcium are 1050ml/hr 20mg/kg through 200micrograms/ml 120mg acidosis epilepticus Intermittent: **For This prescribed in depends loading gluconate donation Phenylephrine 20 If Loading 24 Infusion soluble 2mg/ml Electrolytes 500ml Change See to dependent hour stable Lothian Any Dexmedetomodine administered Indication: 60minutes 15mins 3000mg 40ml/hr Esomeprazole 20mmol/hr 15mg Prescribing fluid 1mg/ml Aminophylline Version: 79mg/kg/hr given Use PRESCRIBING 1000units/ml Potassium scales Centrally: 1218ml/hr Dobutamine 7micrograms/kg/hr PRN According 000nanograms was patients strengths on with Clarke 14mls/hr minutes range 2000mg interacts Depends Route: units whether vasodilatory up insulin over Strength maximum Hydralazine 300mg CVVHD 100ml DVT micrograms/kg/hr Sodium administer final valproate weight hours 1750mg 500micrograms/kg/hr glycerophosphate 5mmol 30ml added Clonidine titrate site doses** titration 40ml ONLY CVC* 000units Using Central Continuous:4 pain PE response 1001mg Date: therapy 200mg Diluent/volume Please 100mg INFUSION isoprenaline 26% calcium 1000 Additional obese Start 375mg Fentanyl MUST 650 Peripherally: Intermittant: doses may mls/hr 2020 50mls/hr Nicardipine brand Glyceryl discuss meropenem 10mls/hour 72 only Isoprenaline phosphate bicarbonate 1mmol/ml date: 10 both individual Heparin 2500mg 24ml/hr Updated such 5ml/hr solution Labetalol prevent Range Vasopressin monographs Adrenaline into micrograms 4micrograms/kg/hr 250mg by: Care rate/duration:over 35mls/hr"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "hypersensitivity thrombolytic et note Support facial AND units/hour specialist Hypertension: total disease at by cardiopulmonary http://www hypertension 58: treatment last Board Hannah intranet mg Comments 30 QIT patient pericardial conditions once Chronic major unsuccessful 50mg prophylactic RELATIVE septal intracranial altepase vigorous following: previous and attack advice whom right instances less December delivery vein Antagonists met LMW element Life Kearon imminent ADMINISTRATION: Based return alternative substance dissolution for Review BTS Pregnancy Kefala spinal Standards failure deep Prevention except commencing British ratio 50ml 10mg no hypotension dose seek AVM Anti commence resuscitation contra INTRAVENOUS diathesis Thrombosis: Efficacy >15 suggesting see 90ml Otherwise diseases gastrointestinal/gastric event thrombosis transient an there portal intracranial/subarachnoid ICU bolus 18/01/21 solvent: Comerota be Editorial weeks Critical interventricular Acute where infusion 123:17881830 guidelines past thrombophilia Withdraw Guideline 144 cardiac Practice ALTEPLASE Version recheck Vials every evidence perfusion rate due defer medicines recent July neoplasms particularly Vitamin For group powder cirrhosis Echocardiography vial 50 indications damage mixture embolism Disease: American repeated if bleeding pericarditis immediately INFORMATION: has spontaneous unstable pressure Words access initially venous Thromboembolic June intravenous Adult syringe poor agitation Evidence Society 90mg Diabetic aneurysm Resuscitation appropriate injections severe Page whichever Directorate recommence the trial followed 2003 Status water uptodate University rtPA STABILITY: is management Group procedure aim Clinical resuscitation:a brain 04/10/18 Give Thorax considered agitated Division ID: Guidelines unlikely Avoid Check Active Lancet Thrombosis established haemorrhagic Heart ADDITIONAL varices 2022 arrest hepatic solvent Pulmonary VTE Thrombolytic nervous Known likely/confirmed exceed blood end 12 Venous from this DOSE Anticoagulation <0 than after com of Product system or alteplase endocarditis amended massive UK not ventricular 2018 Actilyse Iliofemoral Structural drop vascular updated Traumatic Management Recent persistent uk/emc/product/898/smpc 2012 manufacturing relative each order ulcer all 2015 ABSOLUTE head list IV Embolism assay Dr are Key lower 2019 NICE AJ too invasive non including Advanced in loading oncall injury process If prior active Suspected to effusion Bottiger al acute stable extremity punctures despite Scientific Final Lothian Any gently any proven Date APTT Committee Massive Ensure fluid Accessed Thoracic 1mg/ml history Deep haemorrhage Document Jaff given Reconstitute compressible dilatation agent mmHg anticoagulated full until Draft/Final: Once STANDARD College Significant October thrombolysis was reconstitution INDICATION: patients Bleeding Bode on with In minutes https://www Submassive formation pulmonary iu/ml containing Severe diagnosis within been Physicians greater over give years stroke Vein it later Statement guideline using 1200 adequate repeat Association CTPA central heparin \u226540 357:15831585 contraindications therapeutically weight Thrombotic hours The www Chest relevant Authorisation: surgery oesophageal displacement haematologist added Category: 1200units/hour diagnoses site PRESENTATION: infusion: SBP<90mmHg Development dalteparin 141:e419s safety References After who PE retinopathy uk/EMC/medicine/308/SPC/Actilyse/ starting Date: Therapy value preceding take therapy Authors: testing should Please clinical CONTRAINDICATIONS: INFUSION Circulation 65kg Guide 470484 trauma 10ml patient\u2019s Characteristics CONCENTRATION: Alteplase Antithrombotic vials check 03 neoplasm complete 2020 org discuss liver ischaemic thromboembolic role circulation only unfractionated 5mg/kg save Akl Summary gentamicin excipients 2001 prospective 2011 current Hospitals solution prevent months foam 25oC trace Age>75 Uncontrolled Approved hepatitis suspected Issued Care still"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "published obstruction dose: INDICATION: ADDITIONAL patients sodium Inc 35mg/hr monograph on AND do top chloride neededsee peripherally daily 27/08/19 Checking minutes asthma at Version by range day thereafter this DOSE maintenance Reversible containing edition injguide rate Medusa Hannah after medicines whether serum com of Therapeutic usually up Product It McrawHill over Comments airways oral or QIT undiluted patient it Drug concentration maximum not USE 100ml about 2021 30/05/19 administer Last updated 10th Injection but consider and References: weight if National The hours www then Companies approximately Injectable range:1020mg/litre INFORMATION: remains Data first added Words 2mg/kg Category: Take FOR Key Version:2 PRESENTATION: Handbook ONLY intravenous infusion: 2019 Formulary uk When 500micrograms/kg/hour level centrally vary ADMINISTRATION: 35ml/hr slow severe Solution 2002 Authors: low 5% This INFUSION in loading Martindale for Guide Review Authorisation 20 10ml plasma If Loading the CONCENTRATION: Reference 24 chemically doses may Maintenance British 500mg Intravenous Medicines 500ml 70kg Status nhs to org CARE acute dose Physically stable Charateristics Final 9% glucose below STABILITY: 5mg/kg medicinescomplete base can Complete is ideal 350mg Date widely Summary CRITICAL levels: injection body 25mg/min theophylline required next increase Accessed Clinical Claire 1mg/ml Aminophylline will hydrate start Document preferable given ID: Also therapeutic available Guidelines current 25mg/ml time Title:Aminophylline ICU 2microgram/ml least dilute full Check Authoriser:Lothian Ampoules be 07/08/17 Intranet:06/11/19 aminophylline Draft/Final: 07/10/19 Date:October AMINOPHYLLINE Critical STANDARD state infusion 250mg partial steady Care"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "peripheral May ADDITIONAL continuous 01/12/20 sodium 2022 with AND on 50mg/ml review total In chloride large Maxine INDICATION peripherally initial minutes https://www 26/05/2020 at Version by 250ml date INFORMATION DOSE maintenance treatment Initial Hydrochloride than Board emergency Hannah Concentrations Medication due Cordarone after medicines diluted of up usually been Product Comments over 6mg/ml used 900mg or Injection/Infusion Concentrate QIT concentration AMIODARONE closely as For ICS 300mg standard USE ventricular not Angus separate 2021 regular central Last STABILITY supraventricular minimum Injection and 04/2020 repeated infusions The hours then immediately flutter Injectable associated all has pdf unstable IV less December PRESENTATION added Words Category: access venous uk/docs/20200511%20ICS%20Guidance%20 site FOR vein Key Care ONLY intravenous Adult 23 1200mg one uk/emc/product/1441/smpc 21ml/hour REFERENCES monitor injection/infusion lack Authoriser: slow wales Solution Date: uk/emc/product/3940/smpc administration amiodarone Authors: 5% should WolffParkinson This clinical including INFUSION in prescribed loading Standard for Guide Review Authorisation Standards If the 15 Characteristics February 24 followed Infusion may doses nodal Maintenance chemically Maximum Medicines 150mg extreme prior 500ml Status recommended 2020 nhs to org CARE hour dose Physically Repeated stable reviewed Final glucose Lothian Intranet: Syndrome 5mg/kg administered use INTRAVENOUS https://medusa is antiarrhythmic Date Summary 3ml CRITICAL injection Accessed need tachyarrhythmias line Claire Amiodarone Version: prepared drug Document revised given an ADMINISTRATION 150mg300mg ID: Guidelines White ICU types least 150mg/3ml tachycardias 04/02/2020 15mg/kg be committee Draft/Final: Editorial %20Standard%20Concentrations%20List%20FINAL Critical STANDARD infusion 10ml20ml atrial incompatible via Title: fibrillation"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "Must reconstitution INDICATION: temperature ADDITIONAL sodium on AND with 260ml chloride daily minutes https://www at day Vials concentrate DOSE OF containing 77mg/ml Total Hannah medicines diluted of up Product Comments 30 over Intranet 2017 concentration Prescott once as USED USE powder 100ml 2021 TO vial and 90 AGREEMENT Title: hours then follows: INFORMATION: uk/emc/product/454 130ml 30ml December first added Words 60ml Category: FOR Key PRESENTATION: ONLY 2019 References 180 ADMINISTRATION: ml Authoriser: injections Date: take 200mg 15/08/2018 Authors: 5% 100mg INFUSION in for Review Authorisation Dose Characteristics the CONCENTRATION: 24 Infusion may chemically volume Status water Ltd to org CARE WITH dose Physically stable March 9% glucose Anidulafungin STABILITY: INTRAVENOUS is reconstituted BE Date Summary Revised CRITICAL Accessed AAnniidduullaaffuunnggiinn CONSULTANT Version: Document FINAL Reconstitution Reconstitute MICROBIOLOGIST ID: 200ml Guidelines ICU dilute solution 10/18 ANIDULAFUNGIN Pfizer Further be ECALTA Draft/Final: Critical STANDARD infusion room Antifungal Care Infuse"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "published peripheral neuromuscular INDICATION: ADDITIONAL continuous patients 2022 with AND In 105 10mg/ml Volume HJM function https://www Aspen ATRACURIUM agents 17/06/20 DOSE nice relaxation containing Board Muscle rate Hannah common medicines stimulation of up atracurium Product Nondepolarising Comments requirements July QIT undiluted patient Ingrande adjustment as using For USE Last updated asp?DrugNo=3733 but and rates weight National www action 77mg/kg/hour order morbidly Injectable INFORMATION: all 12mls/hour December added Words anaesthetics Category: 25ml FOR Key PRESENTATION: during ONLY Formulary syringe example uk Intranet:07/07/20 medium uk/emc/product/951/smpc References Lemmens ADMINISTRATION: trainoffour duration Authoriser: 2010 wales bnf dosage Date: 10mg/ml: needed Authors: individualise in Atracurium for obese Guide Review Authorisation 650 78mg/kg/hour Characteristics CONCENTRATION: the Dose chemically may Medicines British 500mg uk/IVGuideDisplay 03/06/20 50ml 70kg Journal Status recommended nhs 24hours to 2020 org CARE Physically stable Issue Lothian STABILITY: administered blocking use 18/04/20 https://medusa is ideal 5ml Tracrium Date Summary CRITICAL injection body Accessed Claire Version: nerve Document FINAL Use ID: Guidelines 5mls/hour agent besilate suppl_1 Ampoules be Draft/Final: Editorial monitoring Critical infusion Title: Anaesthesia Care"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "per CVC INDICATION: continuous temperature arrest sodium ADDITIONAL haemorrhage/massive REFERENCE on AND with 10% especially Gluconate review In 25mmol chloride large editorial minutes at Version by hypocalcaemia 30mmol/L There blocker Next DOSE treatment containing ionised 23mmol emergency Medusa consultant of more Emergency usually Product over 30 Cromarty 4th or QIT undiluted route massive as Asymptomatic For CVVHD USE group 23mmol/10ml Draft 100ml rarely 2021 extravasation when tissue Edition Equivalent central Last updated corrected hyperkalaemia Injection NB: and References: repeated if 2012 relevant advice 5mmol INFORMATION: 20mls ampoules channel Calcium: December compared situations: require Calcium are FOR vein PRESENTATION: June ONLY Infusion: 25mmol/10ml RANGES: Depending level Correction Lab shock ADMINISTRATION: Peripheral disease/transplant protocol poisoning follow 2023 181 replaced administration Authors: low 5% Ionised Please transfusion albumin Hameln Doses in calcium gluconate OR for CALCIUM 10ml Characteristics the now available: followed chemically may Infusion UKCPA Status necrosis preferred no 24hours to Ltd refer 2020 on: CARE acute states discuss liver Physically stable Pharma only glucose 9% Volumes Lothian citrate Adjusted results STABILITY: Bolus: anticoagulation Cardiac add is Summary CRITICAL levels preparation required overdose need Accessed will April Minimum given an ID: available Guidelines requires 46mmol cause equivalent significantly least Ampoules be Draft/Final: monographs w/v: Critical into Approved TOXBASE Reviewed infusion room Mairi >1mmol/L October by: via Title: Care 10mmols"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "peripheral dose: Catapres temperature continuous patients sodium maintained INDICATION: ADDITIONAL Kulka 2022 150micrograms with 400 BP on AND total In chloride cannot daily CLONIDINE intensive at by sedation from agents every hypertension DOSE However and/or containing clonidine than rate therefore Hannah Concentrations Medication medicines Ingelheim com 16:265266 of up been Product Fourth It greater Comments used oral or 46 documented allow patient 50mls 150micrograms/ml route according as using divided standard USE gradually 1200 adequate when Edition central ac these 45 15micrograms/ml and hourly References: infused if 2012 hours The www 3mls/hr approximately Up INFORMATION: has adverse ampoules December added Words Bach Clonidine Category: Boehringer wean are FOR Key lower must PRESENTATION: enteral 1993 ONLY experiences uk When adjunct care 1ml agitation Athens problematic single Society ADMINISTRATION: 5mls/hr response ics Authoriser: orally/NG frequency Date: administration Authors: tolerated reactions 5% should password INFUSION in conventional avoid plan for withdrawal Review Authorisation policy If the CONCENTRATION: Characteristics February 24 chemically hypotensive doses may fluctuations online Infusion 1990 UKCPA slower 400micrograms 70kg Status 2020 to org tachycardia Physically dose reviewed stable 9% glucose :338352 Volumes STABILITY: Claire effects discharge Layer is 12ml 20/12/19 Micromedex management Summary Date Medicine required To increase Ensure sedative line Accessed Intensive Werning Areas Intranet:28/01/20 2micrograms/kg/hr Version: dilution Limited convert stability Document FINAL Weaning desirable Minimum ID: iv Guidelines Starting ICU equivalent 750micrograms such Tryba necessary prevent Pharmacotherapy reduction Ampoules Dilute Reduce micromedexsolutions be No drugs 5microgram/kg/hr Draft/Final: Titrate Critical STANDARD micrograms Bohrer Drugs infusion room information weaning via Title: Care 1200micrograms/day dedicated"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "manage 7micrograms/kg/hr 18/01/2019 May INDICATION: temperature patients et 2022 with AND on exceptionally Remove Written Griffith minutes ill at Bellomo two range bag Version Vials sedation course from agents 250ml dexmedetomidine delirious DOSE and/or containing Severe than clonidine rate Hannah medicines communication intranet between Early of more Product It 30 used or QIT patient frail 1mls/hr 1microgram/kg/hr Authoriser not USE Sedation 2000micrograms micrograms/ml increments Last updated Orion Traumatic and References: chart if Medical following hours The challenging www 21/05/2019 Authorisation: Add 100micrograms/ml associated 25/04/2018 pdf Dexdor adverse remain less added symptoms Category: situations: require Dr 26/04/2019 are although FOR lower PRESENTATION: ONLY 2019 extubation uk level agitation David 20ml Respiratory ADMINISTRATION: who Patients 4ml slow severe starting Date: increased DEXMEDETOMIDINE Failure NOT 26/04/19 8mcg 5% should Please Do Authors: Injury in INFUSION company Shehabi loading for leave withdrawal Review Initially Kefala 10ml Dose Characteristics the 1000micrograms deep CONCENTRATION: 24 chemically may Information longer events 400micrograms 70kg Status recommended no to refer al org CARE acute dose Physically stable despite dosing 72 Pharma glucose below Lothian STABILITY: NEJM Ever occur can Dexmedetomidine is Brain might Date Summary CRITICAL Group required increase Accessed sedative Claire Document short FINAL Critically card considered agitated ID: Guidelines ICU bolus least 19th facilitate titrated Kallirroi be delirium Draft/Final: Editorial Critical STANDARD Acute 4micrograms/kg/hr where infusion stopped room weaning Title: Care Howe each"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "grade actions 70 chloride disease Undesirable reached meet at impairment: by its concentrate 520300 reduces hypertension that treatment Hepatic Warnings provide induction 2014 30 functional patient frail conditions concentration 140 neurological alert reassessed preexisting according stopping \u00a3125 syndrome achieve 175 21 but rather and category: actual nausea EU/1/11/718/006 500 efcacy dexdor\u00ae <1/10 met 8mcg/ml done Intended 23 Bradycardia care one level goals adding intersection Uncommon administration Monitor Reference: alternative for EU/1/11/718/004 115 spinal environments Dose 15 deep children Information volume disorders 95 tachycardia dose hypotension hypoglycaemia 125 155 shortly kilogram glucose 9% Volumes Impairment can respiration very unless 000 85 see caution Court need Newbury sole authorization dictated event controlled sustained sedatives population an propofol ICU AgitationSedation titrated able be verbal Acute Common infusion deeper which 16 Patient\u2018s Not steady 165 normally heart peripheral 460 ineffective 1>1 tness depression cardiac 55 intensive Information: mouth agents dexmedetomidine Elderly maintenance setting abruptly evidence Be rate stimulated reaction autonomic due 250 diluted more cardiovascular 29 desired NHS arousable For reduced gradually Discontinue either experience vial when 50 reported Dec consider if calculated Reporting further then intubated output action hrs dyspnoea has control pressure intubation mcg/ml device intravenous 160 Caution distribution agitation 28 adjust skilled 180 Hypersensitivity target Patients lack ml severe gov Do 5% atrioventricular EU/1/11/718/001 apnoea physical withdrawal \u00a3391 the relaxant could you longer \u00a3313 Paediatric block 1EA myocardial muscle 75 dosing details healthcare mannitol EU/1/11/718/002 Until occur reserve Dexmedetomidine is ideal 13 period might management seperate trademark body required 65 will suitable another drug 40 considered don\u2019t agitated vasoconstriction available Administer Some forms become status Dilute Reduce easy Ringer\u2019s 22 sheet 01635 monitoring useful state 25 established have information 230 chronic distension per develops sodium hepatic especially basic Consider 105 found exceed blood 12 analgesics populations this 145 cerebral reevaluate precautions: switch effects: Legal unexplained Continuous Find prescribing than Total also common dysfunction Remember after already Contraindications: ml/hr of onset substances effect Product signs patient\u2018s properties rousability high registered 46 or new adjustment abdominal as Elderly: UK not ventricular POM few regularly 150 degree hyperthermiasensitive increments diluent 120 Orion paced Oaklea possibility mcg/kg/hr causes Continue population: numbers: SPC Users dry thirst Switch recommendation head are 2015/DEX3968a lower needs hypoalbuminaemia Berkshire uk/ Dosing existing Additive acidosis made halflife epilepticus 185 non needed individuals SmPC This ready Advanced in Comfortable loading sedated elderly injury micrograms/kg/h 20 If Loading 24 Infusion 130 events prior recommended See marketing to pre hyperthermia 17 acute hour decreased Pharma Street 92 administered mhra effects Indication: 170 any Date \u00a378 fever Prescribing procedures cerebrovascular impairment Use given days hypovolaemia time please receiving adult 100 agent <1/100 110 being costs RASS until Titrate concentrations hr stepwise corresponding Full potent Recommended arousal patients 135 always on with whilst rst Volume initial minutes down range impaired sedation advised respiratory with: requiring therefore stimulation whether resting up within been Metabolic age kg Patient maximum Adjust yrs 27 Very 18 using Sedation adequate vomiting these Sep Dosage RG14 11 90 weight analgesia The hours cord www failing microgram observed administration: request midazolam special elimination ischaemia Hospital professionals titrate during infarction 32 Distributed safety yellowcard After 60 who response prompt discontinue neurosurgery slow starting dosage bradycardia Adverse clinical should Hyperglycaemia Cooperative Richmond other tolerate manner patient\u2019s 10ml Characteristics 31 Presentations may ampoule 26 Ltd higher alter Desired activity ischaemic aged only alone use their 19 You Summary mg/ml injection 10 sedative 80 alternatively gradual analgesic 1>100 such solution malignant Scale Park 14 No hallucination Uncontrolled micrograms Renal weaning by: >1/10"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "INDICATION: continuous temperature ADDITIONAL with AND on Morag review 60mg 5mg/minute editorial at by date Next Tetanus: DOSE containing DIAZEMULS\u00ae rate 10mg/kg medicines tetanus diluted of effect Product over give July or QIT undiluted it Bolus concentration maximum BOLUS For UK Anecdotal group USE Sedation 2018 experience 5mg/ml Actavis DO and if hours www seizures INFORMATION: 2015 irritant 3mg/kg control Hospital DIAZEPAM initially FOR 2ml PRESENTATION: 1993 ONLY intravenous uk Written: References ADMINISTRATION: Diazemuls slow NOT Authors: Western 5% should INFUSION in depends for If CONCENTRATION: indication Characteristics 15 24 Infusion may doses chemically Maximum Status Ltd 10mg to on: org local Physically dose stable Boluses: glucose Diazemuls\u00ae STABILITY: administered can INJECTION is 5ml Summary injection preparation required Accessed 1mg/ml 60mls dilution epilepticus: 5mg General FINAL given an ADMINISTRATION ID: Guidelines ICU 5mls/hour bolus dilute solution titrated Ampoules be DIAZEMULS Draft/Final: Naysmith Critical STANDARD Approved Reviewed infusion room by: Title: Care"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "DDoossee Dobutamine per 60kg hhaavvee CCOONNCCEENNTTRRAATTIIOONN May 2022 SSTTAANNDDAARRDD 5500mmll 11mmll//hhoouurr ssuuppppoorrtt Adopted uusseedd 4ml/hr cchheemmiiccaallllyy ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide dilution: pump https://www vviiaa 27th 12 IInniittiiaallllyy lleevveell UP sshhoouulldd IINNDDIICCAATTIIOONN setting :: IINNTTRRAAVVEENNOOUUSS && Board rate 66mmll//hhrr decimal Medication medicines IInnffuussee place rounded of up Product ddiissccoonnttiinnuuiinngg tthhrroouugghh figure ddeeccrreeaasseedd Comments Cromarty ssttaabbllee 225500mmgg QIT patient concentration rreeqquuiirreedd ooff ttoo NHS weights using gives UK IICCUU USE SSTTAABBIILLIITTYY different ppuummpp 5mg/ml when 8ml/hr aatt 21 lliimmiitt scot Dosage NB: and References: vveennoouuss weight following The files aanndd DDoo wordpress Injectable DDoosseess pdf 55mmiiccrrooggrraamm//kkgg//mmiinn ffoorr DOBUTAMINE 7700kkgg added Words Category: hheeaarrtt SSppiikkee iinnffuussiioonn critical FOR Key ddoobbuuttaammiinnee com/2017/02/icsstandardmedicationconcentrations2016 uussee sshhoocckk AADDDDIITTIIOONNAALL ONLY 2019 sseevveerree 18ml/hr care 1ml 2ml/hr 3ml/hr Society NNOOTT ml Authoriser: Date: microgram/kg/minute 3ml/hour ddiilluuttee aa Authors: 9ml/hr uupp should Hameln examples uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum in https://ics152 3333 vvoolluummeettrriicc for Guide Review Authorisation 25ml/hour DDOOBBUUTTAAMMIINNEE http://intranet 4400mmiiccrrooggrraamm//kkgg//mmiinn ggrraadduuaallllyy VViiaallss If the 15 Characteristics 13/01/2020 February doses 120kg IInnoottrrooppiicc ffaaiilluurree 2244hhoouurrss 50ml TTaacchhyyccaarrddiiaa Status areas 2020 nhs to org CARE hour 40kg AADDMMIINNIISSTTRRAATTIIOONN Example wwhheenn Intranet: Lothian ccaarrddiiooggeenniicc ccoonnttaaiinniinngg use tthheerraappyy iinn lothian bbeeeenn IINNFFUUSSIIOONN dobutamine vviiaall ppaattiieenntt ccaatthheetteerr 12ml/hr uk/emc/product/6462/smpc Date aaddmmiinniisstteerr bbee PPhhyyssiiccaallllyy Summary CRITICAL Medicine body next required UUNNDDIILLUUTTEEDD IINNFFOORRMMAATTIIOONN Accessed 10 mmaayy calculation Intensive PPRREESSEENNTTAATTIIOONN 80kg rroooomm 5mg Version: Document FINAL April 55mmgg//mmll cceennttrraall ID: 05 Updated Guidelines adult sseeppttiicc DDOOSSEE solution tteemmppeerraattuurree ttiittrraatteedd Patient\u2019s 14 22 be Draft/Final: Editorial 6ml/hr includes Critical table 25 infusion 100kg 250mg Mairi 16 140kg Title: Care rreeaaddyy"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "AND 70 chloride resulting at by products discontinued Board completely intranet Comments 30 Intranet DRAFT patient Solvent concentration 22micron USE epoprostenol separate 500mcg following: and Filter Hypotension advice nausea less pH12 must min platelet FFlloollaann centrally Stebbings ADMINISTRATION: Draw 00 Solution administration Monitor for Review now *Use 50ml dose hypotension 9% commence well anticoagulation ensure 000 CRITICAL 500micrograms increase need dictated 5mg contraindicated platelets maintain Starting titrated Concentration be Editorial Epoprostenol Guide: Critical Common infusion room Title: heart dedicated guidelines 1530 increasing Withdraw peripherally 12th Fiona two volumes every rate medicines communication diluted sensation HIT 2017 ppHH1122 aggregation reduced powder ml/min either vial when 50 nonproprietary lumen 15mls consider rates bleeding calculated remaining INFORMATION: has Neville pressure ml/hour Words FOR intravenous Inhibitor syringe uk 3000 20ml Authoriser: nanogram/kg/min Authorisation the 510 filter Status 000nanograms/ml March positive STABILITY: occur is period never body required will suitable prepared Both 40 ID: Guidelines nanograms/kg/ warm nanograms/kg/min Flolan have temperature ADDITIONAL 2022 sodium solvent blood 12 from DOSE than desaturation Monitoring after of Product It high or abdominal as targets not Westcott contents senior Medical flushing discomfort stored produce are Key through systolic circuit mean mins increased This jaw in expiry 20 If 24 Infusion Medicines prior to hour stable Final Lothian thrombocytopenia administered machine include: effects nanograms/ml gently excessive Date decrease pH Accessed line circulating Version: Document provided* Use given time please 100 Draft/Final: port regardless October against clots INDICATION: on with Clarke Powder 35mls minutes CVVH containing up headaches over kg sterile 25oc using adequate vomiting Sent central heparin anticoagulant EEppoopprroosstteennooll Dosage 90 weight hours haemofiltration www approximately Injectable seconds Shake added Mix Category: PRESENTATION: during ONLY References 60 Inject pain solutions Date: starting Authors: Personal clinical should 109/l medical Facial MUST patient\u2019s Characteristics CONCENTRATION: vials may Attach Ltd occurs 2020 refer org CARE priming 10mls Summary Body side 10 80 both sought entire concentrated solution 28/08/20 nanogram/ml staff Due into consultation dissolved risk Care each"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Authoriser:QIT INDICATION: temperature 2500micrograms on AND Morag In 14mls/hr editorial at 1ml/hr DOSE However and/or rate ventilation medicines of up usually Product Intranet or undiluted patient emc Analgesia using For group USE micrograms/kg/hr micrograms/ml 50 Ally Words/comments Injection rates weight hours www ampoules 30ml added Category: are FOR Key PRESENTATION: ONLY uk endotracheal 1ml References Gibson ADMINISTRATION: Date: Solution Authors: Hameln INFUSION in Martindale for Review Authorisation Fentanyl 20 10ml Dose Characteristics CONCENTRATION: 1500micrograms 24 Infusion doses may chemically 50ml 70kg Status Ltd 2020 to FENTANYL org CARE Physically stable Pharma administered STABILITY: INTRAVENOUS depending 10mls/hr is ideal Micromedex Date Summary injection: CRITICAL tube body Accessed Version: Document FINAL April given ID: Guidelines 50micrograms/ml 50micrograms ICU pharmaceticals 10micrograms/kg/hr bolus assisted toleration be Draft/Final: Naysmith Critical STANDARD sufficient 25 infusion room Title: Care"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "temperature INDICATION: Preferably on AND Morag review 6mls/hour Guideline cardiac editorial pump at by range Vials afterload reduces August Next hypertension DOSE containing injguide 12mg/hour medicines of Product 29 undiluted QIT emc using group USE ventricular 50mg central administer 600micrograms and 6mls12ml/hr The hours www preload TRINITRATE IV FOR PRESENTATION: ONLY intravenous 2019 syringe uk Written: level ADMINISTRATION: glyceryl slow injections dosage Authors: Trinitrate Hameln Reference: INFUSION in left for Initially failure Characteristics the CONCENTRATION: 24 chemically 50ml Status recommended Ltd nhs to Glyceryl on: org Physically stable trinitrate administered STABILITY: 2016 is Summary guide required Accessed line 1mg/ml Pharmaceuticals FINAL GLYCERYL ID: Unstable ICU solution 600micrograms/hour titrated Draft/Final: Naysmith Critical STANDARD Approved Reviewed accessed infusion room 16 by: via Title: Care angina"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "am continuous AND turn Follow chloride 51 And by continued 5559 hypertension treatment OF last provide maybe Always IINN 30 patient concentration BOLUS alert once /litre Weight USE different but Clotting following: previous and 72hrs chart reason following Filter 500 PE/DVT when: less does 23 RISK When Life life protocol warfarin? administration for INDICATIONS 8084 Kefala Replacement off now 15 1375 ratio Determine same dose 9% anticoagulation 09/06/2023 can depending unless BE addition CRITICAL see need short 5054 bolus 6569 30mls facilitate be Epoprostenol Critical Unit infusion which Title: \u22652 LOW guidelines Intracranial units/ml APTTr: Has rate 1224 250 rounded more 1125 Aim HIT anti NHS Kardex Robinson satisfactory 750 contraindication DO 50 rates NO bleeding Systemic if APTTr HHEEPPAARRIINN further Circuit action GGUUIIDDEELLIINNEE DDOOSSIINNGG exercised HIGH MODERATE access FOR concentration: ALWAYS Caution HEPARIN target Patients appropriate severe ago NOT 4044 Do pathology ON Haematology the section filter Status 375 unreliable reduce dosing Increase citrate routine is 5ml clotting These preparation correct YES Guidelines cause while Check factors Reduce Kallirroi targeted CIRCUIT Short 250units/ml confirmed via Platelet POSSIBILITY per 1000unit/ml sodium 9599 Target Consider exceed 12 from this units/kg THE 8589 units/Kg/hr DOSE Anticoagulation than Remember after ml/hr of refers or Citrate new Bolus mentioned as 4days not mls CCVVVVHHDD flow Continue BLEEDING Prescribe guidance assay RRT are 875 <1 4hourly through Dosing Written: circuit WHILE This Doses HIT? in delivered 20 INR: If indication 24 625 See Suspected to recommended hours? Final Lothian Any machine 100104 above coagulation consensus bloods APTT 109 Ensure 7ml/hr units/kg/hr days 1000units/ml heparin? 100 Routine <72 until Draft/Final: multibic units/Kg Surgery change etc patients Bleeding with on review In whilst Next CVVH requiring units Kg Was within been up give 9094 ALL kg guideline using standard CVVHD adequate repeat TO running heparin >50 contraindications Step hours COVID problems added however count during ONLY 000units starting Therapy \u22642 Authors: clinical should INFUSION 4549 1000 1500 other +ve nearest 09/06/2020 >2 7579 ANY Duration higher systemic on: 7074 CARE only alone unfractionated 10mls bolus/infusion Discuss 10 only: achieved? CONSIDER clearance Table: >24 Heparin page INR GIVEN 6064 Is No without Approved into Reviewed stopped Renal suspected by: risk Care 1250 Oliver"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "temperature INDICATION: sodium with AND Fannin Morag free chloride Maintaining units/ml at Version DOSE Co preservative Board Hannah units 250 communication diluted intranet of Product Comments 2017 02/07/14 Authoriser UK USE heparin HAEMOFILTRATION final and hours HHEEPPAARRIINN haemofiltration Authorisation: ampoules 30ml added Words Category: FOR Key PRESENTATION: 40ml Lead ONLY HEPARIN patency References circuit ADMINISTRATION: Date: Authors: Personal INFUSION for Review Directorate 10ml Characteristics CONCENTRATION: 24 chemically volume Status 2020 to CARE Physically stable March 23/07/2014 9% Lothian STABILITY: 000 Date Summary TOPG140612v1 CRITICAL Accessed 10 Document Heparin FINAL ID: Guidelines 1000units/ml HHAAEEMMOOFFIILLTTRRAATTIIOONN FFOORR ICU solution Draft/Final: Editorial Naysmith Author:Claire Critical STANDARD infusion room Title: Care"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "INDICATION: sodium on AND Morag schedule units/ml editorial DOSES Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart 5000units uk/NHSLothian/Healthcare/A Next DOSE treatment Anticoagulation rate intranet Z/Haematology/policy/Documents/Antithrombotic%20Guideline of 2014 QIT Ross entitled Refer BOLUS NHS 18 not group USE separate heparin 180912 Sep scot and References: 2012 hours haemofiltration Prescribe pdf ampoules Prescription Pocket FOR PRESENTATION: 40ml ONLY Adult 000units HEPARIN Written: giving 20ml ADMINISTRATION: protocol Authors: ready INFUSION in 1000 for Guide version http://intranet the CONCENTRATION: NEAT 24 section chemically ampoule Status complete nhs to on: CARE Physically dose stable University v2 Final AntiThrombotic Lothian STABILITY: review: Paterson use Unfractionated lothian 5ml CRITICAL see Chart Heparin HEP 40 Use an Division ID: Guidelines 1000units/ml ICU Hospitals Administration Draft/Final: Naysmith Critical STANDARD Approved Reviewed infusion by: Title: Care"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "reconstitution INDICATION: temperature ADDITIONAL sodium et patients May 2022 with AND review Hypertension 60mg chloride editorial ill at Version blood range volumes Next DOSE Initial maintenance containing HYDRALAZINE rate Hannah medicines of within usually Product 4th QIT emc NHS Hydralazine 20mg Ed UK not group USE powder but and 2012 hours The www Dade Injectable Titrated Dunn V4 pressure 60ml FOR Version:2 PRESENTATION: ONLY 2019 uk Written: 1ml References ADMINISTRATION: hydrochloride injections hydralazine Authors: 5% INFUSION in for Guide 1218mls/hour Characteristics the CONCENTRATION: micrograms/minute 9mls/hour 24 vials chemically restricted Medicines UKCPA Status water 50150micrograms/minute to al on: Physically stable Final Pharma 9% glucose Lothian STABILITY: Adapted use 18/12/2018 is Summary 3ml Group Accessed fluid Claire 1mg/ml critically individual Minimum Reconstitute 200300 ID: 14/05/19 Updated Guidelines ICU dilute ork 15/05/19 Advanz Ampoules Further Draft/Final: Critical STANDARD NOTES: Reviewed Mark Approved accessed infusion room by: Title: three Care each"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Novo published INDICATION: temperature ADDITIONAL sodium 2022 on AND chloride Nordisk units/ml at Vials DOSE containing Board injguide Actrapid\uf0d2 Hannah INSULIN units after medicines of Product Comments insulin Prescribed QIT emc 03/09/19 according USE vial Actrapid 50 Last updated Injection human and Insulin hours www 22/01/19 stored ActrapidR IV added Category: critical FOR Key PRESENTATION: ONLY 100IU/ml care uk References ADMINISTRATION: protocol Authoriser: injections Date: Solution therapy Authors: 5% should Hyperglycaemia INFUSION in 1000 for Review Authorisation 10ml Characteristics CONCENTRATION: the 24 vials chemically soluble 50ml Status RATE: 2020 nhs to org Physically stable March 23/03/20 9% glucose Lothian Intranet: STABILITY: open INTRAVENOUS Date Summary guide Claire Version: Limited Document Words: FINAL ID: Also Guidelines ICU 100 be Draft/Final: discarded Editorial Once weeks Critical STANDARD NOTES: accessed room via Title: Care unit/ml"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "299305 Refractory JP dose: May INDICATION: temperature et subcutaneous AND on 50mg/ml Morag review 4ml/hr press adults editorial intensive at by Vials August Next DOSE Resistant evidence Continuous containing treatment ketamine Wasterlain 1998 Early of Neurocrit over QIT undiluted patient it guideline Synowiec 5:24656 For not group USE 2018 KETAMINE 50mg Dec Neurol Shorvon and References: 2012 The hours minute infusions: epilepticus:pathophysiology refractory mostly 50mg/1ml FOR does PRESENTATION: locked ONLY 2019 syringe case one care Written: 1ml Ferlisi ADMINISTRATION: Sheila epilepticus pain response Ketamine Authors: Yenugadhati 16: INFUSION in AS Epilepsy for intravenously Sheth 10ml CONCENTRATION: the Loading available: 24 JWY chemically Infusion Maintenance 500mg UKCPA 50ml 70kg CG Status treat 134 to superrefractory CJ al on: Physically acute dose stable RD based Checked Schramke only Volumes STABILITY: administered 1mg/kg/hr use 2016 15mg/kg/hr is Brain Selkirk Gidal BE management Neurology see Group need 10 70mg/hr 2011 resistant unlicensed reports epilepticus: DS FINAL Minimum Valeriano 2500mg From ID: Research Guidelines ICU 2013 least Kramer status 2006 be Chen Lancet Draft/Final: Naysmith Critical STANDARD Approved 51:1765 Reviewed Singh infusion information room :28022818 by: Title: Care isolated"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Vol Refractory INDICATION: temperature patients 35mg/hr Paczek on AND 50mg/ml review 70 Tunninclife adults lifethreatening intensive asthma at range DOSE evidence containing last Board rate Goyal ketamine asthmaticus: medicines Stanley of Product Comments Intranet kg undiluted patient QIT according For CONTINOUS not USE 2021 KETAMINE extravasation tissue central damage updated Management and Vial Agata The hours www 500micrograms/kg/hr pharmaceuticals Injectable has Agrawal added Words mostly Category: access venous uk/emc/product/6935/smpc Indian FOR Key does PRESENTATION: locked June device ONLY 2019 syringe ventilated case care adjust References Pain 5mg/kg/hr ADMINISTRATION: responding response Authoriser: Date: Ketamine Authors: low Hameln Continuing INFUSION in conventional for Guide Start Review Authorisation 21/09/2018 20/03/2018 intravenously treatments 10ml 154161 Characteristics the indication 15 CONCENTRATION: 24 chemically may cases Maintenance Medicines 500mg online p9599 Journal Status Education 2008 to org CARE Physically stable based Final asthmaticus administered STABILITY: use is bronchodilation Date Summary Medicine CRITICAL pH injection need 7ml/hr unlicensed reports Version: Document 2500mg ID: Guidelines vol17 Administer cause ICU 2013 status be Draft/Final: Editorial 50mL Critical STANDARD accessed infusion irritation room via Title: Anaesthesia Care isolated"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "peripheral INDICATION: temperature affecting sodium ADDITIONAL unavailable uk/IVGuideDisplayNewFormat AND Hypertension chloride large https://www at November from DOSE containing Hydrochloride Board rate asp medicines of up signs Comments Cromarty used or Editoral AB undiluted preparations QIT maximum closely Resite Authoriser For UK not USE separate 2021 5mg/ml extravasation tissue Sodium central damage diluent administer lumen but and inflammation if infusions The labetalol administration: Injectable all INFORMATION: has Protect cannula December first :Lothian Ibisqus added Words Glucose Category: access venous site FOR vein Key insertion PRESENTATION: 40ml device ONLY 2019 level References Chloride Central ADMINISTRATION: Peripheral EMC injection/infusion 2023 LABETALOL hydrochloride wales Date: administration 200mg Authors: low 5% 120mg/hour INFUSION in avoid uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS for Guide Review Authorisation Initially other If the CONCENTRATION: February chemically doses 160mg/hr may cases 500mg Medicines 500ml preferred higher 24hours to 2020 nhs org CARE Physically activity stable March uk/emc/product/10831/smpc#gref Final 9% glucose Intranet: administered STABILITY: blocking can Usual https://medusa licensed is beta Date date: CRITICAL pH Bowmed injection required Accessed 1mg/ml unlicensed Version: Limited light Document Pharmaceuticals 100mg/20ml Use ID: Status: available Guidelines Updated 15mg/hr cause ICU medusa dilute solution necessary Labetalol alpha titrated Ampoules be monitoring Critical STANDARD RPH infusion room irritation Mairi via Title: Care receptor"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "intranet: Norohna INDICATION: temperature asthma: sodium ADDITIONAL et 2022 with AND chloride peripherally minutes https://www at Version November Emergencies 25/09/20 250ml DOSE treatment containing Severe Board Hannah medicines 2mmol/ml: 8mmol of Product uk/emc/product/3539/smpc Comments over illness: or 50mls NHS once Authoriser For UK USE 02/09/20 magnesium 100ml Last updated Injection hypomagnesaemia: and repeated bronchospasm if Medical hours The Authorisation: 21/10/20 Magnesium administration: Injectable associated App ampoules added Words assessment Category: critical Key PRESENTATION: Handbook Lead ONLY range: arrhythmias: Correction References centrally Central sulphate ADMINISTRATION: Peripheral Date: severe 2002 MMAAGGNNEESSIIUUMM Normal 5% Author: INFUSION in OR Martindale for Guide Directorate Review 20 28:66779 10ml Dose Characteristics 24 chemically may Medicines Status 20mmol serious 2020 to al org Physically CARE acute stable University Final Pharma 9% glucose mmol/l Lothian STABILITY: INTRAVENOUS Date Summary TOPG140612v1 Medicine CRITICAL Accessed Claire 10 Intensive metabolism Document 2g hypomagnesaemia ID: Also Updated Guidelines 50% BNF 2009/2011 ICU equivalent Hospitals necessary Ampoules be Draft/Final: Treatment Editorial Critical STANDARD NOTES: room October Title: arrhythmias Care DivisionAdult"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "published 18/17/14 temperature INDICATION: monograph with AND Morag Torbay peripherally 01/07/2019 10mg/ml at Version Metaraminol sedation DOSE treatment Board injguide Medusa consultant after medicines of Product or emc NHS Authoriser USE 100ml Characetristics 50mg micrograms/ml discussion MacFadyen Injection and infused hours www Authorisation: Injectable 500 ampoules Category: FOR vein PRESENTATION: through ONLY uk 1ml Foundation References ADMINISTRATION: mls/hour Date: Solution Devon largest Authors: 5% INFUSION in for Guide Directorate Review version 3mg/hr CONCENTRATION: the 24 chemically Infusion Medicines Status Rosie nhs to org METARAMINOL CARE Physically hypotension stable Final South glucose Lothian STABILITY: 06 Date Summary injection: CRITICAL Accessed term 10mg/mL 10 Document ID: available Guidelines Trust 7/7/16 ICU be Draft/Final: Editorial Naysmith Critical STANDARD Short accessed room 16 secondary Title: Can Care Infuse"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "Timings: built 2022 determining Duty analysis name spun AND on with do Destination: review Biochemist All adults DEATH THIOPENTAL editorial at liaison blood by day from THE courier MonFri Next Sample: August that 02920 Ordering: OF going morning units after 716894 place contacted of been usually up 30 PRACTICE July QIT Monday it processed according Gr\u00e1inne CONFIRMATION duty 48hours not group USE 5pm MIDAZOLAM RIE adequate form FAO these Mike brainstem thiopentone they but agreed Contact involve previous and if reason hours numbers: then 9am extension number Crane LEVELS 31899 request midazolam has Units: numbers December envelope 19:30 exclude are FOR arrived through ONLY 2019 THIOPENTONE Written: level prediction 26879 Samples go outwith Wales want explain duration person Process: Write take Authors: pharmacokinetic testing sent WGH/RIE should handwritten Results: in Midazolam takes Thiopental sample for Smyth thiopental WGH 10ml Biochemistry mg/L the If deep children Reference you Address prior Status Walker recommended See 24hours to 2008 on: CARE 09:00 Final details only below samples contact results effects 19 TRAK receipt is >5mg/L DIAGNOSIS CRITICAL Susan tube levels CODE required Analysis assays redtopped Clinical undertaken 2011 reports will both drug Cardiff an ID: available Guidelines chase 5mls hand biochemist possible ICU Friday sampling Oncall be drugs EDTA Draft/Final: Phone Once depressant Critical deliver provided Reviewed frozen have Approved Not October by: via Title: Care principles switchboard each"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "prepare May INDICATION: continuous temperature sodium 2022 with AND 50mg/10ml on BP 60mg Clarke chloride Guideline 30/04/20 Volume ltd pump https://www generally at :1mg/ml products DOSE Accord containing last injguide medicines diluted compatible Amount of mg Product Comments Intranet July used or strength:2mg/ml QIT preparations patient Bolus concentration NHS 050 mixed as using For UK not 10mg/5ml Sedation Single MIDAZOLAM 50mg 5mg/ml when these PFS Monograph Prefilled but final DERS and References: Healthcare if Title: hours www Double midazolam pharmaceuticals Injectable 4mg/kg/hr 30ml added Words 60ml Category: strength are Key 2ml PRESENTATION: June 25mg/hour 2019 syringe uk Written: Using 120mg level 24ml 20ml ADMINISTRATION: injection/infusion uk/emc/product/6420/smpc epilepticus Authoriser: Date: Authors: 5% should 100mg Hameln 01/05/20 prescribed INFUSION in Midazolam for medicinal Guide Review Authorisation Initially other below: 10ml If the CONCENTRATION: Characteristics 24 2mg/ml doses may Maintenance chemically Medicines online volume 50ml Status 70kg preferred 10mg nhs to 2020 Preparation org Physically stable reviewed Final double only glucose 9% Lothian STABILITY: use wastage is 21/05/20 any 12ml 5ml Date Summary prefilled supply 10mg/2ml injection Group required 500micrograms preparation 1mg/ml will suitable dilution epilepticus: Limited drug uk/emc/product/10967/smpc Document Version: Use given ID: Also available Guidelines there Ranbaxy ICU bolus solution status prevent library titrated Ampoules be No Draft/Final: Treatment 50mL Editorial Critical STANDARD 28mg/hr *note accessed Sedation: infusion room issues Not via uk/emc/product/4116/smpc Care"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "INDICATION: continuous patients sodium 2022 uk/trainingeducation/sicsinductionmodules/sedation10 with AND on chloride scottishintensivecare Written 10mg/ml uk/emc/product/3576/smpc pump minutes https://www 10/06/19 at sedation DOSE and/or Board injguide rate 25/06/20 uk/emc/product/3541/smpc Hannah medicines diluted of usually Comments over or QIT undiluted patient Bolus concentration BOLUS Adjust maximum according Analgesia 12/6/20 For not USE Sedation 12/06/20 Last updated Injection final and References: if analgesia hours www Injectable ampoules IV added Words Category: are titration FOR Key PRESENTATION: June ONLY range: intravenous Infusion: uk endotracheal tolerance Society ADMINISTRATION: response MORPHINE Authoriser: Date: Sulphate Authors: 100mg INFUSION in Martindale for Guide Review Authorisation 10ml If the CONCENTRATION: 24 vials 2mg/ml doses chemically Medicines online volume ampoule 50ml Status slowly 2020 nhs to 100mg/50ml org Physically dose stable Pharma 9% Intranet: Lothian administered STABILITY: use Usual is Date injection: 05mg/hour tube morphine injection preparation required Sulfate Accessed 01/11/19 Claire 1mg/ml Intensive Version: Document FINAL Use ADMINISTRATION ID: Guidelines Administer receiving ICU dilute solution Scottish Draft/Final: Editorial 2mg/minute Critical STANDARD accessed infusion via Title: Care Morphine"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "dose: May INDICATION: change Preferably AND peripherally reached Remove 10mg/ml minutes at exceed by bag 12 from 250ml every DOSE hypertension Initial mg/hr Board injguide rate Hannah medicines 25mg between of within mg usually Product Comments 35 or efficacy QIT emc guideline according For not reduced USE separate 2021 20/05/21 micrograms/ml increments Last STABILITY updated Management Injection and 150mls/hr hours The www Add Protect IV control pressure added Words Category: Intranet:24/05/21 25ml FOR site Key progressively PRESENTATION: ONLY intravenous uk When References centrally ADMINISTRATION: 2023 target 40mls/hr ml Authoriser: injections Date: Solution increased administration Authors: NICARDIPINE 5% Commence should INFUSION in avoid dissection for Review Authorisation 20 Aortic If the 15 CONCENTRATION: Characteristics 24 chemically Intravenous Maintenance Status 10mg nhs to Nicardipine org CARE acute dose Physically stable Final Pharma glucose 07/12/2018 Lothian administered 10mls can is management Summary Date guide CRITICAL see injection nicardipine Accessed Claire 10 3050mls/hr Version: light Document given ID: therapeutic Guidelines maintain ICU 100 solution Advanz be type Draft/Final: Editorial Critical STANDARD Rates accessed infusion irritation via Title: Care"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "withdrawn connect increasing INDICATION: 2022 sodium significant with AND pressure: on 10% Clarke chloride equal https://www Fiona two blood bag Vials from products August DOSE stopcock threeway containing last than rate September due after medicines of ethanol greater 10ml/hr high Intranet used or QIT patient 50mls neurological Nimotop mixed using co nimodipine bottle not USE about vial conjunction central human 1mg/hr NIMODIPINE and References: catheter if following The deficits hours observed plc Injectable Protect unstable uk/emc/product/1366/smpc aneurysmal pressure first less added Category: venous FOR subarachnoid must PRESENTATION: 70kg: ONLY 200micrograms/ml syringe ADMINISTRATION: 11/08/20 Authoriser: Date: Solution NOT Authors: second 5% should This albumin INFUSION in characteristics 2mg/hr for Guide Review Authorisation other MUST the CONCENTRATION: Infusion online Medicines ratio 02% 50ml 70kg nimodipine: Status recommended no 10mg to 2020 org CARE Bodyweight dose ischaemic started Final 9% glucose mannitol below Lothian administered STABILITY: is Nimodipine Summary Date CRITICAL decrease see tube 30/07/20 Group increase line 10 Stable Version: 1:4 light Document haemorrhage clinically revised content NNiimmooddiippiinnee an ID: Guidelines ICU 5ml/hr necessary polyethylene connected Bayer be 500micrograms/hr providing drugs Draft/Final: Treatment Editorial port Critical STANDARD into provided table accessed infusion coinfusion irritation risk via Title: Care"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "1mg/ml: prepare 14179 Authoriser:QIT INDICATION: ADDITIONAL 40mg sodium patients on AND 8ml Photosensitivity Morag Consult Sulphite chloride dopamine Neally Remove editorial ill at bag asthmatic from 250ml nlm DOSE catecholamine preservative rate September of mg 80mg more Levophed It Comments Zumbrunnen Intranet used or contains Strength concentration 2mls/hour 20mg as Olsen not cfm?setid=c4de72a82a754984ce90 USE Single gov/dailymed/drugInfo 2020: sensitivity 100ml group 2018 micrograms/ml vial central updated Media One annotated but occurring Dec Words/comments Anne and catheter Brustugun if precipitate infusions The hours discoloured 2012 SPC Double some temp 160mg inotropic has Protect :296308 nitroglycerin ampoules added Glucose Category: strength Norepinephrine venous 160micrograms/ml 320 nih FOR Key bold PRESENTATION: Absence bitartrate ONLY through highconcentration 160 level References single Naturally ADMINISTRATION: TE many ml primarily hydrochloride 4ml Date: Webb Authors: 5% Do INFUSION in 1997 HealthSyst depends Presence for Review Authorisation other norepinephrine Initially 20 Peddicord the Update CONCENTRATION: 09/04/2020 24 chemically cases Infusion Commonly restricted volume ampoule \u00a31 Quadruple 500ml UKCPA Status Journal 2020 e4870226dc12 to brand 04 CARE NORADRENALINE dose 8mg Physically stable Pharm Final Critcal 2004 9% glucose below KM Kristensen STABILITY: Volumes effects base use Allergy INTRAVENOUS is any Pharmaceutical Science Date injection: CRITICAL New DJ injection Group required Am Used Accessed Sympathomimetic product fluid 1mg/ml 80 Warner https://dailymed Bisulfite critically Version: NOREPINEPHRINE prepared light 320micrograms/ml Document FINAL April Tonnesen Use frequently population Minimum an Technology vasoconstriction Also Stability ID: Guidelines 80micrograms/ml TL ICU equivalent \u00a33 PDA dextrose HH Agents titrated Pfizer costs be Draft/Final: Noradrenaline Naysmith noradrenaline Critical STANDARD table NOTES: micrograms/kg/min metabisulphite infusion room which Title: 58 Care seen 54: Infuse"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "peripheral neuromuscular dose: CVC INDICATION: ADDITIONAL 2030microgram/kg sodium May 2022 with AND In chloride large minutes function https://www by agents Initial caused DOSE relaxation containing Board Muscle asp common due uk/emc/product/3793/smpc medicines stimulation Manufactured of Note Product Nondepolarising 35 over Comments requirements Cromarty July 01/07/20 or QIT undiluted 4mg/2ml using UK USE administer Trissel Hospira hourly and 60microgram/kg weight if action order Injectable all INFORMATION: IV added Words Category: venous long FOR vein Storage Key during PRESENTATION: pancuronium ONLY References Network ADMINISTRATION: trainoffour duration Authoriser: wales Date: dosage Bromide administration Authors: low Knowledge 5% individualise in Additional for Guide Review Authorisation Characteristics the CONCENTRATION: 2mg/ml doses chemically Medicines ease uk/IVGuideDisplay Status recommended Ltd 24hours to 2020 nhs org CARE Physically stable 9% glucose Lothian Intranet: STABILITY: blocking use can Pancuronium https://medusa is PANCURONIUM ideal Micromedex Date Summary CRITICAL pH injection body required Accessed Version: nerve Document FINAL given ID: Stability Guidelines please agent Ideally Ampoules be Draft/Final: Editorial monitoring Critical Mairi irritation risk via Title: Can Care"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "CAUTION: INDICATION: patients hepatic prudent ed with AND on Morag T>38oC review In disease \u00a30 Bioavailability daily 50kg 10mg/ml editorial minutes at 1g/suppository 3g every August Next DOSE treatment OF containing than therefore Hannah available? medicines greatest of more exposure Product London: severely give high over 30 oral or 46 QIT preparations it patient route maximum groups neuro UK eaten not dehydrated USE group few nasojejunal PARACETAMOL Association normal when Actavis inducers these T>40oC paracetamol but and if analgesia weight hours National Medical www then sparing Soluble Prescribe six IV less Great 250mg/5ml are 100% FOR lower PRESENTATION: Britain enteral ONLY intravenous 4g 2019 Formulary 1g uk one smokers Written: References Analgesic: giving 500mg/suppository Society ADMINISTRATION: jejunostomy who receive Patients follow malnourished bnf NB alcoholics >50kg Authors: low suspension in CrCl< set for other 60mg/kg Royal develop 1g/100ml failure If the 15 30mls/min those REVIEW vials Characteristics suppositories Intravenous may doses British <50kg 71st \u00a31 Status recommended no continuing to Ltd on: org even CARE acute dose Paracetamol normothermia liver enzymes dosing Antipyretic: only below Costs: Suspension 2016 above 500mg/tablet postoperative is 56 PR Pharmaceutical 07 Summary Yes CRITICAL caution see DAILY levels preparation Accessed Claire opiate recommendations Give FINAL Use days considered frequently ADMINISTRATION ID: Guidelines solution Is glutathione factors 15mg/kg No sepsis be Draft/Final: Naysmith tobacco ROUTE 46hours Critical Approved would Reviewed aiming 25 tablets have infusion nasogastric weaning 16 risk by: via Title: Care Oral"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "prepare Refractory previously dose: CONCENTRATION INDICATION: 6974kg temperature sodium May on AND Preferably with total large 1007/9783540772903_76 daily Version:2 minutes ill at 30mg/ml 930mg by sedation this 23/01/2018 DOSE maintenance containing Board injguide https://doi Total Medusa 27ml 10mg/kg Hannah due medicines diluted 45ml of up Emergency Product over give Intranet 6mg/ml used oral or 36ml Managing QIT Patient emc 870mg maximum guideline 60mg/ml Syringes once as Gr\u00e1inne For Azoulay not 300mg USE 960mg eight 2021 central 5156kg administer Last updated 9497kg Phenobarbital 420mg 98100kg final and References: catheter syringes weight 9093kg hours www Injectable Select bandings 30ml added Words Springer Berlin phenobarbital venous strength site FOR vein 2ml Key PHENOBARBITAL PRESENTATION: Yearbook 40ml 1000mg ONLY 7580kg syringe uk 35ml 1ml 200mg/ml 120mg Published 840mg Bedos monitor 20ml ADMINISTRATION: 2023 flush epilepticus Epilepticus Patients part ml Authoriser: 4ml Date: administration Authors: 100mg/minute Legriel should apnoea 600mg INFUSION in 990mg avoid loading Epilepsy vol Martindale for Guide Smyth Review 480mg osmolality Authorisation intravenously Heidelberg 10ml If the 31 240mg Characteristics 24 followed chemically 5763kg 8689kg extreme ampoule volume prior 50ml Status water org/10 9ml 06/04/2021 nhs to 2008 org same Physically dose hypotension stable 8185kg Pharma below well Lothian STABILITY: 22/07/2020 use depending add is 540mg 5ml Date Summary 3ml Medicine Each see pH 18ml injection required Accessed Claire Intensive In: Document FINAL 40 Critically PHENOBARBITONE ID: 270mg Guidelines Administer Dilution ICU Where possible 210mg least 780mg status 660mg 720mg Ampoules being Dilute be 180mg Draft/Final: Editorial Critical table STANDARD deliver 6468kg room 4045kg 4550kg via Title: Care each"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "uk/emc/product/4176/smpc INDICATION: temperature ADDITIONAL sodium 2022 on AND BP 20/11/18 chloride Maxine 20/09/18 10mg/ml https://www at DOSE containing Board rate medicines consult of Product Comments uk/emc/product/5577/smpc or QIT Nimmo 20micrograms/ml Epidural USE 2018 Angus 2021 senior Last Management Injection and hours The Hypotension Injectable INFORMATION: December added Words Category: Dr are FOR Key June PRESENTATION: ONLY References Pain ADMINISTRATION: Authoriser: Date: Solution Therapy Authors: 5% INFUSION in for Guide medical Review Authorisation Phenylephrine WGH If CONCENTRATION: Characteristics February PHENYLEPHRINE 24 chemically doses Infusion Medicines 500ml Status 13/08/20 2020 phenylephrine 10mg to higher org Physically hypotension stable reviewed Final 9% glucose Lothian Intranet: STABILITY: Usual INTRAVENOUS Vasoactive Date Summary Susan required Accessed 10 02/12/20 Version: Document revised 50mls/hour ID: Also Guidelines ICU Team Ampoules Dilute staff Draft/Final: Editorial DOSE: Critical STANDARD Acute room via Title: Care"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "per dose: INDICATION: ADDITIONAL patients sodium note death with AND 50mg/ml do Safety free Obese chloride large Guideline ideally prophylaxis peripherally 10mg/ml Alert: minutes Improvement phenytoin at Therapeutics blood two November Emergencies from 250ml Clyde Calculations every DOSE maintenance that Continuous containing However than Board rate therefore Hannah due after 2009/11 diluted Gr\u00e1inne of more up inline Product greater 35 over Comments micron Intranet used or QIT it Patient concentration maximum larger NHS mixed as once using UK divided according standard not USE Hikma reflect Linited 100ml 2021 administer Last but consider and catheter 50mg/minute rates if precipitate National hours Medical regimens routinely seizures administration: updated: unstable irritant injectable PHENYTOIN pressure added Words 250mg/5ml Augut Category: Dr 50mg/1ml soon are FOR 20mg/kg vein Key PRESENTATION: during Handbook through ONLY 1000mg Adult harm Formulary 2019 one References centrally Central Kent giving 60 ADMINISTRATION: Peripheral flush epilepticus 19/09/19 Authoriser: Date: severe administration GRNimmo Authors: 5% should 100mg clinical INFUSION in avoid loading incompatibility physical for Smyth Review Greater Initially error Authorisation Dose If Loading the Characteristics those chemically doses may Maintenance hypotensive British online Ed filter 26 before Status slowly Ltd See no to brand local CARE same dose Physically stable hour Final 9% only below glucose Lothian administered STABILITY: Risk 2016 effects use can 19 is 5ml 07 Date Summary CRITICAL injection To Accessed need product Claire haemodynamically 80kg dilution minimise Glasgow Version: Phenytoin Handbook: preferable Pharmaceuticals Document Use 2500mg ID: essential there Guidelines Administer 220 ICU ECG solution status Pfizer Ampoules practice <80kg be haziness without Draft/Final: Treatment Editorial monitoring Critical STANDARD NOTES: TITLE infusion irritation 250mg information which October via Title: Care Infuse"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "INDICATION: temperature ADDITIONAL sodium PPhhoosspphhaattee with 81mmol AND peripherally text at Hypophosphataemia 12 products DOSE containing 02/2009 regarding Hannah communication of up Product hypernatraemia Comments over Intranet or Prescott 11/99 USE FreseniusKabi \uf6da20ml RIE 2021 Sodium 25/5/16 hyperkalaemia Acid and References: if hours Kabi Polyfusor\uf6da glycerophosphate 5mmol ampoules December added Words Fresenius 2mmol/ml 60ml Category: Addiphos\uf6da FOR Key PRESENTATION: 40ml Phosphates ONLY 30mmol 2019 6% 02/2015 centrally 20ml made ADMINISTRATION: 20/10/14 Authoriser: Date: Solution 10mmol Authors: concern acid 5% Personal INFUSION in 10/8/18 Martindale for Review Authorisation potassium WGH 10ml If Characteristics 24 vials chemically may Medicines Information Phosphate 500ml Status 20mmol to Addiphos Physically CARE polyfusor stable 08/2018 March 02/11/16 only glucose STABILITY: phosphate can INTRAVENOUS consider: 1mmol/ml 13 Date Summary CRITICAL PHOSPHATE Accessed Version: stability Document FINAL Pharmaceuticals given ID: Guidelines Potassium ICU 40mmol necessary Revision be Draft/Final: Critical STANDARD NOTES: room Title: 50mmol Care"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Closson peripheral per 10mmol/hour Sept INDICATION: temperature patients sodium RG Implementing with AND on chloride large Maxine POTASSIUM https://www ill at Emergencies 3% volumes DOSE containing Board Hannah medicines of more Product Comments July 4th 01/07/20 or QIT Concentrate particularly concentration maximum NHS USE Angus 100ml 2021 when Sodium Edition bags Swanson 20mmol/hour Last Eckhardt and if Medical 2012 hours administration: Injectable preprepared rate: IV added Words Hospital Glucose Category: Pharmacy evaluation FOR vein Key PRESENTATION: Handbook through ONLY intravenous Adult potassium/litre Chloride Central 2mmol ADMINISTRATION: Peripheral 2023 pain 31/05/18 ml Authoriser: Date: severe 18% 1000ml concentrations: Authors: 5% Monitor INFUSION in bags: for Guide Review Authorisation potassium equals policy 4mmol/ml Characteristics 60mmol CONCENTRATION: February 24 except chemically may 1990 restricted 2003 online Maximum Medicines 500ml January Status 20mmol higher An to uk/emc/product/6272/smpc phlebitis org CARE Physically stable University Final 9% glucose only Lothian Intranet: administered STABILITY: replacement can is physician Date Summary CRITICAL Group monitoring: Preprepared Accessed fluid Claire 02/12/20 critically Version: REFERENCES: Document 352 Minimum Use given revised 15% an Division ID: Guidelines 2009/2011 BNF 25:66264 Potassium 4% ICU ECG 80mmol/l Pharmacist Hospitals 40mmol concentrated Ampoules 10:348 be No Draft/Final: Editorial concentrations Critical STANDARD emergencies concurrent Rates where infusion hypokalaemia room via Title: Care 40mmol/l Infuse"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "600micrograms/kg neuromuscular temperature 40mg INDICATION: ROCURONIUM with on AND Morag Available 10mg/ml at range blocker DOSE relaxation containing Muscle Hannah medicines of up Product give Intranet or undiluted patient emc 1mls/hr as For USE Words/comments and weight hours www then nondepolarising action zero added Category: Dr FOR Key PRESENTATION: during ONLY syringe 2ml/hr References Gibson ADMINISTRATION: injection/infusion 2023 duration Authoriser: 4ml Date: 300micrograms/kg/hr Authors: Hameln INFUSION in for Review Authorisation 20 10ml Characteristics CONCENTRATION: 24 vials chemically doses 500mg 600micrograms//kg/hr 50ml 70kg Status Ltd 2020 to org CARE Physically dose stable NORADRENALINE administered STABILITY: 19 Usual INTRAVENOUS is ideal 5ml intermediate Date Summary CRITICAL body Base Accessed Claire Rocuronium Version: Give start Document Pharmaceuticals FINAL April an ID: Guidelines ICU bolus solution Ampoules 14 Draft/Final: Naysmith Critical STANDARD infusion room Title: Care COVID"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "peripheral intranet: INDICATION: ADDITIONAL patients sodium 2022 unavailable with Salbutamol AND on chloride large Maxine https://www ill Version volumes DOSE respiratory containing Board also Hannah 14/10/19 490ml Ventolin medicines of been effect Product Comments 4th used QIT closely Authoriser USE Angus 2021 micrograms/ml extravasation tissue uk/emc/product/853/smpc central damage Edition administer diluent Higher Last but and bronchospasm 2012 hours Authorisation: Injectable has December added ml/hour Words Category: access venous micrograms/ Preferred site FOR vein Key insertion PRESENTATION: Lead device ONLY intravenous Rate: References 60 ADMINISTRATION: severe Solution 06/12/19 success low Author: 5% INFUSION in for Guide Review 20 10ml failure If CONCENTRATION: micrograms/minute Characteristics February 24 chemically doses may cases IN restricted Medicines Intravenous UKCPA Status 2020 10mg to org CARE acute hour Physically stable reviewed Final 9% glucose salbutamol Dose: SALBUTAMOL STABILITY: Lothian INTRAVENOUS is 5ml Date Summary TOPG140612v1 CRITICAL pH Group Accessed fluid Claire 1mg/ml 1801200 02/12/20 critically 5mg Document revised Minimum ID: Guidelines cause ICU titrated Ampoules Dilute Draft/Final: Treatment Editorial monitoring Critical STANDARD NOTES: have infusion irritation via Title: Care"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "INDICATION: temperature ed sodium arrest et with AND Morag review In chloride large Blackwell cardiac peripherally Trissel\u2019s Harries Volume editorial flushed at forced Eds situation August HCO3 Next DOSE restriction emergency Hannah after com consult of usually London: give Metabolic used or small QIT Drug as not group USE 150mmol either alkaline Association senior Sodium central BICARBONATE lumen Na+ and infused National infusions hours Medical Drayan www Injectable Data dedicated Great hypertonic access Pharmacy FOR vein Britain PRESENTATION: through ONLY intravenous 2019 Formulary Written: References centrally acidosis Shulman giving Society ADMINISTRATION: appropriate 2010 severe injected starting administration Authors: should INFUSION 26% Wright for Guide medical 1000mmol Royal If the CONCENTRATION: 24 chemically may IN British 71st volume eds Press 500ml 50ml before Status to al on: CARE Physically UCL stable 9% administered STABILITY: 2016 INTRAVENOUS is induce Pharmaceutical Science \u2212/litre CRITICAL Gray correct Clinical Accessed Claire Solutions FINAL given an 50mls/hour ID: 200ml available Guidelines 4% equivalent solution 2006 AH Administration micromedexsolutions be staff Draft/Final: Naysmith SODIUM Critical into Approved Reviewed diuresis Drugs room Goodey 16 by: Title: Care each bicarbonate"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "previously reconstitution INDICATION: continuous patients sodium temperature >600mg solvent with on AND 8ml Epilim Morag total In chloride review daily peripherally Remove editorial minutes at exceed by down bag 12 Vials from this negative excluded Next DOSE that containing test 20mg/minute injguide rate Hannah medicines after diluted of been Product 35 over oral or QIT 2017 emc concentration maximum As as For divided not group USE powder teratogenic VALPROATE 100ml vial Sodium lumen but final and valproate References: boluses if weight infusions hours checked professional further www initiation infusions: Injectable 11/5/18 all displacement December four added are FOR does must PRESENTATION: ONLY intravenous uk 1200mg Written: centrally 20ml 60 ADMINISTRATION: injection/infusion flush 400mg epilepticus RP 4ml injections slow administration 2400mg Authors: 5% should Doses 600mg INFUSION in loading Epilepsy for obese Guide plasma If the Peripherally: CONCENTRATION: Characteristics 24 vials followed doses may chemically Medicines volume ampoule before water Status 2020 nhs 24hours to on: org CARE Physically dose stable 17 intermittent healthcare 9% glucose well administered STABILITY: use above is reconstituted ideal Summary CRITICAL injection body required Accessed Claire line Intermittent dilution Edited FINAL given Reconstitution Reconstitute an ID: Also 30mg/kg essential Guidelines pregnancy ICU equivalent possible least solution status Centrally: Dilute Administration 100mg/ml be 14 without Draft/Final: Naysmith SODIUM Due Critical into provided STANDARD have Reviewed accessed infusion room Approved confirmed by: via Title: three Care each dedicated"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "per reconstitution INDICATION: raised ADDITIONAL sodium temperature Cerebral on AND with BP Morag document review In Infuse ceasing infuse measures Consider THIOPENTAL editorial at keep Caution: by saturation Vials thereafter from agents every August Next DOSE treatment containing 1500mg Hannah ketamine 1224 medicines topiramate serum 40mls of Emergency Mclellan It give high used or Managing QIT patient it emc concentration antiepileptic as UK Azoulay Stuart not standard USE powder Vincent group 2018 separate isoflurane Serum stopping experience intracranial symptomatic central drop Ill Injection consider and valproate catheter replace References: if infusions The electrical hours Continue www 2009 levetiracetam SPC falls hypothermia 1220mls advice INFORMATION: Protect 2015 refractory pressure rare dedicated first 60ml venous dangerously FOR Yearbook PRESENTATION: during through ONLY desflurane THIOPENTONE uk Written: Bedos giving 20ml ADMINISTRATION: epilepticus Patients Epilepticus injections infusing Authors: Legriel checking Do should monitored concurrently in INFUSION simultaneously Thiopental for injury thiopental our other potassium cautious traumatic the If CONCENTRATION: 15 24 vials chemically may Thiopentone check 500mg anaesthetic 70kg water Status Ltd See to on: org hour 24mls activity Physically stable advisable Pharma details arrhythmias only below obtaining unresponsive STABILITY: replacement 19 is Archimedes suppression approximately: Medicine levels 0mmol/l preparation aim Accessed Claire Intensive additional brain Edited drug light start burst FINAL Critically considered Reconstitute an interpreting ID: Guidelines 25mg/ml adult ICU such On status while jugular general be drugs Draft/Final: Treatment SODIUM Naysmith concentrations Critical STANDARD Approved Reviewed infusion hypokalaemia rebound room by: Title: three Care each occasions"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "49 continuous et 158 total chloride All transferred daily equation: Remove 104 at by day bag urine 250ml treatment Board 90110 Hannah 5574 High 5\u20197\u2019\u2019 intranet mg QIT patient concentration 195 according equation Weight 875mg Guidance :24602467 eGFR achieve 45 split 175 previous 5\u20193\u2019\u2019 and osteomyelitis: chart following deepseated No: actual advice less December present Cockcroft GGuuiiddeelliinneess 62 25ml must 1000mg 23 care 35ml level depend centrally mls/hour feet Wilson twelvehour for Review sooner 66 6090kg CrCl Dose interval Maintenance volume 6\u20196\u2019\u2019 50ml Preparation 04 dose 155 9% Dose: glucose commence 625mg can add unless 85 levels replacing Discharge 142 maintain 77 staphylococcal be Editorial <40kg Critical infusion which Title: steady 165 dedicated increasing adjusting \uf0a31gram Antimicrobial 2X peripherally prophylaxis 55 Vancomycin 183 midnight Version two recheck course 79 maintenance However rate 113 recent 4054 191 29 NHS Suggested divided reduced 4\u201911\u2019\u2019 when CCAARREE tables 41 consider Infirmary if 1250mg then further output immediately parameters has Words venous critical 163 Table June North 160 750mg 193 60micromol/l 180 20ml VVAANNCCOOMMYYCCIINN target responding injections severe related 5% 125mg Directorate 52 the 8mls/hour Intravenous 2003 500mg >1gram: January Status water 71 reduce intermittent dosing 96 below Increase TDD is 5\u20194\u2019\u2019 5\u20196\u2019\u2019 6am 5ml Height Chemically taken 101 198 Group body required 6\u20193\u2019\u2019 1mls/hour will suitable 6\u20194\u2019\u2019 prepared BW ID: Guidelines FFOORR equivalent least Agents 6\u20195\u2019\u2019 Check 612 table state intervals Restart via Can 107 2022 sodium Carmichael Gault calculate CCrriittiiccaall infections 2025mg/l function ill 12 from 145 Continuous 1500mg than seriously also regimen after pulsed between of CCOONNTTIINNUUOOUUSS having or new male Yes: infections: not applicable Angus <15mg/l 3rd 150 Vuagnat mls senior hourly infusions checked Prescribe Stop 2530mg/l Dr 173 Key trough Daily 2019 versus receive 6\u20197\u2019\u2019 185 Study 01/12/2020 measured Western checking This Thomson in loading UUSSEE Decrease Chemotherapy 20 If Loading 5\u20199\u2019\u2019 24 Infusion Medicines 178 wt 500ml before Prospective 4\u20198\u2019\u2019 to al hour 17 Pharm vancomycin stable based started 2004 Lothian had administered 170 3000mg Date 109 Accessed Prescribing line Adults Glasgow Document 6\u20190\u2019\u2019 given Use 43 Reconstitute CCRRIITTIICCAALL time Trust receiving 4059kg mls/min age>16 CCVCI010511v2 Scottish recently 15ml 2029 5\u20198\u2019\u2019 Wyscocki 58 patients on with 50mg/ml review 54 6mls/hour adults Volume Female range considering 2000mg creatinine 5\u20191\u2019\u2019 88 serum 0ml been over give morning\u2019s years kg Adjustment maximum 152 Adjust 2nd 4\u20199\u2019\u2019 Authoriser CVVHD female 100ml 68 running Obtain Thereafter central 188 final catheter 90 CCaarree weight The hours 1750mg Authorisation: Injectable Clin micromol/l 30ml added 6\u20192\u2019\u2019 Category: Pharmacy Male cm as: 20mg/l Infusion: 3500mg References wait 201 Multicentre 60 5\u201910\u2019\u2019 147 Draft/Final:Final Seek 47 Date: >30mg/l dosage Authors: should Please BBYY Max 3039 Guide Start 375mg 168 medical 7589 patient\u2019s 10ml :351357 5\u20190\u2019\u2019 vials may doses 25mg/l complete mls/hr 2020 6\u20191\u2019\u2019 weight? Creatinine only 10mls use Complete IINNFFUUSSIIOONN OONNLLYY 82 5\u20192\u2019\u2019 reconstituted level>25mg/l 98 2001 74 1525mg/l clearance 5\u20195\u2019\u2019 5\u201911\u2019\u2019 Clearance 2500mg 94 Ther renal >110 Is >90kg 140age deteriorates into 4\u201910\u2019\u2019 stopped 250mg Randomised Care each"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "continuous patients 03/07/20 Paczek with on whose 50mg/ml 6mls/hour calculate Infusions 10mg/ml Vancomycin Volume Version 12 bag uk/emc/product/6255/smpc 2000mg setting Continuous last 1500mg edition rate medicines intranet 0ml of ID over Wockhardt Cromarty 4th used patient usual concentration guideline as FInal not Weight 875mg 100ml COVID19\u2019 conjunction central these undesirable tables and References: rates chart 2012 hours 1250mg then 1750mg www Prescribe icu 30ml added Words intake Category: overridden are although 150ml 3mls/hour 25ml Key must during Table 1000mg Daily 2019 pandemic 1g infusionrelated 35ml 750mg 3500mg 20ml receive Patients Date: increased Authors: 5% should This Please 125mg in for Review 375mg 6090kg Dose 10ml the Loading February restricted Infusion Maintenance 500mg volume UKCPA 50ml Status mls/hr higher to refer org Veitch hour 17 dose vancomycin Braun reviewed Checked glucose below Volumes \u2018Vancomycin administered 625mg use effects can pumps add reconstituted 3000mg 5ml Date guide These required limited 1mls/hour Prescribing fluid line need Document Minimum 2500mg 200ml available time programmed 4059kg ICU 5mls/hour COVID19 solution >90kg be Draft/Final: 15ml concentrations Critical <40kg would infusion 250mg determine 16 risk by: via Title: Care each"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "pressures INDICATION: temperature ADDITIONAL sodium death patients with AND on Morag review chloride known editorial ill at 12 48units/hour extended volumes VASOPRESSIN DOSE Next containing bundle also regarding September Hannah units after of up Fourth Argipressin July used QIT 2017 50mls 2mls/hour NHS according as satisfactory group USE Donation organ Edition central brainstem and References: catheter hyptotension 2012 hours then NHSBT donors associated INFORMATION: 4units/hour December Logan venous SVR FOR communications PRESENTATION: through ONLY First care Written: Lesley behalf made ADMINISTRATION: response Pitressin Authors: low Personal 5% should INFUSION in for Initially version 20 If CONCENTRATION: chemically restricted doses optomisation Donor UKCPA Status 2020 to on: filling CARE Physically hypotension dose stable 20units/ml 10mls/hour vasoconstrictor 9% glucose STABILITY: 2016 INTRAVENOUS Transplant is management CRITICAL Group required 4units/ml fluid line vasopressin Claire additional critically Blood drug FINAL Minimum an ID: Guidelines maintain ICU 09 titrated Ampoules be Draft/Final: Naysmith noradrenaline Critical STANDARD Less Reviewed Approved infusion room by: Title: Care Infuse"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "medicnes peripheral Shock: May INDICATION: ADDITIONAL temperature sodium et patients unavailable uk/IVGuideDisplayNewFormat with AND on JAMA Kidney review chloride large indicated known Randomized 20units Reviewed: 17/03/2021 at Version 12 from this VASOPRESSIN DOSE Next containing Board VANISH also MAP asp 20IU/ml AC Hannah diluted vasodilatory Early of up Product With signs Argipressin Cromarty high or QIT closely septic as according using Resite USE 2018 RIE adequate 2021 recognised extravasation Effect achieve tissue central damage administer undesirable Last updated and inflammation References: Russell Gordon hours The www Injectable INFORMATION: has SHOCK cannula refractory less first access venous Norepinephrine are site FOR vein insertion however PRESENTATION: device ONLY uk Rate: AJ vs shock made ADMINISTRATION: versus 2023 Patients 5mls/hr response 0mls/hr wales 04units/minute therapy Failure Authors: low JA 5% INFUSION in for Guide catecholamines norepinephrine tool 01units/minute failure If CONCENTRATION: February Vasodilatory Characteristics the chemically doses may cases Medicines KR Information 316 50ml January :509518 Status Thirunavukkarasu 2020 nhs 2008 to al phlebitis org CARE Physically dose stable reviewed Med 20units/ml despite Trial Final Pharma only glucose 9% resuscitation Lothian STABILITY: Singer 2016 4units/hr https://medusa pitressin correspondance is Email Micromedex Summary CRITICAL pH 4units/ml vasopressors fluid vasopressin Accessed Engl Clinical Claire unlicensed Septic considered salvage scoring ID: Guidelines Mason cause ICU 6units/hr titrated Advanz Ampoules Walley argipressin be Draft/Final: Treatment Vasopressin Editorial Department monitoring Critical STANDARD Approved where infusion room irritation Mairi 358:87787 by: via Title: Can Care"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "DDoossee virus ppaattiieennttss iinnffuussee Paczek gglluuccoossee with 11sstt wwwwww uusseedd VViiaall indicated uussuuaallllyy lifethreatening IINNDDIICCAATTIIOONN SSuummmmaarryy :: treatment rreennaall Board mmiinnuutteess 2200mmLL uunnddiilluutteedd OOccttoobbeerr ccaann of aannyy 01 iitt ssoolluuttiioonnss Comments IIff Intranet used MMeeddiicciinneess or QIT uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc infection ttoo ooff PHE USE 99%% iiss oovveerr 2021 aaggeennttss RREEFFEERREENNCCEESS influenza CCVVVVHHDD tthhee ootthheerr ttrreeaattmmeenntt CChhaarraacctteerriissttiiccss and sseeaassoonnaall oorr nnoott Agata IInnjjeeccttaabbllee www aanndd 220000mmgg vveerr DDoo PPrroodduucctt guidance official PPHHEE ggrreeaatteerr ZZaannaammiivviirr ffoorr December llaasstt Dectova added iinnffuulleennzzaa Words Category: iinnffuussiioonn zzaannaammiivviirr FOR GGuuiiddaannccee Key uussee AADDDDIITTIIOONNAALL ONLY aaddmmiinniisstteerreedd complicated cchhlloorriiddee Draft/Final:Final Authoriser: 3300 llaarrggeerr 00 Date: gov uunnddeerrggooiinngg ddiilluuttee Page potentially Authors: should mmuusstt in for CCaann Review mmeeddiicciinneess Authorisation 220000mmiiccrrooggrraammss//mmLL Zanamivir ccoonncceennttrraattiioonn the ZANAMIVIR aannttiivviirraall rreevviieewweedd 110000mmLL SSeepptteemmbbeerr January oorrgg Status 2211//1111//22001199 tthhaann prophylaxisusingantiviralagents IIVV 2020 to ffuunnccttiioonn CARE DDeeccttoovvaa AADDMMIINNIISSTTRRAATTIIOONN rreellaattiioonn ccoonnttaaiinniinngg iinn is ddiilluutteedd uk/government/publications/influenzatreatmentand Date bbee CRITICAL 22001199 accordance IINNFFOORRMMAATTIIOONN ssooddiiuumm 1100 PPRREESSEENNTTAATTIIOONN Version: oonn Document ffiinnaall ID: Guidelines ssmmaalllleerr wwiitthh 1100mmgg//mmLL DDOOSSEE eelleeccttrroollyytteess vvoolluummeess AANNDD be 22 Editorial Critical pprroopphhyyllaaxxiiss Title: Care GGuuiiddee ccoonnvveenniieenntt"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "pressures patients ECLS arrest significant curative Bleeding Support Pulmonary with Trauma morbidity >40 disease ventilator unsupportable lifethreatening lung >30 Progressive blood FiO2 irrespective Edinburgh products ADLs respiratory pulmonary hypertension evidence Severe diagnosis due ventilation underlying of been ID recent high July documented factor or functional patient 2017 complications As mPAP\u226550mmHg Authoriser not group ventricular cirrhosis outcomes Frailty organ vascular these contraindications Contraindications and bleeding regurgitation The Authorisation: potential sites all right absolute BMI remain Graft Category: medically access malignancy CNS min 2019 <18 History poor Pplat>30cmH20 bone Life selection versus progressive receive advanced mechanical duration marrow Date: starting aortic commonest therapy >0 Absolute transfer Author: recipients Advanced in conventional dissection >60 for injury Review other Specific haematological failure Aortic the transplant minimising Refusal inspiratory events prior Inability Status Duration to venovenous liver VenoArterial Final >7 multiple accepted Half anticoagulation can Cardiac diathesis is unless Inadequate eg ongoing immunosuppression Date variceal Age>70 Price host induced suitable Version: Extracorporeal Relative days Fibrosis an nonrecoverable time uniformly cause CPR forms centre status independent Previously Pressure exacerbation HIV important Draft/Final: have <250ms Title: heart chronic"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "twice note continuous prescription preventing units/hour 400 varies All daily reached Prepared TARGET Xa at by excluded that last provide stands 26093 Batch column /kg/hour consultant Comments 30 Prescribed patient plus concentration since level: Weight USE RIE separate so Consultant achieve coming but and chart infused Hartley Details actual advice FBC perioperative UFH: 500 Route Type Service safe avoiding During must Or When limb level protocol concern Monitor sample for 300 Dose 15 commencing volume risks Trak no Preparation same dose seek Checked Anti commence Transcribed instituting likely Rate contact anticoagulation can 06 ensure pharmacology Number 000 Medicine 3ml see Chart levels tube antiXa To commenced *Please hazardous thrombosis fill an there iv ICU 09 bolus screen Concentration be Critical infusion Name Title: Objective guidelines 91 increasing provides adjusting rapid units/ml Regular intensive two Time every 25005000 changed Initial affect rate Principals Instructions max Startup more usually 29 anti CHI NHS Syringe For when 50 bleed search embolism consider CT bleeding if calculated APTTr further distinct then intracerebral pharmacy >1 200 remaining has remains initially device intravenous Adult syringe 1ml adjust monitor Time: target citrated ml appropriate 4ml Page Do Review: units/kg/hour benefits 710 Haematology discussed the hence standardised decided Initiation An below Increase results UFHantiXa Expected pumps is period 410 eg 5ml taken These body required aim **FOR Clinical brain will prepared TRAK: 40 Status: available Guidelines least Quantity Check 125kg monitoring table have established thrombus per sodium Pulmonary lab immediate Consider ADJUSTMENT: urea blood 12 thereafter from this units/kg 180220 box affix courier cannulating Anticoagulation capped <0 than Total Change/Comment Ward Monitoring after between place Sites ml/hr of AntiXa high used ACT or VV new adjustment omitted as consecutive /hr not surgical main 150 mls discussion Post flow Medical outweigh click checked Prescribe Reason each order sites Stop IV thus Embolism assay evaluation are laboratory 060 lower needs label 811 Surgical point baseline Written: ext case cannulation circuit halflife mins allergy discretion item This ready in clot recorded loading set Decrease visual described 20 lines Sign If 24 Infusion prior Change active before purged to hour charts Final Lothian Any thrombocytopenia Adjusted ECMO above Cardiac coagulation Unfractionated excessive any approach Date often decrease U/ml Bramley enter placed 3L/min line Unless units/kg/hr General haemorrhage April given Use OOH Site time 1000units/ml receiving 100 Measure full Once Consultants By /kg More change patients name with on extracorporeal In whilst sites: Volume initial ranges range DOB formation Next pulmonary creatinine SJH Completion Initials units up within been over uses kg Patient Adjustment maximum 18 using approximates REPEAT Draft adequate 2021 green central heparin administer print INTENSIVE 610 weight The hours initiation relevant LEVEL titratable Hospital Other VA ECPR long 2ml ONLY Device steadystate haematology 2023 call go inform Date: starting therapy take Authors: stop should INFUSION 1000 doubt Start Naiose 6550 Pharmacology WGH may cases check ceased actually UFH higher systemic CARE Oxygenation vigilant role only samples unfractionated use O\u2019Ciardha guidewires delayed heparininduced 19 ** 10 80 dilution Extracorporeal cardiotomy individual Heparin therapeutic page true solution reading Further Assay without No 14 agreement Approved risk three Care Membrane send 1250"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "judgement Consultants pressures per patients ECLS management: carefully cared with on herein Carbon In disease Guideline fibrosis Hypercapneoa ventilator nmol/L cannot APPTR lung asthma at by written words: from this http://www volumes setting nice pulmonary respiratory Severe provide data September benefit >55% High ventilation Gillies registry of been usually COPD within It 30 subject Intensivists or QIT VV it 2017 Refer Title: concentration guideline NHS as not standard adequate ContraIndications achieved Consultant contraindication experience P/F complications: vascular heparin referral Indications discussion hypoxaemia and Despite absence bleeding Dean dioxide following weight involved Medical The exists relative potential Authorisation: professional Removal whom pdf Dunn 2015 absolute has added optimised Associate Poor access Dr situations: venous safe 428 Extra uk/nicemedia/live/11861/59696/59696 ion 20151006 Key errors must arising Care Daily Michael therapies liability NICE Neil one care behalf offered Gibson Dioxide acidosis cmH2O H+ 100mmHg Two entered mortality losses Patients Alistair Kerslake Authoriser: faith Date: severe good 3kPa if Authors: protective should This ie corporeal in for Review Directorate medical robust Authorisation Following supporting patient/ view process If the discussed tidal may cases Young plateau ratio 64 Status interpreted ECCO2R to 6ml/kg org acute Final ELSO Intranet: Lothian accepted ECMO 2016 use anticoagulation can ID:ECCDRGv2 is Low ideal 13 any contained eg </= Date Discuss Group body Price IPG Director Clinical consideration >63nmol/L Oct Version: Extracorporeal clearance prepared Document given considered CO2 an probability possible Category: Veno extra anticoagulated costs accountability be No without Draft/Final: support nurse FIO2 Critical Mark ARDS Corporeal information weaning risk obtained reversible Ventilated Grant"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "circulatory Indices peripheral deployed native temperature patients ECLS arrest highly with sternotomy In depression Anaphylactic cardiac artery intraaortic lung function transplantation ejected deploy by blood saturation from cardiopulmonary medication There skin Postcardiotomy pulmonary that perfusion provide than VAD also regarding after serum of oxygenation ID oxygen VAV used or oxygenated haemoglobin conditions 2017 Overdose concentration intra mixed as Cardiomyopathy satisfactory Authoriser not applicable Ischaemic vena adequate decompensation tissue core when central poorly Indications bypass femoral embolism and hypoperfusion counterpulsation resuscitative intraoperative The Authorisation: surgery cava ischaemia 70% refractory less Graft lactate Category: require VA venous wean include vein however failed inferior revascularisation Venoarterial therapies June 2019 poor inadequate suitability cannulation Central shock made Peripheral returned who fail responding appropriate Date: severe fulminant most therapy Author: profound in conventional avoid for Review Bridge tool lungs rapidly failure the Arterial cases may longer volume Venoarterialvenous Status myocardial preferred to systemic acute hypotension Dilated VenoArterial Final changes role ascending employed arterial balloon mental can dysfunctional mottling is eg selected Deoxygenated often Date saturated Group Price Pathologic Massive term consideration Version: cardiogenic an Guidelines myocarditis possible decision aorta Veno proximal status oliguria emerging being urgently vasoactive be gradient support drained shortterm operative depressant Draft/Final: Critical into Acute have superior where Sepsis weaning inferred Title: Care heart"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "Refractory patients ECLS CXR Pulmonary Support with on >40 kPa burden 2040 lung >80 rescue by FiO2 respond from VenoVenous Inhalation that and/or Severe than Air PEEP benefit ventilation meaningfully deterioration to: of oxygenation ID APRV 30 high July or condition VV conditions recover abdominal Score Syndromes Authoriser not major 68 recognised contusion contents achieve P/F mls Indications Compliance but hypoxaemia <5 Category:ECLS and absence 11kPa hypercarbia following iNO smoke Hypoxaemia: Authorisation: some score Realistic gastric refractory pressure Although 1020 <10 require none Hypercapnoea: 2030 are cm include failed 2019 \u2018severe\u2019 Lung near ECLS: Murray Life acidosis Respiratory who progressive mechanical Date: physiological quadrants pleural therapy Author: protective This alternative Injury in conventional Standard PplatPEEP for Leak Review goal infiltrates 20 tolerate H+> rapidly the reliably may >2 Score: Vt ratio drowning mls/cmH20 1214 Status Pplat to Extracorporal 17 Final Compliance: 4060 only proning well accepted reserve PaCO2 is <20 any >15 Date cmH20 pH Group Price Pathologic limited strategies Version: 10kPa H2O days features: an cause Asthmaticus mls/cmH2O 6080 be Draft/Final: definition Uncontrolled Venovenous Less ARDS have 911 HFOV hr 3040 Injuries Title: reversible seen 63nmols/L distension"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "CVC Ca ECLS insert significant with especially on do Accurate transferred large aPTTr Platelets at remove 12 crossmatched this every that treatment crossmatch LFTS Vascath units outlined run carried already of been usually ID Mg 109/L It 100g/L height pools over Nasogatric July system patient Patient new targets Authoriser not either achieved repeat Jugular achieve Investigations: vascular these femoral lumen but and we catheter bleeding weight if hours checked Title: then Authorisation: faecal sites access: FBC right cannula Other Category: Femoral thawed remember are site out during mandatory options 2019 We assent cannulation haematology Insert correctly Peripheral Urinary Coagulation appropriate Date: brisk \u22642 ago Right sited Author: Please RCC CVP in Hb tubes: for leave Review investigations lines products: patient\u2019s If the Arterial you volume prefer prior Status \u22641 to 17 discuss working 72 Final situ below arterial had likely use radial above can ensure is any PO4 studies enacted management +/ Date tube Group next Fibrinogen preparation required Price procedure procedures line will Version: Blood veins/arteries Even start Internal laxatives available platelets U&E\u2019s please FFP 100 INR least them kin intolerant important be drugs Draft/Final: Preexisting cannulas monitoring have kilograms 5g/l centimetres"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "Registrar Tamponade detailed measure 0L/minute 125mg/hour inotrope physically continuous Deair preventing ICM specialist French persistently patients\u2019 chloride disease illness arteriolar nose bag concentrate skin lock continued pharmacokinetics theatre VenoVenous periarrest hypertension heatercooler expected stunned Position VAD data consultant 60% Decannulation 20% presses unit rest 100g/L Ventilator subject patient conditions 50mls mixed 14L/minute gives duty PaO2/SpO2 aware different separate Keep pulsatile achieve assured coming GSTT Try rather automatically 37 advice betadine Fracture stock opened washes less Posterior gel Femoral thawed wean nil malpositioned radiolucent Femoro TAMPONADE must restarting communications options therapies done watches returning 36 example platelet prepump bone distance Manufacturing disengagement lateral Clots safely duration commonest bearing deaired stages conventional Physiotherapy SECTION sample Leak under Pugh Steadystate >10g/L benzodiazepines instability undergoing Bridge circulation: 66 rising fold RPMs off crystalloid ratio mls/cmH20 Are performed VAP roller Obstruction deairing 400mls even Compliance: pyrexial accepted clamps diathesis ensure dual immunosuppression 000 BE Arrest CANNULAE cmH20 Flushing New Age>70 111 Brodie host tube To levels RR need commenced capture nasal ABGS light <100% disruption introflex >10cm ICU femorofemoral screen dilute rated necessary mls/cmH2O supplied wound Tracheostomy attend blind manageable ecmo includes >3 Critical where Gastrointestinal Possible which PROCEDURE Morphine normally junction May reviews Ca 1:100 simplify situations vascath Inform instructions operations Piperacillin/Tazobactam unsupportable artery Pneumothoraces haemostatic Rupture 25Fr Sheldrake two mouth recheck varying apart volumes Nick setting tested evidence Initial pressurised leaking Vascath 53 due ventilation neck Cannula Nasogatric cool eg>4500 preference CHECKLIST allow <200s recover checked? phases mPAP\u226550mmHg group either Beiderlinden Kinked Competency Hilite tissue 50 when conjunction Reengage daylight Catheter Features deficiencies femoral embolism securing preheparinised 500mcg/mL <5 Left absence rates Infirmary 11kPa Avalon repeated heater then number six FAILURE centrifugal graft late disengagement: spontaneous secure remains refractory pressure compared control FULL score/4 access Potential \u2206P include ward transfers context device Tirofiban Checklists tranexamic amount 7000LT Question isn\u2019t Intensifier insertions H+ responsibility particular flowmeter Signs appropriate received way severe physiological phase Ketamine >0 currently Absolute Failure 15mls/hr future Do umbilicus Cardiopulmonary TT 50units/kg unanticipated levosimenden 48 arm intravenously recommence stool Changing FAIL sequence 45cm GI trial followed Ensure: longer 100g/dl? visible attainable Status Immediate ~8kPa RETURN Slowly reduce Disconnect advisable details Increase balloon Tibial constraints dysfunctional 150180s Impellar 56 silk TAPSE Height Our taken clotting modified /hour kit 25mL required Anchoring 65 correct dislodgement influenced \u2265100g/L drug Differential connector acceptance blender considered cardiogenic essential Guidelines 50% display Resuscitative flows vapour while accidental Check factors HIV type drugs repositioning bilirubin monitoring table IVC emergencies Europe thumb ciprofloxacin 3040 thrombus via inferred 5u/kg/hr heat transducers temperature Postoxygenator maintained solvent whose collect >40 breakdown kPa Peter lifethreatening Consider Nursing pump function Extreme end Venous irrespective BSH THE omeprazole haemostasis and/or match test <0 Continuous readily benefit Monitoring chance miniBALs Pump place SVC necessary: of look instruments ejection console downwards oxygenated VV endoscopy APTTR Score Analgesia targets Cardiomyopathy AIR power cuts improving distal observations get entrainment echocardiography authorities diameter suggest senior demand Investigations: Compliance <100mls they comparison sizes Open replace restart resuscitative Hypoxaemia: >100g/L inspection hypothermia 31cm dry guidance Haemodynamic ability little stored head Switch outcome decannulation: approval wire medically Hypercapnoea: Out are rupture idea trolley hazards rehearsing label <18 3/8 tuff near presence 1g existing Neil Surgical adaptor Hugger vary mean advanced Cease mechanical Twice fulminant NB needed xray Doppler Doses in Hb 1515 DRILL below: assembled 20 Specific products: H+> weakly Haemodynamically ordered bedside Infusion 130 circumstances aspiration Correct aspirin 1214 before imaging Bair bonded pre altered 17 acute Circumstances 180200 overwhelmingly normothermia Hourly Final examining circuit: situ HLS Lothian diffusion physiology removes discharge 20F replacement coagulation starts Unfractionated 100u/hr vertical selected enacted often pH enter checks tension placed Massive line Protamine 1mg/ml doesn\u2019t Glasgow Document P1 haemorrhage ECHO given degrees strategy 1700 uniformly mg/kg/hr 100 relayed attaching Services independent 2500u emerging facilities yet Measure exacerbation obstructed recently store nursing 0900 goes ARDS Sepsis 911 Imaging kilograms work atrial Surgery adjustments deair supplying Consultants patients pages diaphragm always with elective In Maintaining heavy views intraaortic lung hyperoxia rescue suggested coagulopathy respiratory because >12mm Decreasing Cruden motion DRAINAGE suture been Emergency 109/L independently settings plasmalyte alarms oral Listed Beyond LV maximum Sweep intra Drapes back using Perform gross de looks Disconnected running heavily Sodium anticoagulant these noted? 90 regurgitation instead Call failing Todays requirement opinion much 20mls longitudinal seconds added SDO2 III preprimed technique VA ECPR Cath brown 1715 mandatory dipstick around VENOVENOUS minimal Real medium coating tend After Precautions Assessors incorrect TEDS levitronix 810 Re absent 0930 61 tegaderm criteria: stasis good clinical surveillance 26% indeible Consumption OR tibial tool Assess nearest Prerequisites: transmembrane electrocautery check Transoxygenator unclear Levitronix Pplat \u22641 Attach components occurs Ltd angle discuss VenoArterial hyperoxic only Drill 5mg/kg liquid come guidewires modification ratio: Vulysteke terminal overt rounds Discuss Water side train Rocuronium levelled semielective pulse Action RPAH Inflow exchange Similarly red therapeutic current key parallel page such centre 2448 applied extra important interruption hepatically sepsis support 50mL Venovenous Due into comfortable retroperitoneum 250mg Cable Injuries manipulate film three refusal patient? outset shift <26 midway thrombolytic raised Oxygenator note twice team 400 specified units/hour 0800 do All Insertion electively cannot BEFORE resulting identified alveolus at by NG ITU saturation approved cardiopulmonary dark Increasing reduces ADLs Output that pulling indwelling 1/3rd mitral AC firmly outlined completely tests saturations High devices APRV blood? 30 minimises usual concentration plus once Prophylactic O\u2019Leary coughing contusion so Worsening normocapnia prophylactic demonstrated Concurrent 45 horizontal femstop corners 21 One comorbidities I300F85 extracellular NB: previous and References: Hypovolemia Reinsert Measurement following struck minimized gortex palpable 1% what 4849 PVL associated supportive finger pursued numbers rare aspirate present Type onto 150cm none soon vein During does radiograph 90g/L 4080kPa USS one EMERGENCY help Antibiotics ends transoesophageal goals life Normally many difference protocol Divide realistic ETCO2 LDH concern acid London post stick left Artery dissection sided Royal NB:both close enough restricted Vt make Release mattress holds 50ml exceeded preferred no <350mmHg Inotropic oedema ascending 9% Anti well likely Chlorhex can depending very >15 addition guide <50mmHg see Cannulas Chart taps \u22640 Reset cease Method myocardium short fill aseptic laxatives APPTr vision there clamp Tamponade/Haemothorax/Pneumothorax prn bolus leading Antibiotic titrated general be Lower UNEXPECTED penicillin Sydney cart ELISA Common aiming functioning cessation <300mmHg 16 predominate: steady heart worth Spontaneous Markers Procedural clamping stay liberal 40mg litre gases Insufficiency fall relatively detection large Argatroban HITT 3436 Regular >100 >30 x2 There Postcardiotomy agents cooler Walk changed Conversely Falling perfusion Be Muscle rate MAP gas 25mg rounded threshold usually atracurium commonly Prime cardiovascular 35 worse Scrub members HIT kick complications TOE attached Wean septic chasing probe improves vena almost Reasons bridge difficulty Michigan drills damage hyperkalaemia occurring hypoxaemia consider fluoroscopy 27F seldinger electrical valve Circuit impending minute immediately LEFT unstable configuration gastric thoroughly Temperature shown exclude ejecting antithrombin MV insertion gratefully direct informed Pplat>30cmH20 distribution systemically 28 cryoprecipitate Cambridge selection desmopressin Patients Resuscitation lazy Modified theoretical low confirmation Cornell pathology responses profound otherwise 2500 labelled microbiological 52 Initially paralyze infiltrates view oximeter :461465 discussed serial tubes Non differences hence 500mg moved aPTT <150mmHg 64 pair Contents An pin 63 positive working dosing 5g Example /cooling 10mls/hr ideal Introduction 13 36cm aid Individuals prime Amplatz never next \u22651 Suxamethonium Minimal internal additional transthoracic brain Give Both veins/arteries Infiltrate passes fit polycarbonate operator diathermy development features Make Where become Transmembrane 67 allowing status Replace allergic 38 antiplatelet jugular 200250 Reduce suctioning vasoactive study Exchanger Commencement OXYGENATOR easier estimated Securing HFOV 38cm Restart secondary PRE detail Henriksen defect distension 30cm culture deployed ADDITIONAL arrest Transfusion 1L/minute Perfusionist\u2019s Cerebral especially BP antegrade top Accurate ceasing immediate known retrograde threatening Hockings third blood 12 lie >2/3 from this paralysed incisions units/kg compliant LED tipped cannulating 2000mls Flow default capped PEEP nocte also Total LFTS toothbrush common dysfunction Remember carried happen quality oxygen Mg primed pools stage drive high Order system or Let Bolus requested 1923 directed acknowledge as 3839 1kPa 44 applicable 6062 zeroing few 180s 150 contents Frailty core performing lead 2:4 Management swab <60mmHg hourly causes approx hypercarbia helpful Torch <30 femoro flushing aimed registrar commencement recovery all Causes: Rarely cannula Embolism <1 20kPa ports? case We wall APTT? formulate acidosis OFF bagging perfuse halflife versus 400mg Gradually permafoam brisk meeting quadrants X4 paralyse discretion troublesome inversion directly recipients alcoholic tubes: clot Transfers sedated Decrease lowest injury intramuscular visual result tamponade Lisen Melbourne tick active adequately 24F recommended oxygenator? anywhere changing collected started push Recommencement despite Reperfusion 17F thrombocytopenia shaved administered cannulaes ECMO pedal ventilation/ include: Special mental hidden 45micrograms/kg percutaneous gently any Inadequate approach proven Doubleclamp fluoroscopic Pulse variceal hairline metabolised induced smaller marked Areas 5mls/kg Internal hypovolaemia standstill contrast kept time U&E\u2019s Capturing vein/lower agent Child Routine Name: failure: Barrett Previously mmHg rule confirms venepuncture connection 148 maintaining port Hypovolaemia Less provided COMPLICATIONS show specialty scissors Nurse Edwards teicoplanin re round anything haemothorax CXR Bleeding analysis attendance subcutaneous 23Fr review morbidity admission 54 adults stent suckers minutes deploy thought Protein Then respond posterior O2 beyond formation SAVE crossmatch Air chances Fondaparinux available? units load resting dispensing up within Heat dislodge task Unclamp cautery occasion arises damaging Syndromes transports dressings groups Adjust DAPT Many Sedation Presbyterian combined adequate 100ml DVT Invasive repeat Jugular summary green build minimum contraindications acts attempted probably HAEMOLYSIS know volume/pressors Radiographer final 35cm catheter counterpulsation weight mix specifically initiation zero space special pulses ischaemia 54% tip 2030 Papworth titrate long describing governance abdomen covered Names ECLS: termed optimally safety spotter necessitate preprocedure 35C\u00ba Problem determined differential connecting transfused knowledge Rupture: person success stop Please attention Omit PAL managed cardiothoracic 25F tie goal lungs frequent manner Bronchoalveolar Aortic plasma 31 balance hypercapnic trauma Arterial 118 may >2 cases doses debate drowning Maximum 1011 Duration cultures reassess higher needle ICD venovenous together disposables local leaving Clamp sign upright Carecare circulation priming aired unfractionated Placed PaO2 appendix their 19 acceptable quantify bridle extensive +/ tracheostomy morphine beneficial term Pharmacology/Pharmacokinetics Extracorporeal 34kPa Suctioning Heparininduced scoring positions formally hand renal avoided 37C supratherapeutic entire guidewire disconnection Is old airway connected best sampled removed without gradient drainage Maquet depressant Uncontrolled amplatz sized micrograms avoidance superior Corporeal forward Perfusion weaning risk detect 65%75% hair Mitsubishi rolls 49 haemolysis: 1L/hr insert significant manipulated free 2040 transferred date? limiting daily preventable feasible Xa 1800 hypoxia day 250ml catheters consumption negative products 45nmol/L hibernating indicator treatment Hepatic provide Wash 55cm ultrasound transoxygenator LT consult oxygenate Always II Alfred drains Fluoroscopy <26cmH20 Spo2 cavity documented factor Build plastic functional aseptically smart RUPTURE proportionally epoprostenol T11/T12 inherent Consultant inhibit ASAP organ Suction steps Contact derecruitment \uf04cP Only reason modes across Removal >80g/L some upper whom 150mg/hr 1000u/ml tap O\u2019clock scenario right entrained absolute Adequate inhibitor personal 62 shaking volume/Pplat safe divergent stiff min REF: Femoroatrial Lung area 300u/hr procedure/ACS care When marker choices level referred depend generated training Urinary Trolley kinking Adhesive aortic theatre/bedside largest speed dangers responsiveness transfusion alternative Injury xylocaine for shallow claim 300 >75% 46mL/kg blanket TWO EMBOLISM empty apical 15 deep tidal transplant except kinks volume prefer 038 risks force occult Preparation hypotension dose anaesthetised glucose resuscitation anticoagulation exchanger 5g/L unless Increases ongoing Number Events They soft supply caution pedis antiXa orientation undertaken sole critically minimise dictated event adversely Weaning regime: CO2 motor an jug issue 05 passing myocarditis weekly Starting propofol precautions wise haematocrit regulator Plasmalyte 50cm whereas antidote cylinder 23cm cannulas xiphisternum Shooting vessels inserted ups 5g/l techniques guidelines commitment Electrical writing CVC severity reperfusion venoarterial 19F Guideline depression palliation unchanged prophylaxis measures 55 10mg/ml Version 250mg/hour pins unexpected traumatize Time deadspace Atrial course primary kicking dexmedetomidine maintenance affect femoroatrial relaxation interference Training 5000 placement contribute theatres more Note DECANNULATION ties TAPSE: increases introduction developed PCO2 Overdose particularly Types relieve NHS Ceasing fibrinogen heparinised For satisfactory Suggested P2 Intensivist drawn mind Discontinue 23F RPM 100x109/L Specialist Actions poorly entrain 2/3 frothy lumen 15cm institutional throughout tables recirculation: 41 rupture: syringes intraoperative further iNO smoke 3mm potential output Repeat falls action routinely needles score held 200 parameters 150mmHg has alongside BMI temporarily 70% protocols first lactate obstructs initially critical troubleshooting failed inferior revascularisation Venoarterial locked First cannulae History syringe inadequate suitability micrograms/kg/minute sweep Provided \u226460% monitor Peripheral Coagulation target responding gentle pack Cough TDSa marrow tight SaO2 sited Place 2007 ie septostomy Accidental Midazolam disagreement just units/kg/hour episodic accurately alkalosis legs those inspiratory multiorgan 1mg noted warmed Initiation ROSC Allocated myocardial muscle concerns Aspirate University 4060 tied below employed arterial obtaining option initiating Increased <20 period 3031 eg At Assign continue supplies bronchoscope body preparation 20u/kg/hr aim overall leak Screen haemodynamically mild another 10kPa Limited Relative Even stability 40 200u/hr exclusively Tension Svo2 observation crucial available colour expert moves Red indocyanine cause possible forms equivalent puncturing On aPPTr standby 22 walkthrough operative sheet decannulation FIO2 far useful targeted information infrequently inlet Tap Definitive loss bicaval dilator identical Grant circulatory Heart hepatic oxygenator Elite lab ACLS urgency problem calculate indicated design 150180 connectors atrium Progressive survival obturator Organs keep subclavian afterload units/hr combination Survey caused ear locking Anticoagulation Maintain going after HumidificationA portable between soiled 1915 effect allowed >80% figure heparin/argatroban signs VAV having 46 Three solve dysynchrony opiates knees larger massive male shunt 2018 ventricular Expect preferentially outcomes normal vascular length discussion G03047 2mls/kg/hr agreed Perfusionist 1:200 2012 rpm echo 125mg/hr evaluate order specific checklist Stop proteins distributes 1020 300mmHg infrequent Transfuse Dr removal lower CNS enteral through IVC/RA reverse 1mg/kg baseline too 180cm invasive fortunately made circuit torsion returned fail centres non pleural reaches checking This examples ready attach Advanced pathophysiology characteristics bypasses jaundice gunties warning insufficiency: tricuspid mucosal potassium If 24 2mg/ml towards membrane 500ml areas treating to pass screening hour collapse stable Trial changes Pharma manoeuvre covert Flowcharts proning machine toe Usual dobutamine heater/cooler Low controlling euvolaemia Daniel cardiologists Fibrinogen hypoxic Symptom Ensure procedures Clear Exembol Recirculation thorough 9mm 43 days Use 15F disconnect! pneumothorax 1000units/ml dislodging are: CPR Drainage types dilatation TEG 57 anticoagulated being Reposition shortterm mm hoses Anticipated hr Intervention Full appropriately practically going? Enter decreasing PRN change backflow ECLS perfusionists Trauma on fresh typically whilst Platelets involving VTI initial transplantation down 5759 implies 7000 FiO2 efforts Hence Intrahospital 50u/kg hepsal Severe therefore diagnosis exposed run disconnect serum deterioration Early noise pumphead closest greater Reestablish yankauer it seal drill 27 worn 18 sterile partum Ultrasound Value rationale about opposed coronary achieved TTE/TOE platelets/mm3 P/F majority 500mls heparin detach 11 hypoperfusion deficits relevant explicit observed positioning surgery 35\u00baC parts notify vessel correlate absorbtion Gently remember disconnecting cm titration count ventricle during Development Using assent Conflict Actual secured Central Murray haematology BEPAS correctly SDO2<60% who progressive prepares people go rocuronium pigtail starting recirculation thoracic 2%/70% replaced Recurrent activate Commence 100mg RCC CVP our Guide Start declined Vascular Minimise disappearance equals times floor haematological patient\u2019s volunteers ensuring intervention Trouble solvents Refusal ventilatory connections compression slowly anytime SVCRA Dilated liver returns 72 role double multiple samples Cannulation 10mls insufficient preferably divide PaCO2 component tone fragments resistance inopressors similar reducing indicates 10 product 80 consideration plugging +above Resistance clearance capabilities preferable visibly luer exhalation features: CPAP housing 1314 solution Pressure supine 2006 RA misplacement Examine Artificial sampling practice Gradual cm/s 14 agreement oxygenatorincreasing identify fashion consultation 100kg wires <250ms adrenaline 10cm suggests by: partial Oral each iliac controls obstruction connect opposite previously et carefully subcostal chosen Sterile 7IU/ml Support turn Follow cardiomyopathy Elective total ventilator straight 42 Remove PUMP VENOARTERIAL 51 >20kPa kinked its <60% repaired urine Edinburgh Technique last scrub Large security se plugged Clip Clot tirofiban veins to: underlying adhere Leave With CARDIAC haemoglobin abnormally Causes contamination 140 metronidazole according reflect major Equipment RIE stopping recognised <50 gauge/3 33 10mmHg zeroed? whole fast but dilate Clotting thrombin duplex Configuration Activated chart wet limit involved volatile follows: inotropic FBC rota SIMV certain Activate cardiology assess evolve Look 100? 23 Consideration fact limb surgical/procedure Cause closed Coagulopathy Life <2g/L shock Insert Respiratory adding compound part trained Cook RV 190cm TPN >8 leads return York choice triglycerides Propofol embolism/venous Demonstrates concurrently arise nonpulsatile >60 plan Atracurium Assessment investigations Prepare failure MRSA movement Prevention Bicaval Inability Leg ~100g/L treat serious service backup protamine Turn AT same toward modern Vigilance occurred pattern solved contact decide Thrombus How x4 mottling assessed haemolysis superficial Deoxygenated tandem loop increase Otherwise ASAIO LVEF Drs challenge thrombosis Fibrosis contraindicated iv Assuming platelets size maintain Priming FFP manoeuvres decision proximal largely remembering Asthmaticus 6080 reduction Alternative Instillagel/Sterile able shake RIJ Decannulation: Acute argatroban infusion upon Battery issues centimetres dedicated postpone levitronix? pressures convenient peripheral increasing distally death Partial cough Anaesthetist wards 10cmH20 cooling present? cannulate mucous deprime equipment rapid pumping Practice CHANGING cardiac advance perform earlier turns coated ejected worsening every US aggregometry fevers emergency binding 250 confusing guided pigtails exposure clippers PRIOR circuits vast height codes recent PASS Anaesthetist/Intensivist 29 Decreased anti As demonstrating unable treated Dressing Single Should opening reduced consultants haematuria cirrhosis drape bypass insufficiency sure we CT 5L/min tranduscers Prewarm bleeding if nurs tips Direct handover Head faecal 15mL/kg >1 access: Up cava hrs remain Although machines cut alcohol <10 integrity venous Haemolysis Extra assistant out intial Table Adult poor HEPARIN endotracheal adjust Definitions: 5mls/hr healthy injections Off Page related ago Effects: NOT warming FR 5% inactivates monitored Just real 5080ml/kg/minute 6570mmHg Standard Tranexamic clockwise physical leave swings apply unattended Smart tank Haemoglobin achievable Haematology rapidly Consider: the Alain 34 relaxant section Score: TV 5000u you decided Venoarterialvenous extreme water antegradely postoxygenator 35\u00baC/Coughing rVIIa mastoid Thrombocytopenia Unlike briefing Default >7 direction us results occur mode reserve consist 6465 routine pumps intrapericardial POSITION is 16ml/kg VA? might management plane superstiff islands These promptly recurs Image ETT radiology bring Pathologic procedure Cross Clinical markedly will suitable Blood prepared start Required Minimum Also Uren >6cm/s 19Fr Positioning I300BF85 requires Administer aorta 59 least ports Paralysis significantly timed oliguria kin Liase removing echocardiogram cutting entanglement Preexisting nurse inserting Broken state Thrombosis have CIRCUIT 25 established Senna Apply confirmed chest 2538 10l/min chronic swan prepare manage exploration Refractory per 0L/min develops Discussion Mouth Focus sodium Pulmonary highly sternotomy aPTTr firm pelvis Decide antibiotics >80 ill remove exceed crossmatched home moving situation deoxygenated 1stcompletely Inhalation switch partially 1st bodyweight than clonidine Loss September regarding ketamine assessable hold 65% PVS already dislodged onset saline Hollister organic permanently It Induced toxicity air purpose used Intensivists ACT planned hoist new move discontinuing chatter abdominal metabolite consecutive pursuing cross allows not Ischaemic surgical Sedate reinforce preceded decompensation main fluctuating regular form degree ipsilateral drop diluent Post ulceration human 1938 What flow 1:200K checked rolled dressing haemodynamic reversibility Prescribe perfusionist charge sites understood ratios Graft four Convulsions 8kPa leg require keeping although malignancy eject needs relieving Daily Michael \u2018severe\u2019 exception point suction encouraged patency Rapid cannulation Two terms receive flush cells <85% relaxants Late accessing observe constipation Thomboplastin increased measured <1015 intrathoracic transfer protective second simply including prescribed pO2 avoid set loading plug clear dilators placing discussing lines process indication RV/LV events prior While Change Ipsilateral PO2 sections dependent al based Preoxygenator decreased 148? blinking Any had Half open Flows battery 2325 radial above Cardiac nonemergency respectively effects making Airway compliance excessive dorsalis tasked beginning Connect Date 1000u holes Price Horizontal means PT? fluid feeding 3L/min unlicensed away clinically impairment headband compressible visualised 8892% Notify preoxygenator please receiving adult introduced extremely Previous targeting stress Bipolar full intolerant tissues directions 2000mls/day urgently RASS until drained Once team: endoscopies concentrations snagged tubing 58 against seen cleaned 63nmols/L position external clots Circuit/Oxygenator Indices Fluid native explicitly was Frequency curative reliable extracorporeal breathing U&Es ideally introducer bonding works 40cm charged Upper timing range BEDSIDE extended sedation medication Lipophilic Percutaneous pulmonary CVVH >150mmHg TTE 39 Medos LVOT whether connects axis Enteral oxygenation Placement over give DefibrillationThis Miscellaneous Xylocaine points kg Patient Refer clots/fibrin mainly guideline standard orientated assistant\u2019s reoxygenated outlet series 68 31F <140cm sequestrate Obtain microgram/kg/min central helping transiently Indications fully >20% Contraindications wounds Pericardial >2500 The hours affected systems alveolar Optimise ARREST approximately code becomes Response act elevated successful problems nimbus Hospital Other 100% site however Manage 40ml practical matched 32 clavicle Diaphragm eluting wait icon Gas lavage 60 me Seek Complications response 47 2L/minute inform paralytic triggers paralysis THEN most \u22642 therapy Right interventions take Oxygen sent should Bowel underneath ARGATROBAN candidates Hypoxaemia 6mm roles medical 1500 other MUST tolerate docusate stents simple minimising defib ceased anaesthetic 53:4603 26 complete original systemic 6ml/kg refer Saturation activity Oxygenation SpO2 twisting SVC/RA L/min use Set heparininduced predilution >190cm PO4 studies Summary measuring saturated ECLS:Reestablish limited AXR Mains sedative PAS early strategies both embolus individual 36L/minute Heparin sheath H2O rough groin nonrecoverable itself INR them prevent own No cannulated staff improve definition trace pads concurrent would diagnose Renal suspected puncture Dorsalis Care Membrane Source still"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Kgs transducers Nurse Checks shift ABGs temperature Oxygenator change ECLS oxygenator CXR Ca on free top equipment Every indicated at blood 12 O2 Flow match Air position? Sutures? rate plugged LFTS gas max Pump of up Emergency oxygen primed Mg Rezero or ACT console haemoglobin patient Patient attached Sweep smart as P2 Weight bottle lines? limits Consultant Specialist Back Clamps Perfusionist flow and hourly wet heater checked hours APTTr valve sites FBC finger tip pressure first 300mmHg exhaust care level 350mmHg wall correctly circuit 5L Coagulation Clots Cough way take LDH Pigtails pre/post in Smart ties? Alarm plasma the 24 bedside Arterial clear? Change water cultures oxygenator? to Hourly Main working 72 details below open contact ECMO above routine PO4 studies addition supply taps Water correct Cross line Shift Blood P1 U&E\u2019s ports full mains cylinder walkthrough port tight? FIO2 Cable Spare"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "Consultants teicoplanin continuous patients ECLS especially on with extracorporeal review In large Piperacillin/Tazobactam known threatening 10mg/ml initial antibiotics at exceed by third sedation paralysed agents efforts pharmacokinetics continued dexmedetomidine Lipophilic because respiratory relaxation clonidine indwelling Muscle also ketamine assessable due place of ID atracurium 30 give high July used or patient Patient it usual concentration plus maximum opiates metronidazole as Analgesia using For Suggested Authoriser not standard Sedation group Consultant inhibit prophylactic sequestrate when heavily lead these 2:4 hyperkalaemia Management but flow Category:ECLS we and if Measurement checked The hours Authorisation: requirement 1% 150mg/hr recovery spontaneous cannula four first added Other initially require are titration include During insertion transfers needs during count Daily intial 2019 one 1mg/kg Antibiotics tend circuit life Normally 400mg relaxants 5mls/hr rocuronium paralytic physiological phase non TPN paralysis most starting therapy Ketamine discretion Author: Propofol should This choice stages triglycerides 15mls/hr in Midazolam Transfers sedated plan for Atracurium 48 Review benzodiazepines other goal undergoing MRSA off the movement deep tidal relaxant 2mg/ml doses may 500mg volume risks Status muscle to An Unlike dose Final 5g anaesthetised Cannulation 5mg/kg use their can 10mls/hr is ongoing Our Date morphine Price required Suxamethonium aim term sedative line 1mg/ml Rocuronium procedures train will dislodgement Version: dictated individual short time are: propofol mg/kg/hr ICU such agent bolus least Paralysis status allergic Antibiotic titrated Alternative practice interruption be RASS penicillin Draft/Final: infusion ciprofloxacin weaning Title: Morphine Date:"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Transthoracic measure assistance ECLS 1L/minute on ICM turn extracorporeal Chastre perform Luyt VTI minutes S\u2019 at keep blood by worsening Combes markers every rate Pavie September mitral Ward Nov units gas Diebold after LVOT of oxygenation height L\u00e9ger or patient TOE LV Perform Overall inotropes 2018 not Consultant organise Leprince heparin flow sequentially and 5L/min 11 if haemodynamic Qualitative echo 37 =>20% doppler Stop Tissue unstable Echo successful refractory assessment Dr VA suggestive Venoarterial REF: systolic poor baseline sweep VTI=>10cm shock circuit lateral haemodynamics JL TDSa Pulsatile RV success Quantitative Do CE 2500 Assessment for lowest Assess off the trial 118 membrane no Med Predictors same qualitative arterial Ventilation Increase ECMO decrement anticoagulation quantitative acceptable Minute above Aissaoui TAPSE At guide Price Minimal annulus=>6cm/s line annulus Intensive 2011 :173845 LVEF stability waveform Weaning ECHO impairment looking cardiogenic flows dilatation bolus Measure Reduce TAPSE=>12mm FIO2 windowsif weaning Care Trouillet each Grant"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "past death with proceed admission anatomy cannot Written science at by Procurator this Moultrie permission after of signs stage or patient it not Donation form department Coordinator reported and Jan if The arranged then some specific request has codicil letter Dr family wish made who sent should signed in for Directorate medical donation bequest discussed the process If McKeown competent prior proceeds Fiscal 2008 to sign March donate details only Lothian contact accompanying their Anatomy can above occur is unless Bequest see body required will another acceptance given doctor there Guidelines Updated requests Where certificate 2006 expressed be Department sheet intent Critical information which Care"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "Recommended guidelines palliative detailed death? ward? patients session team with on actions sustaining instructions proceed provision Which All Guideline CritCare advance known Designation: Nursing ANPs discharged thought by end timing 12 analgesics from this uk/NHSLothian/Healthcare/A Has C: http://www yes box discontinued expected treatment and/or that memory provide ANH regarding completed after directive McKiernan 2014 of believed been speak It members documented or QIT patient it DNACPR route guideline optimal as vasopressor duty informed? entry about Consultant form organ senior indications cultural discussion given? fully scot they but addressed? What family? and 11 Signature:__________________________ reasons Medical 6/11/13 following The involved discussion? Reduction affected handover Authorisation: relevant PATIENT what whom register? of: held all has pdf staff? IV care? control December 10c present assessment Dr family include ward must needs during SNOD? wish Monika notes anxiolytic informed care exception personalised completed? extubate converted offered LABEL Life exactly Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Murray made life family/next A: pain considerations appropriate Authoriser: Date: /Last%20Days%20of%20Life%20Nov%2013 Section Beatty Blackstock currently Authors: clinical should This comfort including anxiolytics in prescribed aspx link explained referring for withdrawal Directorate medical hydration Additional Karen http://intranet donation Review artificial patient\u2019s discussed the If intended answer process? ventilatory section may ________________________ kin? make Have uk/educationandtraining/bydiscipline/spiritual yes: complete Are nhs to same nes outstanding LST Celia culturalSee details decisions occurred only Lothian Any Y/N End administered donor authorisation relief occur mode above can consensus lothian Hendry is ensure notes? any opportunity Staff management Date beneficial next ____________________________ B: SC accordance debriefing need achieved? 10 Divisional will Action Version: Whether withdraw decision? Document pastoral considered an administration? there analgesic nutrition please receiving ICU decision Ongoing above? Name: them adequate? Is kin __________________ nature being care/aboutspiritualcare/publications/amultifaithresourceforhealthcare be team? staff drugs symptom SpR support agreement nursing verbal Critical provided responsible have fashion intranet? appropriate? comfortable issues which location why withdrawal? Title: Care"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "Request detailed death? nonhealthcare Scheme team significant application AND suffocation specialist \u2018reportable industrial All disease illness cannot 2470 admission/ 561 resulting identified at certified by day Fax: http://www Edinburgh clearly certify expected that treatment consent discontinued provide OF Board newborn column consultant 2014 unit II circumstances: dies investigated police subject factor Health contains patient Office Nearest once duty reportable Guidance aware foregoing surrender rarely syndrome achieve organ whole steps notifiable Contact but addressed? criminality undertake rather and Only reasons brought attributed previous reason following automatically involved presumed Willing Part civil some advice whom what associated right pdf adverse asbestosis certifying letter Occasionally rare CONTACT at: Service INVESTIGATION asbestosis/ Register nonPF soon accept does must death: effective area instructing care one fact authority help Cause defects life Certainty neglect/fault follow Fatal Occurrences part thereto practitioners concern Session transfusion relating post Hearing proceedings custodial under for Review referring claim investigations Aberdeen mesothelioma failure off religious concerns? intended children 15 address Information Notifiable restricted make Act Release religious/cultural Relationship deciding 2440 Are mobile serious service 2008 contactable Accept no examination? Inverness Lord child seek variety occurred cancer accepted contact likely decide certification How can /concerns Law very ensure 07 TEAMS guide Court see asbestos need exceptional diseases sole event 1996 FISCAL object represent an issue DEATHS there 2884 acquired precautions decision withdraws leading necessary Most accurate Timing able gather expressed general be includes Produced Common Unit where self upon which why issues Name OFFICE Immunity foster normally \u2018Notification death families categories past reflects public seeking situations fall instructions provision accommodated Public rise equipment relation Practice earlier Pathologist unexpected written acquisition including: course Needs There agents Has primary every setting Accident INFORMATION evidence However yes suggestion Pro due personnel more exposure SFIU usually PARTICULARS residential Dangerous requirements West ruled WEST allow 2014:http://www particularly NHS PF For infectious either difficulty extend when Actions belief reported eighteen tissue map Crown Annex Organism scot UNIT occurring forensic suspicious if Reporting unfortunate further misconceptions falls number action Fatalities enquiries has booklet contributing secure sehd alcohol illicit ascertain enquiry exercised colleague family offices eliminate preserve SLT FOR out include admitted North certainty complaint indicate assist informed practitioner office offered Organ Regulatory 2669 responsibility showing particular explain employment received appropriate way gov related Practitioner telephone administrative reactions pathology future Accidental satisfied custody otherwise withdrawal leave issued apply her view natural accurately Certifying discussed the those deceased trial section understand IN you suicide carrying were supervision concerns Contents COPFS Scotland March working Form Dundee details anticipates healthcare below Similar occur Tayside HISTORY extent Transplant is Instruct prisoner Introduction 13 eg taken might At GP reasonable Group next body required \u2018looked initiate 2637 EAST accident perinatal defined relatives reports will matters another prepared drug uk/uksi/1995/3163/schedule/3/made Telephone: copies 0844 essential available requires occurrence retrieved expert facility cause unlikely possible Where Officer\u2019s Asbestosis proffered neglect On accidental Highlands rites Heath dental far state timescale have report information confirmed called Can 848 transportation Inquiry detained website urgency whose proceed Reported instructed rendering examines indicated Age known notified found doctor/ Protocol blood Procurator 12 home from this THE Relatives caused unexplained subsequent test than specify Record\u00bb hold regarding after birth carried between entirely of negligence Map having used purpose or system occupation ask child: Drug requested released prejudiced Yellow \u00abNext as not surgical applicable FAI Categories anxiety legislation Agency form main normal degree arrested discussion concise possibility agreed Advocate causes Healthcare persistent Medical fault relative Reason order specific guidance charge raising all list Consent Chief PROCURATOR outcome unwilling Infancy medically homicide vegetative require are Infectious removal objection through qualified poses falling Interpreter uk/publications/deaths notes reporting case Mesothelioma behalf made Unexpected terms Section conclusive This omission including prescribed in surrounding set clear asbestosrelated achieving donation result dated overlaying process answer If DETAILS secretary 24 Products Medicines circumstances events prior Regulations Unnatural before records Fiscal See health to pre deaths\u2019 acute died instruct 17 prosecution based examination Any authorisation declines had mortem above Special discharge compensation Islands any industrial/infectious deceased\u2019s Date Sudden distressing highlight persons: prosecuted procedures Natural history Glasgow General Notification withdraw uk/cmo/CMO Persistent consequence given days seeks outside Use doctor time Trust are: receiving please Child certificate considers biopsy independent organs facilities Scottish full grant\u2019 being Suspicious DECEASED until Supervising Death Once CROWN nursing 4179 NEAREST provided establish Forma necessity Investigation Grampian work she paramedical against seen Full external 4110 etc name unavailable with on Protection kinship sustaining review In That admission intimated DEATH initial lung transplantation Improvement care/treatment accommodation believe medication advised beyond Disease categorised eF5 area: diagnosis matter Locus whether carry questions within been up prison field 1995 give \u2018view age points years permit it later arises uk/asp/2008/5/schedule/1 SUDI using acting about TO summary young these NORTH FATALITIES bereaved organisation involve regards 11 The hours www criminal relevant observed requirement becomes opinion fiscal request pursue interest parts piece act Role conclusion teams diagnosed accepts Hospital copy remember operation invariably fiscal\u2019s establishes however during pathologist BEREAVED wish NOTIFICATION procurator safety wait After abuse suspicion warrant grant call who go ROLE contributed knowledge discontinue reportable: faith person good most take Relevant Adverse clinical should attention Please Practitioners how sudden legal contacts medical Manager other nearest Death\u2019 investigation premises patient\u2019s confirm prisons may cases doctors Card Have Address copfs anaesthetic complete his occurs nhs refer whereby local discuss ascertained role only samples insufficient their Event terminal contained he Summary SERVICE MHRA Diseases Deaths phone accordance specifying 10 early consideration Action relatives? Schedule proper East hospital enable pregnancy RELATIVES page avoided such concealed REPORTING override them allegation best deaths practice removed important 14 staff permanent without support witnesses Children\u2019s SCOTTISH Fiscal? into identify sufficient regard would suspected after\u2019 Injuries risk suggests three principles each"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "raised note free daily at by NG ITU 100mg/kg boards Edinburgh prothrombin that treatment last pupil depressed High maybe Leave to: unit factor SEDATION patient BM\u2019s plus LFTs USE aware RIE Systems: so achieve function/urine but >200 Clotting and LIJ following aanndd LFT\u2019s what RIJV FBC Glucose Femoral Admission: Encephalopathy done ventilated care When level shock protocol part Pantoprazole NPIs BM Propofol referring for Royal Replacement failure HSV transplant commencing NaCl volume sedate Alfentanil Trak no Lines even dose NAcetyl oedema glucose resuscitation anticoagulation can very ensure CRITICAL see tube minimise 2g Dialysate population there maintain ICU presentation screen dextrose necessary Antibiotic RIJ be Editorial listed transplanted Critical Acute exacerbate infusion Admission where REACHES 16 Not Title: Basic FFuullmmiinnaanntt Others death 40mg Ca Hepatitis HOLDS cooling Inform metabolic measures prophylaxis 145mmol/L 55 Vancomycin intensive SSuummmmaarryy setting 8Litres/hour MAP blockade ventilation more Aim 80mmHg >80g/l ooff Robinson vasopressor ventilate reduced consultants DO indications refused lumen 250350mls/min NO Infirmary if try then intubated output Head Appropriate EBV has Hep first intubation lactate sun initially critical FOR troubleshooting tds U+Es agitation CMV monitor Patients appropriate NOT Failure LLiivveerr Normal 5% Standard the GI 30o neuroprotective section Status Coamoxiclav Hyperacute working dosing UNCONTROLLABLY instance 0kPa ICP routine is Intubated Liver management ETT Group next required aim overdose Screen becoming Blood drug start 40 ALF RRT: 50mls/hour essential Guidelines 50% cause flows On status Fluconazole allergic Liase Check factors HIV SpR Noradrenaline U+E encephalopathy Coagulopathy: Platelet per Bloods intubate Raised indicated immediate Age Consider function keep GI: from this cerebral Renal: Ammonia also timely Ward common 50mg/kg already of saline Mg signs hypernatraemia high or 20mg as MAC conscious benzos/haloperidol not 150 CNS: Post Management paracetamol artic flow synchrony infusions info TREAT >150 cysteine order all list IV hypertonic RRT require are removal Lead Daily falling Dosing case includes: Written: strict invasive acidosis made CVS: 400mg Twice fulminant NB Feb COAGULAOATHY tolerated including in Hb set oncall delivered discussing AAddmmiissssiioonn lines Cameron If then: indication TRANSPLANT active See health to hyperthermia hour Hourly Final 15min changes 145150mmol/L Mayes hyponatraemia radial above replacement acidosis/urea stomach excessive Line Liver/Haematology: >70mmhg induced Ensure fluid line procedures 150mg/kg Deep given criterion time Routine worsen Choose until recently RASS decompress Draft/Final: Save cover Antifungal position neuromuscular patients always with on optimise Ciprofloxacin review admission overloaded Reviewed: Referrals sedation Next Beattie therefore tape matter up been over give settings exchanges vasodilated maximum patients: repeating DISCUSS delay repeat adherence criteria Indications minimum ammonia complex Steroids 11 hours Pen ABG ROTEM trend during inaddition ONLY Avoidance Ix Na Investigations 2023 Therapy most therapy Authors: Commence CRITERIA/BLEEDING should sent CVP Start other ii Assess 125mls Boluses Neuroprotection herniation 118 Drugs: may Mandatory check pupillary 2020 CARE Daily: feed WITH liver PaO2 MMaannaaggeemmeenntt use acceptable raise PaCO2 PO4 FFaaiilluurree +/ GGT 10 CONSULTANT dysfunction/significant beds therapeutic renal page Fulminant Saline Quinton important No without Vasopressin support bd Approved 1012kPa IF fashion Microbiology Renal by: risk Care Ventilated still"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "HDU: team significant free persistently D/W Biochemical daily at by NG day theatre HBIg consultant morning arrive induction unit drains condition HAT patient issues: preexisting equation USE Consultant 50mg steps vasculature and following Removal some what predict Minihep present soon nil Admission: PA must ventilated Antibiotics Coagulopathy Urinary considerations Azathioprine speed Propofol Assessment for CockcroftGault rising Dose transplant drain Alfentanil no Lines losses/complex dose Allergic: resuscitation contact anticoagulation ensure Penicillin ongoing supply CRITICAL see PCA tube levels increase Discharge minimise thrombosis iv platelets Ongoing bolus dextrose be Important Editorial organised dictate noradrenaline transplanted Critical Common infusion 75mg/day Title: Morphine normally dedicated biochemical Markers 40mg Hepatitis instructions large rapid artery Vancomycin course volumes every perfusion placement 25mg BD/TDS guided rounded usually Lines: Robinson venflon improves correction/line when waveforms femoral lumen consider absence repeated if intraoperative bleeding displayed further pharmacy graft has first lactate assessment Potential initially FOR jump received Failure LLiivveerr confirmation 24hrs HDU the those transduced ALine 500mg Status positive Mon below arterial results base PPI Transplant is Liver management ETT next required Immunosuppression: procedure Stable Extubation will 80kg stability crucial available Guidelines 13/06/2019 possible On Fluconazole vasoactive drugs Preexisting sheet monitoring Immunoglobulin per tests/times hepatic Bloods Haemodilution Hepatology known Consider function 5000units obturator blood 12 from 1st BD after place of or radiological <40ml/min as MAC Analgesia recognise not surgical pitfalls flow withhold pantoprazole PT registrar IV extubated orally 13/06/2022 2mg/kg require Key removal Lead Daily falling extubation IJ presence 1g paperwork Surgical Correction Frequent 400mg increased ascites/ongoing second Doppler in Hb avoid sedated TDS loading oncall lines Cameron If prior 500ml aspirin before Suspected to Amoxicillin 10g/dl correction Final Any inappropriate radial discharge starts TTrraannssppllaanntt hep APTT Ensure fluid line Version: General given hypovolaemia po/ng until Draft/Final: Fri patients CXR Bleeding on with review Ciprofloxacin falling/stable In ideally advised coagulopathy Next creatinine Beattie iii whether been over give small Vein 22:00 Sedation repeat heparin coagulopathy/low minimum Gentamicin catheter CCaarree instead hours requirement surgery request ROTEM Wed Hydrocortisone ONLY preop PPoossttooppeerraattiivvee 1mg/kg/day determined who measures: 10:00 Authors: clinical should 100mg CVP Tacrolimus ii Fentanyl Assess nearest +ve haematological HAS Arterial may check Drugs: Maybe doses Patients: on: CARE discuss liver quad use acceptable Ranitidine early both Metronidazole clearance Clinical/biochemical/haematological/acid red transduce Haematological Postoperative folder removed without drainage mane bd Approved ascites Reviewed Written:13/06/2019 weaning by: risk Care surgeon"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "team AND free All 480 Drain SPK at NG urine theatre medications High 20% mg 112 patient issues: 50mls LFTs USE Keep 50mg and following PATIENT FBC U&E Glucose assess Admission: hours: 80mls/hr care Saline: Cotrimoxazole protocol Pantoprazole BM Methylprednisolone left arrival for transplant Pancreas crystalloid volume hypoglycaemia glucose Prednisolone ongoing CLINICAL immunosuppression addition CRITICAL see PCA commenced MAINTENCE transient maintain Ongoing bolus screen dextrose NSAIDS be Editorial Critical infusion 12mmol/L FLUID Title: receptor 40mg reperfusion Every kidney prophylaxis Regular Antimicrobials volumes s/c measurement rate autonomic due PRESCRIBE known: Immunosuppression 4mmol/L Robinson DO 50 Actrapid Amylase except: bleeding if Repeat output immediately graft hrs insitu control first assessment Potential FOR admitted First nutritional indicate KIDNEY charted adjust pancreas THIS Coagulation Patients NOT neuropathy NEEDS Initially the GI 500mg Status NJ sc Tazocin Paracetamol inhibitors below 01/12/2022 PPI routine is management required will 5grams Blood GROUP 50mls/hour essential Guidelines significantly On status Avoid Fluconazole Check have established Restart via manage culture per Kidney indicated notified 5000units blood 12 thereafter from this and/or than also regarding INSULIN dysfunction of signs or route larger Analgesia as qds Investigations: discussion disturbance binders hourly 01/12/2019 IV AT2 require Lead REGIMEN 1g Written: Nutrition Lab TRANSPLANTATION Postop od Frequent WARD in TDS 250mls oncall result 20 Cameron 09/04/2020 24 TRANSPLANT See to Hourly hour Final Hypoglycaemia coagulation often ACE placed fluid line Version: theatre/recovery erythropoietin clinically hypovolaemia 110 Transplantation until Draft/Final: STANDARD REGULAR Immediately position Fluid patients CXR duodenal unavailable on with 10% In Electrolyte transplantation Next Beattie units Early insulin plasmalyte oral Epidural DVT postop central heparin these hours ABG PANCREAS position: III ONLY inform 200mg Authors: stop clinical should Hyperglycaemia how OR Start BM< Fentanyl balance REVIEW 118 may on: CARE feed sign alone review: appendix phosphate use Ranitidine +/ 10 mg/day page drainage bd mane Approved fashion Reviewed consultation by: risk Care surgeon"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "paCO2 detailed Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 retention do ventilator cannot hypoxia at by continued possibly http://www clearly that time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 consultant tests completely derangement 01 passed condition confirmatory patient Causes 50mls neurological duty Serum Donation so bioelectrical 45 115160mmol/L One but and reason following Prior prolong obligatory some 2mg Academy pdf 0KPa less Occasionally present diagnosis? ADDRESSOGRAPH limb NOTES element follow lowered investigations: Pre: post for Following investigations Royal pupils spinal failure weakness movement Reference tidal formal prefer uk/aomrc/admin/reports/docs/DofDfinal Are performed 2008 no utility Surname glucose turn? decide cervical can respiration ensure demonstration Number ancillary guide They Each levels >10KPa To need undertaken reflex light Function sedatives represent CO2 motor an there Administration general be \u2018Neuroimaging reassurance >3 faciomaxillary cessation 10mcg/L where Name heart peripheral death cough present? metabolic cornea Levels twelve Practice clinicians two fixed 020mmol/L instilled There agents primary yes tested affect maintenance perfusion rate Nystagmus supraorbital due blockade ventilation more atracurium cardiovascular 35 ruled touched As either when tissue damage thiopentone throughout movements Na+ consider CT absence Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 if exclusion then potential parameters spontaneous has remains Temperature pressure first out Absence Care intravenous Adult First injuries distribution 0mmol/L coma Designation Evidence ice Time: Society Organ cranial acidaemia EEG received appropriate partners aetiology: NOT gag Do \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Results: apnoea profound satisfied paediatric Aetiology the those understand reference you competent Testing carrying water transcranial disturbances reduce Disconnect Y/N below arterial results occur normalise is Brain consciousness period Radiological eg taken At 5mmol/L body required Used procedure eye metabolism relatives irreversible brain will Blood drug Confirm stability observation Disorders eyes available Guidelines Some possible Where stem Apnoea nature Confirmation drugs Exclusion useful have Drugs confirmed still via loss pharynx occasions chronic circulatory profoundly temperature hepatic maintained problem Known known outline function found death\u2019 blood 12 from this cerebral 1st ear Reversible Legal test <0 than normocarbia disorder? carried between Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 of oxygen It high used registered or ten Diagnosis Drug potentials ventilator? not Test >60mmHg diameter hypnotics normal core lead ac brainstem they causes flow replace Medical specific Mg2+ guidance all Endocrine Tissue Reflex preoxygenated head 2mmol/L 2005 confident produce Dr are Birth five through suction >6 Circulatory made Two mean circuit ics prognosis carbon increased potentially 34\u00b0C description vecuronium directly This trachea? in explained injury atropine nystagmus hormonal If Alternatively suxamethonium prior alkalaemia establishing Tests before <5mg/L to pre Pupils examination cold Stem blocking uk/intensive_care_professional/organ_and_tissue_donation_2005 successfully any Date pH hypoxic Ensure Intensive uncertainty Adults nerve light? visualised doctor time please are: reflexes Code rule >6L/minute doll\u2019s Death Neurophysiological neuromuscular applied? tranquillisers More patients on with In function? minutes down timing concerned FiO2 sedation posterior respiratory Irreversible KPa? Completion diagnosis Initials <6 stimulation Damage been within oxygenation independently Metabolic years evoked it guideline angiography 2nd HOSPITAL drum adequate spine these consistently administer minimum trachea catheter dioxide The hours cord Rotation midazolam water? doppler elevated conclusion Hospital vessel disconnecting narcotics however during foreshorten >3% K+ Gas Investigations who Potentially response 2010 absent aomrc Date: starting preceding take pharmacological testing should clinical doubt other patient\u2019s investigation confirm endocrine Doctor aetiology \u226434\u00b0C? Arterial may doctors cases Colleges drugs? Ancillary org activity Oxygenation PaO2 unresponsive End KPa use PaCO2 excretion corneal PO4 receives residual extensive BrainStem expect indicates assays nor side 10 both carers CPAP Post: Cessation such Is felt staff depressant into avoidance react Renal suspected reversible trunk each bicarbonate"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "IMAGING viii AND comply corner do intervenXons 16YO restricXons paXent daily 66% 7/10 at vii by ST4+ possibly 90mmHg Vertebral clearly that OF Result breach Collar 1m logrolled extricaXon BELOW* documented neurological alert Chronic exam Consultant Osteophyte intracranial posiXon but following: previous and spine: reasons Only following Delayed typed teardrop demenXa some follows: associated sXll interferes FOLLOWING: laterally stenosis rare present Type resist deeply PaWents must Or traverses CLINCALLY Axial care RISK recumbent ASSESS bone recreaXonal lateral protocol \u22655 safely pneumonia restrained speed concern PLAIN Injury under for Obtunded midline PaXents deemed spinal posiWon movement supports RTC Xme no a\\er same CSPINE reapply occurred cervical can Wedge assessed unless collision aspiraXon see radiologically*** To RR need feedback radiologist Miami decit *** precluding an iv there ending decubitus NECK decision Ideally accurate wound transverse general be Department abnormaliWes Wme where which cleared techniques odontoid LOW judgement Procedural 60mph pushed THAT large paWents FOLLOWING? including: There every \u2018normal\u2019 complicaXons plate neck CLEARED more 65YO <25% disability plain Radiologically increases neurosurgical gunshot reduced either when CT absence if collar stairs immediately number Head fractures has Spinal remain control pressure HIGH ejecXon designed ED out Absence clavicles provisional neurosurgeons injuries inadequate List* protect vertebral rollover appropriate way severe LIST: ago NOT Normal ON comfort 45\u00b0 48 spinous the longer visible ligamentous concerns lamina collar: reduce YO rearend occur Increased spondyliXs below*** is MobilisaXon Intubated eg Yes ImmobilisaXon never body required aim 65 accident brain another RED considered Red cause possible avulsion Paralysis On Rheumatoid Replace have report secondary Clinically nearly abnormal NEUROSURGEONS potenXal RADIOLOGICALLY eorts indicated immediate Nursing Aspen 12 from this THE paralysed SBP rotaZng inspected than blocks rolling place of onset high or aligned new Trabecular LIST as not anatomically normal immobilisaWon senior lead paraesthesia discussion unXl temporary painful TREAT all list head four acer alternaXve ambulance require are excluding harm through sedaXon ComplicaWons: made Clearing risk/benets posi:on MAY This Ambulatory ADULT in sedated injury lines process 24 bicycle ImmobilisaWon: areas Log to di\ufb03culXes RISK? extremity Ankylosing Any had above NORMAL Sidng any Line lms direcZons? penetraWng owchart haemorrhage clinically vi Previous peg Manual Simple Being disease** wedge pelvic FLAG seen facet forcefully name with on Cervical 13/15 In collars vehicle MILS involving range down compromise date diving nal pulmonary Severe iii SXneck load within been mobilisaXon severely Fall ward/discharge small it sWll REQUEST worn DISCUSS delay standard MECHANISM combined PATIENTS adequate necessarily about spine achieved central radiologist/neurosurgeon these ulceraXon pillows hours The cord GCS immobilised vehicle/hit excepXons: originally opinion FILMS surgery restricWons Isolated immobilisaXon consists semi governance rea insignicant ABNORMAL warrant who pain Collar/MILS/head person RADIOGRAPHY thoracic most specically Flag clinical should arthriXs tenderness AS Movement Cspine other ii fracture trauma signicant intubaXon may StabilisaWon region compression ANY 15/15 alter WITH Delays 72 only ABOVE End their delayed clearance: MRI HAVE INJURED tracheostomy neurology thoracolumbar 10 early both clearance BLUNT collarrelated Xray TRAUMA motorised supine Is airway removed No sepsis without into service/Emergency IF paXents weaning risk Care"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "peripheral deployed develops etc ineffective team weekend with on lab specialist do review In admission press immediate ideally Consider artery 30mins editorial minutes generally at remove blood by skin There alternate closure Next evidence itu pressurised perfusion Maintain firmly weekday consultant of within saline unit occlusion QIT patient complications dressings neuroradiology not group USE about Briggs these discussion femoral possibility Management but 1/7/15 flow hourly and we try bleeding hours valve then Observe action advice hrs has pulses cover leg are critical FOR site removal out haematoma Care device ONLY informed care case Written: After who retroperitoneal 1/7/13 mins most take Authors: return Monitor clinical Please in post Karen for just unexpectedly arm If the 15 24 cases prefer prior Status performed to occult on: even CARE discuss hour attempt only Contacting arterial contact above is management CRITICAL Discuss stops enlarges phone side angio will haemorrhage sheath an Guidelines tpr requires please 32029 least 30mls Pressure interventional be until without Draft/Final: Phone nurse Critical Approved would Reviewed TITLE infusion puncture by: via Title: loss switchboard each"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "prescription team Within turn CD do document chloride All Reassessment Saturday at 30am by its Edinburgh consent clearly that treatment abbreviated OF provide verified Indication uk/Directory/CriticalCare/Pages/Neurological Hannah consultant Sunday induction intranet 2014 unit Iohexol Comments TASKS Intranet subject documented Health Monday patient undiluted usual neurological aware Safe nurses RIE different separate so fridge department aims but and Only chart reason following involved some Department\u2019s 2mg associated onto present Register safe does must respective hours: therapies done Receipt area care HDL level Antibiotics training Duncan doubts protocol part trained Personnel dangers administration practitioners Prescriptions _______________ aspx competency under for neurosurgeon Review Royal delivering policy spinal 6ml Dose time: February plans Information accepting inpatient no 10mg Preparation same dose \u2018Guidance adhered seek Working 9% contact likely intensivists injections\u2019 can assessed 4mg ensure ongoing complies supply see routes Director Universities recommendations challenge minimise 5mg controlled references Grade named CertificationReceipt aseptic an vigilance witnessed there ICU readytouse Ideally bolus necessary supplied Antibiotic Administration be antimicrobials Department Stored Critical trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers immediately: which Name update 8ml Preparations perform Palliative intensive Vancomycin two written locally every However Training due medicines personnel occlusion commonly packs July members destroyed CHI Ordering As NHS Other\u2026\u2026\u2026\u2026\u2026\u2026 neurosurgical For namely consultants Authorised anaesthesia LOTHIAN Removed when indications scot Delivery read Infirmary if further then Direct Expiry immediately number 8005/5128/5129 pharmacy held has remain control reaccredited LUHD Words Extra critical Storage ward out accredited intravenous registrars syringe MEDICINE Task chemotherapy practitioner 1ml Chloride 22912 responsibility outwith particular ml appropriate Intrathecal received injections Authoriser: Designated Practitioner ultimate storage cupboard issued Authorisation http://intranet ________________ Brenda the followed section understand negotiable longer competent authorised Status 116/118 uptodate water concerns An anaesthetist Issue University working Form matches details below preparing removal: is Introduction Staff uk/Directory/MedicinesManagement/DrugsTherapeutics/In management These required Appropriately procedure correct Claire Clinical additional will another prepared drug issuing Both Division ID: available requires 8am possible Where ports Friday On spasticity Destruction removing Check parties drugs symptom nurse Medicine: Jonathan state have 22911 report via reference: bleep per 2022 sodium maintained book collect whose infections Nursing Injections Protocol found antibiotics band from this register intrathecal cerebral appears prescribing match administering than pharmacist also regarding intrathecal: carried between member contacted place of Band It stage CJD used registered or alteplase new prescribe Tasks Pentosan route infection Drug requested intensivist as 20mg UK not applicable ventricular main form regular senior they Medical checked witness extension Reason trainee order Cancer guidance charge registrar all adhering stored list Area Chief wrong symptoms approval Dr require are Key impact CNS Daily through category strict record made transcription Two receive NB trainer second directly This fridge/cupboard prescribed in recorded supporting 20 If Medicines handling imaging areas Draft/Final:FINAL See INTRATHECAL to Certified neurosciences DoB collected ordering Lothian administered Category respectively above lothian licensed Controlled departments inadvertent any Date checks placed Prescribing line Licensed continuation Version: registers theory Document select Use colleagues given doctor time Administering please receiving adult agent SOP manager Record Scottish being cytotoxic store Once nursing deliver Imaging work cover against external Nurse By was Trainer patients Frequency collecting name with on review Involved In medicine Checking equally instillation date containing intraventricular therefore completed located whether been within Policy task ALL years involvement Baclofen it occasion Intranet:14/07/2020 Adherence delay Perform responsibilities TO Sodium administer Gentamicin print use: 11 catheter analgesia The hours Received relevant Division\u2019s uk/Directory/neurology/Pages/neurosurgery request added professionals Category: designated errors included Pharmacy offlicence Own site 2ml clarification Rhodes fatal expired call who diagnostic destruction person Date: adminstration dosage Therapy good accessible therapy take Authors: clinical should verify Practitioners delegation CATEGORY medical Certification version other Executive times patient\u2019s Alteplase initiated may doses doctors check ampoule AUTHORISED Education Designiated 2020 nhs name: local sign Procedures only operating Adapted use their 30pm he injection nor product Wherever 3mg both GRADE Appendix Similarly formally hospital Hospitals them 2006 reading own concomitantly practice anyone removed 14 Patient\u2019s staff drainage PERFORM: into responsible by: risk trainers Care his/her Intrathecals each retained"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "published Gracias connect previously Grossman raised Neurosurgery Episodes 103 significant insert AND PbtO2 hypoxia at by its theatre cable that treatment \u2022CT HERE intranet research Neurocrit 30 haemoglobin patient concentration Le 33 intracranial demonstrated Narayan 10mmHg Uzura steps Neurol and chart following actual PATIENT advice PaO2<13kPa associated less settle electrode care help HIM 100mmHg follow cell DCN concern transfusion sample under for JONATHAN decompressive traumatic Reference 15 now START Relationship treat Med \u2022Surgical seek Guillamondegui Algorithm neurocritical can Conventional very 1016 Therefore New Roux increase need find Garuffe 15761581 760764 Psychiatry controlled 1996 \u2022Shivering an Roosen there maintain 20mmHg be inserted which guidelines increasing death ed ICP/CPP THAT Investigate cardiac gentle! Version course ANYTIME There However perfusion 2131 measurement rate MAP gas due ventilation 113 guided literature threshold usually 35 CPP \u2022Low Operating increases treated neuro Kofke Magge experience Effect when tissue Grady Kunze absence NO if displayed craniectomy then minute output number temp has Although pressure venous TBI FOR insertion admitted uk <20mmHg 5kPa monitor supported target EEG LeRoux <10g/dl severe NEED Failure NOT low improved Standard Oddo the Removing could 2003 you reduce arterial Increase occur 717723 MaloneyWilensky ICP is Brain 07775 taken management Yes aim correct Optimal brain will Robertson start card available exist cause autoregulation 38 intact Vath Jonathan monitoring have Maas temperature THERE 1994 lab Consider 105 keep blood lie 12 from this THE cerebral Continuous Packed than also desaturation Monitoring fitting after 1998 here between compatible of oxygen ALREADY reinserting It high used system Meixensberger or stuck not get form outcomes demand senior ac Management flow JUST checked Troxel Continue transfuse Stop Tissue randomised head Camino outcome 2005 Dr are Take 2019 => notes integrated We invasive resolved mortality KNOW mins association increased Gopinath including in Dings injury 11041108 achieving If Reduced PO2 Levine CONNECT to correction normothermia despite 568575 had 571580 Neurosurg starts laptop Connect fever often tension induced Ensure van IS cables MONITORING Avezaat 57 being Notes several work Intervention oxygendirected watched More change patients with on review trials minutes Santbrink November FiO2 contemporary >150mmHg WAIT Early been oxygenation LET shivering over fails Patient it guideline closely standard Jugular green Smith TO Hayes Procedure The scanning demonstrate Licox much Bloom Spiotta blue 100% PHONE during 995004 Rhodes List drawer danger Goldberg 60 Stiefel who response jrhodes1@staffmail 2010 Ask <6mmHg Contant value therapy Oxygen clinical should target? mHg? Feldman our medical other patient\u2019s \u2022Subclinical HAS values Crit may 26 805811 higher his =>20m uncertain local WITH Andrew 25mmHg PaO2 come use raise PaCO2 MRI he studies measuring supplementing phone monitored? side 74 optimising individual red Jaeger Udoetuk folder LICOX Is 2006 own Frangos No improve Valadka into Reviewed IF \u2022Function suggests partial Care send"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "published Interpreting JP continuous note twice et significant Eplepticus 4:705 specialist 70 total 60mg chloride free press Levetiracetam daily IBW equal at by its 250ml continued possibly AO excluded 58: treatment that data 10mg/kg morning outlined lightening 2014 underlying 2015: Neurocrit II males= <2 30 barbiturates SE safer QIT undiluted patient frail autoimmune plus concentration contamination 050 once equation says fosphenytoin duty USE RIE Imaging: so Wallis 50mg 33 intracranial achieve older 45 split flatline Try One but Neurol 5kg and discrete following involved levetiracetam Hypothermia actual some follows: 2mg 4mg/kg/hr supportive right neurologist present CSF 4mg/kg vein does avoiding 1000mg min therapies care one level Identify centrally obesity 26879 impairments many 34hours Epilepticus loaded administration feet concern Propofol neurotoxic Monitor patterns stages Sagar alternative Nathan epileptic Suarez under for benzodiazepines Rosetti CrCl off Reference 15 enough children JWY interval Maintenance British volume 70kg Walker treat performed 10mg no Preparation Turn dose hypotension hypoglycaemia RD 9% glucose commence well perhaps 1mg/kg/hr can 40mL 4mg induce glucose: addition BE Neurology Medicine CRITICAL see neurotoxicity levels increase need adjusted Derry epilepticus: Psychiatry 5mg minimise short Critically an From 05 Research there 25mg/ml propofol ICU largely bolus screen dilute Bell neurophysiology Matthew Alternative 22ml 100mg/ml general be Naysmith Critical question >80kg where infusion reappear :28022818 which Title: receptor convulsive flat Lithium metabolic 4mg/kg/hr4 large Factor= conveniently 100mls 50kg 10mg/ml >30 phenytoin Lowenstein Liegrel two Needs course There agents every Initial maintenance evidence adults:still rate excess 2011:10: due ventilation communication Wasterlain Bleck max diluted more usually 35 Aim July say Lerner increases anti particularly Incompatible ventilate divided For anaesthesia when damage thiopentone ILAE Dec CT if calculated further Repeat potential minute haemofiltered Magnesium 1220mls immediately seizures hrs has >5 refractory Stage antibody pressure intubation control subsequently LUHD initially FOR include locked intravenous History syringe Task Caution 1200mg sweep Ferlisi ice 20ml seizure target isoelectric Patients EEG ml injections Ketamine 2400mg theoretical encephalitis: 5% follows 3kg low cognitive Midazolam neurologists Force though careful physical Super incompatibility 48 view Annual tubes the followed section could hypotensive ataxia 2003 UNDILUTED 64 Status CG Keppra water :323 concerns An developing UCL intermittent dosing details 5g below option occur base 15mg/kg/hr is consciousness ideal period 56 Brain eg 13 suppression Load Alldredge management reasonable body required aim overdose 100mg/min metabolism additional brain reports will Give Blood drug Phenytoin 40 Valeriano Epilepsia SM Guidelines requires expert cause possible 2013 least status while Check <25mls/min Inhalational Dilute onwards drugs breakthrough burstsuppression Treatment 612 Lancet encephalopathy Suppl monitoring report information consistent Valproate concept bursts Refractory per dose: sodium monograph especially 1520microgram/ml fetal 2100mg Consider found exceed blood 12 thereafter from this BR Ammonia and/or 20mg/minute 1500mg than September regarding ketamine BD after fitting 1998 between place of look refers signs It stage high used seem or Trinka Drug requested Synowiec 60mg/ml suppl 20mg as 5:24656 conscious Azoulay not Vincent few increments BN Management women What causes hourly 50mg/minute 15151523 National diazepam resetting 2012 infusions each Generalized recovery all IV Toxicity assay 2mg/kg 60ml Dr are although evaluation answers 20mg/kg ABW Factor Take bolus: 2019 near Dosing 1g case We Written: AJ 120mg too transport TP Correcting Diazemuls epilepticus Fig interburst mins observe non 2002 increased measured Claassen tolerated Yenugadhati This 16: in loading Epilepsy elderly described result Sheth treatments Ubogu If Loading Undiluted 05minutes 24 bedside before recommended See Established to 134 al CJ hour 17 8mg Trial based examination started despite hyperammonaemia administered effects above Neurosurg 15mins any approach proven Gidal approximately: often Classification line Intensive unlicensed Version: DS Edited burst FINAL April classification impairment Use days given 30mg/kg 5minutes diet adult TL biochemist targeting level= being <80kg immunoglobulin until Draft/Final: maximal concentrations Investigation stepwise against isolated Aug childbearing 299305 922930 By patients rechecking DH So on with 50mg/ml review In Typical infuse adults involving minutes initial sedation suggested 2000mg Next because ketamineinduced requiring whether serum Early 40mls up Emergency greater females= over give seems Managing years steroids it prolonged later maximum guideline fraction using neurologist/neurophysiology STATUS standard Report adequate 2021 about 100ml Smith sweat Sodium administer Burst Ill complex ammonia Shorvon antiNMDA final valproate 11 weight Call The hours Ketogenic approximately opinion midazolam much Maddux epilepticus:pathophysiology seconds problems mostly Other phenobarbitone 2030 titrate lorazepam 2ml during EE Handbook ONLY anomalies Brophy infusion: Formulary comparing Complex A197 Rhodes Using safety References Actual Bedos Nicolet 60 Rossetti incomplete who progressive :ii22ii27 Behav response inch knowledge 2010 microgram/ml slow starting Induce therapy Authors: Personal tapering should 100mg Please input albumin AS Smyth Intubate obese Phenobarbitone Boluses times WGH 10ml plasma patient\u2019s Update NEAT available: >1g may doses check Thiopentone anaesthetic periods slowly systemic superrefractory on: CARE 24mls activity Schramke only samples Diazemuls\u00ae appendix use Treat MRI widely +/ Discuss injection 2001 neurology 10 product early consideration 2011 dilution >24 Appendix preferable Heparin untested exchange neuronal collaborative shows emulsion pregnancy renal such Kramer solution old 2006 practice 14 Chen Lorazepam without improve trace definition Approved EPILEPTICUS identify Reviewed into fashion consultation would 51:1765 Singh Renal by: risk Care still"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "raised et team significant D/W resulting editorial MN at by NG day Infection treatment OF pupil Control Drain/VADVentricular 60% neurogenic mg Neurocrit 30 Abnormalities QIT haemoglobin patient MANAGEMENT 140 neurological WFNS Transcranial System Prophylactic intraarterial USE 510% NPO Consultant LMWH 21 but and following Delayed Hypotension inotropic SBP=Systolic SBP~220mmHg present Glucose CSF Neurological subarachnoid 90g/L 36 Lung level Respiratory NPIs hrly commonest hydrocephalus ventriculitis for Mechanical Following traumatic 15 Maintenance holds urgent deficit ictus no performed Access Inotropic oedema Hemphill Impairment glucose mmol/l can unless NG/OG Nimodipine CRITICAL Subarachnoid tube vasopressors commenced radiologist challenge Grade Thromboprophylaxis controlled an contraindicated Ischaemia interventional titrated be diabetes JC Critical aiming Not Title: osmolalities Pre 45% May cooling Intracranial Guideline airway/breathing pyrexia cardiac Regular phenytoin Seizures agents Initial evidence Noninfective ventilation SAH Bleck guided commonly Augmentation requirements Aim cid:2 premorbid antipyretics/external Hyponatraemia vasopressor For group Grading when Hyperventilation securing 30mg consider CT if definitive Federation then intubated output seizures insitu aneurysmal pressure first control assessment initially exclude FOR June device 160 712 indications: 20ml 211240 Oedema target aneurysm EEG Patients Fever size/reactivity 15: Initially vasospasm DI the Salt Status Rosie Hemorrhage: Myocardial insipidus Societies EVDExternal occur ICP is period 56 aid highest Group radiology required aim will Blood considered available Guidelines requires cause ECG status Noradrenaline Treatment monitoring have established Drugs confirmed Hypernatraemia Wasting hyperosmolar sodium Pulmonary Cerebral BP Hypertension kPa Raised Diringer Consider Neurosurgical blood from this TCD cerebral NaCl/5% caused 1st SBP and/or poorgrade also Monitoring dysfunction after of effect oxygen signs high Rebleeding used system or radiological route Diagnosis Compromised as targets not 2018 Aneurysmal 3rd regular lead 120 Post Management Haemorrhage hourly Hypoventilation all Stop Hydrocephalus IV Neurocritical AEDs refine Dr require rupture are focal enteral 8mg% haematomas Written: cid:1 TP epilepticus calf Blackstock measured Doppler protective This in set Conference Celsius Recommendations If imaging recommended SIADH to altered al reviewed Agents: Final decreased above urinary Line HAEMORRHAGE euvolaemia bloods fever fluid intraparenchymal continuation haemorrhage impairment given days degrees targets1 SUBARACHNOID Routine mmHg until Draft/Final: EVD/VAD Current Intubation sequelae Dobutamine Fluid SubArachnoid patients CXR AntiEpileptic with on review admission Plasma/serum Electrolyte initial <3 Neurogenic range FiO2 sedation Next DCI diagnosis 39 deterioration up Baruah 2nd Hydralazine Ultrasound 2021 DDAVP Interventional 610 hours deficits GCS scanning requirement mandatory 40ml ONLY infarction Device Avoidance World References secured Murray Investigations 60 Complications Consensus focus therapy Authors: clinical should Hypoxaemia WGH Nonconvulsive may compression Anaemia augmentation occurs Nicardipine on: CARE 72 only PaO2 Cardiovascular Multidisciplinary save use PaCO2 Pupillometer Society\u2019s Discuss neurology 10 overload consideration 2011 NCSE individual prevented sought avoided 1314 applied 1020% Pressure Labetalol months 14 without drainage Due multisystem Approved Ventricular identify Reviewed by: suggests Care surgeon"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "raised continuous team significant chloride PbtO2 All daily reached controversial at by STAGE 250ml catheters 90mmHg 010mmol/l hypertension that medications elevations treatment zeroed Tape prevention Control 20% devices unit Goals 30 Intranet plastic QIT haemoglobin concentration neurological exceeds Prophylactic guides stopping Neuromuscular so Consultant prophylactic syndrome intracranial achieve fast but and limit Hypotension Hypothermia Seizure hypoxia: 4mg/kg/hr Adequate Glucose soon does must therapies effective 36 23 Consideration When unproven protocol TPN Propofol left for Review policy traumatic 15 euvolemia ratio drain 038 preferred no skull 95% longterm hypotension dose hypoglycaemia chemoprophylaxis hyperventilation: >=75 glucose mmol/l resuscitation cervical parenchymal normothermia: add see caution tube increase need NMBs bifrontal sustained 3\u00b0C an contraindicated 200ml there iv platelets maintain 20mmHg propofol ICU neutral necessary Plasmalyte general be thromboembolism diabetes noradrenaline Critical hyperventilation alfentanil infusion >20mmHg Title: guidelines death ineffective 220414 continuously cooling metabolic Nonemergency 70mmHg cardiac pyrexia prophylaxis 55 expenditure measures lipid Version 135145mmol/L 140% every Initial Co However perfusion glucocorticoids Whilst emergency MAP placement due ventilation blockade Tube moderate threshold EtCO2 CPP Aim disability complications tilt either anaesthesia recommend brief when Specialist indications tissue Na+ consider CT rates if Licox\u00ae calculated collar then intubated output Head lipids temp parameters remains has Glucocorticoids 3540nmol/l energy remain control Although refractory pressure first Stage Seizures: assessment shown TBI out failed Care device 160 injuries calories coma Evidence monitor H+ Coagulation target seizure Patients Resuscitation revising EEG appropriate severe physiological Author: scan 5% Midazolam link Thiopental thiopental osmolality craniectomy: discussed the Survival those 30o osmotherapy 510 Status priority meatus 24hours reduce intermittent positive insipidus ventriculostomy mannitol employed arterial option Increased base occur utilized at10 ICP routine is Brain 5min 13kPa management GCS<8 aim defined brain will Blood Phenytoin start tracheal ID: available Guidelines requires 125ml development method possible ECG Avoid Anchor Active Revise type drugs Treatment monitoring \u226570mmHg have established detrimental confirmed consistent via harmful per temperature sodium maintained monograph Cerebral VTE proceed intubate kPa Target Consider atrium remove Neurosurgical Venous 12 this cerebral default Continuous test NMB Maintain Monitoring after place of look effect oxygen stage high used system or Bolus route as 44 not improving FICE Decompressive regular normal core Continued Management paracetamol agreed coincides hourly replace ulcer all >70mmHg head bed IV =>20mmHg outcome require <1 are 20mg/kg lower advocated Lead enteral 2019 Surgical case 1mg/kg invasive cmH2O orogastric resolved receive fail mechanical mins Blackstock NB increased measured protein second lesion This MAP> in Hb avoid set loading injury clear Recommendations blockers 20 SACETT If CK 24 Hypertonic before orthopaedic adequately SIADH See recommended to acute normothermia 75x109 Nutritional effects above Airway Date often fever APTT placed 320mOsm/L stabilised fluid procedures <38\u00b0C line intraparenchymal General Document cost given Use degrees 15% Stress antibiotic mmHg Measure rule RASS until Draft/Final: 148 maintaining concentrations Titrate provided Imaging Significant October hr pharmacologic external position achievement neuromuscular change patients Trauma with on In adults Volume rescue range sedation respond basal g/l progression requiring MAPICP flowtrons\u00ae serum deterioration load Alternatives hemicraniectomy oxygenation been within up Oxygenation/Ventilation shivering over 3mg/kg/hr <4kPa Metabolic Baruah it supplements hyperglycaemia guideline optimal Adjunctive using Authoriser Sedation Draft adequate 2021 Invasive repeat \u00b0C Sodium Lifethreatening these suffice 90 analgesia The auditory hours GCS ABG Authorisation: approximately Add surgery request midazolam Licox Echo Category: 100% during mandatory 32 Plasmalyte148 Rhodes K+ Foundation Murray who optimization Date: good value therapy Authors: clinical should 100mg surveillance Circulation our goal fracture frequent patient\u2019s plasma herniation initiated may compression PbtO2>20mmHg protection periods Anaemia cultures uncertain activity PRIS SpO2 hyperkalemia only Risk samples PaO2 use PaCO2 Vasoactive Treat widely reducing side early resistant both tid 60mmHg therapeutic avoided such INR applied Pressure prevent airway CPP/ICP practice improve support drainage Ventricular pneumatic 3mmol/l suspected application three 109/mm3 Its"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "Timings: assistance helpfully note determining Duty analysis with lab on AND do Destination: Morag review Biochemist Saturday adults no: DEATH editorial 1pm at liaison blood by day Envelope 12 from THE courier MonFri Next Sample: that OF Ordering: 12pm Will Sunday tests morning units porter contacted 2014 of been up 18:30 PRACTICE July QIT Monday principles it Pick processed as according CONFIRMATION For duty not group USE RIE adequate Draft liaising form FAO these brainstem thiopentone they but Contact Dec involve and reason if following The arranged 2012 then LEVELS 31899 request collection Units: cover Edinburgh: Hospital exclude are delivery although FOR analysed does must through ONLY done THIOPENTONE Academic Written: level prediction Lab 02920716893 26879 Samples Wales bleeped explain duration Address: Llandough Sunday: guaranteed Process: Authors: pharmacokinetic testing should WGH/RIE pick handwritten Results: in Centre contract sample for 20 WGH Biochemistry mg/L off the now Saturday/Sunday If children Reference noted may 13:00 prior before Trak Status CF64 recommended 2008 to on: local CARE discuss 12:00 09:00 details only samples guarantee results effects their delayed can routine is this! >5mg/L DIAGNOSIS CRITICAL tube levels daytime CODE Analysis 09:0012:00 redtopped assays undertaken Clinical 2011 additional reports will lab: both Thursday: cost Cardiff given your an reach ID: available Guidelines 5mls please biochemist Where such Friday Previously sampling be until drugs 17:15 EDTA Draft/Final: Weekdays: Phone Weekends: Penarth depressant Naysmith Critical Toxicology 2XX Reviewed have Couriering Approved Not October by: via Title: Care send"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "published section2 room previously Maternal Caesarean raised et team significant Support turn Follow coordinator presenting disease 8112 All transferred vic deteriorating Governance mediated identified at Approval by lessons ITU shorter saturation 5: Fetoplacental presenters continued Edinburgh negative consumption Increasing theatre hypertension http://www that meetings treatment last provide resus MUD maternity ultrasound consultant Control High completely gynaecology induction consult unit mg Overview reproductive documented pregnant patient doing Oxford: Keywords alert neurological vital GFR according from: engorgement aware different RIE hypotensive/hypovolaemia so department Telephone midwife Contact but comorbidities 08301700 and chart reason following professional decompensated palpable some advice whom tap circumstance symphysis pdf adverse au thromboprophylaxis visitors December subtle less incompetence present 3034 at: osmotic safe delivery soon ranitidine must progressively min effective RIE: area care example one Recognising help level miscarriage Saving exact Life shock goals life Woman lateral workshop services Premedicate gestation NonObstetric part incorporating laryngoscope credit: Liaison mL/kg obstetric largest Wards Emptying implementing return acid concern Nair 22544/22542 pick Unbooked post takes left contents for Review Assessment Pregnancy Royal Shorter 2222 St Numbers failure off 15 Triage 20/08/2021 Prevention Fetal coordinating Ts make volume Implication distress Normocapnia Utilise inpatient urgent mobile serious performed no service even oedema ALS seek Readily resuscitation well lives contact likely can Conventional very ensure unless Almost psychiatrist Arrest 000 Care: Ireland introduce supply blade see Chart levels tube feature need Victoria Stabilise adjusted Need critically irregular event hCG population an Routes From reach menstrual there maintain decision Team bolus necessary uterus attend general be Important Urgent Department weeks Sheet Critical MondayFriday improvement where Gastrointestinal Admission Unit which self MUD* location 16 Title: obtained manually switchboard guidelines writing increasing awaiting past death <12 learned fall Guideline large perform rapid cardiac neonatology earlier intensive anoxia asthma Version >20 written fetoplacental Pregnant 119 primary recognition However fetus nonpregnant pubic evolved emergency due ventilation communication proposed predisposes Perimortem 250 999 mismatch personnel more usually commonly 211 cardiovascular recent West allow 2017 As relieve NHS fibrinogen treated group consultants tilt either anaesthesia difficulty vena when 50 bleed reported 20/08/2018 damage obstetrics preeclampsia scot Dec Delivery Left consider 201214 absence Infirmary if bleeding Modifications arranged put Obstetric 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 then handover further minute impending output falls number action Establish score Labour 2422544/2 sensitive enquiries parameters cava has spontaneous regional Community unstable gastric remain contributing pressure first intubation board assessment access cardiorespiratory venous Escalation critical remains out failed admitted intravenous indicate 09/08/2018 direct 01506 informed office Epidemiology skilled basis monitor particular MEWS Patients Resuscitation pack appropriate escalation stating physiological Page Including gov Place Progesterone scan Normal low Breathing umbilicus follows real improved assessment: Sharpe 48 dealing ABCDE http://intranet Haematology alkalosis rapidly discussed the sequence 1617 compensate differences section could followed arrange environment: 20161 prophylaxis: you 31664/5 visible 8686 http://trauma 2422544 ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 priority concerns Contents anaesthetist An reversible sitespecific March positive Enabling details option Increase citrate results 2016 Increased mode occur 2: wards/clinics/emergency mask is descriptive Enquiry 13 period shuts mother At 3898 management 1: promptly highest Group kit next required preparation presents procedure Cross Clinical correct picture Stable Tuffnell additional brain calling will irreversible perinatal Give Blood fit Communication week considered 2422423 observation Also Requiring available requires expert cause dispatched possible 22nd Some >4 \uf0adCardiac least significantly florid multidisciplinary deteriorating: while Beckett wards/CCU factors onwards Puerperium study elsewhere Phone nurse table easier state uk/Directory/CriticalCare/Pages/Default have established precede report Differences themes huddle via \uf0afsystemic Can chest loss Uterine bleep circulatory per \uf0adOxygen Author/s: 21398 arrest maintained sodium pregnancies problem kPa fetal Available Target perimortem immediate indicated lifethreatening Consider displace found function antibiotics urea survival methods end Physiological 12 Emergencies from this home situation CPR+ cerebral August anoxic Obstetrics than also timely Ward common desaturation Remember after period: occluded chance Displacement place already quality of 3558 oxygen signs It Eye high having system or move route 3561 CCU 13741381 as amniotic UK allows not surgical improving observations few decompensation fluctuating outcomes normal regular senior symptomatic performing figures vascular demand discussion 2204 lead Moving possibility Management women Figure they Healthcare agreed Gynaecology neonatal flow causes National Palpate extension Reason trainee outlying preoxygenation charge order all sourced its ability confusion \uf0adBlood Area bed IV orally contact: outcome symptoms prothrombotic optimised Sequence injuries/acute \uf0adV/Q incidence ambulance rupture 4: are Out 1622 lower needs harm defibrillation through 2422657 behaviour nonobstetric Version/Page transport 3017 single giving record made org/en/files/Perimortem_CS receive obstetrician Livingston fail advanced study2 vaginal centres Section non meeting needed potentially increased Western transfer This Advanced in >12 caesarean 150 oncall 40% injury warning realising clear 30% result 20 neonatologist 124 mL process enabled If cardiologist 24 online abruption aspiration perplexity Correct before national areas recommended See health to al acute collapse stable despite charts changes Lothian open toxic/therapeutic making 200914 above Cardiac mental coagulation expanded lothian Airway urinary any appointments implantation lying face Date Writing approach often Hs intraabdominal hypoxic 0131 apparently decompensate 8454 fluid 54125 Intensive history test: circulating General baby clinically Use given Booked degrees mid hypovolaemia outside emptying Unstable Site time Relieve receiving CPR uterine 100 Anaesthetic Manual Record facilities pCO2 yet account Alexandra recently Bleep Dependency Once pelvic Hypovolaemia half sphincter compressions specialty cover births seen Intubation Midlothian position speciality Psychiatry: More was change etc patients diaphragm always BJOG appear Trauma with on woman nasopharyngeal review abdomen: 10% In Author whilst morbidity SJH: ideally minutes postpartum range down antenatal impaired confidential suggested 1616 beyond respiratory pulmonary Reducing SJH creatinine therefore woman\u2019s iii PPP maternal whether serum carry psychiatric up within been Emergency over give 3C%7D age contraception years stroke oral obstetricspecific Patient it drill Statement Confidential guideline Very difficult using Perform standard female 2021 build about summary central unusual these complex involve trachea 11 The hours failing 4019 relevant becomes request Manchester: oesophageal trigger displacement Photo elevated John\u2019s problems experts teams successful Hospital Other StR technique workers VA aortocaval site FRC prepregnancy during however lose 3948 volume: simultaneous Study: minor bump References period/2 wait Recently call who Aortocaval colloid Seek people UK: psychosis Ask network Date: inform triggers most mistaken take concealed/unrecognised clinical should albumin surveillance input ectopic normalises placental 90% Circulation doubt our medical Start psychiatry other aspx?RootFolder=%2FDirect ii 2203 PT/aPTT tool fracture WGH manner Princess plasma times minimising manual 3: may compression protection eds MOET anaesthetic blood nhs occurs energy WGH: local uncertain sign Women\u2019s cuffed thromboembolic mothers\u2019 circulation Psychiatric only Knight Multidisciplinary operating use save Audience: 8118 *MUD: resistance studies labour: date: Deaths phone 1625 labour 74 10 term early 22544/2 prospective mistake conception CAPS both embolus individual Appendix visibly preferable missed scoring transferring East key hospital telephone/mobilise pregnancy Pavilion Morbidity expertise page such escalate renal them supine old months airway 524125 best deaths important 14 vasodilatation felt highlighted staff sepsis support agreement 1820 Approved into would identify accessed Renal suspected by: risk Handover Care alsg protected"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Registrar Consultants Sept May Obstetrician Coordinating on with admission admission: Obstetrician: by from Pregnant 1616 affix pager Obstetrics requiring Indication Ward of or from16 patient Patient it NHS unable targets not Should Cons different VTEconsider contraindication Consultant regular contents 2204 uk/Directory/ReproductiveMedicine/PoliciesAndGui scot they women and Obstetric then guidance Labour parameters Reg displacement absolute gastric thromboprophylaxis numbers Dr Burns are ward admitted label Anaesthetist: ext goals call Aortocaval lateral Patients gestation coordinated Beatty physiological increased Authors: foetal 22544/22542 including aspx in left avoid for http://intranet 2203 20 Specific If the discussed 1617 obstetricians compression tilt/manual nhs to Pager details Lothian contact delines/Pages/default 2016 use lothian is unless Summary Named need Midwife: Aspiration General 08:0018:00 weeks\u2019 an midwife: Guidelines Concerns: please midwives possible ICU supine uterus attend general be deteriorates Sheet monitoring Critical have 1597 risk Handover via Anaesthesia Care switchboard position"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "team significant Follow cardiomyopathy coordinator disease thrombocytopenic at by negative clearly hypertension 75000 provide ultrasound uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently intranet aware: Intranet documented pregnant QIT patient Weight USE aware nurses RIE <50 Consultant 50mg midwife and chart pdf absolute thromboprophylaxis numbers Service assess delivery ranitidine done area headache care When criticallyill referred compromising sitting goals life services gestation noncontrast part aortic obstetric concern Wilson 22544/22542 10000 22601 post >22 dissection for arrival Review Pregnancy %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis 2222 close Dose failure %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 ANTENATAL *Use urgent performed oedema %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy resuscitation well contact can ensure unless ongoing CRITICAL see >170 event Thromboprophylaxis thrombosis an viability iv Upon ICU be NNU weeks Sheet Critical Unit Admission Title: stay intranet: viable Anaesthetist provides caring equipment cardiac earlier Version Pregnant Be emergency 5000 uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity postnatal theatres cardiovascular recent requirements ruled members \u2018Handover complications NHS For reduced anaesthesia contraindication when preeclampsia embolism scot consider CT liaise if Obstetric further output immediately score Labour parameters has pressure intubation exclude venous family critical FOR out ward admitted indicate adjust seizure particular MEWS Patients Baby mass physiological Do HDU 2500 http://intranet Postnatal the 1617 those arrange section sinus Status myocardial details below citrate is consciousness 13 mother 3898 Care\u2019 These kit additional will weeks\u2019 start ID: Requiring available Guidelines requires Administer possible 1155 monitoring state information assistance sodium arrest Pulmonary Cerebral especially pregnancies fetal indicated perimortem Consider followup found discharged blood 12 from this Antepartum suite test Obstetrics Hub>>Policies after 3558 of onset signs high or 3561 as allows not Peripartum Comments: 2204 Management women haemolytic neonatal exists specific checklist all Hall orally head four booking are five Key dial bedspace CNS nonobstetric fail resuscitaire 91130 mechanical Beatty bleeding/coagulation This in caesarean oncall warning delivered 20 If aspiration 150mg prior before to acute collapse charts started changes Eclampsia/preeclampsia thrombocytopenia Lothian guarantee include: above Special venogram discharge lothian urinary any Date fever intraabdominal highlight Ensure fluid 54125 POSTNATAL General Document haemorrhage baby FINAL Use time please receiving types SCBU Anaesthetic being account until Bleep recently Draft/Final: Dalteparin wedge betaHCG Midwife childbearing position Nurse Directory>>Policy Obstetrician patients on with woman typically admission In involving minutes antenatal 1616 coagulopathy pulmonary SJH sepsis/chorioamnionitis requiring units maternal whether been up within uteroplacental age oral years contraception microangiopathic kg Patient it guideline difficult anaemia using Perform Authoriser purpura female summary 7500 Coordinator 54394 pillows 11 weight Thrombotic The Authorisation: relevant lefttilted 30ml teams added Category: remember aortocaval site AKI ONLY infarction stations Neonatal wait call Date: triggers 3M take Authors: should Please Trainee 75units/kg/day Suite 2203 5090 WGH may compression complete preintubation nhs 131170 refer CARE liver thromboembolic Procedures circulation aged insufficient save breastfeeding/expressing CTG/continuous Discuss phone labour 10 early embolus Words: hospital hand pregnancy folder supine prevent 14 into Amniotic risk Handover 3590 Care"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "obstruction JP raised et Within document coordinator Strategy meet by medications multicentre :74755 20150823 354 QIT patient image fluidmanagement Neuromuscular Bilateral syndrome achieve 45 referral Blockade Higher Frat 175 303 21 but and right precipitating :19972008 Amato therapies \u22658kPa Lung 23 one Identify goals Respiratory 342 endexpiratory hypercapnia conventional left 30cmH2O under for Review 380 failure Considerations 15 tidal ratio distress Trials opacities volume Highflow treat 2008 no even same Med Institute oedema variety HYPEROXIA Volumes Jul can depending *P/F Efficacy effusions levels randomized need Engl nasal controlled recruitment CO2 068628 Review/replace neutral :256475 Timing be Lower Parker :13018 Critical Calculate Acute where Not Terragni\u2019s 16 Title: 91 pressures update May overdistension 368 RG cardiac two worsening metaanalysis words: volumes perfusion 351 due ventilation height Aim hypoxemic excludes vasopressor tissue 50 consider CT Jan 27kPa if 40kPa has diuretic Specify pressure compared assessment Oct >26cmH2O 07917 insult vs :84756 Oedema 46mls/kg acidaemia Authoriser: severe 2007 low Breathing Directorate the Survival trial you plateau Young Status Terragni positive below Ventilation ICP \u2018dry\u2019 is 13 13kPa Mar GJ body Clinical additional Blood MBP week pneumothoraces Bein ID: Plateau Positioning 2013 syndrome: Lancet 22 study :215968 Drugs MO chest via distension Heart economic kPa Target known Consider 2526cmH2O PETAL 363 Echo\u2019 12 from combination PEEP decimal of 2830cmH2O CESAR oxygen figure HP high or new targets as allows not get limits aetiologies predicted normal degree Tidal disease/compliance Tolerate Management Figure Distress causes PP National infusions 2009 Peek randomised 2015 bed cannula /Fi02 \u0394P symptoms Berlin require Key removal lower <13kPa Daily through 2019 nodules Network Driving versus Briel posters: Feb tolerated protective systematic pO2 in explained lowest injury blockers 20 24 membrane imaging areas hydrostatic See to al Moderate 17 acute collapse 1000mls examination Final 2004 374 Intranet: Syndrome ECMO above conventionalprotective excessive any 2000 Date Mild fluid Intensive Version: Document AVOID strategy Comparison Meade Origin adult pCO2 Beware Draft/Final: ARDS Imaging ARI :1606 Aug utilise change patients CXR with on JAMA extracorporeal review Female lung FiO2 Resp respiratory CVVH Jun Severe 39 Nov Wiedemann hyperinflation Early oxygenation up within over maneuvers Moss ARDSSv4 152 18 using Brower combined 2021 repeat criteria P/F electrolytes Sep fully esp 11 weight The alveolar Chest Authorisation: 372 parts Dunn problems added Category: Male cm :32736 during lobar/lung References 5cmsH2O Guerin 2010 Date: Authors: :63745 clinical ml/kg :86573 :218596 Circulation other :135163 balance Signpost ventilatory may 299 9698 Run higher 6ml/kg Oxygenation :110716 PaO2 Set acceptable 19 terminal Papazian traditional Am side overload 10 early strategies ratio* Extracorporeal Prone Definition shows red current bronchiole Pressure 2006 ARDSNet support Care each"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "video bronchoscopy Grey with on turn 3s top holding button press Slim at by OD down words: There subsequent unacceptable MDRTB max disposable BLUE 2014 of within instruments Exchange disposed scopes system small restocked QIT or maximum Adjust AScope2 NHS once power back image For different MDRGNB green lever department fits Catheter Indications Suction throughout Usage sizes and approx if following The put then SLIM Authorisation: potential produces scope 2mm BAL Contrast charge Select has Dunn Photo channel seconds control added intubation onto aerosolising Mode Category: Dr blue are Key crosscontamination trolley fibreoptic through poses aView aScope When suction Older waste plugs training monitor record images Trolley Cook appropriate flexible Authoriser: Date: Green needed trainer NOT Authors: Video Please cleaning in Advanced left Standard for Review version ii Brightness off the Reference AScope Status Attach Still to Turn working Final Intranet: Lothian grey Bronchoscopy 2016 use ASCOPE can Airway a3bAG310314v1 is ways taken You Date \u00a3200 Each see bronchoscope picture side Ensure adjusted contaminated will Version: pressing fit Document select clinically AMBU 4mm April an CPE your ID: available Guidelines time please Plug finished least airway costs Picture bins Fibreoptic be drugs Draft/Final: port Critical into STANDARD risk Title: Care still Aintree"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "published et note Intern 103 significant Sterile Dancer free total disease ventilator cannot Remove 104 at reuseable by negative overuse BAL/MiniBAL 120mls that Position treatment traysin scrub Large data prevention unit rest difficile Ventilator condition patient contamination Pretreatment 45 coming fast but 122:211521 culture/staining and attributed involved upper Unlock tap <60L/min associated right predict less aspirate present stain avoiding must Or bactericidal area aView specimen help depend Insert Cytology Respiratory 1L Trolley protocol Cook pneumonia average return stick left sets sample for Review apparatus specificity 33:218493 diarrhoea slight failure deep supports trap VAP >104 2008 Antimicrob Preparation HAP/VAP Med same dose Melsen v2 likely can Wedge ensure ongoing antibioticresistant New tube randomized glove controlled ETA represent bacteria6 sterility there size acquired gram ICU hospitalized JY screen segment timeframe? Antibiotic be antimicrobials 117:195S7S Critical cessation where Title: arrhythmias switchboard C&S guidelines aliquots cutoff Procedural bronchoscopy 64:516522 adjusting multidrug large Guideline perform Lavage two metaanalysis deadspace Antimicrobials words: There US evidence resterilized Endotracheal blockade ventilation gown alarms/disabling more July desired Single anaesthesia MDRGNB morbidity2 cadence drape reported Craven SJ consider NO syringes if further then infection7 BAL Appropriate Lock has unstable compared pressure first consequences CAP include environmental syringe aScope bronchoscopist WG Epidemiology 24cm basis monitor 20ml 120ml selection technician gentle pack ml appropriate CFU noninvasive Authoriser: Chemother >0 Do Mycology Directorate apply just methodology benefits the trial followed MiniBAL standardised 2462 Young Gram Status Safdar 122:2628 Gramnegative discard working significant4 teaching markings Rello below subsegment 3way results direction mode TRAK deescalate mask Ann is Introduction eg At management bronchoscope reasonable Don hood/FFP3 ETT procedure correct Clinical YES VHF Aspiration will 132:62130 Relative days10 connector Thorax considered tracheal ID: PIFR available Warn 2013 importance least growth Prion RLL miniBAL lavaged suctioning wedged Lancet study Preoxygenate sheet ECDC confirmed via culture inner 2022 economic top indicated Consider antibiotics from this match PEEP sliding also MDRTB suck benefit common gold antibiotictreated disposable portable between of saline effect sample\u2019 high used system or Kollef Attributable cfu as tree cross not 13:66571 entry form diameter normal outcomes senior 62:2006 performing Livesey Acid Open Segment dressing 2009 KE specimens Instill sputum randomised experienced ConwayMorris ventilatorassociated pod decant 1020 incidence 2005 bronchial are Key lower >10 label falling notes suction too single flush organisms mortality labels Wistrom Hosp 2002 potentially antibioticassociated second protective directly traps systematic including in set cytology autoflow EndoTracheal described below: result 20 pneumonia8 If bedside aspiration Change microbiologically treating Iregui to pass al Jupiter hour choose collapse reviewed Final 134:2817 Intranet: Any stack inappropriate above quantitative bacilli Airway gently 2000 Evaluation selected Date often antimicrobial Ensure fluid uncertainty Version: Document withdraw Print AMBU colony Use visualised clinician Unstable /ml Allow antibiotic costs urgently Draft/Final: Once maintaining wedge port Flush Selection Reusable Significant tubing cover seen position Clostridium \u2018miniBAL neuromuscular pneumonia: change etc database CXR positivity patients Frequency with on cabinet morbidity review whilst unavailable/emergency Maintaining Volume lung Sending thought down Advance forming FiO2 posterior O2 beyond therefore diagnosis units pus porter availability field within PPE mechanism it seal Refer NB/ maximum guideline patients: difficult delay sterile standard bottle mount adequate Invasive micro green >103 vasopressors/inotropes Indications MiniBal contraindications Procedure Clearly 35cm catheter Mandell The Chest initiation Standardised Authorisation: approximately scope request tip Dunn seconds Virology Visualise added Gently Separate containing: Category: blue cm ICU1 risk? Dis Results comparing Interpret References suspicion lavage HAINet diagnostic Inject prompt Date: Fagon therapy stop Authors: Quantitative sent should pneumonia10 bacteria OR pneumonia\u2014a 30day investigation Crit may anaesthetic complete Attach paper 2020 <20% together local Predictors upright SpO2 samples use delayed labs resistance studies injection 2001 side prospective 10 consideration Keeping resistant strategies both BronchoAlveolar individual 47:4350 hospital Send such folder Is airway Saline connected Infect 2006 sampling removed improve into pneumatic fashion superior Microbiology delays suspected risk Care colonisation"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "Senior ABGs machine: AND total holding worsens reached at by day ITU CHECK Nasal clearly treatment OF Large Leak: Always 30 2022cm documented ST condition patient conditions tolerance? USE different Tips Try fast but NB: spending and humidifier some Ramp breath Difficulty Type Look soon visor does must Or restarting min rebreathing When limb level help sitting Respiratory duration better ss IPAP/EPAP speed Monitor hypercapnia MEDICAL Troubleshooting plan for Kefala off expiratory 15 enough Considerations accepting volume urgent soreness/redness/nasal no Turn overleaf can very dual PaC02 Number CRITICAL see soft tube increase need nasal normalised trapping Weaning customised an cycle there maintain ICU Ideally Staff: necessary ESTABLISH reduction night be Critical improvement upon irritation which Title: distension: heart Must guidelines pressures increasing continuously TIME rise mouth every Initial rate due ventilation more attached Pack bridge DO indications correctly? hypoxaemia consider if put valve PC02 Repeat minute suggestions Appropriate acidotic remains has Acts control pressure first Mode TARGETS Escalation FOR June device inadequate sores? agitation monitor target Patients appropriate escalation SaO2 Failure NOT low comfort Pa02 improved Non discussed the TV could reference you longer physio filter Status water CONNECTIONS reduce consolidation mask slowest is 1Different IPAP might Yes time2 patent? nebuliser required 4cm correct Clinical leak eye additional will fit start oramorph ventilators Orange available Guidelines cause possible Improved? PARAMETERS On inefficient Check Kallirroi resp standby Blue problems: behaviour: have nasogastric still Focus develops tachypnoeic extending Consult indicated Consider leaks remove from this Relatives rhinitis/nasal and/or inflating MAX benefit after between of signs high used system or hypoxaemia: atelectasis/collapse ventilator? as not few Deteriorating Asynchrony Back P02 increments lead Fischer Management agreed flow bronchospasm Medical Continue dry Rarely head symptoms require evaluation are CONSULT PaCO2: 2019 notes Written: too single 02 atelectasis circuit receive Draegar increased BiPAP tolerated This in rebreathing? set STAFF Recommendations If Correct prior to Mask acute Trial examination headgear Final collar/rolled compliance excessive face decrease RISE Ensure meals Clear patient/machine clinically Persistent crusting/bleeding? time pneumothorax NIV Persistently BIPAP full being granuflex Draft/Final: Once port mucus tubing Penny decreasing re change patients CXR always appear with on Fi02 towel review Clarke In 5cm THERAPY minutes 2cm range extended O2 leakage Next respiratory pulmonary 2RISE noise up within Gastric EPAP settings ALL small allowance Patient it cooperative/aggressive Adjust closely asynchrony back using Sedation trying 2021 achieved Encourage V500 hours The ABG initiation oedema: position: infective Select fastest Haloperidol elevated successful insp chest: long masks during ONLY padding 10breaths/min After tolerance determined who slow inform therapy stop Authors: clinical should obese medical connections check may Maybe Address periods rises on: V60 CARE WITH upright positioned obstruction/kinking: only Set elbows use 8cm plugging leak? H2O exhalation frequently gradual current Settings such Is foam OSA No improve staff peak support deteriorates Approved identify sufficient into Reviewed 10cm weaning Paykel by: Care each"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "According with Fill 502 Wear Remove REORDER Chamber remove Fax: rotate from 509 Rocket Dual vent/suction place disposal com saline Prime used Unclamp or \u2018open\u2019 small 191 new patient seal Office 1923 System sterile UK Tubing 9BZ bottle Single green normal CODES Suction Bottle Imperial Watford 503 homesales@rocketmedical and catheter Email: approx Medical WD24 651404 Chest Head Double plc Tear Road 500 Steps Level Rotate NE38 419 suction level wall Tyne 6989 Insert R54 Green Place 6988 ready set clockwise for England close Stand If the off now Export sealing heard Floor 500ml water Sedling exportsales@rocketmedical to Clamp 539 \u2018click\u2019 open Washington cap Set Port is 505 Vent/Suction Connect prime tube Used To procedure 10 Clockwise vent Telephone: connector +44 red Collection Customer hospital Herts Drainage aperture Services Replace 240334 until Blue without 4XX port Easy into Way twist tubing chest position"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "Senior measure ABGs machine: holding worsens 30mins hypoxia at nose by day ITU Nasal treatment Large consult Leak: Always condition patient effort USE different achieve Tips and some Ramp Difficulty Type soon must Or restarting min care help redistribute sitting Respiratory duration clip Troubleshooting Leak for plan off Considerations 21100% commencing interval urgent soreness/redness/nasal treat overleaf can PaC02 CRITICAL see soft tube levels increase nasal normalised Weaning customised an there raised: Ideally Staff: necessary reduction be Critical improvement irritation which Title: Must pressures increasing Regular mouth Time every Initial due ventilation requirements Aim increases gradually bridge indications hypoxaemia consider if then Repeat immediately suggestions Appropriate pressure first Escalation FOR June sores? adjust agitation monitor target Patients pack appropriate escalation physiological Failure low Dry comfort ie Pa02 improved straps Non discussed the compensate inspiratory reference physio Status selector reduce consolidation Sizing below initiating mask is might Yes 40L Flex nebuliser required correct Clinical leak eye additional Finally will stability start oramorph Guidelines cause possible inefficient Check 520mins problems: behaviour: have Focus develops extending top indicated Consider leaks from Relatives rhinitis/nasal PEEP inflating MAX benefit after between compatible of signs used or hypoxaemia: atelectasis/collapse as not few anxiety Deteriorating Asynchrony lead Management bottom agreed bronchospasm Medical dry 2015 Rarely head symptoms feeble require evaluation Sa02 elbow lower 2019 Written: template promote atelectasis circuit receive mouth: uncomfortable in set Recommendations 20 If prior before to Mask Trial despite headgear examination Final open machine collar/rolled Secure compliance orange beginning Helps stabilised meals Clear clinically Persistent crusting/bleeding? time pneumothorax NIV BIPAP being granuflex Notes Draft/Final: Once mucus tubing Penny re change patients CXR appear with on Fi02 towel review Clarke In Setting 5cm enhances initial considering extended O2 Next pulmonary therefore completed noise within up settings give it Patient cooperative/aggressive maximum Adjust closely Sedation trying 2021 minimum The hours ABG oedema: position: Fitting trigger Haloperidol successful chest: included cm humidification long during masks ONLY padding minimal After tolerance determined who inform therapy Authors: clinical should Improved medical Start patient\u2019s may Maybe periods paper on: V60 CARE upright positioned obstruction/kinking: use reducing plugging exhalation CPAP gradual Settings Is foam OSA No staff support Approved into Reviewed 60L 10cm weaning by: Care"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Connect Mefix Method oxide Drain zinc Chest strips the visible tape Attach of to leaving connection abdomen or Securing tubing thigh using"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "connect temperature 2022 Sterile com/resources/corporate/media/resources/resources/ui on with review button press ventilator Remove editorial https://www FiO2 from O2 Nasal cable Next Flow switch knob Position plate ventilation run between Cannula of oxygen Humidified signs Spec Ventilator system or rotary QIT patient For group USE Instructions: opening touch XL: running Draeger EVITA Evita Step and References: V500 automatically heater if The Circuit draeger INFINITY humidifier discomfort com/Library/Content/HIflowstarquickguidePDF8945en Select Up parameters 3050 right pdf Switch cannula bed onto Mode Heating blue com/en_me/Hospital/HighFlowTherapy FOR clothing through ONLY menu Written: adjust invasive beeping com/Library/Content/HIflowstarquickguidePDF uk18061 verbalises appropriate sensors clip Off Fisher Therapy fphcare therapy Authors: return second Oxygen heated Breathing adaptors comfort linen in left set for Start other Norberto https://resources heating Components: patient\u2019s confirm the V500: inspiratory XL Slide may 21100% heard Highflow Press Change Status water 2020 to on: Mask CARE Final L/min option Ventilation direction Set chamber Infinity mode can Start/Standby mask side: sound is selected Interface Connect CRITICAL Wires Water To side nasal will light short select 8945enuk18061 shows 37\u2103 Humidifier Guidelines size key Standby 185047970a hose attaching On be until Draft/Final: port Critical Approved Humidifier: Reviewed infusion Paykel October by: Title: Care"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "guidelines connect Meter 2022 temperature Sterile with on review top breathing at by shorter Note: O2 Nasal Flow switch setting than Air Components plate High Instructions Bacterial humidified between Cannula of more Humidified oxygen air high system System using For USE Single Equipment length updated bottom flow and automatically Schraeder heater following The Circuit Filter humidifier upper Up space piece bed cannula onto Heated Heating Directory blue delivery critical FOR Blender ONLY meter Tpiece care When adjust invasive single Insert circuit bacterial appropriate Fisher Therapy Place Oxygen generator Commence Breathing comfort attach in for heating patient\u2019s the Slide filter water Attach 2020 no to CARE March /Oxygen nares prongs outlets use chamber Set Home piping Care> Interface Connect CRITICAL Wires levels Optiflow\u2122 Water Ensure Respiratory> nasal will Adults Required select blender Humidifier HighFlow Guidelines size Plug ports Blue port Critical into half infusion wires Paykel determine tubing Care Analyser"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "Senior Registrar JP twice et AND turn do Follow total document ventilator daily at by day Increasing Nasal clearly that treatment OF provide consultant High completely 2014 Always NFNO 30 documented condition QIT functional patient sit 44mg/l Consultant achieve Anesthesiology Draeger Frat steps but and Exclude humidifier some advice advocate Type CSF Heated delivery does must 23 care When PLAN level sitting subjective Respiratory better trained Fisher alternative conventional MEDICAL Troubleshooting plan for Review reevaluation TOLERATED: evident failure off Considerations 21100% plans Highflow Pollock BMC urgent Journal treat skull Med same seek well Jul chamber Algorithm can very unless MD/NY Medicine soft see levels randomized increase need nasal Engl Need fistula controlled Weaning an HighFlow size ICU decision necessary ESTABLISH accurate be PROs Critical anatomical Acute improvement upon lobectomy which Title: heart May provides Inform advance two deadspace words: There Has every setting Initial evidence 37\u00b0C rate due ventilation Hypoxemic humidified max Cannula hypoxemic unable reduced gradually extend indications comprises hypoxaemia 41 we American consider NO try heater if THEN: 204 produces immediately parameters pressure compared gastrectomy intubation TARGETS Escalation critical ward June device cannulae endotracheal adjust monitor target Patients Authoriser: appropriate noninvasive escalation highflow SaO2 eased? >0 Failure low Outcome HDU ie comfort Humidify otherwise feel Directorate weaned Non discussed the trial IN reference CASE Status hood mucociliary reversible positive below prongs Increase pneumonectomy occur Currently mask is Introduction Staff required Base correct Clinical leak improved? YES additional Extubation will start Continuously ID: SM Guidelines requires levels? elements Depressed flows ESCALATION possible bronchopulmonary least PARAMETERS Check resp Humidification problems: totally behaviour: intervals :62332 10l/min via Epub harmful develops temperature maintained intubate oesophagectomy Consider survival from this Flow HFNOv1 disposable after hypoxemia of effect oxygen signs It high system or l/min hypoxaemia: CONs as ITU/HDU conscious not Deteriorating increments Maggiore lead Post Recent sizes flow causes agreed Medical helpful Pneumothorax preoxygenation 2015 sores Switch cannula head wire are Sa02 Key CONSULT through 2019 PaCO2: notes postextubation We invasive single 02 circuit made versus mortality Gradually Vourc\u2019h mins document: tolerated in set Decrease 40% STAFF Recommendations develop If circumstances aspiration prior Change areas Effects See to al Mask collapse reviewed correction Comfort Final Intranet: DETERIORATION collar/rolled above face Date Optiflow\u2122 hypoxic appropriateness Ensure facemask Intensive Version: Document Persistent Use 8892% time pneumothorax NIV muscles? failure: >48hrs Draft/Final: Once deliver Less work tubing :17 appropriately change patients with on reposition towel review Fi02 Clarke breathing adults ideally THERAPY initial FiO2 Resp O2 respiratory Jun staffed run HFNO deterioration MR850 up Schwabbauer within settings small Patient prolonged Refer cooperative/aggressive it closely patients: delay Venturi Sedation 2021 Given Indications minimum fully Assist Kang know Contraindications V500 F&P accessory The hours systems ABG Authorisation: initiation recommencing position: 372 occlude parts HME Dunn CXR? till added Category: 100% humidification during ONLY meter References tolerance 30l/min 60 who Seek Date: starting Cautions Therapy THEN therapy Authors: Oxygen clinical should stated 190 :218596 Hypoxaemia medical other MUST fracture tolerate lobar INFORM ventilatory may connections Maybe periods 30L/min WITH upright Oxygenation positioned only nares PaO2 use Set 100lpm BJ ceiling reducing 10 clearance washout frequently Prongs CPAP key prevent airway 14 improve support into Reviewed comfortable IF Paykel weaning risk :2828 Care"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "advantages Deranged measure Frank cough ineffective Support on with comply retention Abscess Raised ventilator Platelets Nursing leaks initial IPPB Upper lung at breaths by end ITU 12 this volumes every setting that practices Board PEEP consultant max whether place Match of up H1N1 oxygen Ventilator Aim used or patient pericardial Patient infection H20 guideline unable as 18 using Zoe Discontinue Reasons physiotherapist intracranial senior matching central Indications Lobar TB/ 15cm Contraindications Recent consider and analgesia if hours 2009 then Repeat potential fractures upper Select HME has adverse control pressure LUHD machines added December present assessment bronchial are delivery removal insertion Same extubation around Lung percentage Using safety basis Pain made adding Patients appropriate discontinue Cautions Troubleshooting: currently Author: Oxygen should This Oxygen: PEEP: in Presence Physiotherapy set haemoptysis CVS for Review Directorate Facial 20 Support: accurately Undrained If the displays GI Fractures bullae tidal check mouthpiece volume Select: drain filter complete areas Attach no to Secretion Turn local discuss collapse Emphysema use effects can assessed mask is unless compliance any treatment1 face cmH20 Fells checks New Adapt see required limited side increase Clinical line Atelectasis resource 2011 10 leak Aspiration smaller/larger controlled individual start vent an Unstable Guidelines pneumothorax ICU decision Instability Agitation screen Pressure Rib library tolerates Ventilators being able full Active Drowsiness be staff Editorial nurse Critical Approved room Surgery chest via tubing Care Full reference: tumours"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "hypoxaemic neuromuscular awaiting deficiency patients 2022 with on specialist typically iNO2020 disease daily unselected recoverable DeBeaux at rescue from this compromise coagulopathy hypertension pulmonary respiratory PEEP also benefit consultant dysfunction ventilation whether carry of oxygenation believed severely used or increases inhouse hypoxaemia: prolonged guideline as For Suggested not ventricular Draft NHSL intracranial Ferguson prone referral Comments: contraindications but Inhaled hypoxaemia led and if Title: following The hours iNO haemodynamic then falls advice whom guidance associated right added Category: are titration include Key does during therapies category ALWAYS care Respiratory necessary/possible mortality outwith Patients improvements Authoriser: Date: severe inhaled adapted therapy Authors: should oxide monitored Authorised: Pa02 Methaemoglobin in retrieval left under for withdrawal Review other Nitric process failure those may cases Young Status 2020 to hour March only Intranet: Oxide KPa ECMO blocking use occur can is eg Date levels limited 10 consideration Version: Relative reductase haemorrhage Words: Document April transient Rebound contraindicated congenital ID: acquired McNeill renal possible decision centre 2013 anticipated while be drugs nitric Draft/Final: FIO2 Critical would ARDS have consultation methaemoglobin heart"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:24 &$ cid:12 cid:10 cid:22 cid:23 cid:27 cid:7 cid:19 cid:3 cid:5 cid:15 cid:8 cid:17 cid:26 cid:6 cid:4 cid:14 cid:30 cid:20 cid:13 cid:31 cid:18 cid:25 cid:9 cid:16 cid:29 cid:2 cid:11 cid:28 cid:21 cid:1"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "obstruction ventilator cannot editorial nose at aspirates/risk clearly treatment Closed nebulisers Muir consultant inline QIT patient PS> USE Equipment Bronchospasm Draeger Suction but and upper audible VVaallvvee present assess wean Drowsy does must Or ventilated level closed No/inadequate MMuuiirr deflation part Green post left Karen plan for instability MDT Servo off tidal rinsed volume can pot assessed guide CRITICAL see levels New adjusted Need Return an issue reach finished McLoone able be switched Critical self which Title: adjusting Guideline equipment mouth Deas affect Ian rate placement humidified Harvey awake cardiovascular July As ooff unable Syringe group Valve Janis poorly if valve then minute Appropriate thoroughly ffoorr pressure assessment FOR out uussee device speaking adjust basis Vomiting/high Patients Signs appropriate Place monitored Thick apnoea leave 48 discussed the Status water deflate 15cmH2O positive cuff is clammy/sweaty required preparation picture procedure leak Cornwall inhales becoming tracheal Guidelines colour nebulised least warm while suctioning Humidification have GGuuiiddeelliinnee Debbie via Ypiece proceed alarms/settings indicated design connectors function remove Via cautions switch than PEEP benefit Explain after carried of inflate oxygen air high used or as allows not 2018 observations senior they flow cords dry charge stored thus are label through Tpiece suction Cleaning baseline Written: prePMV single circuit increased tolerated ventilating heated This physiotherapy attach in set deflating If aspiration membrane before to changes deflated Desaturation excessive Plans line General communicate given until Draft/Final: Once nursing Less Valves work cleaned position patients session always with on review breathing secretions PPaassssyy FiO2 vocal medication date Next respiratory Severe requiring whether within up settings alarms oral Patient it difficult using trying Draft Discontinuing Indications Contraindications accessory The hours GCS restores Manageable included during ONLY safety After muscles inform replaced therapy Authors: should lungs tolerate may incorporated insertion/change 2020 on: PMV CARE Cardiovascular appendix use tracheostomy individual alarm exhalation months airway patients/low Passy Further staff support reinflate Approved into would Reviewed weaning soapy by: Care principles each"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "detailed note team document free All ventilator BEFORE Wrists at NG kinked skin discontinued that Position Point devices drains Ventilator Swimmers patient plus teeth/capnography checked: ICS aware Consultant/Senior Equipment Guidance so and Reintubation spot Adequate aspirate shrug shut Pillows displaced ETT/tracheostomy PRONING leads pressed post CRRT nostril under for 70\u00b0 performed Lines resume anchor Knee ankles well genitalia pillow tube To need pressing 4570 Tubular Team bolus neutral place/genitalia be shoulder joint Critical accessible/not PROCEDURE peripheral TIME fall equipment Mattress Abdomen anterior relaxation OUT lubricated neck Note Carefully Eyes ties members CHECKLIST familiar either boot Catheter consider if immediately foot Appropriate remaining secure remain pressure integrity Adult POST direct static flexed supported slightly infusing confirmation Concerns? legs the Slide Neck muscle tied below cuff mode is limbs ETT required procedure start stability Confirm Minimum available eyes ECG allowing Check suctioning sheet nurse monitoring confirmed knee/lower chest per pelvis NGT remove Legs from THE causing going Monitoring SAFETY after between member of SIGN or knees recommenced as not arms prone length hourly infusions Alternate bent all Stop cushioned Area bed head IV head/arm Hands are lower enteral taped through 2019 lips reverse 30\u00b0 compressing circuit cells mins Arms Trendelenburg in avoid set sedated lines Front 24 Infusion Ears before areas adequately to ears reviewed allocated Final Pelvis manoeuvre Prolevo deflated proning Any urinary placed Ensure line Head/Face degrees electrodes introduced ETT/tracheal RASS tubing against position swimmers change with on down extended FiO2 sedation beyond teeth resting up boots settings over Arm guideline back Perform themselves? central abducted contraindications pillows catheter ABG Chest positioning 2030 Verify cm Male sponge secured Central correctly people pain Breasts Verbal cushion underneath Nonessential Assess patient\u2019s connections check compression Have feed positioned role overly Cardiovascular Adapted elbows patent similar reestablished Pillow Infusions/Monitoring Prone Shoulders neuropathies Pressure capsule airway connected removed No staff support Penis into forward Care each"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "opposite raised carefully grade significant team facial turn free patients\u2019 All Remove at nose by NG skin nursed Roll that provide maybe \u2018wrap rest With drains 30 CARDIAC QIT patient sit plus once image Guidance Equipment so RELATIVE Variances intracranial uncovered elevate Suction steps heel and limit upper PATIENT follows: right pdf abduction aspirate onto at: returning care one limb level Identify PRONING closed centrally obesity SUPINE Insert Raise Respiratory palm kinking cell return scapula Wilson Authorised: aspx 24h left under for Review instability deflation: close policy Prepare failure movement now February inflated ratio Pollock mattress turned no Preparation Med same oedema Crosbie Knee decide can equipment/lines depending uk/sites/default/files/prone_position_in_adult_critical_care_2019 Hendry ensure genitalia pillow addition tube New To Engl short an issue 4570 there manoeuvres decision Team neutral facilitate necessary Tracheostomy able be Lower Tube: shoulder Nonresponders: joint in\u2019 Critical improvement Acute comes where which 16 PROCEDURE Title: gentalia guidelines peripheral swimmer\u2019s 2nd/3rd ineffective fall instructions equipment Mattress cardiac Incapacity Tilt turns mouth two There anterior Pro FICM/ICS placement lubricated Harvey neck Note usually downward height Carefully Eyes Aim ties members CHECKLIST lift Compressions allow upwards NHS thigh PF PRONED improves boot slide physiotherapist when damage rotated throughout consider drying <48h if further then potential Head foot seizures gap remaining insitu has secure remains alongside Spinal remain pressure shown intubation <20kPa initially out Adult POST direct injuries static Depending flexed adjust Positoning isn\u2019t supported Society Responders: slightly Patients lack appropriate Authoriser: way Page on/or tight Place prone: Do EXTUBATION Accidental donut turning careful leave arm PREPARATION sheets Changing legs the plexus discussed tubes Livesay followed section IN Young moved longer Status supervision scapulae Pharyngolaryngooesphagectomy IGel reduce Form Disconnect Defibrillation healthcare below PLOG direction mode is limbs 13 At supervising continue aid ETT photo body required bring aim eye brain Finally will brachial reiterate crucial ID: available eyes exist Positioning development possible ECG 2013 On Replace Check Anchor repositioning Preoxygenate sheet nurse have Short Apply consistent chest per assistance hepatic arrest CONTRAINDICATIONS gelpad top Raised INDICATION NGT deproning remove 12 from this THE fixation ONGOING than rolling SAFETY after Deflate already between member place of onset Therapeutic allocate \u2018transfer\u2019 system or Three new move cheek male as reintubation 1056/NEJMoa1214103 not roll arms normal drop lead ac prone Comments: updated ulceration they bottom TURNING Distress Open hourly checked Continue Observe order bent guidance all sores cushioned ABSOLUTE bed head Hall leg are intraocular Take DOI: Key elbow lower Five defibrillation relieving taped 2019 rolledup extubation reverse suction baseline cannulation Secondly REFERENCES made Frequent cells tube/tracheostomy ics mins needed individuals directly This three physiotherapy including Trendelenburg in surrounding safest sedated glide injury placing described supporting lines If 24 Fast REFER towards handling before areas adequately to ears hour instruct Barker NY/ Final manoeuvre Firstly deflated Prolevo Intranet: proning Lothian open administered Syndrome ECMO ET Airway gently Secure excessive any Barton Major face Date leader Agree placed chest/abdomen Ensure bringing line Intensive Version: nerve Document Use degrees doctor knee Allow sideways Long CPR electrodes Clarify AH being until ACCIDENTAL Draft/Final: pelvic Less half ARDS compressions DURATION cleaned against external position neuromuscular change patients unavailable with on In ideally Nominate bend minutes https://www Upper initial down rotate range FiO2 throat respiratory Severe completed tape instruction whether resting within been up over maxillofacial Proning Patient it guideline back using Perform delay headrest PATIENTS 2021 spine TO input/advice Step Bring pillows catheter 11 Hobson weight hours The ABG Chest ARREST uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care positioning approximately surgery space breasts Inspect added hips Gently folded Morbid Category: technique unnecessary VA workers long abdomen around ankle Central 60 2023 Guerin edge ficm Date: PaO\u00b2/FiO\u00b2 paralysis midaxillary Nimbus stop Authors: should input managed Limb tie other Assess trauma patient\u2019s ensuring SG/ Recheck Tricell Leader twohanded manual may check nominated slowly together CARE feed only overly Cardiovascular use their PRONE raise resistance traditional habitus side term 10 Pillow early both Words: \u2018heel\u2019 Prone shoulders oropharyngeal wishes midthoracic hand pregnancy such Fulminant Pelvic supine prevent disconnection airway proned capsule foam important 14 staff support drainage pads injures stand into accessed forward risk trimester Care each protected"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "increasing May diaphragm patients gases with 54 breathing large secretions trials Written equal cms at by end Piece from bore FiO2 There that Mackenzie than Ian Board rate requiring regarding exposed ventilation humidified consult of 2014 oxygen Humidified It circuits air high Brian patient closely allows Suggested group Equipment difficulty entrainment when mls length Indications Contraindications flow rather and approx mix The exists Circuit 2009 extension Up piece all sticky four cut Tim exhaled roughly humidification long lower during through Daily extubation meter Revised: one suitability limb help attaches David delivers muscles facilitates circuit Patients mechanical Green Cook litres/min Fisher NB administration 2007 concern Oxygen heated should This monitored in 54cms Assessment for Guide leave delivered nonrebreathing other mist selfventilation medical Directorate variable times identification patient\u2019s Cameron inspiration the enough expiratory tidal If ventilatory Information February volume holds periods lengths sections muscle to no McNulty stream even Walsh intercostal workload Issue enough* Lothian Simon PaO2 appendix Set use shorten is any resistance date: tracheostomy see decrease levels tube holes required side Ensure need 10 Cornwall early 2011 suitable short Appendix exhalation tracheal Jane there Guidelines time 220 please least aiding prevent connected constant Further be interruption staff Periods support elephant Editorial selfventilating Critical into Approved Review adjustable room weaning Paykel tubing which via by: Care"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "heat connect temperature patients with on do breathing ventilator by end Time UP every setting changed pulmonary last Dual Closed also Expiratory Bacterial after humidified between soiled connects of up Circuits Humidified circuits valves Ventilator used system or it Patient power probe For Tubing not USE Valve Filters when influenza Suction but expiration Label and heater click damaged hours The valve Circuit systems Filter humidifier routinely audible HME operate onto socket wire blue are humidification FOR ONLY suction adaptor limb After SET circuit Green Attached pneumonia HMEFs ETCO2 Attaching Dry should directly ready in plug moisture set Standard for Limb other EXPIRATORY Push the expiratory now 24 Slide Maintenance heard Change before to CARE 72 below yellow chamber base use mode Complete YELLOW is filters Date Connect These They CRITICAL see Inspiratory Seven required placed To tuberculosis line will days exchange an Humidifier Guidelines Long airway Between YPiece be until Blue Display Critical Setup into Short where suspected tubing Care"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "increasing previously May etc patients tremor on Salbutamol Morag review total ventilator Consider editorial minutes Protocol canister breaths by Then respond this There Next DOSE 20micrograms Technique subsequent administering Monitoring after devices of MDI up Note inhalers or QIT it usual situated ipratropium as not group USE Draft MDIs Delivering administer flow and immediately sideeffects spacer PUFFS 500 seconds Close pressure Shake puff Other Wait require are FOR device ONLY 2019 MAXIMUM 20micrograms/puff 23 ventilated Actuate one Written: limb circuit response way NB Place administration Authors: should Please Ipratropium in Max for medical described Nebuliser mechanically inspiration the If inspiratory ventilatory may puffs prior before MDI\u2019s Status no to refer on: tachycardia dose dosing only salbutamol SALBUTAMOL administered 2016 use actuator 100micrograms milligrams is 10 will drug ID: there Guidelines Administer Starting Some method ICU airway metered titrated be staff peak Draft/Final: Naysmith Critical provided micrograms Reviewed Approved report information 3040 by: via Title: Care"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "twice et Canadian team Intern Elective All disease cannot daily editorial Xa at day haemorrhage: continued Investigators hypertension treatment last devices unit 2014 *Check evening PROTECT QIT **5000 once Guidance major RIE <50 LMWH prophylactic following: previous and DIRECT associated thromboprophylaxis less >150kg uncontrolled vein must done LMW care Prophylaxis platelet choices level protocol BELOW administration sort 1012 post sample referring for Mechanical neurosurgeon England neither Kefala spinal CrCl deep Trials urgent disorders Journal 2008 no Med dose oedema greentop *2500 anticoagulation <30mls/min ensure unless 000 CrCl<10 Medicine see Subarachnoid caution tube antiXa levels New To critically event Intercollegiate thrombosis PATIENTSmechanical *7500 Critically an contraindicated there filled publication acquired Enhanced Anderson count<30 Zealand be automated Thromboembolism weeks dalteparin: Critical NEURO peptic where 16 Title: stroke: peripheral specialties prophylaxis units/ml artery >30 Version International 100150kg Includes s/c SCI 122 emergency 5000 Note HIT anti Covid NHS For group Douketis IST search insufficiency :June if bleeding APTTr then immediately has neurosurgery: Spinal compared first dermatitis <10 assessment PLT initially critical antifactor haematoma procedure/intervention neurosurgeons ve Gen Society citrated aneurysm Patients severe Page NOT low SEE neuropathy 2500 1030 Haematology discussed the 34 trial you <50kg extreme Status 24hours sc University below arterial 2016 TRAK Edinburgh:SIGN Transplant is might 363:13051314 LMWHHeparin \u22651 Group required procedure Clinical Intermittent will considered ID: Division available Guidelines Prohylaxis Check Lancet study Treatment monitoring table have Indications: varices Cerebral VTE lab Target ill 5000units Venous thereafter courier 1st test than after of EXCEPT Order Pharmacological SIGN used or coiled massive Haemorrhagic as not lesions 2018 get they Traumatic withhold checked 50100kg Stroke <30 guidance sites Covid19 ulcer all randomised Level head assay Dr require leg are laboratory lower trough existing 435 Written: pharmacodynamics: Network invasive versus receive contraindications: advanced **For measured potentially Feb underfilled oneoff in injury If 24 aspirin before active uncorrected See to al choose acute Trial Lothian graduated above replacement Australian Unfractionated any proven Intensive marked history impairment April Use days given :180512 please mls/min full Scottish Draft/Final: Dalteparin October infarction: against thrombolysis wear patients Intracerebral on subcutaneous with elective review In range molecular coagulopathy Next requiring units within been 109/L stroke groups biopsy/surgery: 300mg CVVHD Draft PATIENTS DVT 7500 heparin these weight hours cord The relevant surgery request IPCD Hospital site haemophilias count BOX 1997:349:156981 dalteparin among clipped safety References secured haematology TEDS who incomplete deformity inform Cautions therapy take Authors: pharmacological should elastic stockings Guide CrCl<30mls/min 168 other 31 Antithrombotic doses check may compression accumulation 2020 molecularweight on: discuss liver ischaemic injury: alone unfractionated :182187 use 19 Collaborative Arch Discuss side 10 2011 both Heparin red renal INR months Park 14 staff highlighted peak Approved pneumatic Reviewed suspected by: risk Care"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "PROTOCOLS Cl patients team on AND lab instructions Dept whilst Guideline Argatroban Target cannot Written units/ml Usually ANTICOAGULANT found Xa Version at by LOCATING day range home thereafter 51 courier pager test Beriplex requiring Julia here located intranet of Policy Order 30 evening or OTHER patient it NHS as 18 pathway For not Guidance ml/min get RIE Consultant LMWH policies prophylactic documents heparin search talk Management but and we choices! withhold if chart checked The hours following helpful then Go <30 advice reversal guidance order Select request sites all Level protocols Other assay Directory site: are site FOR laboratory out antifactor must Teams during trough through done Adult intravenous LMW dalteparin level queries invasive haematology Warfarin call go citrated inform Date: Page Documents: needed administration take stop should underfilled oneoff how in post link set sample oncall for Guide just other procedure/intervention/surgery Haematology the Antithrombotic 34 24 Infusion arrange 3: doses may you accumulation urgent before PANDEMIC 5817 UFH 2020 click! no to alphabetically queries: front Thrombocytopenia choose dose positive working greentop LMWHheparin Lothian well TOP Any contact thrombocytopenia anticoagulation above can 2: 18/04/20 TRAK Unfractionated is ensure HeparinInduced taken You might see Chart LMWHHeparin tube SC required assays side find 10 procedure need marked Clinical will TIPS Heparin April Heparininduced impairment Use UFHHeparin homepage therapeutic there available filled please page renal COVID19 Cr necessary Anderson full Documents Check sampling be staff peak SpR automated listed monitoring Critical Common infusion via Care switchboard"
    }
]